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Trypanosoma brucei is a single-celled parasite which lives in the blood of its 
mammalian host and is spread by the tsetse fly. T. brucei is able to survive in the 
bloodstream, despite immune attack, by periodically switching its surface protein 
coat (called a Variable Surface Glycoprotein, VSG, coat) to a new form which is 
unrecognisable to the immune system. A second strategy, called differentiation, also 
prolongs infection. When high numbers of dividing ‘slender’ parasites accumulate in 
the blood, the parasites differentiate to non-dividing ‘stumpy’ forms which prevents 
rapid host death. These stumpy forms are important for the spread of disease because 
they are the only form that can survive being ingested by a tsetse fly. When 
trypanosomes are grown for long periods in the laboratory they lose the ability to 
differentiate from slender to stumpy forms. It has also been reported that these 
laboratory-adapted trypanosomes switch their VSG surface coats significantly less 
than differentiation-competent populations of trypanosomes. It therefore appears that 
differentiation capacity and VSG switch frequency may be linked. To investigate if 
these processes are coupled, I studied trypanosomes which were differentiation 
competent but in which different genes responsible for making stumpy forms could 
be silenced. This provided a tool to study VSG switch rate in the same populations 
where differentiation capacity could be switched ‘on’ or, upon silencing of a stumpy 
formation gene, ‘off’. 
 Two different experimental approaches were used to ask if VSG switch rate 
is directly linked to differentiation capacity. The first approach measured the VSG 
switch rate of differentiation competent and incompetent trypanosomes, and found 
that there was no significant difference in VSG switch rate between the two 
populations. The second approach studied the number and identity of VSGs within 
the two populations. Differentiation incompetent populations did not express less, or 
different, VSGs. This demonstrated that VSG switch rate and differentiation capacity 
are not linked. To back up our observations, a population of differentiation-
competent trypanosomes was grown in the laboratory until the parasites lost the 
capacity to differentiate. When the VSG switch rate of the differentiation-




switch rate had not decreased. This provided further evidence that the VSG switch 
rate and differentiation capacity are not linked. To understand why the parasites had 
lost the capacity to differentiate, I studied the genes which were either expressed 
more or less of after laboratory-adaptation. This analysis identified a number of 







African trypanosome infections are characterised by antigenic variation to 
avoid host immunity and by the production of transmission stages to promote disease 
spread. Laboratory-adapted (‘monomorphic’) lines of Trypanosoma brucei are 
reported to switch their expressed VSG antigenic coat at a much lower frequency 
than ‘pleomorphic’ populations recently transmitted through tsetse flies. These 
laboratory-adapted parasites also lose the capacity to differentiate into transmission 
competent ‘stumpy forms’. It is unclear if the reduced rate of antigenic variation is 
directly coupled to the loss of pleomorphism or whether the processes, although co-
selected by multiple passage, are independent. 
To address whether monomorphism caused a concomitant change in the 
frequency of antigenic variation, an ‘inducible monomorphism’ model was exploited. 
This exploited pleomorphic RNAi cell lines that would inducibly silence genes 
required for stumpy formation. This provided a tool to switch pleomorphism ‘on’ or 
‘off’ inducibly, without long term passage. Thereafter, two approaches were used to 
ask if the induction of monomorphism directly influenced antigenic variation: in 
vitro flow cytometry-based VSG switch assays, and VSGseq, a targeted sequencing 
approach. These assays demonstrated that the induction of monomorphism did not 
reduce VSG switch rate nor generate a reduction in expressed VSG diversity, or 
change the expressed VSG subset.  
To extend this analysis further, the prolonged in vitro passage of a 
pleomorphic cell line was used to select isogenic monomorphic populations with 
reduced capacity to generate stumpy forms. These selected monomorphs cells did not 
exhibit a reduction in VSG switch rate compared to the parental pleomorphic 
population, thus corroborating the observations with the induced monomorphic cells. 
To understand the loss of pleomorphism in the selected cells, an ‘evolve and re-
sequence’ approach and RNAseq analysis was adopted. Interestingly, the ‘selected 
monomorphs’ were depleted of transcripts whose expression was associated with the 
stumpy and insect forms of the parasite. Particularly, a number of CCCH zinc finger 
proteins, such as ZC3H20, were significantly downregulated. These RNA-binding 




Overall our results demonstrate that T. brucei antigen switch frequency and 
pleomorphism can be uncoupled, and provide new insight into the molecular control 
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1.1 Trypanosoma brucei 
Kinetoplastid parasites are a fascinatingly complex and diverse group of 
eukaryotes. Their cell biology is replete with curious variations of the norm - novel 
mechanisms of gene expression control, metabolism and cell structure name only a 
few. A single, large mitochondrion characterises members of the Kinetoplastida 
order, within which is a complex network of kinetoplastid DNA (kDNA) comprised 
of mini- and maxi-circles (Cavalcanti and de Souza, 2018; Lukes et al., 2002). One 
such example of a parasite within this intriguing Order is the unicellular flagellate 
Trypanosoma brucei. 
 
1.1.1 Human African trypanosomiasis (HAT) 
The kinetoplastids are responsible for profound morbidity, mortality and 
economic loss, particularly in rural areas where health infrastructure is lacking or 
absent. T. brucei is the causative agent of the neglected tropical disease Human 
African Trypanosomiasis (HAT), otherwise known as sleeping sickness. Those at 
highest risk of exposure to the disease typically live in rural communities which rely 
on agriculture, animal husbandry, hunting or fishing (WHO, 2018). HAT is a highly 
focal disease, its geographic distribution strictly governed by the restriction of the 
trypanosome’s arthropod vector, the tsetse fly (Glossina spp.), to 360 HAT foci 
within 36 Sub-Saharan African countries (Franco et al., 2014a; Wamwiri and 
Changasi, 2016) (Figure 1.1). The Palpalis group of Glossina (G. palpalis palpalis, 
G. p. gambiensis and G. fuscipes) are found in West and Central Africa and transmit 
the T. b. gambiense subspecies, whereas the Morsitans group (G. morsitans) are 
found in East Africa’s savannah woodlands and are involved in T. b. rhodesiense 








Figure 1.1 Distribution of T. b. rhodesiense and T. b. gambiense HAT cases from 2010-
2014. Figure from (Franco et al., 2017). 
 
Most African trypanosomes are readily lysed by human ApoL1, a high 
density lipoprotein (HDL)-associated serum protein. ApoL1 forms anionic pores 
within the trypanosome lysosome following the internalisation of trypanosome lytic 
factor (TLF) into the endocytic pathway by the trypanosome’s haptoglobin-
haemoglobin receptor (TbHpHbR) (Drain et al., 2001; Perez-Morga et al., 2005; 
Vanhamme et al., 2003). Both T. b. gambiense and T. b. rhodesiense, however, have 
evolved means to resist host trypanolytic serum factors, and thus cause human 
infection. An expression site related gene termed ‘serum resistance associated’ 
(SRA), identified in the ETat 1.10 expression site (ES), is responsible for conferring 
immunity to ApoL1 in serum-resistant T. b. rhodesiense strains (De Greef and 
Hamers, 1994; Xong et al., 1998). Unlike most ESAGs, SRA is not expressed on the 
surface, and is instead trafficked to the flagellar pocket before being endocytosed 
into the endolysosomal system (Stephens and Hajduk, 2011). It is here that SRA 
colocalises and binds to ApoL1, preventing it from forming pores within the 
lysosome. T. b. gambiense resistance appears to be categorised into two groups, 1 
and 2 (Capewell et al., 2011; Uzureau et al., 2013). Group 1 parasites possess a 
conserved single amino acid substitution within their HpHb receptor which lessens 





and furthermore express TgsGP, a gene which encodes a 47kDa surface protein 
which localises to the flagellar pocket (Berberof et al., 2001; Uzureau et al., 2013). 
Deletion of TgsGP in wild-type group 1 T. b. gambiense was shown to render 
parasites sensitive to lytic human serum, and reintroduction of the gene into the 
knockout clones could restore resistance, thus demonstrating that TgsGP is essential 
for protection against human serum in group 1 T. b. gambiense (Capewell et al., 
2013a). Group 2 parasites show variability in their resistance, and since they have 
still been shown to internalise TLF it has been proposed their resistance may be due 
to neutralisation of the effects of ApoL1, or by a different means of avoidance than 
Group 1 (Capewell et al., 2011).  
Though the two subspecies may be morphologically indistinguishable, the 
diseases caused by T. b. gambiense and T. b. rhodesiense differ widely in their 
epidemiology, onset of symptoms and prognosis (Franco et al., 2014a). Infection 
with T. b. gambiense accounts for >98% of all reported cases and causes chronic 
infection (WHO, 2018). Those infected can expect to survive for months, or even 
years, before the onset of symptoms in latter stages of the disease (Checchi et al., 
2008). In contrast, T. b. rhodesiense disease is fulminant with disease progression 
rapidly reaching fatality within the course of around 6 months (Odiit et al., 1997). 
Uganda is currently the only country known to house both forms of the disease, 
however these are separated geographically (WHO, 2018). Both diseases are 
characterised by an early (haemolymphatic) stage and a late (neurological or 
meningo-encephalic) stage. In the early stages of disease, the parasites replicate 
within the blood, lymph and subcutaneous tissue (Trindade et al., 2016). This stage 
of the disease may be accompanied by non-specific symptoms such as malaise, 
headaches, intermittent fevers and dermatological problems, such as pruritus (Franco 
et al., 2014a; Kennedy, 2013). As the infection progresses, the parasites cross the 
blood brain barrier and infiltrate the central nervous system (CNS). In this latter 
stage of disease symptoms intensify, with sensory, motor and behavioural 
disturbances occurring alongside a loss of coordination and the affliction which gives 
the disease its name, a disruption in sleeping patterns (Kennedy, 2013). Left 
untreated HAT is usually fatal, though it is becoming increasingly apparent that is 





asymptomatic state, or even resolve infection entirely, in the absence of treatment 
(Capewell et al., 2016; Jamonneau et al., 2012; Sudarshi et al., 2014). In a 2 year 
study of cytokine levels in T. b. gambiense HAT patients, trypanotolerant individuals 
(who had positive serological responses but undetectable parasitaemia under the 
microscope) were associated with higher levels of inflammatory cytokines, in 
particular IL8, compared to HAT patients and healthy endemic controls (Ilboudo et 
al., 2014). The prevalence of asymptomatic carriers could threaten WHOs disease 
elimination programme by accommodating continued disease transmission between 
humans. Thus, more must be done to understand the impact of these individuals on 
disease transmission and elimination (Berthier et al., 2016). 
 
1.1.2 Animal African trypanosomiasis (AAT) 
The T. b. rhodesiense subspecies, as well as T. b. brucei, is capable of 
infecting both wild and domestic animals such as cattle, wildebeest, horses and dogs, 
though the animal disease burden caused by these subspecies is considerably less 
than that caused by T. congolense or T. vivax (Giordani et al., 2016). The resulting 
wasting disease, termed nagana, is characterised by anaemia, loss of productivity and 
fertility and emaciation. In areas which rely so heavily on agriculture and animal 
husbandry, AAT limits the potential for agricultural development drastically. Animal 
mortality, reduced crop cultivation and diminished meat and milk yields all impact 
farmers’ livelihoods. Indeed, AAT is considered the most economically significant 
disease of livestock in Africa, losing the industry billions of US dollars in revenue 
annually (Giordani et al., 2016; Welburn et al., 2006).  
 
1.1.3 Current therapeutic options 
The World Health Organization (WHO) have targeted elimination of T. b. 
gambiense sleeping sickness as a public health problem by the year 2020, and 
sustainable disease elimination by 2030 (WHO, 2012). National Control 
Programmes’ implementation of surveillance, control and treatment guidelines set 





supply of therapeutic drugs, has allowed the number of reported cases to drop to 
2804 in 2015, the lowest number of reported cases since global data collection began 
~80 years ago (WHO, 2012, 2018) (Figure 1.2). However, under-detection and 
under-reporting, due to an unstable social climate or geographical inaccessibility, 
means that the likely number of cases is in reality nearer 20,000 (WHO, 2013). 
Elimination of T. b. rhodesiense is considered less feasible since it causes a zoonotic 
disease, the parasite being predominantly found within wild and domestic animal 
reservoirs rather than human hosts, these being harder to regulate (Franco et al., 
2014b). Though T. b. gambiense causes anthroponotic disease, such is our limited 
knowledge of T. b. gambiense animal reservoirs it is worried that cryptic animal 




Figure 1.2 Number of recorded T. b. gambiense (red) and T. b. rhodesiense (blue) HAT 
cases per year from 2000-2014. The numbers in green are the projected cases per year as 






Until very recently, five different drugs have been used to treat HAT (4 of 
which are licensed), however none of these drugs is without flaw (Table 1). High 
toxicity, long treatment periods, parenteral administration, drug resistance and low 
efficacy all contribute to the unsatisfactory nature of these chemotherapeutic options 
(Barrett et al., 2007). On the 16th November 2018, however, the European Medicines 
Agency (EMA) adopted a positive scientific opinion of fexinidazole, the only 
available oral monotherapy to treat both early and late T. b. gambiense HAT to date, 
following a successful Phase 2/3 trial (Deeks, 2019; Mesu et al., 2018). The drug is 
taken orally once-a-day for 10 days. Fexinidazole was initially discovered in the late 
1970’s by Hoechst AG (now Sanofi), however it was not until 2009, when the non-
profit research and development organisation Drugs for Neglected Diseases initiative 
(DNDi) entered into a partnership with Sanofi, that the drug was entered into clinical 
development as a cure for both early and late stages of T. b. gambiense HAT 
(Pollastri, 2018). Fexinidazole, a DNA synthesis inhibitor, was shown to cure murine 
models of acute T. b. gambiense and chronic T. b. brucei (the model for stage 2 
HAT) (Torreele et al., 2010) and in a randomised phase 2/3 open-label non-
inferiority trial with 394 patients from the Democratic Republic of Congo and the 
Central African Republic was shown to have 91% success at 18 months (success 
being deemed as patient survival, no evidence of trypanosomes in any bodily fluid, 
no rescue medication and having a cerebrospinal fluid white blood cell count £20µl). 
This was comparable to 98% success at 18 months observed upon treatment with 
nifurtimox eflornithine combination therapy (NECT) and therefore within the margin 
of acceptable difference (which was set at 13%) (Mesu et al., 2018). Furthermore, 
unlike other late stage HAT drugs, fexinidazole displays little to no non-specific 
cytotoxicity. Fexinidazole is therefore an exciting development in the race to 
eliminate T. b. gambiense HAT as a public health problem by 2020 since it 
eliminates the need for patient hospitalisation and intravenous drug treatment. A 
fexinidazole phase 3b trial that started in 2016, and has enrolled 116 patients, is due 
for completion in March 2020 (DNDi, 2019b). 
The benzoxaborole, acoziborole (AN5568/SCYX-7158) is another promising 





stage 2 T. b. gambiense HAT. Acoziborole is the result of the DNDi’s own lead 
optimisation optimisation project (having initially been identified as a hit in an 
Anacor chemical library screen) and was selected as a pre-clinical candidate in 2009 
(DNDi, 2019a). The therapeutic dose of the drug is administered once, orally, as 
three tablets (DNDi, 2019a). The phase 2/3 trial commenced in the last quarter of 
2016 in the Democratic Republic of Congo and as of 2018, 191 patients were 
enrolled. The trial is expected to be completed by April 2020, with approval from the 
EMA to be sought in 2021 (DNDi, 2019a). The target of acoziborole has been 
chemically and genetically validated as the endonuclease CPSF3 (Tb927.4.1340) and 
the mode of action as inhibition of mRNA maturation (Wall et al., 2018). 
To date, no functional vaccine to protect against HAT has been developed. 
The transferrin receptor, invariant surface glycoproteins (ISGs) 64, 65 and 100, b-
tubulin, actin, microtubule-associated proteins (MAPs), trans-sialidases, cation 
pumps, GPI and cysteine proteases have all been quoted as being ‘promising’ 
vaccine candidates yet not one of these has led to a successful field trial (reviewed in 
(La Greca and Magez, 2011; Magez et al., 2010)). Two factors have been blamed for 
hampering vaccine development efforts. Firstly, the parasite is able to switch its 
Variant Surface Glycoprotein (VSG) surface coat to an antigenically distinct form 
and remove VSG-bound antibodies from its surface (described in detail in Section 
1.2) and secondly, trypanosome infection has been shown to abolish host B-cell 
memory function, therefore preventing proper induction of a protective response 
(Radwanska et al., 2008). 
The application of innovative technology could offer novel methods of 
trypanosome control. Nanobodies are ~15kDa single-domain antibodies derived from 
camelids which can be used to efficiently target a drug to parasites (Stijlemans et al., 
2017). Nanoparticles loaded with pentamidine and coupled to a nanobody were 
shown to reduce the curative dose for T. b. gambiense in a mouse model by 100-fold 
and, furthermore, circumvent known drug resistance mechanisms (Stijlemans et al., 
2017; Unciti-Broceta et al., 2015). Silver and gold nanoparticles were recently shown 





parasites than mammalian cells (Adeyemi et al., 2018). However, nanoparticle 























































































































































































































































































































































































































































































































































































































































































































































































































































































































































1.1.4 Trypanosome morphology and cell cycle 
T. brucei is a unicellular parasite which must undergo extreme morphological 
rearrangement throughout the different stages of its lifecycle. The cell’s elongated 
shape, tapering to the anterior, is strictly maintained by its highly organised 
cytoskeleton directly below the pellicular membrane (Portman and Gull, 2012). The 
cortical microtubules are highly polarised, with their + ends all orientated towards 
the posterior of the cell (Robinson et al., 1995), and are cross-linked to both each 
other and the flagellar membrane (Gull, 1999). In addition to their role in 
maintaining cellular form, the network of microtubules furthermore engage in 
fundamental roles in mitosis, cytokinesis, segregation and organelle positioning 
(Robinson et al., 1995). The organelles are focused within the posterior end of the 
cell with the most posterior structure being the flagellar pocket, the only site of endo-
/exocytosis within the cell (Field and Carrington, 2009) (Figure 1.3). A single 
flagellum extends from the flagellar pocket to just beyond the anterior pole of the 
cell, and is attached to the entire length of the cell body by a structure termed the 
flagellar attachment zone (FAZ). Other single copy organelles include the 
mitochondrion (which uniquely reaches along the length of the cell), kinetoplast, 
lysosome and basal body. 
 
Figure 1.3 T. brucei cell structure. The locations of various organelles are highlighted. 

















The positioning, replication and segregation of these organelles throughout 
the cell cycle is a tightly orchestrated process (Robinson et al., 1995). Analogous to 
the typical eukaryotic cell cycle model, trypanosomes pass through the G1, S, G2 
and M phases. Perhaps predictably though, the parasites’ cell cycle is distinguished 
by a number of novel control mechanisms and intricacies (Hammarton et al., 2007). 
The broad events of trypanosome cell cycle replication are described in Figure 1.4 
(though most of the work on the trypanosome cell cycle has focused on the insect 
procyclic form of the life cycle, as shown in Figure 1.4, replicative bloodstream 
forms follow a similar sequence of events). The use of fluorescent cytological 
markers to stain the nuclear and kinetoplast DNA, such as the nucleic acid stain 
DAPI, allow for rapid and quantitative visualisation of cell cycle position via 
fluorescence microscopy or flow cytometry. 
 
 
Figure 1.4 The cell cycle of procyclic form T. brucei. (i) In G1, cells have one kinetoplast 
and one nucleus (1K1N). The cell cycle begins with the elongation and maturation of the 
probasal body. The mature basal body is linked to the kinetoplast through a structure called 
the tripartite attachment complex, ensuring coordinated kinetoplast and basal body/flagellar 
replication.  (ii) The basal body replicates in a microtubule mediated process, matures and a 
new flagellum begins to grow. In procyclic form trypanosomes, the new flagellum is 












This connector mediates the transfer of structural information to the new flagellum via 
cytotaxic inheritance. In bloodstream forms there is no evidence of a flagellar connector. (iii) 
The growing daughter flagellum closely tracks the shape of the original flagellum. 
Kinetoplast (K) DNA replication commences just prior to that of nuclear (N) DNA 
replication and furthermore takes less time to complete. (iv) The basal bodies segregate, 
which in turn drives kinetoplast segregation. The cell is now 2K1N. (v) Nuclear mitosis 
occurs without breakdown of the nuclear envelope or chromosomal condensation. The cell 
becomes 2K2N. (vi) and (vii) Cytokinesis separates the cell into two 1K1N siblings. 
Cleavage furrow ingression initiates at the anterior pole of the cell and progresses along the 
longitudinal axis of the cell, passing through the two flagella. From (Field and Carrington, 
2009; Hammarton et al., 2007; Matthews, 2005; Moreira-Leite et al., 2001; Robinson et al., 
1995). 
 
1.1.5 Trypanosome life cycle 
Delivery of infectious metacyclic trypomastigotes to the dermal connective 
tissues by the bite of an infected tsetse fly initiates infection in the mammalian host 
(Figure 1.5). In the bloodstream, metacyclic trypomastigotes differentiate to 
proliferative long slender forms which rapidly increase in number. Differentiation is 
accompanied by repression of the mitochondrion as the parasites begin to generate 
ATP through the conversion of glucose to pyruvate (Haanstra et al., 2012). The 
trypanosome’s glycolytic enzymes are housed within a unique membrane-enclosed 
organelle, the glycosome (Opperdoes and Borst, 1977). Proliferating cells evade the 
mammalian immune response via antigenic variation of their variant surface 
glycoprotein (VSG) coat (Horn, 2014)(see Section 1.2) and, upon reaching a critical 
cell density, differentiate to quiescent, transmission-competent short stumpy forms 






Figure 1.5 The major mammalian and tsetse developmental stages of the T. brucei life 
cycle. Circular arrows depict proliferative stages. Figure adapted from (Langousis and Hill, 
2014). 
 
Upon ingestion within a tsetse bloodmeal, stumpy cells differentiate 
synchronously to replicative procyclic forms within the endoperitrophic space of the 
midgut (Vickerman, 1965; Ziegelbauer et al., 1990). Over 48-72 hours, the VSG coat 
is progressively lost and replaced with a less dense, GPI-anchored GPEET and EP 
procyclin coat (Roditi et al., 1989; Turner et al., 1988b). GPEET expression is 
gradually decreased as the cells establish infection (Vassella et al., 2000). Glucose 
disappears from the bloodmeal within minutes, and as such procyclic cells display 
full mitochondrial activity after 14-24 hours as they begin to produce ATP through 
the oxidative phosphorylation of L-proline (Besteiro et al., 2005). Four days post 
bloodmeal, procyclic cells penetrate the peritrophic matrix and migrate to the 
proventriculus where they undergo gross morphological restructuring coupled to an 
asymmetric division, producing one short and one long epimastigote. Short 
epimastigotes attach to microvilli within the salivary gland mediated by dendritic 





















differentiate to metacyclic trypomastigotes and detach in preparation for delivery to 
the mammalian host. To aid immune evasion metacyclic trypomastigotes themselves 
acquire a variant surface coat. However, with at most 27 variants present, the 
available repertoire of metacyclic VSGs is far more limited than that of slender forms 
(Barry et al., 1983; Turner et al., 1988a). 
In a significant discovery, it has recently been demonstrated that mammalian 
skin (Caljon et al., 2016; Capewell et al., 2016) and adipose tissues (Trindade et al., 
2016) are additional anatomical reservoirs for bloodstream form T. brucei. Both 
infective replicating adipose resident parasites, termed adipose tissue forms (ATFs), 
and transmission-competent ATFs were found besides circulating bloodstream form 
parasites in mice. Though morphologically similar, the bloodstream and adipose 
resident trypanosomes were transcriptionally and metabolically distinct, with ATFs 
showing consistent upregulation of genes encoding enzymes involved in fatty acid b-
oxidation (Trindade et al., 2016). Such an adaptation would allow for the ATFs to 
exploit a new environmental carbon source. The significance of these ATFs in the 
context of chronic sylvatic infection has yet to be confirmed, though they may 
contribute to the maintenance of tsetse transmission when blood parasitaemia is low, 
as is often seen in these reservoirs. Additionally, the nature of the tissue that they 
reside in might allow for more rapid accumulation of the density-dependent 
differentiation signal, stumpy induction factor (SIF, see Section 1.3) (Silvester et al., 
2017). 
 
1.2 Antigenic variation 
Within the mammalian bloodstream T. brucei encounters a hostile 
environment, with the hosts’ immune system constantly battling to control the 
infection. Yet despite this barrage of host innate and adaptive immunological 
defences, T. brucei has evolved to thrive. The parasite possesses the extraordinary 
capacity to periodically switch its expressed VSG coat to that of an antigenically 
distinct alternative, and thus evade antibody-mediated detection and clearance, via a 





1.2.1 The VSG coat and host interactions 
Over 107 glycosylphosphatidylinositol (GPI) -anchored VSG molecules of a 
single protein species form a densely-packed homogenous surface coat enshrouding 
the trypanosome. VSGs are homodimers of two 50-60kDa subunits, with each 
monomer consisting of a large exposed N-terminal domain (NTD) and a smaller 
concealed C-terminal domain (CTD) connected by a flexible linker, Linker 1 (Figure 
1.6) (Carrington et al., 1991; Schwede et al., 2011). The NTD shows huge variation 
in its amino acid sequence, except for the localisation of a number of conserved 
cysteine residues, yet has a conserved tertiary structure (Carrington et al., 1991; 
Cross, 1996). In contrast, the CTD amino acid sequence remains relatively well 
conserved. Recent structural analysis has suggested that the linker region confers 
high flexibility, allowing the freely diffusing VSGs to adopt one of two different 
conformations, relaxed or compact. Such structural flexibility is hypothesised to 
allow the integrity of the protective barrier to be maintained in response to changes 
in protein density on the surface coat (Bartossek et al., 2017; Bulow et al., 1988).  
 
 
Figure 1.6 VSG structure. Each VSG monomer is highlighted in blue or grey, respectively, 
and the C-terminal domain in purple. The widest part of the VSG, for the left two VSGs this 
is ~5.9nm, whereas for the right two VSGs this is ~6nm, is highlighted in red. The VSG 






The surface coat is the primary target of the immune response, and it is to epitopes 
within the highly immunogenic NTD that host antibodies are targeted (Hsia et al., 
1996). Protruding ~12-15nm from the plasma membrane, VSGs serve to conceal 
small invariant surface antigens, such as transferrin and haptoglobin-haemoglobin 
receptors and hexose transporters, from antibody detection (Schwede et al., 2011). 
Modelling, however, has predicted that the coat is not completely impenetrable to 
host antibodies, with IgG predicted to reach within 5nm of the plasma membrane 
(Chattopadhyay et al., 2005; Mugnier et al., 2016; Schwede et al., 2011). 
Furthermore, two invariant surface proteins, ESAG 4 and ISG 65 were predicted to 
be similar in size, if not larger, than the VSGs themselves and thus likely accessible 
to antibodies (Schwede et al., 2011). Following a VSG switch, it has recently been 
estimated that parasites require ~4.5 days to completely replace their VSG coats and 
that for the initial 29 hours post VSG expression switch, the parasites remain 
vulnerable to host IgM antibodies (Pinger et al., 2017). 
In addition to their shielding function, VSGs contribute to the removal of host 
antibodies from the cell surface. Bound immunoglobulins act as ‘molecular sails’ and 
are sorted by hydrodynamic flow to the posterior of the cell as the parasite swims 
forward (Engstler et al., 2007). From here the VSG-immunoglobulin complex is 
endocytosed in clathrin-coated vesicles at the flagellar pocket (Allen et al., 2003). 
Host antibody is degraded within endosomes and the VSG, now free of bound 
immunoglobulin, is trafficked back to the surface. At any one time it has been 
estimated that 90% of VSG proteins are present on the surface, whilst three quarters 
of the remaining 10% are present within endosomal compartments (Grunfelder et al., 
2002). It has been suggested that parasite recognition and clearance is primarily 
mediated by a T-cell independent and IgM response. In vivo infections of IgM-/- mice 
have been shown to progress with similar kinetics as in wild type mice however, 
therefore implicating that immunoglobulins other than the IgM, specifically IgG, 
play a role (Black et al., 2010; Magez et al., 2008; Mugnier et al., 2016). 
Despite continuous removal of surface-bound immunoglobulins, once a 
sufficient antibody titre is reached, the hydrodynamic flow is overwhelmed and the 





switch variants which have arisen in the population, and express an antigenically 
distinct VSG, escape destruction and continue to proliferate. It is this periodic 
destruction of a given variant, followed by the outgrowth of antigenically distinct 
variants, which creates the characteristic undulating waves of parasitaemia typical of 
bloodstream trypanosome infection (Figure 1.7) (Horn, 2014).  
 
 
Figure 1.7 A simplified model of antigenic variation in trypanosomes. As the 
parasitaemia in the blood rises, immune responses are mounted towards specific variants 
which are ultimately cleared from the system. The infection continues, however, because 
antigenically distinct variants within the population escape detection and accumulate in 
number. In reality, each peak could be composed of ~100 different variants, though only half 
of these will surpass 1% of the total population (Hall et al., 2013; Mugnier et al., 2015). 
 
1.2.2  The VSG archive 
With antigenic variation playing such a pivotal role in the maintenance of 
chronic infection, it is unsurprising that trypanosomes have dedicated over 20% of 
their genome to the archive of VSG genes (Morrison et al., 2009). The trypanosome 
genome houses ~2000 different VSG genes, though only 5-10% of these actually 
encode intact and functional VSGs (Marcello and Barry, 2007). The rest are 













VSG fragment to form a complete VSG gene, critical to the expansion of the 
potential VSG repertoire and maintenance of long-term infection (Hall et al., 2013). 
The majority of archived VSG genes are located in silent subtelomeric arrays on the 
11 diploid megachromosomes, which are orientated away from the telomere and 
consist of 3 to ~250 (pseudo)genes (Barry et al., 2005; Berriman et al., 2005; Horn 
and Barry, 2005). Additionally, trypanosomes have evolved a highly specialised 
repertoire of ~100 30-150kb aneuploid mini-chromosomes and 1-7 larger 200-700kb 
intermediate-chromosomes, presumably to expand the VSG repository (El-Sayed et 
al., 2000; Wickstead et al., 2004). Mini-chromosomes contain a 20-80kb central core 
of tandem 177 bp repeats and most, though not all, house a single VSG gene at their 
subtelomere (Horn and Barry, 2005; Wickstead et al., 2004). 
 
1.2.3 VSG expression sites 
Expression of a VSG relies on the positioning of a VSG gene within one of 
~20 telomere-proximal bloodstream expression sites (BES, Figure 1.8a) present on 
the megabase- and intermediate-chromosomes, of which only one is active at a time. 
Expression sites are large (~50kb) polycistronic transcription units, transcribed by 
RNA polymerase I (RNAPI) within a discrete extra-nucleolar structure known as the 
expression site body (ESB) (Navarro and Gull, 2001). Cotranscriptional trans-
splicing produces the individual mRNAs (Huang and van der Ploeg, 1991). 
The general framework of BESs is highly conserved (Berriman et al., 2002; 
Hertz-Fowler et al., 2008). Following an RNAPI promoter is up to 11 members of a 
diverse family of polymorphic genes and pseudogenes, termed expression site 
associated genes (ESAGs), the functions of very few of which are known (Berriman 
et al., 2005). ESAG 6 and 7 together encode a transferrin binding protein complex 
whilst ESAG 4 encodes a receptor-like adenylate cyclase which may be involved in 
regulation of the early immune response (Salmon et al., 2012; Steverding et al., 
1994). Though the ordering of ESAGs on the BES largely remains the same (ESAG7, 
6, 5, 3, 4, 8, 3, 2, 11 and finally ESAG1), not all expression sites contain the complete 
repertoire of ESAGs, with gene duplications or deletions, pseudogenes and 





2000). Such variation in ESAG expression between BESs is hypothesised to allow 
for species-specific adaptations. For example, it has been suggested that transferrin 
receptors encoded from different BESs have different transferrin binding affinities 
(Bitter et al., 1998; Gerrits et al., 2002; McCulloch et al., 2015), though this remains 
to be proved in vivo (Salmon et al., 2005).  
Between the ESAGs and VSG gene, lies an extensive stretch of conserved 
AT-rich DNA repeats (so called ’70 bp repeats’, though in reality the repeats consist 
of a 76 bp consensus sequence) which act as a recombinogenic ‘hotspot’ (Campbell 
et al., 1984; Hovel-Miner et al., 2016). Approximately 1.5kb downstream from the 
repeats is the VSG gene, which itself is followed by > 10kb of telomeric T2AG3 
repeats (Horn and Barry, 2005). 
A conserved telomeric region associated with VSG loci has recently been 
described in T. congolense, representing the first report of a VSG ES in that parasite 
(Abbas et al., 2018). The structures, present mostly on the minichromosomes but 
potentially also on the megabase chromosomes, were ~20-40,000bp in length and 
consisted of a conserved core 369bp repeat which stretched up to 25kb in length, 
conserved non-coding elements (CNEs), a VSG gene and, on ~20% of telomeric 
contigs, protein coding genes. These protein coding genes, however, were not 
orthologous to T. brucei ESAGs (Abbas et al., 2018). Though the telomeric region is 
not structurally homologous to the T. brucei BES, the subtelomeric positioning and 
functional similarities suggests that an ancestor common to T. brucei and T. 
congolense possessed a subtelomeric ES which has since diverged (Abbas et al., 
2018) 
 
1.2.4 VSG switching 
Switching of the expressed VSG to an antigenically distinct alternative allows 
the trypanosome population to survive host immunological attack. An antigen switch 
may be facilitated by transcriptional changes amongst the BESs, or alternatively, 






Figure 1.8 Mechanisms of antigenic variation within T. brucei. (a) A typical subtelomeric 
BES from the megabase chromosomes with the RNAP I promoter, ESAGS, 70 bp repeats, 
VSG gene and telomere depicted. (b) In situ transcriptional switching. (c) Duplicative gene 
conversion. (d) Segmental gene conversion. (e) Reciprocal telomeric exchange. Figure 
adapted from (Matthews et al., 2015). 
 
Transcriptional switches, otherwise termed ES or in situ switches, encompass 
the silencing of an actively expressed BES and the subsequent activation of a single, 
previously silent, BES (Figure 1.8b) (Van der Ploeg et al., 1984). The strict state of 
monoallelic VSG gene expression following an in situ switch is controlled by a 
complex network of epigenetic control factors and is furthermore influenced by 
telomere-positional effects (reviewed in (Cestari and Stuart, 2018)). In addition to 
these epigenetic control factors, allelic control may be furthermore controlled at the 
transcription elongation and RNA processing level, since low levels of transcription 
still occur on silent BESs (Kassem et al., 2014). 
Since the number of archival VSG genes is in vast excess to the number of 
BESs, it is perhaps unsurprising that the predominant means of VSG switching is 
expedited by DNA rearrangements (Robinson et al., 1999). These recombinatorial 
events exploit (a) sequence homology between VSG flanking regions (duplicative 



















instability of the telomeric environment (reciprocal telomeric exchange) (Boothroyd 
et al., 2009; Horn, 2014; Pays et al., 1985; Pays et al., 1983).  
Driven by homology within the 70 bp repeat regions flanking VSGs, 
duplicative gene conversion (GC) involves the duplication of an intact ‘basic copy’ 
silent VSG (from either another BES or from elsewhere within the genomic VSG 
archive) and the subsequent transposition of this expression linked copy (ELC) into 
the active BES (Figure 1.8c) (Campbell et al., 1984; Hovel-Miner et al., 2016). The 
displaced VSG is simultaneously deleted. Initiation of a GC VSG switch is still not 
fully understood, though induction of a DNA double-stranded break adjacent to the 
70 bp repeat region was shown to increase switching in vitro ~250-fold and, 
furthermore, spontaneous DSBs could be detected within this region (Boothroyd et 
al., 2009). Why the 70 bp repeat region would be a specific target for DSBs has not 
yet been explained (McCulloch et al., 2015). The region upstream of the 70 bp 
repeats commonly delineates the 5’ boundary of gene conversion, though Hertz-
Fowler et al. reported in ~10% of VSG switches studied in monomorphic 
trypanosomes that the entire BES was replaced by duplicative transposition of a 
complete, new BES, including the promoter region (Campbell et al., 1984; Hertz-
Fowler et al., 2008). Similar to, though seen less frequently than GC, is reciprocal 
telomeric exchange (Figure 1.8e). Here, the telomere of a silent BES is exchanged 
via cross-over for that of the active BES, though unlike in GC the VSG gene is not 
deleted and instead remains on the silenced telomere (Pays et al., 1985). Imperative 
to the expansion of the VSG repertoire is segmental gene conversion, otherwise 
known as ‘mosaic formation’. Mosaic VSGs are assembled upon the recombination 
of at least two archival VSG gene or pseudogene ORFs to create a novel coding VSG 
gene (Figure 1.8d). The accumulation of segmental gene conversion events generates 
strings of VSG variants that exhibit a degree of sequence homology, yet are 
antigenically distinct (Hall et al., 2013; Lythgoe et al., 2007). Despite building 
evidence that mosaic VSG formation is critical to maintenance of long-term infection 
(discussed in Section 1.2.5), our understanding of the substrates and mechanisms of 
mosaic VSG formation are currently limited. Where mosaic assembly occurs and 






VSG expression is semi-predictable and hierarchical, as demonstrated by the 
ordered, preferential expression of certain subsets of VSG genes within the first 
relapse peaks of parasitaemia, and across the time course of a chronic infection 
(Morrison et al., 2005). Whilst the host immune response does select for the 
expression of novel VSG variants, the hierarchy of VSG expression is a parasite 
intrinsic process that is not driven by the host. The probability that a given VSG gene 
will be activated is highly influenced by the locus type that it resides in and the mode 
of switching (Gjini et al., 2010; Morrison et al., 2005). In situ transcriptional 
switches are favoured early in infection, followed by gene conversion of archived 
intact silent genes into the active BES and finally, mosaic VSG generation via 
segmental gene conversion dominates late infection. More recently, the length of the 
expressed VSG has been shown to be fundamental to the generation of an expression 
hierarchy (Liu et al., 2018). Mathematical modelling predicted parasites expressing 
VSGs of a short length to accumulate more quickly early in infection compared to 
parasites expressing longer VSGs, hypothetically due to the lower metabolic burden 
of producing shorter VSGs. Surpassing the threshold for an immune response first, 
the cells expressing shorter VSGs would act as a ‘distraction’ allowing the slower 
growing cells expressing longer VSGs to accumulate in the absence of immune 
attack. Such predictions were backed up by in vivo and RNAseq data, whereby it was 
found that shorter VSGs accumulated early in infection, whilst longer VSGs 
predominated during chronic infection in the mouse model (Liu et al., 2018). 
 
1.2.5 Regulation of VSG expression 
RNAPI transcription initiates simultaneously on multiple BESs, progressing 
at least as far as ESAG6 before transcription is terminated in all but the active VSG 
ES, resulting in the expression of only one VSG surface coat (Kassem et al., 2014; 
Vanhamme et al., 2000). The control and regulation of monoallelic VSG expression 
is a complex and multifactorial process which incorporates a number of epigenetic 
mechanisms and is influenced by the nuclear architecture and a developmentally-





The eukaryotic nucleus is organised into transcriptionally ‘silent’ regions of 
condensed heterochromatin and transcriptionally ‘active’ regions of open 
euchromatin. Indeed, it has been observed in T. brucei that electron dense 
heterochromatin clusters at the nuclear periphery whilst the electron lucent 
euchromatin is located in the nuclear interior (Ogbadoyi et al., 2000). Inactive 
telomeric BESs are found in this transcriptionally repressed heterochromatic region 
at the nuclear periphery, whilst the single active VSG BES is transcribed by RNApol 
I at a distinct, transcriptionally permissive, extranucleolar site termed the ESB 
(Navarro and Gull, 2001). Metazoan nuclear lamins are critic for maintaining the 
structural integrity of the nucleus, nuclear pore complex (NPC) positioning and 
organisation of the genome into heterochromatin and euchromatin. In T. brucei, the 
450kDa coiled-coil protein Nuclear Peripheral Protein 1 (NUP-1) is an essential 
component of fibres at the inner nuclear envelope and is functionally analogous to 
metazoan lamins (DuBois et al., 2012). Knock-down of NUP-1 resulted in the 
transcription of previously silent telomere proximal BESs and procyclin loci and a 
10-fold increase in VSG switch rate, demonstrating that the structural protein plays a 
role in silencing of telomeric genes at the nuclear periphery and the control of 
antigenic variation (DuBois et al., 2012). A functional interacting partner of NUP-1, 
NUP-2, was also found to play a role in the silencing of telomeric BESs, however its 
knock-down did not cause an increase in VSG switching (Maishman et al., 2016). 
Chromatin remodelling is integral to monoallelic VSG expression and as 
such, the chromatin structures of active and silent BESs are distinct. Active BESs are 
depleted in nucleosomes, indicating an open chromatin state which facilitates 
transcription (Figueiredo and Cross, 2010; Stanne and Rudenko, 2010). In contrast, 
the histones H2AZ, H3 and H4 are enriched on the silent BESs and non-transcribed 
50bp and 177bp repeat arrays, indicating that the chromatin is in a condensed, closed 
confirmation and therefore does not facilitate transcription (Figueiredo and Cross, 
2010; Lowell et al., 2005). A number of histone chaperones, which regulate the 
assembly of nucleosomes, have been implicated in the control of BES transcription. 
The ‘facilitates chromatin transcription’ (FACT) chromatin remodelling complex, in 
T. brucei, is composed of two subunits: Spt16 and Pob3 (Denninger et al., 2010; 





demonstrated that Spt16 was enriched at the promoters of transcriptionally silent 
BESs. Blocking the synthesis of the Spt16 subunit opened the chromatin structure 
around these BES promoters and thus caused a 20-23-fold derepression of silent 
BESs (Denninger et al., 2010; Denninger and Rudenko, 2014). This derepression was 
accompanied by an accumulation of cells arrested in the G2/M stage of the cell cycle 
(Denninger et al., 2010), however by blocking cyclin 6 synthesis to create a mitotic 
block (Hammarton et al., 2003) and observing that silent BESs were not derepressed, 
Denninger and Rudenko (2014) demonstrated that VSG ES derepression was not a 
general feature of G2/M arrest. Knock down of Spt16’s partner Pob3, also caused the 
derepression of VSG BESs (Denninger and Rudenko, 2014). To identify candidate 
chromatin regulators which might act as BES regulators, Alsford and Horn (2012) 
analysed their previously generated RITseq data (Alsford et al., 2011) for genes 
which displayed a high loss of fitness phenotype when knocked down in BSF cells. 
The histone chaperones anti-silencing factor 1A (ASF1A) and chromatin assembly 
factor 1B (CAF-1b) were identified in this screen (Alsford and Horn, 2012). ASF1A 
and CAF-1b were knocked down by RNAi in VSG cell lines which contained a 
promoter-proximal GFP ORF in a repressed BES. Following 24 hours of induction, 
there was an increase in GFP expression, demonstrating that derepression of the 
silent VSG ESs had taken place. Whilst derepression was evident at a promoter 
proximal site, there was no evidence of derepression at the promoter-distal sites, such 
as the VSG gene. This shows that factors downstream of ASF1A and CAF-1b must 
also be involved in ES transcriptional control (Alsford and Horn, 2012; Cestari and 
Stuart, 2018).  
Post-transcriptional modifications of histones by methylation, ubiquitylation, 
phosphorylation or SUMOylation alter chromatin structure and hence, gene 
expression. Disruptor of telomeric silencing 1B (DOT1B) is a histone 
methyltransferase which trimethylates lysine 76 of histone H3 (Figueiredo et al., 
2008). Deletion of DOT1B causes the partial derepression of silent telomeric BES 
sites without affecting non-telomeric loci whilst furthermore permitting the 
expression of two VSG surface coats simultaneously (Figueiredo et al., 2008), thus 
demonstrating that DOT1B is required for monoallelic expression. The kinetoplastid-





J, is a chromatin mark present in BSF, but absent from PCF trypanosomes (van 
Leeuwen et al., 1997). The base is synthesised in two steps: thymidine in the DNA is 
firstly hydroxylated by two thymidine hydroxylase enzymes, JBP1 and JBP2 (Cross 
et al., 2002; DiPaolo et al., 2005), before the glucosyltransferase JGT catalyses the 
transfer of a glucose moiety from uridine diphosphoglucose to the 5- 
hydroxymethyluracil intermediate (Bullard et al., 2014). The presence of Base J 
correlates with the silencing of BESs (van Leeuwen et al., 1997). Base J was found 
to be abundant in the 50bp repeats upstream of the BES promoter and the telomeric 
repeats downstream of the VSG gene of both active and silent BES, however in silent 
BESs the modification was found to be present along the entire length of the BES 
too, including within the 70bp repeats and VSG gene itself (van Leeuwen et al., 
1997). 
In an impressive recent study, Muller et al. (2018) demonstrated a link 
between genome architecture and antigenic variation mediated through the histone 
variants H3.V and H4.V. Single cell RNAseq (scRNA-seq) and Pacbio single-
molecule real-time (SMRT) sequencing showed that deletion of both variants 
(ΔH3.VΔH4.V) induced a VSG switch in 74% of analysed cells through the 
recombination of a pair of ESAG 8 genes present on BES1 and BES15 (Muller et al., 
2018). Deletion of histone variant H3.V or H4.V alone did not induce a VSG switch. 
The mechanism behind this increase in VSG switching by DNA recombination was 
investigated using genome-wide chromosome confirmation capture (Hi-C) and 
assays for transposase-accessible chromatin (ATAC-seq). Deletion of histone variant 
H3.V alone grossly changed the genome architecture and furthermore promoted 
increased interactions among the silent BESs. Whilst deletion of histone variant 
H4.V did not induce significant changes in the genome architecture, there was a 
marked increase in promoter-proximal DNA accessibility upon its deletion (Muller et 
al., 2018). Therefore, the histone variants H3.V and H4.V are involved in regulating 
DNA accessibility and genome architecture and deletion of both induces changes in 
VSG expression (Muller et al., 2018). 
VSG exclusion factor 1 (VEX1) was identified in an RNAi library screen for 





contained within an extranucleolar compartment which, in BSF cells, was closely 
associated with the RNAPI focus of the active BES. In PCF cells, however, VEX1 
was redistributed and had a broad nuclear staining pattern (Glover et al., 2016). Upon 
either RNAi knockdown or ectopic overexpression of VEX1 in BSF cells, there was 
an accumulation of cells expressing multiple VSGs on their surface, as detected by 
quantitative proteomics. RNAseq analysis of the expressed transcriptome in VEX1 
RNAi cells found that there was >26-fold increase in transcripts encoding ES-
associated VSGs, in addition to an increase in transcripts encoding metacyclic VSGs 
(which are also transcribed by RNAPI) and genes immediately adjacent to VSGs 
(Glover et al., 2016). The transcriptomes of VEX1 overexpressors were also enriched 
>21-fold for ES-associated VSGs, however there was also a marked increase in 
transcripts encoding ESAGS (from both the active and silent ESs) and non-telomeric 
RNAPI transcribed genes such as procyclin. This therefore shows that VEX1 
negatively regulates VSG genes, and positively regulates VSG genes and non-
telomeric RNAPI transcribed genes (Glover et al., 2016). A ‘winner-takes-all’ 
mechanism of monoallelic control was proposed by the authors, whereby VEX1 
sequestration at the active ES enables RNAPI transcription of the entire BES whilst 
simultaneously repressing transcription of the other ESs. Repression of the ESs was 
hypothesised to occur in a VEX1-dependent form of homology-dependent silencing 
(Glover et al., 2016). 
Although the mechanisms controlling monoallelic VSG expression primarily 
occur at the level of transcription elongation, a number of factors can influence the 
initiation of RNAPI transcription too, such as class I basal transcription initiation 
factor A (CIFTA) and the presence of the posttranslational modification, small 
ubiquitin-like modifier (SUMO) (Cestari and Stuart, 2018; Lopez-Farfan et al., 2014; 
Nguyen et al., 2014). For a more comprehensive review of the genes implicated in 
the control and regulation of VSG expression, see Cestari and Stuart (2018). 
 
1.2.6 VSG diversity within chronic infection 
The kinetics of VSG switching, and thus immune evasion, predictably impact 





these exert their influence had been poorly understood. The recent application of 
high-resolution, quantitative sequencing approaches to longitudinal VSG switch 
studies has helped to shed light on VSG switching dynamics and diversity within 
chronic infection. 
In theory, a trypanosome should switch its expressed VSG at a rate quick 
enough to avoid immune detection and clearance, but not so fast as to rapidly deplete 
their VSG repertoire of ~400 intact genes. Recent evidence however, has suggested a 
far greater level of variant diversity within individual infections, including within the 
parasitaemic valleys, than was previously appreciated, this being in excess of what 
would be predicted to ‘only just’ avoid immune detection (Mugnier et al., 2016). 
Hall et al. (2013), using a cloning and RT-PCR approach, measured ~20 
variants/peak but predicted as many as 100 variants could be expressed in a single 
parasitaemia peak (Hall et al., 2013). Similarly, a targeted RNAseq approach, termed 
VSGseq, adopted by Mugnier et al. (2015), averaged 28 variants/peak during the first 
30 days of infection, with a maximum of 83 variants within a single peak being 
sequenced (Mugnier et al., 2015). Each peak consisted of a handful of ‘major’ VSG 
variants which made up the majority of the population and a number of rarer, low 
abundance ‘minor’ VSG variants, about half of which would never surpass 1% of the 
population (Mugnier et al., 2015). In accordance with the aforementioned hierarchy 
of VSG gene expression, and despite extreme levels of VSG expression diversity, the 
same VSG variants frequently occurred during different infections (Hall et al., 2013; 
Mugnier et al., 2015). However, of the 48 VSG genes that occurred in every 
infection in the Mugnier study, there was rarely a gene which was always dominant, 
and conversely nor were there any VSG genes which were consistently rare 
(Mugnier et al., 2015). Infections in natural hosts can last from months to years, and 
with a new variant peak consisting of at least 20 variants arising every 5-8 days it is 
not difficult to appreciate that the number of expressed VSGs is obviously far in 
excess of the number of the ~400 intact coding VSG genes. Thus, following 
exhaustion of this intact repertoire, segmental gene conversion comes to dominate 
(Hall et al., 2013). Whilst these studies are undoubtedly informative, it must be noted 
that the mouse model, rather than a natural livestock host was employed for these 





vivax and T. congolense predominate, remains to be seen (McCulloch et al., 2017) 
particularly because the emphasis of mosaic-gene conversion seems much less in 
these species. In support of the models however, a study of plasma pooled from three 
Ugandan patients infected with T. b. rhodesiense found a surprisingly diverse range 
of VSGs to be the most predominantly identified proteins (Eyford et al., 2013; 
Mugnier et al., 2015). 
The interaction, if any, between antigenic variation and the slender to stumpy 
differentiation capacity within a chronic infection also remains to be fully 
understood. Infections are dominated by cell cycle arrested, transmission competent 
stumpy cells which do not switch their expressed VSG (MacGregor et al., 2011). 
How such a high level of VSG diversity is maintained during chronic infection 
despite the predominance of these cells, which were originally thought to limit 
exposure of the full antigen repertoire, poses an interesting question. It has been 
proposed that stumpy cells may contribute to the persistence of rare variants by 
limiting parasite numbers to a level below which the host immune system will mount 
a response (Hall et al., 2013). 
 
1.2.7 Measuring the rate of antigenic variation 
Distinct experimental trends have shaped the study of antigen switch 
frequency in African trypanosomes. Beginning with observations of small numbers 
of switch variants arising in chronic mammalian BSF infections using limited panels 
of VSG-specific antisera, series’ of experiments have subsequently adopted ever 
more sophisticated (and less laborious) means of detecting VSG switch variants. 
Early VSG switch frequency investigations traditionally studied parasites 
isolated from chronic in vivo infections (Gray, 1965; Myler et al., 1985) (though in 
order to demonstrate that antigenic variation occurred in the absence of an immune 
system, Doyle et al. studied parasites for up to 60 days of in vitro culture (Doyle et 
al., 1980)). Such experiments routinely isolated parasites from the animal (on a daily 
or weekly basis) and screened ~1000 cells for the expressed VSG by IFA using small 





infections is not only laborious, but complicated by the fact that it cannot be 
ascertained if a given variant arose from the variant preceding it, or if it is simply the 
progeny of a minor VSG variant already present, but previously undetectable, in the 
infection (Aitcheson et al., 2005). Single relapse experiments in rodents, in which a 
single switch away from the starting VSG is monitored, resolve this uncertainty. 
Miller and Turner (1981) performed the classic single relapse experiment, whereby 
10 homogenous trypanosomes (with regard to their VSG expression) were injected 
into naïve rats. Parasitaemia was monitored until a second (relapse) peak of 
parasitaemia occurred, the mice exsanguinated and the parasites analysed for VSG 
expression based on immunofluorescence staining with VSG-specific anti-sera 
(Miller and Turner, 1981). Using this method, Miller and Turner analysed 47 first 
relapse populations of six clones and found that certain VSG types were expressed 
more frequently in the relapse peak than other, rarer, variants (preceding the finding 
that VSG expression is hierarchical). Later studies performed a variation on these 
experiments, such that immune selection against the starting VSG was mediated 
either by prior immunisation of the experimental rodent (Hartley and McCulloch, 
2008; McCulloch and Barry, 1999; McCulloch et al., 1997; Proudfoot and 
McCulloch, 2005; Robinson et al., 2002) or by incubation of the parasites with serum 
and a VSG-specific antibody prior to injection (Lamont et al., 1986; Turner, 1997). If 
a rodent developed a patent parasitaemia, this indicated that a VSG switch variant 
had been present in the initial inoculum. Perhaps the biggest limitation of 
experiments exploiting the immune system to clear non-switched VAT variants, in 
addition to the need of prior immunisation of animals, is the potential for off-target 
responses. Thus, if the experimental animal is not immune-suppressed, the innate 
immune system may target cells for clearance in a non-specific manner and 
furthermore, antibodies (whether in the rodent or in vitro neutralisation assays) could 
bring about the complement-mediated lysis of all cells expressing similar epitopes to 
the starting VSG, thereby potentially causing some variants to be lost. 
Many methods have been described to quantitate VSG switching in vitro, 
thus removing the need to work with large numbers of immunised animals and 
furthermore isolating the parasite from host factors which may complicate the 





these studies switch their expressed surface VSG at relatively low rates, selection for 
VSG switch variants, or depletion of non-switched cells from the population is 
required to aid detection. One such strategy, at its simplest, involves marking both 
the active and a second ES with different drug resistance genes (Figueiredo et al., 
2008; Hertz-Fowler et al., 2008; Horn and Cross, 1997). Following a period of 
growth in non-selective medium, the populations are treated with the drug whose 
resistance is encoded in the second ES, and are then cloned by limiting dilution. This 
positive drug-selection isolates resistant cells which have stochastically switched 
their formerly expressed VSG (for e.g. VSG 118) to that of the second VSG (for e.g. 
VSG221) via an in situ switch. Such a strategy is obviously limited as it only permits 
the study of the activation and inactivation of two marked ESs. A second, and far 
more thorough, experimental strategy for measuring VSG switch rate was described 
by Aitcheson et al. (2005). RNAi-mediated knockdown of the actively expressed 
VSG causes rapid precytokenesis arrest in trypanosomes in vitro (Sheader et al., 
2005) but does not induce as antigenic switch, as confirmed by fluctuation analysis 
(Luria and Delbruck, 1943; Sheader et al., 2005). Thus, Aitcheson et al. (2005) 
adopted an RNAi strategy for their in vitro switch assays in order to select for cells 
which had switched away from the major VSG221 variant in the absence of immune 
selection. This method was advantageous since it rapidly generated high numbers of 
clonal switch variants, was not restricted to monitoring switching between two ESs 
only and depleted the starting variant with high specificity, though it did rely on tight 
regulation of the RNAi machinery. Briefly, serially diluted cultures of VSG221 
expressing trypanosomes were expanded for 3 generations in 96-well plates to allow 
for an antigenic switch to occur before RNAi against the starting VSG was induced. 
Non-switched trypanosomes rapidly arrested, whilst those that had switched, either 
by DNA rearrangements or an in situ switch continued to proliferate and could be 
characterised following 8-10 days of further culture (Aitcheson et al., 2005). 
Immunofluorescence and PCR amplification of marker genes within the ESs 
facilitated the identification of the VSG switch mechanisms utilised by 127 RNAi 
resistant clones. Similarly, in cell lines transfected with a copy of the Herpes Simplex 
Virus thymidine kinase (HSV-TK) gene in the region between the 70bp repeats and 





Ganciclovir can also select for cells which have switched their expressed VSG, and 
therefore do not express HSV-TK, during the course of an assay (Devlin et al., 2016; 
Kim and Cross, 2010). Since 2009, depletion of trypanosomes from the population 
which have not switched their VSG during an experiment has increasingly been 
performed by magnetic-activated cell sorting (MACS) (Boothroyd et al., 2009; 
Hovel-Miner et al., 2016; Hovel-Miner et al., 2012; Kim and Cross, 2010; Schulz et 
al., 2016). Following a period of in vitro growth in non-selective conditions, live 
cells are incubated with magnetic beads coupled to an antibody recognising the 
starting VSG (Boothroyd et al., 2009; Schulz et al., 2016). The cells are passed 
through a column to which the coated non-switched trypanosomes bind, and VSG 
switched cells pass through. The switched cells are collected in the flow-through and 
cloned by limiting dilution in 96 well plates. Though MACS separation does 
represent a quick alternative to selection with antibiotics or antibodies, it has been 
acknowledged that the many centrifugation steps can lead to shedding of the surface 
coat VSG (Schulz et al., 2016). Another complicating factor is that all steps must be 
performed at 4 degrees Celsius in order to circumvent internalisation of the antibody 
to the starting VSG. To confirm that MACS-enrichment for VSG switched cells did 
not bias results, Kim and Cross (2010) performed their VSG switch assays both with 
and without MACS-enrichment for VSG switched cells and found that the fold 
increase in VSG switching in the absence of TOPO3a was the same whether MACS 
was (10 to 40-fold) or was not (10 to 30-fold) used (Kim and Cross, 2010). 
Just as the experimental methods vary between studies, so too does the 
method used to calculate VSG switch frequency. The majority of recent VSG switch 
studies have employed a simple approach, whereby the switch rate is presented as the 
number of VSG switched cells divided by the total number of cells (which can then 
be normalised to the number of parasite generations elapsed during the assay to 
obtain the VSG switches/cell/generation) (Boothroyd et al., 2009; Devlin et al., 2016; 
Hertz-Fowler et al., 2008; Horn and Cross, 1997; Hovel-Miner et al., 2016; Hovel-
Miner et al., 2012; Kim and Cross, 2010; Schulz et al., 2016). This approach, 
however, is perhaps best suited to measuring relative change in VSG switch 





since a number of variables are not accounted for. The calculation simply expresses 
the proportion of the population which was not expressing the starting VSG at the 
time of sampling. What is not accounted for is the phenotypic or genetic diversity 
within those VSG switched cells (Hovel-Miner et al., 2012). A ‘negative’ cell could 
have switched expression of its surface VSG twice since expressing the starting VSG 
or two cells which appear phenotypically similar could have switched by different 
means to get to the same VSG. This method would not account for either of those 
differences. Finally, there is some experimental evidence to suggest that different 
VAT variants may grow at different rates to one another (Lamont et al., 1986; Liu et 
al., 2018; Miller and Turner, 1981). By normalising the calculated VSG switches/cell 
to the total number of generations measured for the population as a whole, this may 
not account for these differences in growth between VAT variants. A calculation 
which does account for different growth rates (providing clones do not switch at a 
high rate) is the P0 method, developed by Luria and Delbruck (1943) and used to 
calculate VSG switching frequency by Lamont et al. (1986), Turner (1997) and 
Aitcheson et al. (2005) (Figure 1.9). This method carries the requirement in vitro that 
non-switched cells must efficiently be depleted from the population (whether by 







Figure 1.9 The P0 method of calculating VSG switch frequency From Turner (1997) and 
Aitcheson et al. (2015). For Turner experimental method see Section 1.4. Based on 
fluctuation analysis methods established by Luria & Delbruck (1943). 
 
In the majority of the above in vitro experiments, marker genes (primarily) in 
the starting VSG ES have aided characterisation of the switched clones. IFA analysis 
of the expressed VSG or a promoter-proximal GFP (Aitcheson et al., 2005; 
Figueiredo et al., 2008) can confirm that the selection for VSG switchers was 
successful and report on ES activity, respectively. To establish whether the clones 
switched by GC or an in situ switch, clones can be tested in drug resistance assays 
(Hovel-Miner et al., 2016; Hovel-Miner et al., 2012; Kim and Cross, 2010) or their 
DNA analysed by Southern Blot or PCR for the presence of the original expression-
linked copy of the VSG (Aitcheson et al., 2005; Boothroyd et al., 2009; Devlin et al., 
2016; Hovel-Miner et al., 2016; Hovel-Miner et al., 2012; Kim and Cross, 2010). 
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Other studies have defined switch mechanism using RAGE (Boothroyd et al., 2009) 
or Western blot analysis of marker expression (Devlin et al., 2016). A disadvantage 
to methods such as IFA or PCR is that their labour and time intensive manner 
dictates that limited numbers of clones arising in switch assays can be characterised. 
In general, assays characterise tens to hundreds of cells by IFA (though Turner & 
Barry (1989) claim between 24,000 and 153,000 cells/group of 6 mice were counted 
by IFA in their experiments). Flow-cytometry detection of VSG expression can 
circumvent this constraint. Tens of thousands of cells can be monitored for VSG 
expression in less than a minute and, in addition to processing superior sample sizes, 
flow-cytometry also has the advantage of being able to quantitate multiple markers 
simultaneously. Therefore, with the correctly placed markers, a study could not only 
just quantitate VSG switch rate but furthermore determine, for example, if a specific 
genetic perturbation increased the rate of DNA recombination based switches. 
Boothroyd et al. (2009), Hovel-Miner et al. (2012, 2016) and Schulz et al. (2016) 
have all reported on VSG switch rates following FACS analysis of VSG expression 
following MACS. 
The low antigen switch frequency of many laboratory-adapted strains of 
trypanosomes (~1 switch in every 100,000 to 10,000,000 cells) can make achieving 
sufficient depth of analysis in VSG switch assays difficult. As such, many studies 
have elected to artificially increase the rate of VSG switching in cell lines by 
introducing an inducible double strand break (DSB) site into the actively expressed 
VSG ES (Boothroyd et al., 2009; Glover et al., 2013a). This is particularly desirable 
when large numbers of clones are required for characterisation. A polymorphism 
within the VSG 221 ES allows the specific integration of an I-SceI restriction site 
directly adjacent to the 70bp repeats preceding the VSG gene, whilst a copy of the I-
SceI meganuclease ORF under the control of an inducible promoter is integrated at a 
silent site within the genome (Glover et al., 2013a). Addition of tetracycline induces 
the expression of I-SceI, which forms a DSB at the restriction site within the active 
VSG ES. This break is repaired through 70bp repeat recombination, which 
translocates a new VSG gene into the ES, therefore mediating a GC switch. 
Transcription of the ES is not altered. Upon induction of I-SceI expression, 





with the VSG switch frequency rising ~250 fold to 1.5x10-3 compared to an 
uninduced control (1.5x10-5). The donor VSGs which were translocated into the 
active ES predominantly resided in another ES, though 3 of the donor VSGs (~16%) 
had arisen from the minichromosomes (Boothroyd et al., 2009). PCR analysis of the 
region between VSG221 and the ES telomere found that, in I-SceI-mediated 
switched clones, a ~500bp subtelomeric region which was present in unswitched 
clones was lost, therefore suggesting that resolution of the DSB was mediated by 
break induced replication (BIR) rather than crossover events in the 70bp repeats and 
3’ end of VSG 221 (Boothroyd et al., 2009). Induction of I-SceI expression in the 
absence of the 70bp did not result in an increase in VSG switching, thus suggesting 
that the 70bp repeats facilitated repair of the DSB through homologous 
recombination (Boothroyd et al., 2009). Making use of this cell line, and a series of 
70bp mutants, Hovel-Miner et al. (2016) were able to confirm Boothroyd’s 
hypothesis that homologous recombination through the 70bp repeats promoted 
access to the VSG archive (Hovel-Miner et al., 2016). Using a slightly different I-
SceI expression system and VSG 221 ES construct, Glover et al. (2013) instead 
found that 100% of induced cells underwent a VSG switch when the I-SceI RS was 
adjacent to the 70b repeats upstream of VSG 221. When the I-SceI RS was situated 
adjacent to either the ES promoter or the telomeric T2AG3 repeats, VSG switching 
was far less efficiently induced (8% and 28% of clones switched their VSG upon 
induction of I-SceI expression, respectively) (Glover et al., 2013a). The position of 
the DSB within the ES not only influenced the probability of a switch but 
furthermore the mechanism by which a VSG switch would be mediated. As 
Boothroyd et al. (2009) had previously found, a DSB break adjacent to the 70bp 
repeats upstream of the VSG gene resulted in the majority of VSG switches being 
gene conversions facilitated through 70bp homologous recombination. In contrast, 
when the DSB was induced adjacent to the ES promoter or telomere, DNA 
recombination rarely occurred and instead most clones either lost or replaced the ES 
entirely (Glover et al., 2013a). 
Moving forward, it seems that the next experimental phase of VSG switching 
studies will involve the use of deep sequencing methods in order to determine 





segmental gene conversion, investigate VSG expression diversity within specific 
sub-compartments of the mammalian host, and characterise VSG switching and 
expression diversity in T. congolense and T. vivax (McCulloch et al., 2017). Such 
work would build on previous studies by Hall et al. (2013) and Mugnier et al. (2015) 
who both demonstrated the VSG expression diversity during chronic infection is far 
greater than previously imagined, and that SGC is the mediator of this expression 
diversity using the methods described in Section 1.2.6. 
 
1.3 Slender to stumpy differentiation 
Whilst the dynamics of the hosts’ immune response and the trypanosomes’ 
capacity for antigenic variation undoubtedly act together to influence the profile of 
the cyclical waves of parasitaemia, a second biological event within each of these 
waves, the density-dependent differentiation of parasites, also contributes strongly 
(Gjini et al., 2010). An important evolutionary adaptation, this developmental switch 
both restricts parasitaemia, thus prolonging infection, and preadapts the parasite for 
survival upon uptake by the tsetse fly vector. 
 
1.3.1 The slender to stumpy transition and transmission potential 
Upon injection by the tsetse fly, infections are established in the host 
bloodstream by rapidly proliferating morphologically slender forms, which quickly 
increase in number. Allowed to replicate unchecked, slender parasites would rapidly 
kill a host, thus limiting the parasite’s transmission potential (MacGregor et al., 
2011). As a consequence, it is essential that parasites regulate their growth in vivo to 
promote longevity of the host and maximise transmission potential, therefore 
allowing the successful continuation of the parasite’s lifecycle by tsetse fly uptake 
(MacGregor et al., 2011). Such regulation is achieved by a developmental switch 
upon reaching a critical parasite density. During this developmental switch, 
proliferative slender forms respond to the accumulation of a small soluble parasite-
derived factor (or factors) termed stumpy induction factor (SIF) and differentiate to 





Vassella et al., 1997a). Stumpy cells are irreversibly and uniformly arrested in G1/G0 
(Shapiro et al., 1984), and since their abundance increases in response to ascending 
parasitaemia, the parasite population is restricted - prolonging the infection and 
optimising the transmission of the disease (MacGregor et al., 2011). The rapid 
increase in parasitaemia facilitated by slender form proliferation, commitment to 
cell-cycle exit, morphological transformation to stumpy cells and the subsequent 
clearance of quiescent cells by the immune system therefore contributes to the 
typical undulating trypanosome profile (Figure 1.10). 
 
 
Figure 1.10 Slender to stumpy differentiation influences infection dynamics alongside 
antigenic variation.  Proliferative long slender cells establish infection. As the parasite 
density increases, SIF accumulates and, upon reaching a critical density, parasites 
differentiate to transmission-competent, quiescent short stumpy forms. Cellular quiescence 
and immune recognition contribute to the fall in parasitaemia. Parasitaemia rises again as 
slender cells, which express an antigenically distinct VSG, begin to proliferate. Figure 
adapted from (MacGregor et al., 2012). 
 















1.3.2 Morphological, physiological and gene expression changes 
during stumpy formation 
Stumpy cells are the only bloodstream form capable of surviving within the 
harsh environment that the tsetse midgut presents. Accordingly, differentiation to 
stumpy forms is accompanied by a number of changes that preadapt the parasite for 
survival upon uptake by the tsetse fly (Rico et al., 2013). Following reception of SIF, 
and commitment to life cycle progression, stumpy cells assume their eponymous cell 
morphology. The cell shortens and broadens, the flagellum decreases in length, now 
no longer free, the flagellar pocket expands and a pronounced undulating membrane 
develops (Bruce et al., 1912). Intracellular remodelling of the receptor-mediated 
endocytic pathway furthermore translocates the single expanded lysosome to the 
posterior of the cell, with the lysosome sitting anterior to the nucleus (Brown et al., 
1972; Vanhollebeke et al., 2010). The rate of endocytosis itself is increased in 
stumpy cells, allowing the cells to more rapidly clear surface bound IgG than their 
slender counterparts, and therefore resist complement mediated lysis until 
transmission occurs (Engstler et al., 2007; McLintock et al., 1993).  
For the stumpy cells which have avoided antibody killing within the 
mammalian bloodstream for long enough to be ingested by a tsetse fly, the challenge 
for survival does not end here. The tsetse fly midgut is a substantially colder (~17 
degrees Celsius) environment replete with its own humoral immune defences, such 
as antimicrobial peptides (Dyer et al., 2013). Whilst slender cells are particularly 
sensitive to such conditions, stumpy cells demonstrate an increased tolerance to mild 
pH changes and trypsin treatment (Nolan et al., 2000; Rolin et al., 1996). In fact, 
exposure of slender pleomorphic trypanosomes to mild acidic conditions (pH5.5) for 
two hours at 37 degrees Celsius has been shown to accelerate slender to stumpy 
differentiation through an intermediate form and furthermore permits differentiation 
to procyclic forms at 27 degrees Celsius in the absence of citrate/cis-aconitate (CCA) 
(Rolin et al., 1998; Szoor et al., 2013). Similarly, treatment of monomorphic T. b. 
gambiense cultures with trypsin at 27 degrees Celsius stimulated differentiation to 
procyclic forms (Yabu and Takayanagi, 1988) and a similar observation was made 





Whilst the mammalian bloodstream is rich in glucose, the metabolite is of 
scarce abundance within the tsetse fly (Geigy et al., 1959). Instead the insects 
preferentially metabolise amino acids, in particular L-proline (Bursell, 1963; Mantilla 
et al., 2017). As such, blood parasites, which produced ATP through the glycolysis 
of host glucose largely within the glycosome (Opperdoes and Borst, 1977), must 
undergo extensive metabolic reprogramming to exploit the new nutritional 
environment and establish infection within the insect vector. Indeed, it has been 
shown that a full proline catabolic pathway is essential for trypanosomes to survive 
within the tsetse fly midgut (Mantilla et al., 2017). Consistent with their role in pre-
adaptation to the insect life-cycle stage, stumpy cells upregulate genes involved in 
mitochondrial respiration (Brown et al., 1973; Capewell et al., 2013b; Michelotti and 
Hajduk, 1987; Tyler et al., 1997) and also elaborate the mitochondrion which can be 
visualised by stains such as MitotrackerÒ (Molecular ProbesÔ) (Silvester et al., 
2017; Vassella et al., 1997b).  
Mitochondrial genes are not the only transcripts upregulated upon 
differentiation to the stumpy form. Stumpy cells, unlike slender forms, highly 
express the Proteins Associated with Differentiation (PAD) family of surface 
carboxylate transporters (Dean et al., 2009). Upregulated and relocated to the cell-
surface from the flagellar pocket during cold-shock, PAD2 is responsible for 
perception of the CCA procyclic differentiation signal (Czichos et al., 1986; Dean et 
al., 2009; Engstler and Boshart, 2004). PAD1 is only expressed on the surface of 
stumpy cells and has become the gold standard of stumpy form identification. 
Repression of PAD1 expression in slender cells has been shown to be controlled by 
two regulatory sequences within the genes 3’ untranslated region (UTR) (MacGregor 
and Matthews, 2012).  
Further genes demonstrated to be consistently upregulated in stumpy forms 
include those that encode for: ESAG9, a rare ES component only seldom found 
within the VSG polycistronic transcription units (Barnwell et al., 2010; Hertz-Fowler 
et al., 2008); MSP-B, involved in cleavage and shedding of VSGs upon 
differentiation to procyclic forms (LaCount et al., 2003); TbPIP39, a glycosomal 





NT10, a purine nucleoside transporter (Capewell et al., 2013b; Sanchez et al., 2004; 
Spoerri et al., 2007). Predictably, genes encoding glycolytic, cytoskeletal and cell 
cycle progression components were all substantially downregulated compared to 
slender cells (Capewell et al., 2013b; Jensen et al., 2009; Kabani et al., 2009). 
 
1.3.3 Life cycle competency 
Cells competent for the slender to stumpy transition, for example the East 
African Trypanosomiasis Research Organisation (EATRO) 1125 strain 
(http://tryps.rockefeller.edu/DocumentsGlobal/lineage_antat1.pdf), are termed 
‘pleomorphic’. In the absence of tsetse fly transmission, and through extensive 
laboratory passage at high density however, rapidly proliferating and highly virulent 
bloodstream from parasites that have lost the capacity to differentiate in a density-
dependant manner into cell-cycle arrested stumpy forms are selected for (Ashcroft, 
1960). These laboratory-adapted parasites are termed ‘monomorphic’. Monomorphic 
trypanosomes of the Lister 427 strain 
(http://tryps.rockefeller.edu/DocumentsGlobal/lineage_Lister427.pdf) have 
historically been preferentially investigated since they generally show relative 
antigenic stability compared to pleomorphic trypanosomes and grow to high 
densities in vitro, thus easing their characterisation (Cross, 1996). Though 
monomorphic cells themselves are aberrant in their responsiveness to SIF, 
conditioned medium prepared from monomorphs is capable of efficiently inducing 
cell cycle arrest and differentiation to stumpy forms in SIF responsive pleomorphic 
cells (Vassella et al., 1997a). Thus, monomorphic cells must be capable of producing 
SIF but extensive passage has selected for either reduced reception or transduction of 
the differentiation signal (Silvester et al., 2017; Vassella et al., 1997a). 
 
1.3.4 The differentiation signal 
The identity of SIF has thus far remained elusive, though it has been 
characterised as a small (<500Da), soluble and heat stable entity which accumulates 





monophosphate (cAMP) signalling pathway attracted attention following the 
observations that intracellular levels of cAMP fluctuated during in vivo 
differentiation (Strickler and Patton, 1975) and increased over three-fold at peak 
parasitaemia (Mancini and Patton, 1981). Exposure of both pleomorphic and 
monomorphic cell cultures to the membrane-permeable cAMP analogue 8-(4-
chlorophenylthio)-cAMP (8-pCPTcAMP) caused the induction of physiologically 
relevant differentiation events such as rapid G0/G1 arrest, morphological 
transformation and mitochondrial elaboration (Breidbach et al., 2002; Vassella et al., 
1997a). Intracellular levels of cAMP furthermore increased 2-3 fold upon exposure 
to conditioned medium (Vassella et al., 1997a). Despite such evidence, the 
trypanosome genome lacked any annotated cAMP-dependant effector proteins, and 
finally Laxman et al. were able to demonstrate that the results from the prior 
experiments were due to the activity of a hydrolysis product of 8-pCPTcAMP, and 
not 8-pCPTcAMP itself (Laxman et al., 2006). 
 
1.3.5 Quorum sensing signalling pathway 
Whilst not the natural inducer of slender to stumpy differentiation, 8-
pCPTcAMP has nevertheless proved a useful molecular tool. Combining 8-
pCPTcAMP selection and RNA Interference Target Sequencing (RITseq) (Alsford et 
al., 2011), Mony et al. identified an extensive cohort of molecules which together 
formed the SIF signalling pathway (Figure 1.11a) (Mony et al., 2014). Briefly, an 
inducible RNAi library providing 5-fold T. brucei genome coverage (Morris et al., 
2002) was transfected into monomorphic T. brucei cells. Exploiting monomorphic 
cells’ potential to undergo cell cycle arrest and become ‘stumpy-like’ in response to 
8-pCPTcAMP/AMP (Breidbach et al., 2002), library cell lines were grown in the 
presence of the SIF mimic in either induced or non-induced conditions. Uninduced 
populations, where the signalling pathway remained intact, rapidly underwent cell 
cycle arrest. However, where a gene involved in the slender to stumpy differentiation 
pathway was inducibly knocked down, the cells became differentiation defective and 
continued to proliferate in the presence of 8-pCPTcAMP/AMP. RNAi cassette insert 





the reads mapped back to the T. brucei genome (Mony et al., 2014). Groups of genes 
identified in the genome-wide RNAi screen formed distinct positions within the 
predicted signalling pathway, from purine metabolism, to protein kinase and 
phosphatase signal transducers through to RNA-binding effector molecules (Figure 
1.11b) (Mony et al., 2014). The majority of the genes were validated as having 
physiological significance in stumpy formation in vivo. The production of a chemical 
signal molecule upon reaching a critical cell density, and the reception of the signal 
through a cascade of signalling and effector molecules, is reminiscent of bacterial 
quorum-sensing (QS) (Bassler, 2002; Mony et al., 2014; Mony and Matthews, 2015). 
RITseq has furthermore been responsible for the identification of genes involved in 
antitrypanosomal drug resistance and action (Alsford et al., 2012), essential 
mitochondrial genes (Mbang-Benet et al., 2015) and genes essential for normal 







Figure 1.11 Identification of the quorum-sensing signalling pathway. (a) The genome-
wide RNAi 8-pCPTcAMP/AMP screen workflow. A monomorphic RNAi library was 
treated with the SIF mimic, 8-pCPTcAMP. Upon exposure, uninduced cells arrested. 
However, cells harbouring an RNAi fragment which knocked down a component of the 
stumpy formation signalling pathway were rendered resistant to the signal upon induction 
and continued to proliferate. Amplified RNAi inserts were subjected to Ion Torrent 
Sequencing. (b) The genes identified by Ion Torrent Sequencing were ordered into a 
theoretical pathway. Genes highlighted in bold were experimentally validated in vivo. 
Figures from (Mony et al., 2014; Mony and Matthews, 2015). 
 
McDonald et al. (2018) recently utilised an extragenic suppression approach 
to elucidate the positioning of, and dependency relationships between, a number of 
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incompetent RNA Binding Protein 7 (RBP7), YAK and MEKK1 null mutants were 
studied for their differentiation competency in vivo following pairwise inducible 
ectopic overexpression of either RBP7, NEK17 or Protein Phosphatase 1-6 (PP1-6) 
or the inducible gene silencing of the differentiation inhibitor TbTOR4 (McDonald et 
al., 2018). Cells were assessed for their PAD1 expression, morphology, cell cycle 
status and competency for synchronous differentiation to procyclic forms. The study 
revealed complex non-linear relationships between the components (Figure 1.12) and 
furthermore that cell cycle arrest was not always a prelude to stumpy formation, as 
demonstrated by low PAD1 expression in an arrested MEKK1 null mutant lacking 
TbTOR4 (McDonald et al., 2018). 
It has been demonstrated that the density-dependent quorum-sensing 
signalling pathway is not the only means by which life-cycle progression may be 
mediated. Transcriptional attenuation of the active VSG ES in monomorphic cell 
populations was shown to be followed by an accumulation of (reversibly) G1 
arrested cells expressing PAD1, which were somewhat more efficient at 
differentiating to procyclic forms when stimulated with CCA (Batram et al., 2014). 
Simultaneous ectopic overexpression of two VSGs in biologically relevant 
pleomorphic cells, however, produced two phenotypically distinct populations 
(Zimmermann et al., 2017): those which were irreversibly arrested, and those which 
remained proliferative. In the arrested populations, overexpression of the second 
VSG had caused transcriptional attenuation of the active VSG ES. These cells had 
additionally accumulated in G1, upregulated PAD1 expression and were capable of 
CCA-induced synchronous differentiation to procyclic forms (which themselves 
were capable of establishing a tsetse infection). Thus, the VSG ES transcriptional 
attenuation had elicited life-cycle progression in a density independent manner. 
Contrastingly, in the proliferative population, though the endogenous active VSG 
had been silenced following ectopic overexpression of the second VSG the ES 
remained to some extent transcriptionally active (Zimmermann et al., 2017). The 
authors postulated that such an outcome was evidence of an ‘escape mechanism’ 
utilised by the parasites whereby, in the instance of a failed VSG switch and 
complete transcriptional shut-down of the VSG ES, the cells could differentiate to 





transcriptional shut down of the VSG ES, as in the second population of proliferative 
VSG overexpressors, the cells could continue to replicate as slender forms (Silvester 
et al., 2017; Zimmermann et al., 2017). 
 
 
Figure 1.12 Two potential quorum-sensing hierarchy models. Two interpretations of the 
knockdown and overexpression data generated by (McDonald et al., 2018). Alternative 
models to explain the data may exist. The model on the left consists of two non-redundant 
branches, one YAK- and one RBP7-dependant, leading to cell-cycle arrest and stumpy 
formation. The model on the right is linear, and the activities of NEK17 and PP1-6 are 
dependent on YAK. The dotted line indicated the potential for NEK17 phosphorylation, 
either directly or indirectly, by MEKK1. Figure from (McDonald et al., 2018). 
 
1.4 Antigen switch frequency and stumpy differentiation 
capacity: a link? 
Historically, VSG switch studies have estimated VSG switch frequencies of 
10-7 to 10-5 switches/cell/generation, a rate that reflects the background level of 
mutations in other eukaryotes (Doyle et al., 1980; Lamont et al., 1986; Myler et al., 
1985; Turner, 1997; Watkins, 1964). Such studies, crucially, made use of laboratory-
adapted monomorphic trypanosomes that had been subjected to continued syringe 





generations from transmission. To date, as discussed in Section 1.3.3, monomorphic 
trypanosomes are still preferentially investigated in VSG studies owing to their 
relative antigenic stability, ease of characterisation and annotated VSGnome (Cross 
et al., 2014). 
Populations of syringe-passaged monomorphic clones are typically 
antigenically homogenous, with over 99% of the population expressing the same 
dominant VSG. However, moderate to high levels of antigenic heterogeneity are 
observed in populations of life-cycle competent cells that have not yet undergone 
extensive laboratory passage, suggesting that antigenic stability may differ between 
pleomorphic and monomorphic cells (Barry and Emery, 1984; Doyle et al., 1980; 
Turner and Barry, 1989). Turner and Barry (1989) estimated the VSG switch rate of 
T. b. rhodesiense cells less than 100 generations removed from a tsetse fly to be 2-
9.3x10-3 switches/cell/generation, a phenomenon that was shown to be general to 
trypanosomes and not a specific line. This estimated switch rate, however, was a 
summation of a series of immunofluorescence experiments designed to test the 
switch rate between specific combinations of VSGs, rather than the populations’ 
overall switch frequency. It was proposed that, had analysis not been restricted to a 
set of six VSGs, the estimated switch rate would have in fact been higher (Turner 
and Barry, 1989). Switch rates were highly variable (from 1.9x10-6 
switches/cell/generation to 6.9x10-3 switches/cell/generation) and dependent on the 
VSG that was being switched to (Turner and Barry, 1989). The observation that 
recently isolated trypanosomes could switch their expressed VSG at a rate 66,000-
fold times greater than cells subjected to laboratory passage was corroborated by 
(Turner, 1997). Excluding trypanosome genotype and methodological differences 
between studies as explanations for the discrepancies in published VSG switch rates, 
Turner used an in vivo method conceptually based on Luria and Delbrück’s 
fluctuation analysis to show that rates of antigenic variation were significantly lower 
in laboratory-adapted lines compared to those recently transmitted by tsetse flies 
(Turner, 1997). Briefly, two cloned T. brucei lines were laboratory-adapted by 
extensive syringe passage through mice every 2-3 days for a period of three months. 
Mice were injected with no more than three of the syringe passaged clones to allow 





Infections were allowed to develop for 6 days before the mice were exsanguinated 
and non-VSG-switched cells killed by complement-mediated lysis. Groups of mice 
were then inoculated with a known number of the live and/or killed cells. Mice were 
observed for their developing parasitaemia over 14 days, with the VSG switch rate 






where P0 is the proportion of mice that did not develop infection and N is the number 
of live/dead cells injected into each mouse (Luria and Delbruck, 1943; Turner, 1997). 
The switch rates of the two passaged clones were calculated by this method, and 
estimated at 3x10-6 switches/cell/generation and 1x10-4 switches/cell/generation, 
respectively. The VSG switch rates of 4 subpopulations were determined after the 
former clone was subject to cyclical transmission through a tsetse fly. VSG switch 
rates post cyclical transmission were variable, but consistently higher than those 
measured before tsetse fly transmission. Three of the four populations switched their 
expressed VSG at the rate of 2x10-3 switches/cell/generation, the fourth considerably 
less so at 7x10-5 switches/cell/generation. Since the reduction in VSG switch rate 
could be readily reversed upon cyclical transmission, it was postulated that the 
change was unlikely to be due to mutation (Turner, 1997).  
Though with considerable variability, both the above studies have 
demonstrated that recently-isolated, life-cycle competent (pleomorphic) 
trypanosomes switch their expressed VSG at a significantly higher rate than 
populations of cells which have been subject to extensive laboratory passage. It 
therefore seems that stumpy differentiation capacity and antigen switch frequency 
could be linked. 
 
1.4.1 The evidence for a link 
Few studies have formally addressed the evidence for, nor hypothesised the 





differentiation capacity. Using the same low switching trypanosome lines that a) 
have now been passaged as monomorphic cells for decades and b) have likely been 
shared between many laboratories for most published VSG switching studies, 
“monomorphic trypanosomes switch their expressed VSG at a significantly lower 
frequency than pleomorphic cells” has become a dogma of trypanosome antigenic 
variation. Do all monomorphic strains behave this way? What about cells that have 
only recently lost their pleomorphism? Can higher VSG switch rates be selected for? 
Though in the context of a link between switch frequency and stumpy 
differentiation capacity evidence may be lacking, there is abundant evidence to 
suggest slender to stumpy differentiation and antigenic variation themselves are 
coordinated. Development to stumpy forms is accompanied by silencing of the active 
VSG ES (Amiguet-Vercher et al., 2004) and, as explained in detail in Section 1.3.5, 
full transcriptional attenuation of the active VSG ES has furthermore been shown to 
elicit life cycle progression in pleomorphic cells (Batram et al., 2014; Zimmermann 
et al., 2017). RNAi mediated knock down of either VSG 221 or VSG 117 (Lister 427 
variants) has additionally been shown to induce cell cycle arrest, however this is both 
reversible and at precytokenesis, rather than in G1 (Sheader et al., 2005; Smith et al., 
2009). 
Dreesen et al. (2007) have hypothesised that telomere length and antigen 
switch frequency may be inversely related. When the telomeres are short, large 
stochastic terminal deletions of the active BES fall within the subtelomeric 70 bp 
repeat, and thus cause a break-induced replication (BIR) mediated VSG switch. 
Conversely, when the telomeres are long, the deletions fall within the telomere 
region itself and instead cause a further lengthening of the telomere and no switch 
(Dreesen and Cross, 2008; Dreesen et al., 2007). Slender to stumpy differentiation 
became of relevance when it was observed that recently isolated pleomorphic cells, 
which switched their expressed VSG at a high rate, had significantly shorter 
telomeres that those of extensively propagated monomorphic cells which switched 
their expressed VSG at a low frequency (Dreesen and Cross, 2008). Monomorphic 
telomerase reverse transcriptase null mutants (TERT-/-) incapable of lengthening 





compared to wild-type cells, in particular using GC mechanisms (Hovel-Miner et al., 
2012). However, it was not proven whether this increase in switch frequency was 
directly a result of shortened telomeres, or whether it was the result of a telomere 
capping defect caused by the deletion of TERT, as has previously been documented 
in the budding yeast Kluyveromyces lactis (Hovel-Miner et al., 2012). 
A change in antigenic variation upon culture adaptation has not only been 
observed in T. brucei. Serial blood passage (SBP) of Plasmodium chabaudi chabaudi 
enhances parasite virulence and furthermore selects for expression of a dominant cir 
gene (the P. c. chabaudi-specific pir multigene family which encodes for variant 
surface antigens, VSA) (Spence et al., 2013). RNAseq analysis of SBP parasites 
isolated following mosquito transmission found that vector transmission was 
associated with modified expression of the cir multigene family, most likely by 
epigenetic reprogramming, with 57% of the cir genes upregulated across the 
population (Spence et al., 2015; Spence et al., 2013). A decrease in VSA expression 
diversity upon SBP, and the subsequent upregulation of the composition and 
frequency of transcripts following vector transmission, was also observed in human 
infections with cultured P. falciparum (Peters et al., 2002). Parasites which had 
recently gone through a sexual cycle in the mosquito vector switched their var genes 
at an average of 16% per generation, considerably greater than an in vitro grown line 
of P. falciparum, which was shown to switch at a rate of 2% per generation (Peters et 
al., 2002; Roberts et al., 1992). The pili of the bacterial pathogen Neisseria 
gonorrhoeae are important virulence factors and can be switched to antigenically 
distinct alternatives via a DNA recombination pathway similar to that of gene 
conversion in trypanosomes (Serkin and Seifert, 2000). Whilst pili expression is 
relatively stable in vitro, multiple pili variants are recovered following human 
infection (Koomey, 1997; Seifert et al., 1994). The frequency of pilin antigenic 
variation was shown to be influenced in vitro by the availability of iron, whereby 
cells cultured in iron-limiting conditions exhibited switch rates five-fold greater than 
cultures grown in iron-replete conditions (Serkin and Seifert, 2000). Finally, as few 
as 10 in vitro passages of the spirochete Borrelia burgdorferi, the causative agent of 
Lyme disease, selects for low-infectivity parasites missing the 28kb linear plasmid 






The objective of this study was to ask if there is a direct relationship between T. 
brucei stumpy formation capacity and VSG antigen switch frequency. To address if 
loss of stumpy formation capacity was associated with a concomitant reduction in 
VSG switch frequency, the following approaches were applied: 
i) Generation of a sensitive in vitro flow cytometry-based assay capable of 
detecting VSG switch events in populations of pleomorphic and inducibly 
monomorphic cells. 
 
ii) Utilisation of a targeted deep sequencing approach, VSGseq, to determine 
expressed VSG diversity in populations of pleomorphic and inducibly 
monomorphic cells. 
 
iii) Analysis of selected monomorphs in the flow-cytometry based VSG 
switch assay and by whole genome and transcriptome sequencing. 
 
The findings of this study will contribute towards our understanding of the 
complex interplay between antigenic variation and differentiation, and help us to 

















2.1 Trypanosome strains 
The pleomorphic T. brucei AnTat1.1 (EATRO1125) 90:13 trypanosome strain 
(Engstler and Boshart, 2004) was used for generating the inducibly monomorphic 
and selected monomorphic cell lines in this study. The T. brucei AnTat1.1 90:13 
strain contains an integrated T7 RNA polymerase and Tet repressor to facilitate 
inducible genetic manipulations. 
The wild-type monomorphic trypanosomes used in Chapters 3 and 5 of this 
study were of the T. brucei Lister 427 strain and the stabilates were acquired from 
the Schnaufer Lab (University of Edinburgh, UK). The VSGup cell line used in 
Chapter 3 was also based on the T. brucei Lister 427 strain, however the stabilates 
were acquired from the Horn Lab (University of Dundee, UK). 
 
2.2 Trypanosome culture 
Bloodstream form trypanosome cultures were maintained in HMI-9 medium 
supplemented with 20% foetal calf serum (Gibco), 100U/ml penicillin and 
streptomycin and the appropriate selective drug(s) (Table 2.1) at 37oC and 5% CO2 
(Hirumi and Hirumi, 1989). Pleomorphic strains were maintained below densities of 
1x106 cells/ml and monomorphic strains below densities of 2x106 cells/ml. To 
generate parasite stabilates, 2x106 cells were centrifuged at 1500g and resuspended in 
500µl of HMI-9/14% glycerol. Cryovials were initially contained within a 
polystyrene box when moved to -80oC to prevent ice crystal formation. Cryovials 
were removed from polystyrene boxes after 24 hours and stored long term at -80oC 
and in liquid nitrogen. 
To thaw a stabilate, the cryovial was incubated for 1 minute at 37oC and the 
contents added to 2.5ml fresh HMI-9. This was centrifuged at 1500g for 5 minutes to 
remove the glycerol and the pellet resuspended in 10ml fresh HMI-9. Selective drug 
was added to the culture once it was clear that the parasites had survived the 
freeze/thaw cycle. If a bloodstock was thawed the same process was followed, except 





caused the red blood cells to settle to the bottom of the flask and the next day the top 
layer of HMI-9 could be carefully decanted and transferred to a new flask. This 
process was continued until red blood cells were no longer visible in the culture. 
Cells from culture volumes of more than 2ml were counted using a Beckman 
Z2 Coulter particle counter and size analyser (250µl of cells were required/count). 
For cultures of ≤ 2ml, 10µl of cells were removed and counted on a haemocytometer.  
 
Table 2.1: Selective drug concentrations for the T. brucei cell lines used in this study. 
All drugs were acquired from InvivoGen. 
 
 
2.3 cAMP growth assays 
To test differentiation capacity in vitro, cells were exposed to the membrane-
permeable cAMP analogue, 8-(4-chlorophenylthio)-cAMP (8-pCPTcAMP). 
Incubation with 8-pCPTcAMP causes rapid G1 arrest in pleomorphic cells (Laxman 
et al., 2006), but knockdown of a gene involved in the stumpy formation pathway 
would be expected to prevent the cells from G1 arrest as cells remain slender and 
proliferative (Mony et al., 2014).  
Four conditions were tested in triplicate for each cell line: -DOX/-8-
pCPTcAMP; -DOX/+8-pCPTcAMP; +DOX/-8-pCPTcAMP and +DOX/+8-






















pCPTcAMP. On day 0, the cells were seeded at 1x105 cells/ml in a total volume of 
2ml in a 24 well plate. RNAi was induced in the +DOX replicates on day 0 by the 
addition of 1µg/ml doxycycline dissolved in DMSO. The 8-pCPTcAMP was not 
added to the +8-pCPTcAMP samples until 24 hours later to allow sufficient time for 
transcript knockdown. Cell were counted at 24 hour intervals as described in Section 
2.2. Cells were diluted back to ~1x105 cells/ml, when required, to prevent growth 
above 1x106 cells/ml and thus, SIF-mediated arrest. If a population was diluted, 
doxycycline or 8-pCPTcAMP was added to the fresh HMI-9, at the appropriate 
concentration. Cumulative parasite growth was plotted using GraphPad Prism 7.0d 
software. 
 
2.4 Trypanosome infections in mice 
All mice used in this study were MF1 strain females and housed in the 
MARCH Building, University of Edinburgh. MF1 mice are used due to their 
relatively placid nature and large size, thus allowing more material to be collected on 
the final day of infection. MF1 mice are, however, outbred and this can lead to 
experimental variation between infections.  All the infections were performed by 
myself under the PIL number I42D10074, except for those presented in Figure 3.2 
which were kindly performed by Julie Young. All infections were performed 
according to the UK Home Office and Project Licence (PPL number 604373) 
regulations. 
For the generation of slender form bloodstocks, 200µl of HMI-9 containing 
10,000 parasites were injected intraperitoneally into mice. The parasitaemia was 
monitored daily from day 3 onwards by observing for parasites in blood collected on 
a slide from a tail snip. The parasitaemia was estimated using the rapid “matching” 
method described by Herbert and Lumsden (1976). Bloodstock infections were 
terminated when the parasitaemia reached 3.1-6.3x107 slender cells/ml. Terminal 
anaesthesia was induced by placing the mouse in a holding chamber that was then 
flooded with isoflurane. Once the mouse no longer showed a reflex response (as 





chamber and placed on its back with its head in a small cone delivering isoflurane. 
Whole blood was extracted by cardiac puncture into a 2ml syringe containing 200µl 
of 2% citrate to prevent the blood from clotting. After cardiac puncture, experimental 
mice were euthanised by cervical dislocation. 
For analysing trypanosome differentiation competence over the course of an 
infection, infections were established from blood stocks and not in vitro grown 
parasites. The number of cells injected varied depending of the virulence of the 
strain, but ranged from 12,500-750,000 cells diluted in HMI-9 to a total volume of 
200µl. The parasitaemia was monitored daily as previously described. For tracking 
cell cycle status and morphology across the infection time-course, a large drop of tail 
blood was smeared across a microscopy slide that was then air-dried and fixed in ice-
cold methanol. The slides were stored in methanol at -20oC until further use. 
Infections were terminated either when the population had differentiated to stumpy 
forms or, in the case of parasites that had lost their differentiation capacity and 
remained slender, before the parasitaemia became lethal. Blood was extracted by 
cardiac puncture as before. 
Parasites were purified from whole blood by passing the blood through a 
DEAE-C anion exchange column (Whatman) at pH7.8 with PSG buffer (see below). 
At pH7.8, blood is retained on the column whilst the parasites are collected in the 













2.5 DNA cloning 
2.5.1 Genomic DNA extraction 
Genomic DNA (gDNA) was extracted from 5x107-1.5x108 parasites. 
Trypanosomes were pelleted from in vitro culture or DEAE-C column flow-through 
by centrifugation at 1500g for 5 minutes. The pellet was washed three times in sterile 
1X PBS and, after the last wash, the PBS was removed and the pellet was 
resuspended in 150µl TELT lysis buffer (see below) using a wide bore tip. After 5 
minutes incubation at room temperature (great care was taken not to incubate for >5 
minutes), 150µl (1:1 v/v) of water equilibrated phenol/chloroform (Sigma-Aldrich) 
was added. The tube was slowly shaken by hand for 5 minutes before being 
centrifuged at 15000g for 10 minutes. Next, the upper phase was removed and 
transferred to a new tube without disturbing the proteinaceous interface. The 
phenol/chloroform extraction was then repeated as before, isolating the upper phase. 
After the second extraction, 300µl of 100% ethanol was added to the upper phase to 
remove traces of phenol. The tube was mixed by hand for 15 seconds then incubated 
for 5 minutes at room temperature. The tube was then centrifuged at 15000g for 10 
minutes. The supernatant was removed and the pellet washed once more with 100% 
ethanol before being centrifuged at 15000g for 5 minutes. The pellet was dried on a 
bench at room temperature and then resuspended in 20-50µl dH2O containing 
20µg/ml RNase. The DNA content was quantified using a Nanodropä 
Spectrophotometer (Thermo Fisher Scientific). All DNA samples (except for those 
used for whole genome sequencing, see Section 2.18) were stored at -20oC. 
 
TELT Buffer 
50mM Tris-HCl, pH8.0 
62.5mM EDTA, pH9.0 
2.5M LiCl 






If further DNA purification was required, the DNA was precipitated overnight at -
80oC in 0.1 volumes 3M sodium acetate and 2.2 volumes ice-cold 100% ethanol. 
Samples were centrifuged at 15000g for 30 minutes, then washed in ice-cold 70% 
ethanol and centrifuged at 15000g for 20 minutes. The pellet was dried and 
resuspended as before. 
 
2.5.2 PCR 
PCR reactions were performed in 0.2ml PCR tubes (Corning) in a Biometra 
thermocycler. If the purpose of the PCR reaction was to assess the presence of a gene 
or DNA fragment, the GoTaq® G2 DNA Polymerase (Promega) was used according 
to the manufacturer’s instructions. If the PCR product was to be used further for 
cloning or for making a DNA probe, the proof-reading Phusion® High-Fidelity DNA 
polymerase was used according to manufacturer’s instructions. All primers used in 
this study were produced by Sigma-Aldrich and designed using Primer3 software 
(with the exception of the PAC Probe_FWD and PAC Probe_RVS primers, which 
were designed by Dr Federico Rojas) (Koressaar and Remm, 2007; Untergasser et 
al., 2012). Primer Tm was calculated using the following equation, and the PCR 














Table 2.2: Primer sequences used in this study. All sequences are written in the 5’ to 3’ 




2.5.3 DNA agarose gel electrophoresis 
DNA agarose gel electrophoresis was performed to separate and visualise 
DNA fragments. Except for Northern and Southern blot experiments (see Sections 
2.13 and 2.15, respectively), 1% agarose gels were prepared. To prepare a small 1% 
Primer Name Notes Sequence
SPLICED LEADER_FWD Used in VSG-specific RT-PCR to amplify conserved 5' and 3' ends of all VSG mRNAs ACAGTTTCTGTACTATATTG
14MER_RVS TAAGCAGTGTTAAAATATATC





Used in conjunction with PAC Probe_RVS 
AND 3' OUT_RVS primers to verify corect 
integration of the PAC  gene in the VSG 221 ES
TAAGCACTAAGAGCAGTAATAAGTAT
3' OUT_RVS
Used in conjunction with PAC Probe_FWD 
AND 5 'OUT_FWD primers to verify corect 
integration of the PAC  gene in the VSG 221 ES
TAAGCAGCAATATTCCACATCATCA
5' VSG 221_RVS
Used in conjunction with PAC Probe_FWD 
primer to verify corect integration of the PAC 
gene in the VSG 221 ES
TAAGCAAGAACTTGGGCTAGGACCAAGA
HYP2_FWD qRT-PCR primer TAAGCATTGGCCAAACTGTGATGTCG
HYP2_RVS TAAGCACATGCCTGAGATGAACGGTG
NEK_FWD qRT-PCR primer TAAGCAGATGGGGAGAGTATGCGTGA
NEK_RVS TAAGCAAAGGTCGCTGCTTAGGATCA
DYRK_FWD qRT-PCR primer TAAGCACGCGCGTACAGAATTCTCAA
DYRK_RVS TAAGCAGGTGCCCTATGTAGCGTTTG
ZFP3_FWD qRT-PCR primer CAGGGGAAACGCAAAACTAA
ZFP3_RVS TGTCACCCCAACTGCATTCT
NEK21_FWD qRT-PCR primer GCGGTATCTCACTTTGGCTG
NEK21_RVS TAAGCAGATTGTGTCGAGTGGCATCC
TB927.5.4020_FWD qRT-PCR primer TAAGCAGAGCACGGAGGGAATGAAAC
TB927.5.4020_RVS TAAGCATTGCATGTACAGCCCTCTCA
ZC3H20_FWD qRT-PCR primer TAAGCACTGCCTCCGGTACCTCTATG
ZC3H20_RVS TAAGCACATCTCCAAGTGTCACGCTG





Amplify puromycin resistance gene and UTRs 
from pLF12 eGFP_Puro plasmid. FWD and 
RVS primers add VSG 221 ES integration sites. 








BLA_FWD Amplify blasticidin resistance. HindIII 
restirction site
TAAGCAAAGCTTTATGCCTTTGTCTCAAGAAG





agarose gel, 1g of agarose powder (Invitrogen) was dissolved in 100ml of 1X TAE 
buffer (see below) by heating, or for larger 1% agarose gels, 1.5g of agarose was 
dissolved in 150ml of 1X TAE buffer. Once the powder had dissolved, 0.5µg/ml 
ethidium bromide was added and the gel poured into a cast within a gel 
electrophoresis tank. Once the gel had set, the tank was filled with 1X TAE buffer 
and the DNA samples loaded into the wells alongside a 1kB DNA ladder to allow for 
size estimation. The samples were electrophoresed at 120V until the DNA fragments 
were resolved. The DNA was visualised and photographed on a Syngene G:box UV 
transilluminator. 
 





2.5.4 Column DNA purification 
When PCR amplification produced a single band of the correct size, the PCR 
reaction product was purified over a column using the Monarch® PCR & DNA 
Cleanup Kit (New England Biolabs) according to the manufacturer’s instructions. 
The typical final elution volume was 6µl. Products were stored at -20oC for further 
use. 
 
2.5.5 DNA purification from agarose gel 
If a PCR reaction resulted in the amplification of an unspecific product in 
addition to the desired target, the correct DNA amplicon was purified from a DNA 
agarose gel using the Monarch® DNA Gel Extraction Kit (New England Biolabs) 
according to the manufacturer’s instructions. The typical final elution volume was 
6µl. Since a large proportion of DNA is lost during the gel extraction procedure, at 





wells as possible in the agarose gel, to ensure that enough DNA was isolated. Prior to 
cutting, the DNA agarose gel was exposed to long-wavelength UV light for as little 
time as possible to prevent DNA damage. Products were stored at -20oC until use. 
 
2.5.6 Restriction digests 
Genomic DNA or prepared plasmids were digested with the relevant 
restriction enzymes and optimal reaction buffer at 37oC for either 1-3 hours (NEB 
High-Fidelity Restriction Endonucleases only) or overnight for all other restriction 
enzymes, according to the manufacturer’s instructions. Where a digest with 2 
different restriction enzymes was required, and if the reaction buffer was the same 
for both enzymes, the digests were performed simultaneously. If, however, the 
restriction endonucleases required different reaction conditions, sequential restriction 
digests were performed with the DNA being purified over a column (as Section 
2.5.4) between digests. 
 
2.5.7 Ligation 
Ligation reactions were performed using the Roche Rapid DNA Ligation Kit 
according to the manufacturer’s instructions. All ligation reactions were performed in 
triplicate using 1:1, 3:1 and 7:1 insert DNA to vector DNA molar ratios. To calculate 
the nanograms of insert DNA required, the Promega Ligations Calculator was used 
(https://www.promega.com/a/apps/biomath/?calc=ratio). Ligation reactions were 
incubated at room temperature for 1-2 hours before transformation into XL-1 
Escherichia coli competent cells (section 2.5.9). 
 
2.5.8 Preparation of XL-1 Escherichia coli competent cells 
To prepare stocks of XL-1 E. coli competent cells, 5ml of autoclaved LB 
broth was inoculated with 5µl of XL-1 E. coli cells and incubated overnight at 37oC 
in a shaking incubator. The next morning, the 5ml culture was divided into two and 





incubated at 37oC in a shaking incubator until the OD600 was between 0.4-0.5, as 
measured on an Eppendorf Biophotometer. The culture was then divided into 8x50ml 
tubes and the cells harvested by centrifugation at 1000g for 10 minutes at 15oC. Each 
of the pellets was carefully resuspended in 25ml of ice-cold buffer RF1 (see below) 
and then incubated on ice for 1 hour. The cells were again pelleted by centrifugation 
at 1000g for 5 minutes at 4oC and each pellet resuspended in 8ml of ice-cold buffer 
RF2 (see below). The competent cells were then aliquoted in 200-400µl volumes and 
snap frozen in liquid nitrogen before storage at -80oC. Once an aliquot of competent 
cells had been thawed, it was not refrozen for further use. 
 
Buffer RF1   Buffer RF2 
10mM RbCl2   10mM RbCl2 
50mM MnCl2.4H2O  10mM 3-(N-morpholino)propanesulfonic acid (MOPS) 
30mM CH3CO2K  75mM CaCl2 
10mM CaCl2   15% (v/v glycerol) 
10% (v/v) glycerol  pH6.8, autoclave 
pH5.0, autoclave 
 
2.5.9 Transformation of XL-1 Escherichia coli competent cells 
Competent cells were removed from storage at -80oC and thawed on ice 
(100µl of XL-1 competent cells were required per transfection). Approximately 2-
4µl of a ligation reaction or 1µl of a plasmid preparation was added to 100µl of 
thawed cells in a 1.5ml Eppendorf tube and the tube gently mixed. The cells were 
then incubated for a further 20-30 minutes on ice. Cells were heat shocked in a 42oC 
water bath for 40 seconds before immediately being placed on ice for at least 2 
minutes. To allow the cells to recover before selection, 800µl of autoclaved LB broth 
was added and the tube then incubated at 37oC for 45 minutes with occasional 
shaking. 
The pGEMâ-T Easy vector (Promega) used in this study allowed for 





pGEMâ-T Easy vector were recovered at 37oC, 100µl of 2% 5-bromo-4-chloro-3-
indolyl-β-D-galactopyranoside (X-gal) and 2µl of 1M isopropyl β-D-1-
thiogalactopyranoside (IPTG) were spread onto a selective agar plate. The pGEMâ-T 
Easy vector contains a sequence encoding the first 146 amino acids of β-
galactosidase, within which is the multiple cloning site (MCS). The XL-1 E. coli 
cells are lacZΔM15 mutants and therefore cannot produce functional β-galactosidase. 
However, when transformed with an ‘empty’ pGEMâ-T Easy vector, a functional β-
galactosidase enzyme is produced by a-complementation. β-galactosidase hydrolyses 
X-gal and the product of this hydrolysis reaction spontaneously dimerises to produce 
an insoluble blue pigment (Ullmann et al., 1967; Welply et al., 1981). When a 
cloning fragment has been successfully ligated into the MCS of the vector the lacZ 
gene is disrupted and thus no functional β-galactosidase is produced. Therefore, 
bacteria that have been transformed with an empty vector are visualised as blue 
colonies, whilst those that have been transformed with a ligated vector form white 
colonies. 
When a ligation reaction had been used for the transformation, the cells were 
centrifuged at 1000g for 5 minutes and the pellet then resuspended in 100µl of 
autoclaved LB broth. The cells were then spread onto a pre-warmed selective agar 
plate containing 1mg/ml ampicillin and incubated at 37oC overnight. When a 
prepared plasmid had been used, the cells were not centrifuged and 100µl was taken 
directly from the tube and spread onto the plate instead. The next morning the plates 
were removed from 37oC and singular colonies (specifically, white singular colonies 
when blue/white screening was performed) were selected for plasmid preparation 
(see Section 2.5.10).  
 
2.5.10 Plasmid preparation 
For preparation of plasmid DNA, a single bacterial colony was picked from 
selective agar and used to inoculate 10ml of LB broth containing 1mg/ml ampicillin. 
Cultures were grown overnight in a shaking incubator at 37oC. The next morning, 





pellets were resuspended in 300µl of solution I (see below) containing 100µg/ml 
RNase and transferred to a 1.5ml tube. To this, 300µl of solution II (see below) was 
added and the tube mixed several times by hand. After 5 minutes incubation, 350µl 
of ice-cold solution III (see below) was added to the sample. The tube was shaken by 
hand and incubated for a further 5 minutes on ice. The sample was then centrifuged 
at maximum speed for 15 minutes at 4oC, the supernatant removed to a fresh 1.5ml 
tube, and this centrifuged at 15000g for a further 10 minutes at 4oC. The supernatant 
was again transferred to a new 1.5ml tube and 650µl of ice-cold isopropanol added. 
The tube was mixed by inverting several times and then incubated at -20oC for a 
minimum of 15 minutes. The sample was then centrifuged at 15000g and 4oC for 25 
minutes, before the supernatant was removed and the pellet washed in 1ml of ice-
cold 70% ethanol. After a final 5 minute spin at 15000g and 4oC, the pellet was air-
dried and resuspended in 50µl dH2O. 
 
Solution I   Solution II  Solution III 
50mM Glucose  0.2M NaOH  3M Potassium acetate 
25mM Tris, pH8.0  1% SDS  5M Glacial acetic acid 
10mM EDTA, pH8.0 
Autoclave 
 
2.5.11 DNA sequencing 
To confirm ligation of the correct DNA product, prepared plasmids were sent 
for ‘in-house’ sequencing at Edinburgh Genomics, The University of Edinburgh. The 
‘Big Dye Reaction Required’ service was used, and reactions set up as follows: 
1µl plasmid DNA  







2.5.12 DNA mutagenesis 
DNA site-directed mutagenesis was performed using the QuikChange II XL 
Site-Directed Mutagenesis Kit (Agilent Technologies) according to the 
manufacturer’s protocol, with the exception of the final transformation step. Mutated 
plasmids were transformed into XL-1 competent cells (as in Section 2.5.9) and not 
XL10-Gold ultracompetent cells. 
 
2.6 Trypanosome transfections 
The same experimental procedure was followed for transfecting pleomorphic 
and monomorphic cell lines. 
Prior to transfection, 15µg of plasmid DNA (Section 2.5.10) was linearized 
overnight by the relevant restriction enzyme(s) (Section 2.5.6). The restriction digest 
reaction was purified over a DNA purification column (Section 2.5.4) and then 
ethanol precipitated at -80oC overnight as previously described (although two bands 
were produced in the digest reaction the plasmid backbone was not removed since it 
did not contain homologous regions to the trypanosome genome and therefore would 
not integrate instead of the intended DNA fragment). After centrifugation of the 
DNA (Section 2.5.1) the pellet was air dried and resuspended in 10µl of dH2O. 
Overall, 3x107 cells were used for each transfection, including for a ‘no DNA’ 
control transfection that was performed simultaneously. The cells were centrifuged at 
1500g for 5 mins and the pellet washed twice in sterile 1X PBS pre-warmed to 37oC. 
The pellet was resuspended in 50µl of Amaxa Transfection Buffer (Amaxa Basic 
Parasite Nucleofector Kit 2) and 10µl of the linearized DNA. To the ‘no DNA’ 
control, 10µl of sterile dH2O was added instead. The cells and DNA/ dH2O were 
mixed well, transferred to an Amaxa transfection cuvette and electroporated in an 
Amaxa Nucleofector II using the Z-001 programme. The electroporated cells were 
immediately transferred to 25ml of pre-warmed drug free HMI-9 and left to recover 





For the parasites transfected with the DNA, the relevant selective drug was 
added (see Table 2.1) to the flask. The culture was then serially diluted in HMI-9 
medium containing the selective drug in 2ml volumes across the wells of a 24-well 
plate and left for 5-7 days at 37oC. For the negative control, half of the parasites were 
removed from the flask and plated in 2ml volumes into the wells of a 24-well plate. 
This control could confirm that the cells that were transfected did not have 
underlying growth problems. To the remainder of the cells within the culture flask, 
the drug was added and the cells serially diluted across the remaining wells of the 24-
well plate as described previously. Transfectants were identified by microscopy once 
the control cells had died, and were grown for further characterisation. 
 
2.7 Fluorescence microscopy analysis of cell cycle status 
To detect the cell cycle status of trypanosomes, the cells were incubated with 
4’,6-diamidino-2-phenylindole (DAPI), which stains the nuclear and kinetoplast 
DNA. Microscopic analysis of cell cycle status was performed with either in vivo 
derived trypanosomes on methanol-fixed blood smears or paraformaldehyde-fixed in 
vitro derived trypanosomes. 
For methanol-fixed blood smears, the slide was removed from methanol, 
rehydrated in 1X PBS for at least 5 minutes and then stained with ~50µl 10µg/ml 
DAPI in 1X PBS for 2 minutes in the dark. The slides were washed once in 1X PBS 
and mounted with mowiol containing DABCO (see below). The slides were dried 
overnight in the dark and then stored at 4oC until use. 
For the paraformaldehyde fixation of culture derived cells, 1-4x106 cells were 
centrifuged at 1500g, washed twice with 1X PBS and then resuspended in 125µl of 
cold 1X PBS and 125µl of 8% paraformaldehyde. The cells were incubated on ice 
for 10 minutes, centrifuged at 1500g for 5 minutes and the paraformaldehyde 
removed. The cells were resuspended in 130µl of glycine to remove the remainder of 
the paraformaldehyde and stored at 4oC for at least an hour. The cells were then 
centrifuged at 1500g for 5 minutes and the pellet resuspended in 100µl of 1X PBS. 





An 8 well 6mm microscopy slide (Thermo Scientific) was washed with hot 
water, ethanol and distilled water and left to dry at room temperature. To each well, 
15µl of poly-lysine (Biochrom) was added and the slide incubated in a ‘humidity 
chamber’ (a large slide box covered in aluminium foil and filled with wet tissue 
paper). After 15 minutes the wells were rinsed with dH2O and dried at 37oC. 10µl of 
fixed trypanosomes were added to a poly-lysine treated well and incubated for one 
hour inside the humidity chamber at room temperature. After an hour, the excess 1X 
PBS was aspirated from the wells and the affixed cells then stained with 10µg/ml 
DAPI in 1X PBS for 2 minutes at room temperature within the humidity chamber. 
The wells were washed five times with 1X PBS and once the slides were dry they 
were mounted with mowiol containing DABCO, as before.  
 
Mowiol + DABCO 
10% (w/v) mowiol 4-88 reagent (Calbiochem) 
25% (v/v) glycerol 
100mM Tris, pH8.5 
2.5% (v/v) DABCO 
 
The cells were visualised under Zeiss Imager Z2 microscope and 250 counted 
per sample. Images were captured using a QImaging Retiga 2000R Camera and 
edited with ImageJ software (NIH). 
 
2.8 Immunofluorescence analysis 
Immunofluorescence analysis (IFA) was used to detect VSG AnTat1.1 or 
PAD1 expression using specific antibodies. IFA was performed with either in vivo 
derived trypanosomes on methanol-fixed blood smears or paraformaldehyde-fixed in 
vitro derived trypanosomes. For each VSG AnTat1.1 IFA, a positive control (wild 
type T. brucei AnTat1.1 90:13 cells), a negative control (wild type T. brucei Lister 





experiments, the positive controls were T. brucei AnTat1.1 90:13 stumpy cells and 
the for the negative controls, T. brucei AnTat1.1 90:13 slender cells. A ‘secondary 
antibody-only’ control was also included. 
For methanol-fixed blood smears, the slide was removed from methanol, 
rehydrated in 1X PBS for at least 5 minutes and then blocked for 30 minutes in 2% 
BSA/1X PBS in a humidity chamber. The slide was washed once in 1X PBS and 
then incubated for 1-2 hours with the appropriate dilution of primary antibody in a 
humidity chamber. The primary VSG AnTat1.1 antibody (Jay Bangs, USA) was used 
at 1:20,000 diluted in 2% BSA/1X PBS and the primary PAD1 antibody 
(Eurogentec) at 1:1000 diluted in 2% BSA/1X PBS. Excess primary antibody was 
removed and the slide washed for 3x5 minutes with 1X PBS before incubation with 
the respective secondary antibodies for one hour in the humidity chamber. For 
detecting VSG AnTat1.1 and PAD1 expression, an Alexa Fluor® conjugated a-rabbit 
secondary antibody (Invitrogen) was used at 1:1000 and 1:500 diluted in 2% 
BSA/1X PBS respectively. The slide was washed three times with 1X PBS and then 
DAPI stained and mounted as previously described (Section 2.7). 
For VSG AnTat1.1 and PAD1 detection from in vitro derived cells, the cells 
were paraformaldehyde fixed, the microscopy slide poly-lysine treated and the cells 
fixed to the wells as previously described (Section 2.7). The samples were blocked 
for 45 minutes with 2% BSA/1X PBS in a humidity chamber at 37oC. The excess 
block was removed from the wells and the respective primary antibody added to the 
well (antibody concentrations were as used for the methanol fixed cells, see 
Appendix A). After 45 minutes incubation at 37oC within the humidity chamber, the 
wells were washed 5 times in 1X PBS and then incubated for a further 45 minutes 
with the relevant secondary antibody at 37oC within the humidity chamber. The wells 
were washed a further five times with 1X PBS and then DAPI stained and mounted 






2.9 Standalone FACS analysis 
FACS analysis (out with of the FACS-based VSG switch assays) was used to 
quantitate VSG AnTat1.1, VSG 221 or GFP expression within a population of cells. 
For each FACS experiment, a positive control (known VSG AnTat1.1/VSG 221 or 
GFP positive cells), a negative control (wild type T. brucei Lister 427 cells for VSG 
AnTat1.1 staining and wild type T. brucei AnTat1.1 90:13 cells for VSG 221 
staining) and a secondary antibody-only control (except for VSG221 staining where 
the primary antibody was conjugated to a fluorophore) were also analysed to aid 
gating and confirm correct staining.  
For each sample, 2-5x106 culture-derived cells were centrifuged at 1500g and 
washed three times in 1X PBS. If cell viability staining was required, the cells were 
then incubated in 100µl of the appropriate dilution of Zombie NIRä dye (Biolegend) 
for 20 minutes in the dark. T. brucei AnTat1.1 90:13 cells were incubated in a 
1:20,000 dilution of Zombie in 1X PBS and T. brucei Lister 427 cells in a dilution of 
1:50,000 in 1X PBS. An unstained sample served as a control. After viability 
staining, the cells were washed once with 1X PBS to remove excess Zombie stain. 
Washed cells were resuspended in 500µl of FACS fixing solution (2% formaldehyde, 
0.05% glutaraldehyde in 1X PBS). Once in the fix, the cells were incubated 
overnight at 4oC in the absence of light. After fixation the cells were transferred to 
5ml FACS tubes (Corning) and washed three times in 1X PBS. For detection of VSG 
AnTat1.1 expression, the cells were incubated with 200µl of 1:20,000 diluted a-VSG 
AnTat1.1 in 2% BSA/1X PBS for 30 minutes. The cells were washed twice more 
with 1X PBS and then incubated with 200µl of 1:1000 diluted a-rabbit secondary 
antibody conjugated to Cy5 (Jackson ImmunoResearch) in 2% BSA/1X PBS for a 
further 30 minutes. The VSG 221 antibody (Monica Mugnier, USA) was conjugated 
to the Alexa Fluor® 647 fluorophore and therefore only one staining step was 
required. After the block and wash step, the cells were incubated in 200µl of 1:5000 
diluted a-VSG 221/Alexa Fluor® 647 for 30 minutes in the dark. After incubation 
with the respective fluorophores, the cells were washed three times with 1X PBS and 
resuspended in 500µl of filtered 1X PBS. The samples were kept in the dark at 4oC 





Samples were processed on an LSRII Flow Cytometer (BD Biosciences) and 
10,000 events were acquired for each sample. Analysis was performed using the 
FlowJo 10.4.2 software. Fluorescence compensation was applied to the data analysis 
when samples had been stained for VSG AnTat1.1 positivity and cell viability using 
Zombie dye simultaneously. This was because the Cy5 fluorochrome and the 
fluorescent dye had a small region of spectral overlap. The data was filtered using the 
forward (FSC) and side scatter (SSC) profiles to ensure that only intact and singular 
cells were analysed for their fluorescence and the gates for VSG AnTat1.1, VSG 
221, GFP or Zombie dye positivity were determined by the controls and kept 
consistent for each sample within an experimental run.  
 
2.10 RNA extraction 
RNA was extracted from 2-5x107 cells using the Qiagen RNeasyâMini Kit as 
per the manufacturer’s instructions. If the extracted RNA was to be used for RT-
PCR, qRT-PCR, VSGseq or RNAseq applications, then DNase treatment was 
performed using the TURBO DNA-freeTM Kit (Ambion) to remove contaminating 
gDNA. The manufacturer’s protocol was followed using 4U of TURBOTM DNase. 
RNA content was quantified using a Nanodropä Spectrophotometer (Thermo Fisher 
Scientific). All RNA samples were stored at -80oC. 
If RNA clean-up was required, RNA was precipitated overnight at -80oC in 0.1 
volumes 3M sodium acetate and 2.2 volumes ice-cold 100% ethanol. Samples were 
centrifuged at 15000g for 30 minutes, then washed in ice-cold 70% ethanol and 
centrifuged at 15000g for 20 minutes. The pellet was dried and resuspended in 
RNase-free water (Qiagen). 
 
2.11 RT-PCR 
The SuperScriptä III First-Strand Synthesis System (Invitrogen) was used for 
first-strand cDNA synthesis. For each sample, 2 reactions were performed in 





to confirm that the DNase treatment performed after the RNA extraction step was 
sufficient. For VSG-specific RT-PCR reactions, 2pmol of the ‘14MER_RVS’ primer 
(Table 2.2) was used for the first-strand synthesis reaction. For all other RT-PCR 
reactions, 50µM of the oligo(dT)20 primer was used. To each 0.5ml reaction tube, the 
following components were added: 
200ng-1µg RNA 
1µl 10mM dNTP mix 
1µl primer 
RNase free water to a total volume of 13µl 
 
The tube was incubated at 65oC for 5 minutes, before being placed on ice for 
at least one minute. After cooling, the contents of the tube were transferred to a PCR 
tube containing the following: 
4µl 5X first-strand buffer 
1µl 0.1M DTT 
1µl RNaseOUTä 
1µl 200U/µl SuperScript III RT (for -RT samples this was substituted for 1µl dH2O) 
 
In a PCR block, the reaction was incubated for 60 minutes at 50oC. The 
reaction was then inactivated by incubation at 70oC for 15 minutes. To remove RNA 
complementary to the cDNA, 1µl (2U) of E. coli RNase H was added to each sample 
and the tubes incubated at 37oC for 20 minutes. Amplification of double-stranded 
cDNA was performed by conventional PCR (see Section 2.5.2) using gene-specific 







2.12 Quantitative RT-PCR 
Quantitative RT-PCR (qRT-PCR) reactions were performed on a LightCycler 
96 machine (Roche). For each qRT-PCR reaction, single-stranded cDNA, as 
produced in Section 2.10, was used at a concentration of 1:20. Each 25µl reaction 
was set up in triplicate with a corresponding water and -RT control. Transcript 
abundance was quantified relative to the internal control TbZFP3, for which the 
reaction conditions differed. Reactions were set up as below: 
Samples for testing 
12.5µl Power SYBR Green PCR Master Mix (Applied Biosystems) 
1.5µl 10µM FWD primer 
1.5µl 10µM RVS primer 
7µl dH2O 
2.5µl 1:20 diluted single-stranded cDNA 
 
TbZFP3 internal control 
12.5µl Power SYBR Green PCR Master Mix (Applied Biosystems) 
2.25µl 10µM FWD primer 
2.25µl 10µM RVS primer 
1µl dH2O 
7µl 1:20 diluted single-stranded cDNA 
 
The reaction conditions were as follows (a melt curve was added to the end of 
the programme to ensure amplification to a single product): 
10 minutes at 95oC 
40 x (15 seconds at 95oC, 1 minute at 60oC) 






Transcript abundances were quantified relative to ZFP3 using the DDCT 
method and then compared. 
 
2.13 Northern Blot 
Prior to performing the blot, all the required equipment was first washed with 
detergent, rinsed with dH2O, sprayed with 70% ethanol, and then left to air dry. The 
DIG-labelled HYP2, NEK and DYRK RNA probes used in this study were generated 
by Dr Eleanor Silvester, Dr Lindsay McDonald and Dr Paula MacGregor, 
respectively, using the Roche DIG RNA Labelling Kit. 
RNA was prepared as Section 2.9 (for the purposes of a Northern blot, DNase 
treatment was not necessary). For each sample, 1µg of RNA was added to 9µl of 
formamide, 3µl of formaldehyde, 2µl of 10X MOPS and 2µl of RNA loading buffer 
(see below). The samples were incubated on a heat block at 65oC before being loaded 
onto a 1.2% RNA gel (see below). The gel was electrophoresed in 1XMOPS running 
buffer for 90 minutes at 150V. 
 
RNA loading buffer   RNA gel 
30% Formamide   1.2 % Molecular grade agarose (Bioline) 
16.6% Formaldehyde   1X MOPS 
1X MOPS    3% Formaldehyde 
0.01% Bromophenol blue 
10% Glycerol 
 
The RNA gel was stained with 1µg/ml ethidium bromide in 1X MOPS for 15 
minutes before being destained twice with dH2O for at least 30-60 minutes. The 
RNA was visualised and photographed on a Syngene G:box UV transilluminator. 
RNA was transferred overnight to a positively charged nylon membrane 





Briefly, a large plastic box was filled to a level of approximately 3 cm with 10X SSC 
(1.5M NaCl, 0.15M tris sodium citrate). Over this, a flat piece of Perspex was placed 
such that the sides of the box were covered, but a small gap remained at the top and 
bottom of the tray. A sheet of filter paper pre-soaked in 10X SSC was placed over 
the Perspex with its ends positioned through the gaps and into the 10X SSC in the 
box below. The RNA gel was then placed upside down on top of the filter paper, and 
clingfilm used to cover the edges of the box to prevent evaporation of the 10X SSC. 
The positively charged membrane, pre-soaked in 10X SSC was placed on top of the 
RNA gel, followed by two sheets of filter paper soaked in 2X SSC, a block of paper 
towels and a large catalogue to act as a weight.  
 
 
Figure 2.1 Northern Blot Transfer Setup 
 
The next day, the transfer was disassembled and the RNA gel visualised 
under a UV transilluminator in order to confirm that no RNA remained on it. The 
membrane was left to dry at room temperature. A Stratalinker (Uvitec) at 0.12 joules 
was used to UV cross-link the RNA to the membrane. 
The membrane was prehybridised for one hour at 68oC in 10ml of 
Hybridisation buffer (see below) within a Techne Hybridiser HB-1D hybridisation 
oven. After 1 hour incubation, the buffer was removed and 600ng of the appropriate 
RNA probe (which had been boiled in 100µl of hybridisation buffer for 7 minutes 














buffer. The membrane was hybridised overnight at the appropriate temperature. For 






2% DIG Block 
 
After the overnight hybridisation, the probe was removed and the membrane 
washed twice for 30 minutes at hybridisation temperature in 2X SSC/0.1% SDS. The 
membrane was rinsed once more for 30 minutes at hybridisation temperature in 0.5X 
SSC/0.1% SDS. In freshly cleaned plastic boxes, the membrane was rinsed for 1 
minute in wash buffer (see below) and then incubated for 1 hour on a shaker in 50ml 
of Maleic acid buffer (see below) with 1% DIG block. After an hour, 2µl of Anti-
Digoxigenin-AP Fab Fragments (Roche) were added to the blocking solution and the 
membrane incubated for a further 30 minutes with agitation. The membrane was then 
washed for 3x10minutes in wash buffer. 
 
Maleic Acid Buffer  Wash Buffer 
100mM Maleic acid  99.7% Maleic acid buffer 
150mM NaCl   0.3% Tween 20 
pH7.5, autoclave 
 
The membrane was soaked evenly in Detection buffer (see below) for 2 
minutes on a shaker and then placed between two sheets of polyethylene. To the 
membrane, 250µM of CDP-Star chemiluminescent substrate (Roche) in detection 





Star/detection buffer was removed and the polyethylene sheets sealed together. The 
membrane was incubated in the dark at 37oC for 15 minutes and then placed within 
an X-ray cassette and exposed to Super RX Medical X-ray film (Fuji) within a dark 
room. Initially films were exposed for 10 minutes, with further exposure times being 
determined from the result of this exposure. Films were developed on a MI-5 X-ray 
film processor. 
 
2.14 Western Blot 
Western blotting was used to detect the expression of the stumpy-specific 
marker, PAD1, in cells isolated on the final day of an in vivo infection. Once the 
trypanosomes had been purified from blood (see Section 2.4), 4x107 cells were 
centrifuged at 1500g for 5 minutes, washed twice in 1X PBS and then resuspended in 








0.0025% bromophenol blue 
 
PAD1 samples were not boiled prior to resolving on a sodium dodecyl 
sulphate (SDS) gel, but alternatively sonicated for 2x30 seconds using a Bandelin 
Sonorex sonicator. Samples were cooled on ice between sonications. For identifying 
PAD1, a 55kDa protein, 10% resolving gels and 4% stacking gels were prepared (see 
below). The resolving gel was poured between two glass plates (a 0.75 or 1.5mm 
spacer plate and a short plate) that were clamped together using a casting frame and 





plate. The gel was covered in a thin layer of isopropanol and left to set at room 
temperature. Once the resolving gel had set, the isopropanol was removed, the gel 
rinsed with dH2O, and the stacking gel added until it reached the top of the short 
plate. Depending on the number of samples to be resolved, either a 10 or 15-well 
comb was inserted between the two plates, and the gel left to set. Once set, the comb 
was removed, the gel was inserted into the assembled gel running apparatus and the 
tank filled 1X TGS Running Buffer (see below). 
 
10% Resolving Gel  4% Stacking Gel 
375mM Tris, pH8.8  125mM Tris, pH 6.8 
0.1% SDS   0.1% SDS 
10% Acrylamide  4% Acrylamide 
0.4% APS   0.1% Ammonium persulphate 
0.05% TEMED  0.1% TEMED 
APS and TEMED were added last. 
 





For each sample, 4x106 cells/sample were loaded into a well and 
electrophoresed at 140V alongside a Novex Sharp Pre-stained Protein Standard (Life 
Technologies) until the bromophenol blue dye reached the bottom of the gel. Protein 
was transferred from the SDS gel to a nitrocellulose membrane (GE Healthcare) 
using a Bio-Rad Mini Trans-Blot® Cell that was assembled according to the 
manufacturer’s instructions. The tank was filled with 1X Transfer Buffer (see below) 












After the transfer, the membrane was removed from the apparatus and stained 
with Ponceau Red (Sigma-Aldrich) for 5 minutes to confirm that the protein had 
been transferred. The Ponceau stain was removed by incubation with 1X PBS/0.05% 
Tween (PBST) for 1 hour at room temperature with agitation. The membrane was 
blocked for 1 hour at room temperature, or overnight at 4oC, with 5% milk in PBST 
and agitation and after this incubated for a further hour at room temperature, or 
overnight at 4oC, with 1:1000 PAD1 1o antibody diluted in PBST. The membrane 
was then washed for 3x5 minutes in PBST. 
For secondary detection of the PAD1 antibody, the LI-COR Odyssey system 
was used. The membrane was incubated in the dark for 1 hour at room temperature 
with an a-rabbit antibody conjugated to the IRDye® 800CW fluorophore (LI-COR) 
diluted 1:7000 in 50% LI-COR Blocking Solution and 50% PBST. The membrane 
was then washed twice for 5 minutes in PBST and once more in 1X PBS only, with 
agitation, before being scanned using the LI-COR Odyssey Imager. 
EF1a was used as a loading control for the Western blot. Detection of EF1a 
was performed as described for PAD1, however using the anti-EF1a antibody 
(Merck Millipore) at a concentration of 1:7000 and an a-mouse/IRDye® 560CW 
secondary fluorophore conjugated antibody at 1:5000. 
 
2.15 Southern Blot 
The DIG-labelled PAC DNA probe was generated from 1µg of PCR-amplified 
PAC DNA using the DIG High Prime DNA Labelling and Detection Starter Kit II 





For each replicate sample, 1µg of gDNA was digested overnight with the 
appropriate restriction enzyme (in a total volume of 20µl) at 37oC. The next day the 
samples were loaded into the wells of a 0.8% agarose gel, alongside a DNA ladder, 
and electrophoresed at 120V until they had run approximately two-thirds of the way 
down the gel’s length. The fragments were visualised under a UV transilluminator 
and a photo taken with a ruler aligned to the bottom of the wells and parallel to the 
DNA ladder (this acted as a reference for band size once the membrane was probed 
and detected). The gel was then soaked in at least 300ml of Denaturation Solution 
(see below) for 2x15mins with agitation, washed with dH2O, and then soaked for a 
further 2x15 minutes in Neutralisation Buffer (see below). 
 
Denaturation Solution   Neutralisation Solution 
1.5M NaCl    1M Tris 
0.5M NaOH    1.5M NaCl 
     pH 7.4 
 
Transfer of the DNA to a positively-charged membrane, and the subsequent 
UV cross-linking of the DNA to the membrane, was set up exactly as described for 
Northern blotting in Section 2.12.  
The membrane was pre-hybridised with 10ml/100cm2 membrane of pre-
heated DIG EASY HYB Granules (Bottle 7 of DIG High Prime DNA Labelling and 
Detection Starter Kit II, Roche) for at least 30 minutes at 55oC. During the pre-
hybridisation stage, 25ng/µl PAC probe in a volume of 50µl was denatured by 
boiling at 95oC for 5 minutes and then rapidly chilled on ice. After 30 minutes the 
hybridisation solution was poured off and replaced with 7ml fresh hybridisation 
solution containing the denatured probe. The membrane was hybridised overnight in 
a hybridisation oven at 55oC. The membrane was washed twice for 5 minutes at 
room temperature in 2X SSC/0.1% SDS with agitation and then returned to the 





Immunological detection of the membrane-bound probe was performed exactly 
as described for Northern blotting in Section 2.12. 
 
2.16 FACS-based VSG switch assays 
2.16.1 Growth phase 
For each experiment, a 30ml logarithmic culture was grown to ~1x106 cells 
and 2x107 cells were removed and fixed for FACS analysis as described in Section 
2.9. From the remaining culture, 1ml was diluted to 6 cells/ml in a volume of 10ml 
(for one experimental condition only) or 20ml (for –/+ DOX comparisons). 10ml was 
spread over a single 96-well plate in 100µl volumes using a multichannel pipette. For 
-/+ DOX comparisons, 10ml of uninduced cells were plated first and 1µg/ml 
doxycycline then added to the remaining 10ml of cells before they were plated out 
over another 96-well plate. The plates were incubated at 37oC and scored for positive 
wells by microscopy after 3-6 days. Typically, each plate returned 5-12 positive 
wells. 
Once the populations were judged by eye to be dense enough for dilution (but 
not exceeding 1x106 cells/ml), three wells were selected to be ‘scaled-up’ in parallel 
in increasing volumes of HMI-9 until there were at least 2x107 cells. For +DOX 
samples, doxycycline was added to the fresh HMI-9 upon culture dilution. The cells 
were washed and fixed for FACS analysis as described in Section 2.9.  
2.16.2 FACS analysis 
Flow cytometry was used to quantitate VSG AnTat1.1 or VSG 221 and GFP 
expression within a population of cells. For each FACS experiment staining controls, 
as described in Section 2.9, were used. For the positive control, 2x107 cells were 
fixed and processed for analysis, whereas 2-5x106 cells were fixed and processed for 
the negative and ‘secondary only’ controls. Each sample was processed for flow 
cytometry as described in Section 2.9, except that the blocking and antibody steps 
were performed in volumes of 1ml. The labelled cells were resuspended in 1ml of 





Absolute Counting Beads (Thermo Fisher Scientific) were added. The number of 
beads within this 40µl varied depending on Lot number, but was typically ~5x104. 
To ensure statistical significance, at least 1,000 bead events were collected per 
experimental sample. Samples were processed on an LSRII Flow Cytometer (BD 
Biosciences) and 1,000,000 events were acquired for each experimental sample and 
the positive control. 10,000 events were collected for the negative and secondary 
only controls.  
2.16.3 Data interpretation 
Analysis was performed using the FlowJo 10.4.2 software. The data was 
filtered using the forward (FSC) and side scatter (SSC) profiles to ensure that only 
intact and singular cells were analysed for their fluorescence.  
The first gate to be applied to the population was that determining VSG 
AnTat1.1 or VSG 221 positivity. To aid gating, the relevant negative, secondary 
antibody-only (for VSG AnTat1.1 staining only) and ‘Day 0’ positive controls were 
used. The VSG AnTat1.1/221 gates were placed directly to the left of the positive 
control peak to account for cells taking up to 4.5 days to fully replace their VSG 
surface coat following a genetic switch. The cells gated as VSG AnTat1.1 or VSG 
221 negative were next analysed for GFP positivity. A similar gating strategy to that 
used to define VSG AnTat1.1 or VSG 221 positivity was used to interrogate GFP 
positivity since, like a VSG coat taking time to be fully replaced, GFP fluorescence 
would not immediately dissipate following an in situ switch of VSG expression. 
Therefore, the gate defining GFP positivity or negativity was placed directly to the 
left of the ‘Day 0’ positive control peak. Gating was kept consistent between samples 
of the same experiment. 
To calculate the number of VSG switches/cell from the FACS data, the method 
described by Schulz et al. (2016) was followed. To convert this value to VSG 
switches/cell/generation, the number of VSG switches per cell was divided by the 
number of population doublings that were calculated in Section 2.16.1 The number 
of VSG AnTat1.1 or VSG 221 negative and GFP positive cells was divided by the 





of cells that had switched VSG expression by DNA recombination downstream of 
the GFP reporter construct. 
 
2.17 VSGseq workflow 
VSGseq analysis was performed in collaboration with Dr Monica Mugnier 
(Johns Hopkins Bloomberg School of Public Health, USA). Parasite growth, 
magnetic activated cell sorting (MACS) and RNA extraction was performed at the 
University of Edinburgh, whilst the RT-PCR, library preparation and sequencing 
were performed at the Johns Hopkins Bloomberg School of Public Health. The 
pipeline used for data analysis (Section 2.17.5) was developed by Dr Monica 
Mugnier. 
2.17.1 Growth phase 
Triplicate populations of -/+ DOX GFPESproAnTat1.1ES HYP2, NEK and 
DYRK RNAi cells were expanded from a single cell as described in Section 2.17. 
However, since a greater number of cells were required, one further ‘scale-up’ step 
was performed, bringing the final culture volume to 125ml. 
2.17.2 Magnetic-activated cell sorting 
Magnetic-activated cell sorting (MACS) was performed to enrich populations 
of GFPESproANTat1.1ES cells for cells that did not express VSG AnTat1.1. The 
MACS protocol for the depletion of VSG2 from an in vitro culture of T. brucei Lister 
427 cells (Schulz et al., 2016) was followed with the following alterations: an a-
VSG AnTat1.1 antibody was used at a concentration of 1:50; cells were resuspended 
in 180µl of the primary antibody dilution instead of 150µl; cells were rotated on an 
orbital wheel at 4oC and not vortexed; 120µl of anti-rabbit magnetic-activated cell 
sorting microbeads (Miltenyi Biotec) were used instead of 110µl; and, where the 
number of cells after pre-MACS RNA, IFA and FACS sample extraction was >1x108 
cells, samples were equally split in two and loaded onto two separate columns (to 
prevent overloading of the column and contamination of the flow-through with VSG 





flow-through, 1ml was washed and fixed for IFA analysis of VSG expression 
(Section 2.8) and the remainder used for the post-MACS RNA extraction (Section 
2.17.3). 
2.17.3 RNA preparation and glycogen precipitation 
RNA was extracted from 25ml of each of the pre-MACS populations and 
from the entirety of the MACS flow-throughs (after the removal of 1ml cells for IFA, 
Section 2.17.2) as described in Section 2.10. The final elution was performed with 
30µl of RNase-free dH2O. 
To purify and concentrate the pre-MACS RNA samples, the RNA was 
ethanol precipitated and resuspended in 10µl RNase-free dH2O as described in 
Section 2.10. To aid in the recovery of the low concentrations of nucleic acids 
present in the post-MACS RNA samples, each of the post-MACS RNA samples 
were co-precipitated with the nucleic acid carrier glycogen (Thermo Scientific) in the 
following reaction: 
30µl RNA 
3µl 3M Sodium acetate 
0.75µl 20mg/ml glycogen (Thermo Scientific) 
75µl 100% ice-cold ethanol. 
 
The samples were incubated overnight at -80oC and the RNA then pelleted 
and resuspended in 10µl RNase-free dH2O as before. 
2.17.4 RT-PCR and library preparation 
First strand cDNA was produced using the SuperScriptä III First-Strand 
Synthesis System (Invitrogen), but with different reaction conditions to those 
detailed in Section 2.11. No ‘without reverse transcriptase’ reaction was performed. 







8µl of RNA 
1µl of 2mM VSG 3’ UTR primer 
1µl dNTP mix 
 
The samples were incubated at 65oC for 5 minutes and then cooled on ice for 
at least 1 minute. After cooling, the following synthesis mix was added to each 
reaction tube: 
2µl RT Buffer 
4µl 25mM MgCl2 
2µl 0.1M DTT 
1µl 40U/µl RNaseOUT 
1µl 200U/µl Superscript III RT 
 
The samples were incubated for 10 minutes at 25oC, followed by 50 minutes 
at 50oC. The reaction was terminated by incubation at 85oC for 5 minutes. To each 
sample, 1µl of RNase H and 1µl of RNase A (Qiagen) were added, followed by 30 
minutes incubation at 37oC. Reaction purification was performed using the AMPure 
RNAclean XP Kit (Beckman Coulter) according to the manufacturer’s instructions. 
The final elution was performed with 32µl of dH2O. To synthesise double-stranded 
cDNA from the first strand synthesis products, the following reaction was set up for 
each sample in 0.2ml PCR tubes: 
32µl single strand cDNA 
10µl Phusion HF buffer 
1µl 10mM dNTPs 
2.5µl 10µM 14mer-SP6 oligo 
2.5µl 10µM SL oligo 
1.5µl DMSO 





The samples were put into a thermocycler with the following programme: 
 
98oC  30 seconds 
98oC  10 seconds 
55oC  10 seconds     x22 cycles 
72oC  45 seconds 
72oC   5 minutes 
 
The PCR reactions were purified using the AMPure XP Kit (Beckman 
Coulter) according to the manufacturer’s instructions, with the final elution being 
performed in 30µl dH2O. DNA was quantified using the Qubit HS dsDNA assay kit 
(Thermo Fisher) according to the manufacturer’s instructions. 
For library preparation, the NextEra XT Library Preparation system 
(Illumina) was used according to the manufacturer’s protocol. The NextEra Library 
Preparation Kit uses engineered transposomes to tagment double-stranded gDNA. 
Tagmentation is a process whereby gDNA is fragmented and tagged with adapter 
sequences simultaneously. The limited-cycle PCR uses the adapter sequences to 
amplify the DNA, whilst also adding the index adapter sequences onto both of the 
DNA that allow for the dual-indexed sequencing of pooled libraries on Illumina 
sequencing platforms (Illumina, 2018). The PCR reaction was cleaned up using the 
AMPure XP system as before, with the final elution being performed in 27µl of 
resuspension buffer. 
The libraries were pooled such that 0.02pmol of each library was present in a 
mixture volume of 103.5µl. The pooled libraries were loaded onto a single Illumina 
Flow Cell and 100bp single-end sequencing was performed in-house on an Illumina 
HiSeq 2500. 
2.17.5 VSGseq data processing 






was kindly performed by Dr Monica Mugnier. Adapters (from the tagmentation step) 
and SP6 sequences (from the VSG PCR step) were trimmed using trim_galore 
(Babraham Bioinformatics) and cutadapt (Martin, 2011), respectively. Sequencing 
reads were assembled by Trinity (Grabherr et al., 2011) and ORFs (defined as a start 
codon to stop codon or a start codon to the end of a contig) of >900bp identified. 
These ORFs were compared against the T. b. brucei EATRO1125_vsgs reference 
database (http://129.85.245.250/Downloads/vsgs_tb1125_all_atleast150aas_cds.txt) 
using BLASTn to identify VSG sequences. Sequences that matched chromosomal 
sequences or non-VSG sequences were removed.  
Since the Bowtie alignment programme (used later in the pipeline) cannot 
distinguish between VSG sequences with >98% sequence similarity using this 
pipeline’s parameters, VSGs with >98% sequence identity were merged using cd-hit-
est (Weizhong and Godzik, 2006). These final merged contigs represented an 
individual VSG, which was included in the reference genome. The reads for each 
sample were aligned to the reference genome using Bowtie, allowing for only 
uniquely mapping reads and no more than 2 mismatches per read. The output 
MULTo analysed csv. file showed the expression of each VSG in each sample, both 
in terms of RPKM (reads per kilobase of transcript, per million mapped reads) and 
percentage of the population (RPKM for that VSG/total RPKM), and the BLAST 




For the RNAseq analysis, RNA was prepared from triplicate populations of the 
parental ‘Start’ GFPESproAnTat1.1ESpro NEK RNAi cells, the monomorphic ‘End’ 
GFPESproAnTat1.1ESpro NEK RNAi cells and two intermediate samples from the 
passage time-course, named INT1 and INT2 respectively.  
The cells were seeded at 2x103 cells/ml in 50ml HMI-9 medium (except for the 
selected monomorphs which were seeded at 1x103 cells/ml due to their shorter 





exceeded 6.8x105 cells/ml and therefore it is highly unlikely that any differences in 
gene expression between the pleomorphic and monomorphic cells are due to a 
density-dependant response to the accumulation of SIF in the pleomorphic 
populations. After 48 hours, the contents of the flasks were centrifuged and RNA 
prepared and TURBOTM DNase treated as described in Section 2.10. RNA quality 
was checked by electrophoresing 200ng of RNA for each sample on an RNA 
formaldehyde gel (Section 2.13) and RNA quantity was determined by a Nanodropä 
Spectrophotometer (Thermo Fisher Scientific). Samples were stored at -80oC until 
shipment. 
For each replicate, at least 1.3µg of RNA was sent to BGI Tech Solutions 
(Hong Kong) for sequencing using the ‘Eukaryotic Transcriptome Resequencing 
HiSeq 4000 PE100’ service. 4Gb of clean data was generated for each RNA sample. 
Raw RNA sequencing data was kindly processed by Dr Alasdair Ivens. Quality 
control of the raw data was performed using the Fast QC programme (Babraham 
Bioinformatics), and paired end reads were trimmed using cutadapt (Martin, 2011). 
Reads were aligned to the T. b. brucei TREU927 genome using Bowtie 2 (Langmead 
and Salzberg, 2012) to obtain counts for the number of reads that mapped to each 
gene. These counts were normalised to the reads per kilobase of transcript per 
million mapped reads (RPKM) to account for gene size and read depth. Group-wise 
comparisons between the ‘Start’, ‘INT1’, ‘INT2’ and ‘End’ datasets were performed 
using the software package limma (Ritchie et al., 2015). 
 
2.19 Identification of single nucleotide polymorphisms 
For the identification of single nucleotide polymorphisms (SNPs) DNA was 
prepared from a single parental ‘Start’ GFPESproAnTat1.1ESpro NEK RNAi population 
and a the monomorphic ‘End’ GFPESproAnTat1.1ESpro NEK RNAi population.  
The parental pleomorphic population was seeded at 2x103 cells/ml in 100ml 
HMI-9 medium and the selected monomorph population at 1x103cells/ml in 100ml 
HMI-9 medium. The cells were cultured for 48 hours at 37oC before the contents of 





2.5.1. DNA quality was assessed by electrophoresing 500ng of DNA for each sample 
on an agarose gel (Section 2.5.3) and DNA quantity was determined by a 
Nanodropä Spectrophotometer (Thermo Fisher Scientific). 
For each replicate, >2µg of DNA was sent to BGI Tech Solutions (Hong 
Kong) for whole genome sequencing (WGS) using the ‘Illumina plant and animal 
whole genome resequencing HiSeq 4000’ service. At least 30X genome coverage 
was generated for each DNA sample. 
The processing of raw sequencing data, identification of SNPs/Indels and 
mapping of SNP regions to the reference T. b. brucei TREU927 genome were kindly 
performed by Dr Alasdair Ivens. Reference ‘Start’ and ‘End’ genome assemblies 
were made using CLC Assembly Cell (Qiagen). The ‘Start’ and ‘End’ reads were 
mapped to the reference ‘Start’ genome using Bowtie 2 (Langmead and Salzberg, 
2012) and SNPs/indels called using SAMtools (Li et al., 2009). A Variant Call 
Format (VCF) (Danecek et al., 2011) file was generated from the SNP/indel scan 
output and a QUAL score cut-off (the Phred-scaled probability that a polymorphism 
exists at a given site) of 200 applied to the data. For each SNP, a 301bp region (the 
SNP and 150 base pairs to either side) were mapped to the T. b. brucei TREU927 
reference genome so that they could be viewed in the context of annotation.  
 
2.20 Statistical analysis 
All statistical analysis performed in this thesis used the GraphPad Prism 7.0d 








3 : COMPARING THE VSG SWITCH 
RATE OF PLEOMORPHIC AND 
INDUCIBLY MONOMORPHIC 









Studies of trypanosome antigenic variation preferentially investigate 
laboratory-adapted cell lines which are antigenically homogenous and exhibit high 
levels of antigen stability. These trypanosomes have been cyclically passaged 
through laboratory rodents, thus selecting against tsetse transmission potential and 
generating highly virulent populations of monomorphic trypanosomes. In the 
relatively few studies of antigen switch frequency in recently isolated pleomorphic 
parasites, it has been estimated that the transmission-competent cells switch their 
expressed VSG at a rate 66,000-fold greater than laboratory adapted trypanosomes 
(Turner and Barry, 1989). It is not yet known if this loss of stumpy differentiation 
capacity is directly linked to reduction in VSG switch frequency, or whether the two 
processes, though both selected by multiple passage, are in fact independent. 
Mony et al. (2014) identified components of the stumpy formation signalling 
pathway through a genome-wide RNAi screen, and demonstrated that their inducible 
gene silencing by RNAi caused pleomorphic parasites to remain slender in vivo, 
despite the accumulation of SIF. These RNAi cell lines therefore provide us with a 
tool to switch pleomorphism ‘on’ or ‘off’ inducibly, without long term passage. By 
exploiting this inducible monomorphism model, we can interrogate antigen switch 
frequency in the same cell lines, but where the populations are either differentiation 
competent or incompetent. By these means we can establish whether antigen switch 
frequency is intimately linked to the developmental quorum-sensing interactions of 
the parasite in the mammalian bloodstream. 
 
3.2 Inducible knockdown of HYP2 and DYRK generated 
inducibly monomorphic trypanosome populations 
Pleomorphic T. brucei RNAi cell lines were studied, whereupon induction of 
RNAi against a particular gene involved in the stumpy formation signalling pathway 
‘turned off’ the capacity for the production of stumpy forms (Mony et al., 2014). 





genes identified by Mony et al. (2014) as conferring insensitivity to SIF when 
knocked down in pleomorphic parasites in vivo. HYP2 is a potential effector 
molecule within the signalling pathway. Whilst the protein shares no obvious 
homology with known genes, a DksA zinc finger motif, involved in the regulation of 
bacterial ribosomal RNA transcriptional responses to oxidative and nitrosative stress 
and the post transcriptional control of quorum sensing dependent genes, is present 
(Henard et al., 2014; Jude et al., 2003; Mony et al., 2014). DYRK is a dual-
specificity tyrosine-phosphorylation-regulated kinase which likely functions as a 
signal transducer upstream of the effector molecule HYP2. The DYRK family of 
kinases are an evolutionarily conserved family in which many members function in 
signalling pathways integral to cellular development and homeostasis (Aranda et al., 
2011). Saccharomyces cerevisiae YAK1, the founding member of the DYRK family, 
has been shown to be a negative regulator of cell proliferation and overexpression of 
Dictyostelium discoideum YAKA causes cell-cycle arrest (Garrett et al., 1991; Soppa 
and Becker, 2015). McDonald et al. (2018) recently used an extragenic suppression 
approach in pleomorphic trypanosomes to demonstrate that NEK17 and protein 
phosphatase 1 (PP1) driven stumpy formation was DYRK dependent, whilst RBP7 
driven stumpy formation was DYRK independent (Figure 1.11). 
To generate HYP2 and DYRK RNAi cell lines, Mony et al. (2014) designed 
RNAi target fragments using the RNAit software (Redmond et al., 2003), amplified 
the sequences from T. brucei AnTat1.1 90:13 gDNA and then cloned the fragments 
into the pALC14 stem-loop plasmid (Bochud-Allemann and Schneider, 2002; Mony 
et al., 2014). The cloned plasmids were then transfected into T. brucei AnTat1.1 
90:13 cells by electroporation. These lines were recovered from storage at -80oC and 
used for this study. 
3.2.1 Knockdown of HYP2 or DYRK in pleomorphic cells conferred 
partial resistance to a cAMP analogue 
To validate the inducibility of the RNAi response, and the concurrent loss of 
stumpy formation capacity upon induction, logarithmic populations of HYP2 RNAi 
and DYRK RNAi cells were grown in triplicate either in the absence or presence of 





100µM of the SIF mimic, 8-pCPTcAMP. Incubation with 8-pCPTcAMP causes 
rapid G1 arrest and limited expression of stumpy-specific genes in both pleomorphic 
and monomorphic trypanosome strains (Laxman et al., 2006). Upon the induction of 
HYP2 or DYRK RNAi, cells would be expected to show reduced responsiveness to 8-
pCPTcAMP, since these genes form parts of the stumpy formation signalling 
pathway. No growth effect was observed in either of the two RNAi lines upon 
incubation with doxycycline alone (Figure 3.1). Uninduced cells grown in the 
presence of 8-pCPTcAMP showed significant growth inhibition following 24hours 
exposure, thus demonstrating that the RNAi remained regulatable, but this growth 
inhibition was only partially relieved upon induction of RNAi against HYP2 or 
DYRK. The induced HYP2 RNAi population remained proliferative when grown in 
the presence of 8-pCPTcAMP, albeit replicating at a slower rate than the untreated 
population. In contrast, growth in the induced DYRK RNAi population stopped after 
48 hours incubation with the SIF mimic indicating limited resistance to 8-




Figure 3.1 Induction of HYP2 and DYRK RNAi in vitro confers partial 8-pCPTcAMP 
resistance. In vitro growth of HYP2 (left) and DYRK (right) RNAi cell lines in the 
presence/absence of doxycycline (-/+DOX) and 8-pCPTcAMP (-/+ cAMP). 8-pCPTcAMP 
was added 24 hours post doxycycline addition. Induced HYP2 RNAi cells were partially 
resistant to 8-pCPTcAMP mediated cell cycle arrest, whereas the DYRK RNAi cells only 
showed very low levels of resistance to the compound. Data represents the mean±S.D (n=3). 
 










































3.2.2 Induction of HYP2 or DYRK RNAi in pleomorphic cells 
generated differentiation defective cells in vivo 
Since the induced RNAi lines still retained some responsiveness to 8-
pCPTcAMP in vitro, the cells were tested in vivo for their SIF-mediated 
differentiation competence upon knockdown of HYP2 or DYRK. Triplicate untreated 
and doxycycline-treated female MF1 mice were infected with either HYP2 or DYRK 
RNAi cells and observed for their parasitaemia. An untreated ‘control’ mouse was 
infected with the parental AnTat1.1 90:13 cells. Blood samples were taken for 
estimation of the parasitaemia by the rapid ‘matching’ method (Herbert and 
Lumsden, 1976) from day 3 onwards. The uninduced HYP2 RNAi cells restricted 
their parasitaemia from ~ day 4 onwards (Figure 3.2a) and transformed 
morphologically to stumpy forms, characterised by their undulating membrane, 
attached flagellum and stumpy appearance (Figure 3.2b, left panel). Induced HYP2 
RNAi cells also showed a plateau in growth, however at approximately 2-fold greater 
parasitaemia than the uninduced cells. On the final day of infection, the induced 
population consisted of morphologically slender, intermediate and stumpy cells 
(Figure 3.2b, right panel). Consistent with the presence of stumpy cells, Western 
blotting detected PAD1 expression in protein isolated from cells purified from the 
blood on day 6 of infection, though at a slightly lower level in the induced cells 
relative to the uninduced cells (Figure 3.2c). Blood smears were fixed in methanol 
from day 3 onwards, and used to assess the cell cycle status of 250 cells. Cells in G1 
adopt a 1K1N (1 kinetoplast, 1 nucleus) configuration. As cells progress through the 
cell cycle however, they first replicate their kinetoplast, becoming 2K1N, followed 
by their nucleus, now 2K2N, before finally dividing. Both groups of cells 
accumulated in 1K1N as the infection progressed, though this was more rapid in the 
uninduced cells (Figure 3.2d). Nonetheless, the failure of the induced cells to fully 
arrest in G0/G1, their diminished expression of PAD1 compared to the uninduced 
cells and their slender morphology despite being at greater parasitaemia than the 
uninduced cells, together suggests that the HYP2 RNAi cells have reduced their 





The differentiation phenotype observed in the DYRK RNAi line upon 
induction in vivo was much stronger. Whilst the uninduced cells transformed 
morphologically to stumpy forms from day 4 onwards (Figure 3.2f, left panel), the 
induced cells remained proliferative, with the parasitaemia continuing to rise until 
the experiment had to be ended on humane grounds on day 5 (Figure 3.2e). The 
induced cells retained the typical long slender morphology and free flagellum 
associated with proliferative bloodstream forms (Figure 3.2f, right panel). PAD1 
Western blot analysis confirmed that the induced cells had remained slender, since 
much lower levels of the stumpy-specific marker could be detected compared to the 
arrested uninduced population (Figure 3.2g). The proportion of the induced 
population in the 1K1N/2K1N configuration remained constant throughout the 
infection time course, whereas the uninduced cells accumulated in 1K1N as they 
differentiated in response to SIF (Figure 3.2h).  
Over decades of laboratory adaptation, monomorphic cell lines have lost the 
capacity to respond to SIF and form transmission competent stumpy forms. The in 
vivo data presented here demonstrates that, upon HYP2 or DYRK RNAi induction, 
cells are unable to fully transduce the SIF signal and have thus become inducibly 
monomorphic. This manifests as the inability to restrict parasitaemia in response to 
SIF, the retention of slender morphology and the reduced expression of PAD1 at 







Figure 3.2 Induction of HYP2 and DYRK RNAi reduces differentiation capacity in vivo 
(a) In vivo growth of HYP2 RNAi cell lines. Sucrose water containing 1µg/ml doxycycline 
was supplied to two mice from day -1 to induce RNAi. The remaining three mice were 
supplied with sucrose water alone. The parasitaemia was estimated from a blood smear taken 
at 24 hour time points from day 3 onwards. The mice were sacrificed before the parasitaemia 




























































































































































grew to a higher parasitaemia than the uninduced cells. (b) On day 6 of infection, uninduced 
cells displayed the typical morphological characteristics of stumpy cells. In contrast, 
morphologically slender, intermediate and stumpy forms were found in the induced 
population. Bar, 10µm. (c) Western blot detection of PAD1. Protein was prepared from 
4x106 cells which were purified from the blood on day 6. The T. brucei AnTat1.1 90:13 
parental cells which had arrested as stumpy forms were used as a stumpy form control (ST). 
Induced cells expressed PAD1 to a slightly lesser extent than the arrested uninduced cells. 
(d) Cell cycle analysis. Blood smears were fixed in methanol from day 3 onwards for at least 
24 hours, then stained with DAPI to visualise the kinetoplast and nucleus. Uninduced cells 
accumulated in G1/G0, seen as an accumulation of 1K1N cells. Induced cells still 
accumulated in G1/G0, though at a slower rate than uninduced cells. 250 cells were counted 
for each replicate. (e) In vivo growth of DYRK RNAi cells. Infections were performed and 
monitored as described for the HYP2 RNAi infection. The mice were sacrificed before the 
parasitaemia became lethal and the trypanosomes purified from the blood on day 5. The 
induced cells did not arrest in response to SIF and continued to proliferate. (f) Morphology 
of methanol-fixed cells from day 5 of infection. RNAi knockdown of DYRK caused retention 
of slender morphology, whilst cells with an intact stumpy formation pathway became 
morphologically stumpy. Bar, 10µm. (g) Western blot detection of PAD1. Protein was 
prepared from 4x106 cells isolated on day 5 of infection. Induction of DYRK RNAi reduced 
the expression of PAD1 compared to uninduced cells. (h) DAPI cell cycle analysis. 
Uninduced cells arrested in G1/G0 as they differentiated, whilst the proportion of induced 
cells in a 1K1N configuration remained relatively constant. 250 cells were counted per 
infection. 
 
3.3 VSG AnTat1.1 was the actively expressed VSG in HYP2 
and DYRK RNAi cells 
Before beginning to design and optimise an assay to interrogate VSG 
switching, it was important to determine which VSG(s) the HYP2 and DYRK RNAi 
lines were expressing, and whether the populations were homogenous or 
heterogeneous with regard to their VSG expression. Identification of the actively 
expressed VSG would facilitate the generation of both ES targeting and VSG 





sequences termed the spliced leader (SL) and 14-mer, respectively (Figure 3.3a) 
(Marcello and Barry, 2007). This allows for the specific amplification of single-
stranded VSG cDNA from total RNA using a primer specific to the 14-mer, which 
itself can then be amplified by conventional PCR using primers targeting the SL and 
14-mer.  
Total RNA was isolated from 5x107 HYP2 or DYRK RNAi cells which had 
been purified from the blood in Section 3.2.2. To control for the efficiency of the 
reverse transcriptase step, an oligo(dT)20 primer was used for single-stranded cDNA 
production instead of the VSG specific 14-mer. This permitted the use of primers 
amplifying a 500bp fragment of actin in the PCR step. Double-stranded VSG cDNA 
was generated as described in Section 2.11, and 10µl of product run on an ethidium 
bromide stained agarose gel. Figure 3.3b shows the results for the DYRK RNAi line. 
The RT-PCR products for the SL and 14-mer primer pair run as a larger ~1600bp 
fragment, with a faint smaller band running directly below it. Fragments of these 
sizes are within the 1500-2000bp range that would be expected for an intact VSG, 
and the presence of two bands most likely represents two different VSGs. The band 
did not change in size upon the induction of RNAi and nor was it different to the 
parental AnTat1.1 90:13 population. The band sizes were consistent with those 
visualised for the HYP2 RNAi line also (data not shown). The positive control 
produced the expected 500bp band size. Minus reverse transcriptase samples (-RT) 
did not produce an RT-PCR product and therefore confirmed that the starting RNA 
samples were not contaminated with DNA. 
The RT-PCR products were purified from the PCR reaction mix before the 
addition of A-overhangs. These allowed the products to be cloned into the T-
overhangs of the pGEM T Easy Vector (Promega). 21 clones were obtained, and 
their DNA digested with EcoRI (Figure 3.3c). Digest products were run on an 
agarose gel and stained with ethidium bromide. The digest products of 18 of the 21 
clones consisted of a 3kB fragment (digested pGEM T Easy Vector) and two smaller 
fragments of ~1000bp and 600bp, examples of which are seen in lanes 4 and 6 of 
Figure 3.3c. The coding sequences for VSG AnTat1.1 and VSG AnTat1.8 have 





contained an internal EcoRI restriction site (Pays et al., 1980). It therefore seemed 
likely that the identity of this VSG was VSG AnTat1.1. EcoRI digest of the plasmid 
DNA acquired from the three remaining clones also produced a 3kB pGEM T Easy 
fragment, however the cloned fragments were ~1500bp (Lane 2 of Figure 3.3c), 
1750bp and 2000bp in length, respectively. The DNA from these three clones, and 5 
of the former clones, was sent for sequencing to identify the expressed VSGs. 
BLAST analysis confirmed that the five sequences obtained for the RT-PCR 
products which gave the double-band profile upon digestion with EcoRI, and were 
expressed by the majority of the populations, matched that of VSG AnTat1.1. The 
sequences obtained for the three clones which did not have internal EcoRI digest 
sites did not match that of VSG AnTat1.1 nor VSG AnTat1.8, however the SL and 
14-mer were identified, therefore confirming that the cloned fragments were really 
VSG RT-PCR fragments. Immunofluorescence analysis of HYP2 and DYRK RNAi 
populations stained with an a-VSG AnTat1.1 antibody confirmed the findings of the 







Figure 3.3 Sequencing of RT-PCR products and diagnostic digests identify VSG 
AnTat1.1 as the primarily expressed VSG in the HYP2 and DYRK RNAi populations 
(a) All mature VSG mRNAs are flanked at their 5’ and 3’ ends by the conserved spliced 
leader (SL) and 14-mer sequences, respectively. (b) RT-PCR amplification of VSGs 
expressed by the in vivo DYRK RNAi populations used in Section 3.2.2. RT-PCR with a 
SL/14-mer primer pair produced a ~1600bp band with a faint smaller band directly below it. 
There was no difference in the bands products by the induced, uninduced and parental 
AnTat1.1 90:13 (WT) populations. RNA which did not have reverse transcriptase (RT) 
added prior to cDNA amplification yielded no product, therefore confirming that the RNA 
samples were not contaminated with DNA. Actin was used as the positive control (+VE) for 
the PCR step. (c) RT-PCR products were cloned into the pGEM T Easy vector and the 
plasmid DNA from resultant clones digested with EcoRI. In addition to the 3kB band 
representing digested vector, two smaller bands of ~1000bp and 600bp were visualised for 
18/21 clones, as seen in lanes 4 and 6. Therefore the cloned VSG RT-PCR products had an 






























an internal EcoRI site. The clones whose digest products were ran in lanes 1, 3 and 5 
contained only the empty pGEM T Easy vector. (d) Induced HYP2 RNAi cells isolated from 
the final day of an in vivo infection stained positive with an a-VSG AnTat1.1 antibody. Bar, 
10µm. 
3.4 Integration of a GFP reporter within the active VSG 
expression site 
Sequencing of RT-PCR products, antibody staining and diagnostic digests 
confirmed that the HYP2 and DYRK RNAi populations were largely expressing VSG 
AnTat1.1, and that induction of RNAi did not induce a widespread antigenic switch. 
To detect and quantify transcriptional switches away from the AnTat1.1 ES, we 
integrated a quantifiable reporter at a promoter proximal position of the AnTat1.1 
ES. This created a scenario where the a-VSG AnTat1.1 antibody could firstly be 
used to detect whether a VSG switch had occurred, and secondly a quantifiable 
reporter could then inform whether this switch had occurred as a result of an in situ 
or recombinogenic switch downstream of the reporter integration site close to the 
promoter. 
The pLF12-eGFP reporter construct (Zimmermann et al., 2017) consists of an 
upstream promoter region (UP), eGFP flanked by the aldolase 5’ and 3’ UTRs, PUR 
flanked by 5’ actin and 3’ aldolase UTRs and a downstream promoter region (DP) 
(Hertz-Fowler et al., 2008). The 5’ homologous region, UP, spans the 1590bp region 
from the 50 bp repeats upstream of the BES promoter to 240bp downstream of the 
BES promoter and the 3’ homologous region, DP, consists of the 1150bp region 
starting from 287bp downstream of the BES promoter to ESAG7. The plasmid can 
therefore integrate randomly into the promoter proximal region of any BES, however 
integration of the construct into only the active ES can be forced with high 
concentrations of the selective drug (Hertz-Fowler et al., 2008). Since the pALC14 
RNAi construct itself encodes puromycin resistance, PUR was removed from pLF12-
eGFP by restriction digest, and replaced by BLA, which encodes blasticidin 
resistance (Figure 3.4a). The plasmid was linearized with SacI and KpnI, and 10µg 





Selection with 10µg blasticidin yielded the GFPESproAnTat1.1ES HYP2/DYRK RNAi 
cell lines (Figure 3.4b). When the VSG AnTat1.1 expression site was active the cells 
emitted a homogenous cytoplasmic GFP signal which was not lost following fixation 
(Figure 3.4c). Populations of clones were ~99% VSG AnTat1.1 and GFP positive, as 
measured by FACS (Figure 3.4d). 
In addition to the HYP2 and DYRK RNAi lines, a GFP ORF was also 
transfected into the VSG AnTat1.1 ES of a pleomorphic NEK17 RNAi cell line. 
NEK17 (herein referred to as just ‘NEK’) is encoded by three tandem genes 
(Tb927.10.5930/40/50) which are indistinguishable by RNAi. NEK was identified by 
Mony et al. (2014) in their genome-wide RNAi screen as a component of 
trypanosome quorum-sensing, and inducible knock-down was shown to ablate 
differentiation competence in pleomorphic cells in vivo, therefore making the 
molecule a potential stumpy inducer (Mony et al., 2014). McDonald et al. (2018) 
more recently demonstrated that ectopic overexpression of NEK was not able to 
restore differentiation competence of AnTat1.1 90:13 RBP7 (another stumpy 
inducer) or DYRK null mutants in vivo, thus demonstrating that NEK driven stumpy 







Figure 3.4 GFPESproAnTat1.1ES HYP2/NEK/DYRK RNAi cell lines express GFP from 
their VSG AnTat1.1 ES (a) pLF12 eGFP_BLA encodes eGFP and blasticidin resistance (b) 
pLF12 eGFP_BLA targets the ES promoter region. The construct integrated into the actively 
expressed VSG AnTat1.1 ES of the RNAi cell lines, generating the GFPESproAnTat1.1ES 
HYP2, NEK and DYRK RNAi reporter cell lines (c) When the VSG AnTat1.1 ES was active, 
the cells emitted a strong cytoplasmic GFP signal. Bar, 10µm (d) FACS analysis of 10,000 
paraformaldehyde/glutaraldehyde fixed cells demonstrated that the GFPESproAnTat1.1ES 
HYP2, NEK and DYRK RNAi reporter cell lines were 98.9% VSG AnTat1.1 and GFP 
positive. VSG AnTat1.1 positivity was measured by a-VSG AnTat1.1 antibody binding and 
GFP positivity by fluorescence emission in the FITC channel alone.  
 
3.5 The GFPESpro AnTat1.1ES HYP2/NEK/DYRK RNAi cell 
lines remained inducible and lost differentiation 
competence upon induction 
To validate that the insertion of an eGFP ORF into the VSG AnTat1.1 ES had 

























mouse infections were established (± induction) with the GFPESproAnTat1.1ES HYP2, 
NEK and DYRK RNAi reporter lines as in Section 3.2.2. Induced RNAi cell lines did 
not restrict their parasitaemia in response to accumulating levels of SIF, and 
furthermore retained their slender morphology (Figure 3.5a). Uninduced cells, in 
contrast, committed to differentiation and transformed morphologically to stumpy 
cells from day 4 of infection onwards, with similar kinetics to the parental T. brucei 
AnTat1.1 90:13 cell line. Northern blots confirmed efficient and inducible RNAi 
mediated knockdown of the HYP2 and DYRK transcripts (Figure 3.5a, inset). NEK 
transcripts were knocked down to a much lesser degree, however since 
hyperparasitaemia and the retention of slender morphology were nevertheless 
observed in the induced lines, this suggested that only small levels of gene 
knockdown were required to significantly reduce differentiation competence in these 
lines. Cell-cycle analysis of 250 DAPI stained-cells from each day of infection 
revealed a reduced accumulation of 1K1N cells in the induced RNAi lines compared 
to the uninduced, indicating a loss or delay in the G1/G0 cell cycle arrest associated 
with the differentiation to stumpy forms (Figure 3.5b). Consistent with the reduced 
G1/G0 arrest and maintenance of slender morphology, induced cells isolated on the 
final day of infection expressed the stumpy specific marker PAD1 to a much lesser 
extent compared to the uninduced cells (HYP2 RNAi) or not at all (NEK and DYRK 
RNAi) (Figure 3.5c). Together, this data confirmed that the GFPESproAnTat1.1ES 
HYP2, NEK and DYRK RNAi lines lost differentiation competence upon induction, 
and were therefore inducibly monomorphic, as demonstrated by the retention of 
slender morphology, reduced G1/G0 arrest at high parasitaemia and diminished 








Figure 3.5 The GFPESproAnTat1.1ES HYP2, NEK and DYRK RNAi lines are inducibly 
monomorphic (a) In vivo growth and final day cell morphology of the GFPESproAnTat1.1ES 
HYP2 (top), NEK (middle) and DYRK (bottom) RNAi cell lines. The mice were sacrificed 
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before the parasitaemia became lethal and the trypanosomes were purified from the blood on 
day 5 (DYRK RNAi) or day 6 (HYP2 and NEK RNAi). Induction of RNAi generated 
populations of cells which grew to high parasitaemia and were slender in morphology. 
Uninduced populations of cells restricted their parasitaemia from day 4 onwards and were 
enriched for morphologically stumpy forms. Northern blot detection (inset) of HYP2, NEK 
and DYRK transcripts revealed varying degrees of gene knockdown upon induction with 
doxycycline. Bar, 10µm (b) Cell cycle analysis of GFPESproAnTat1.1ES HYP2 (left), NEK 
(middle) and DYRK (right) RNAi cell lines. Uninduced cells accumulated in G1/G0 as they 
differentiated to stumpy forms, seen as an accumulation of 1K1N cells. The percentage of 
replicative cells remained constant in the induced NEK RNAi population and increased upon 
induction of DYRK RNAi. Induced HYP2 RNAi cells still accumulated in G1/G0, though at 
a slower rate than uninduced cells. 250 cells were counted for each replicate. (c) Western 
blot detection of PAD1 protein. Protein was prepared from 4x106 cells which were purified 
from the blood on the final day of infection. The T. brucei AnTat1.1 90:13 parental cells 
which had arrested as stumpy forms were used as a control (ST). Consistent with their 
differentiation to stumpy form cells, the uninduced populations expressed high levels of 
PAD1. In contrast, the induced HYP2, NEK and DYRK RNAi cells showed diminished 
PAD1 expression. 
 
3.6 Optimisation of an in vitro flow cytometry-based assay 
to measure VSG switch rate 
The GFPESproAnTat1.1ES RNAi lines are inducibly monomorphic and contain a 
promoter-proximal GFP ORF in their active expression site, therefore permitting the 
study of antigen switch frequency and mechanism in the same cell lines where 
differentiation capacity is switched ‘on’ or ‘off’. VSG AnTat1.1 positivity can be 
measured using an a-VSG AnTat1.1 antibody and the promoter proximal GFP ORF 
allows for the detection of ES transcriptional switches. Many factors had to be 
considered when designing a method to interrogate VSG switching: how should GFP 
and VSG AnTat1.1 positivity be detected; should the assay be performed in vitro or 
in vivo; what scale should the assay be performed on; how should the populations of 





existing switched clones in the parental population; and how should data be 
interpreted and VSG switch rates calculated? 
3.6.1 Designing an in vitro VSG switch assay workflow 
Early studies of trypanosome antigenic variation typically monitored variants 
arising from single relapses in rodents (Miller and Turner, 1981). Variations on this 
technique included immunising mice against a specific (and predominantly 
expressed) VSG and then detecting an emerging parasitaemia after infection (Hartley 
and McCulloch, 2008; McCulloch and Barry, 1999; McCulloch et al., 1997; 
Proudfoot and McCulloch, 2005; Robinson et al., 2002) or depleting a population of 
trypanosomes expressing a specific VSG in vitro by antibody-mediated lysis in 
serum and then inoculating the cells into mice and detecting infection (Lamont et al., 
1986; Turner, 1997). Whilst single relapse experiments account for the potential 
differences in growth rates between variable antigen type (VAT) variants and make 
the exact parentage of a VSG switched cell clear, in vivo VSG switch assays often 
require large numbers of rodents to be screened and prior immunisation of animals 
(Aitcheson et al., 2005). Furthermore, antibodies could clear all VSGs expressing 
similar epitopes to the variant that was immunised against, potentially leading to an 
underestimation of VSG switch rate. During our in vivo differentiation experiments 
the uninduced RNAi cell lines committed to differentiation by day 4, as 
demonstrated by the restriction of parasitaemia and the accumulation of 1K1N cells 
(Figure 3.5). To perform a valid comparison of VSG switch rates, both uninduced 
and induced populations therefore need to be maintained in logarithmic growth (this 
is because arrested stumpy cells do not contribute new antigenic variants to the 
population (Amiguet-Vercher et al., 2004)). Controlling the growth of trypanosome 
populations to defined densities is much more achievable in a culture model than in 
animals and therefore, with this and the prior arguments in mind, it was decided to 
design an in vitro VSG switch assay.  
Many in vitro-based VSG switch assays have been developed to circumvent 
the limitations and constraints presented by in vivo methods (see Section 1.2.7). 
Typically, these experiments consist of a non-selective growth period, in which 





population, for example MACS (Boothroyd et al., 2009; Schulz et al., 2016), RNAi 
against the original VSG (Aitcheson et al., 2005) or Ganciclovir treatment to remove 
cells expressing the HSV-TK gene from the original ES (Devlin et al., 2016; Kim 
and Cross, 2010). This depletion/enrichment step is performed to increase the depth 
of analysis since the laboratory-adapted monomorphic trypanosomes which have 
been used for these studies switch their expressed VSG at rates between 10-7 and 10-5 
switches/cell/generation. Following the depletion of cells that have not switched 
VSG expression, the remaining variants are typically cloned in 96 well plates by 
limiting dilution and then characterised by methods such as IFA, PCR and Southern 
blotting. 
Pilot experiments with the inducibly monomorphic RNAi lines suggested that 
1 in every 100 trypanosomes switched their expressed VSG in the absence of 
selection. Since VSG switching appeared to be occurring at a high frequency, and to 
avoid unintentional bias, the decision was taken not to deplete the RNAi lines of 
unswitched cells following the initial period of in vitro growth. The use of IFA, PCR 
or Southern Blots to characterise VATs is time-consuming and labour-intensive, 
limiting the number of variants that can be realistically studied. Flow cytometry-
based analysis of switch events is advantageous since it firstly allows for the rapid 
processing of millions of cells and, secondly, can detect multiple fluorescent markers 
simultaneously. With the correctly placed markers, flow-cytometry can not only 
identify VSG switches but also report on the method of VSG switching. It was thus 
decided that a flow cytometry-based strategy for the detection of VSG AnTat1.1 and 
GFP positivity should be used. 
With regard to deciding the scale of the assay, we know that the collection of 
10,000 events during flow cytometry gives a confidence interval of 99% (Hedley and 
Keeney, 2013). Therefore, to demonstrate that any in vitro generated VSG switch 
events recorded were ‘real’, a VSG switch assay sample would have to contain at 
least 10,000 switched cells. Following pilot in vitro experiments, ~1 in every 100 
trypanosomes were consistently found to be VSG AnTat1.1 negative. Therefore, to 
measure 10,000 VSG AnTat1.1 negative events, 1,000,000 total events for every 





compensate for loss of sample during fixation and antibody staining, 2x107 cells 
were taken from each FACS switch assay for fixation. In vitro, pleomorphic 
trypanosomes should be maintained below cell densities of 1x106 cells/ml to prevent 
initiation of slender to stumpy differentiation. Therefore, the VSG switch assay 
would have to finish with at least 20ml of trypanosomes at a cell density of 1x106 
cells/ml to produce enough material for analysis. 
To guarantee that recorded VSG switches were independently generated 
during the switch assay, and not a result of the amplification of pre-existing variants 
within the parental population, the assay would also have to begin with either a 
homogenous population of cells expressing the dominant VSG (VSG AnTat1.1), or a 
single cell expressing a known VSG. Since earlier FACS analysis had demonstrated 
that the GFPESproAnTat1.1ES HYP2/NEK/DYRK populations were not homogenous 
with regard to GFP and VSG AnTat1.1 expression (Figure 3.4d), and to avoid an 
additional FACS-sorting step prior to the switch assay commencing, a strategy where 
a single VSG AnTat1.1/GFP positive cell was ‘scaled-up’ in culture was adopted. 
Briefly, a logarithmic culture of trypanosomes was diluted and distributed over a 96-
well plate such that less than one cell/100µl well was seeded. Cells were cultured in 
non-selective medium to allow for in situ ES switching. Following 5 days incubation 
at 37oC, clones were counted with a haemocytometer and three selected to be 
transferred into 2ml of medium. This procedure was repeated with increasing 
volumes of HMI-9 until at least 2x107 cells could be collected for fixation. This 
scaling up procedure assured that firstly, the populations of cells did not grow 
>1x106 cells/ml and secondly, that the expressed VSG population was not restricted 
by bottlenecking. Doxycycline was added to the parental culture just prior to 
dilution, and at every scale up step thenceforth. The basic workflow is shown in 
Figure 3.6. On average, the uninduced GFPESproAnTat1.1ES HYP2/NEK/DYRK RNAi 
VSG switch assays lasted 10 days (range=3, n=18), encompassing 26.93 population 
doublings (± 0.56, n=18). The induced assays also lasted, on average, 10 days 
(range=3, n=17), encompassing 26.69 population doublings (± 0.81, n=17). Since the 
calculated VSG switch rates were normalised to the number of population doublings 





not always run for exactly the same duration. What was imperative was that the 
uninduced and induced populations were maintained in logarithmic growth.  
 
 
FIGURE 3.6 In vitro FACS-based VSG switch assay workflow 10ml of a logarithmic 
uninduced population of GFPESproAnTat1.1ES HYP2, NEK or DYRK cells was diluted to 6 
cells/ml and seeded in 100µl volumes in a 96-well plate. Doxycycline was added to the 
+DOX populations following dilution, and prior to distribution in the 96 well plate. From the 
remainder of the starting logarithmic population, 2x107 cells were fixed and stored for use as 
a FACS positive control/gating aid. After 5 days of incubation at 37oC, the cell density of the 
arising clones was counted on a haemocytometer. Typically, seeding at 0.6 cells/well yields 
3-20 clones per plate. Three clones that were at similar cell densities, and appeared healthy 
when visualised with a microscope, were selected for progression through the assay. Over 
the course of a further 3-6 days, cell counts were taken daily and the cultures progressively 
scaled up by the addition of HMI-9 to prevent the populations from overgrowing. When 
fresh HMI-9 was added to the induced cultures, doxycycline was ‘topped up’ too. When at 
least 2x107 cells were acquired, the growth phase of the assay was ended and cells washed 
and fixed before FACS analysis. Where possible, the volume of the final culture was kept as 
low as possible so that as high a proportion of the population as possible was removed for 
FACS analysis.  
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3.6.2 Interpreting the FACS data 
Prior to fixation, cells were initially washed and incubated with the fixable 
live/dead stain, Zombie, (Biolegend) which reacts with the primary amine groups on 
proteins. When live cells are treated, the plasma membrane excludes the entry of the 
dye meaning that only the surface proteins will react. However, in dying cells the 
loss of the membrane integrity means that the dye can enter the cell and therefore 
bind both extra- and intra-cellular proteins. These dead cells will hence fluoresce 
more strongly than live or unstained cells. The inclusion of this dye meant that GFP 
negativity brought about by cell death could be excluded from the analyses. 
Treatment with the Zombie dye, rather than conventional propidium iodide treatment 
(PI), was selected since the staining occurs before, not after, fixation. Therefore, the 
cellular integrity of the population prior to the potentially damaging fixation process 
could be investigated. Cells were stained with the a-VSG AnTat1.1 antibody as 
described in Section 2.16.2. Immediately before processing samples on the flow 
cytometer, a defined number of CountBright absolute counting beads (Thermofisher 
Scientific) were added to each of the switch assay samples. As the stained cells were 
processed by the flow cytometer, so too were the counting beads. Since the exact 
number of beads added to the FACS sample was known, the absolute number of cells 
in a sample could be determined by relating the number of cells acquired by the flow 
cytometer to the number of processed bead events, and then multiplying by the 
culture dilution factor (Figure 3.7) (Schulz et al., 2016). The quantification of VSG 
switchers and the subsequent calculation of VSG switch rate is described in detail in 






Figure 3.7 Counting beads gating strategy Countbright absolute counting beads fluoresce 
brightly over a wide range of excitation (UV to 635nm) and emission (385-800nm) 
wavelengths. The beads were separated from the population of cells by gating in the PE 
Texas Red (596nm excitation and 615nm emission) channel. At least 1000 beads were 
collected per sample for statistical significance. 
 
One million events were acquired for each triplicate sample by the BD LSRII 
flow cytometer (BD Biosciences). Before determining VSG AnTat1.1 and GFP 
positivity, the flow cytometry data was filtered using the forward (FSC) and side 
scatter (SSC) profiles, such that only intact cells that were processed singularly were 
selected for analysis (Figure 3.8a, panels 1 and 2). Next, single cells were observed 
for Zombie dye positivity (Figure 3.8a, panel 3) with the intention of removing dead 
cells from the population. However, such was a) the integrity of cells following the 
assay, and b) the high stringency of gating for intact and single cells that this stage 
consistently failed to exclude any more than a couple of cells from the population in 
trial experiments. GFP negative events could therefore not be attributed to the loss of 
GFP expression upon cellular death. Since dead cells were so rarely found in the 
populations, the use of the expensive Zombie dye was excluded from the final 
analyses. 
The next gate to be applied to the population was that determining VSG 











clone and the (largely) VSG AnTat1.1 expressing logarithmic population from which 
the switch assay was started were used as negative and positive controls, 
respectively, in addition to a VSG AnTat1.1 expressing secondary antibody-only 
control. Following a genetic VSG switch, trypanosomes require ~4.5 days to 
completely replace their surface coat (Pinger et al., 2017). Therefore, whilst the VSG 
AnTat1.1 signal from cells that had switched early in the assay would match that of 
the negative and secondary antibody-only controls, it was likely that some of the 
VSG switched cells would only lose a small proportion of their VSG AnTat1.1 
positivity. Hence, positioning a gate directly to the right of the negative and 
secondary only controls would wrongly classify cells that had undergone a 
transcriptional or genetic VSG switch, but replaced little of their VSG surface coat, 
as VSG AnTat1.1 positive. Consequently, the gate defining VSG AnTat1.1 positivity 
was placed directly to the left of the positive control. Thus, cells that had switched 
expression away from VSG AnTat1.1, but had only lost a very small proportion of 
their VSG AnTat1.1 surface protein, would still be classed as switchers. 
Cells that were defined as VSG AnTat1.1 negative (circled in Figure 3.8b) were 
next analysed for GFP positivity to determine the mechanism of VSG switch. ES 
transcription has been demonstrated as initiating on multiple silent ESs and 
progressing at least as far as, and including, ESAG 6 before the arrest of RNA 
elongation in all but the active ES occurs (Vanhamme et al., 2000). On an 
unmodified AnTat1.3A ES, ESAG 6 is positioned ~4kbp downstream of the ES 
promoter. That transcription progresses beyond the GFP reporter, which is positioned 
1250bp downstream of the AnTat1.3A ES promoter in the GFP reporter RNAi cell 
lines, could have implications for the interpretation of VSG switch mechanisms. 
Specifically, if a cell were to switch transcription away from the AnTat1.3A ES and 
activate another ES, transcription occurring on the now silenced AnTat1.3A ES 
could still produce a positive GFP signal. Selection against transcription on silent 
sites by the addition of high levels of selective drug (Hertz-Fowler et al., 2008) is not 
preferable since this would either select against in situ switching, or rapidly kill any 
parasite that had. Transcription on silent ESs however, seems to be at a significantly 
lower level that that of the active ES, suggesting that GFP mRNA levels would 





(2000) investigated transcript heterogeneity from 4 regions of active and inactive ESs 
by RT-PCR: (i) immediately adjacent to the ES promoter, (ii) upstream of ESAG 7, 
(iii) a conserved region within ESAG 7 and ESAG 6, and (iv) the VSG itself. In a 
VSG AnTat1.1 expressing clone, the transcripts were predominantly from the 
AnTat1.3A ES. However, 4% and 3% transcript heterogeneity was observed from 
the region immediately downstream of the promoter and the ESAG7/6 segment, 
respectively, indicating that whilst transcription on silent sites was occurring, it was 
greatly attenuated compared to the active ES (Vanhamme et al., 2000). Using the 
same pLF12 eGFP plasmid that has been adopted for this study, Zimmerman et al. 
(2017) furthermore demonstrated mRNA levels of the promoter proximal eGFP 
decreased by 80% in the 24 hours following induction of ES attenuation. Whilst this 
data suggests that transcription of GFP mRNA would be rapidly attenuated, this 
FACS-based assay measures fluorescence from the GFP protein. Although the 
protein itself has been estimated to have a half-life of ~80 hours in Leishmania 
infantum promastigotes (Kamau et al., 2001) and ~26 hours in mammalian cells 
(Corish and Tyler-Smith, 1999), Aresta-Branco et al. (2016) demonstrated by FACS 
that trypanosomes expressing GFP immediately downstream of their active VSG ES 
promoter became GFP negative 120 hours after transcriptional shut down of their 
active ES (earlier timepoints were not measured) (Aresta-Branco et al., 2016). 
Together this data suggests that GFP mRNA is rapidly turned-over but a GFP signal 
could still be detected up to 5 days post-transcriptional switch, albeit at a lower level. 
Therefore, the gate defining GFP positivity was again placed directly to the left of 
the ‘Day 0’ GFP positive control (Figure 3.8c). A cell line which had not been 







Figure 3.8 VSG AnTat1.1 and GFP gating strategies (a) Debris and cell doublets 
were removed from the population using the FSC and SSC profiles. In trial 
experiments, cells were stained with the fixable live/dead Zombie stain prior to 
fixation and antibody staining. The first two gating stages were sufficient to remove 
dead cells and hence, use of the dye was excluded from the final experiments. (b) 
Cells were first analysed for VSG AnTat1.1 positivity based on a-VSG AnTat1.1 
staining. The gate was placed directly to the left of the VSG AnTat1.1 positive peak 
to account for cells taking up to 4.5 days to fully replace their surface coat following 
a genetic VSG switch. A VSG221 expressing Lister 427 clone was used as a negative 
control and a VSG AnTat1.1 expressing clone was used for the secondary antibody-
only control (not shown on the plot). The logarithmic population from which the 
VSG switch assay was started was used as the VSG AnTat1.1 positive control. (c) 
VSG AnTat1.1 negative cells were analysed for GFP positivity to determine the 
mechanism of VSG switch. The GFP positive gate was placed directly to the left of 
the GFP positive peak to account for the half-life of the protein. A cell line which 
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trypanosomes autofluoresce in the FITC channel, the mean GFP fluorescence of the 
negative population is always higher than zero. The population used for the VSG 
AnTat1.1 positive control was also used as the GFP positive control. 
 
3.6.3 Calculating the VSG switch rate 
To extrapolate the VSG switches/cell/generation from the gated FACS plots, 
a method based on the calculations described by Schulz et al. (2016) was adopted 
(Table 3.1). For the following calculations, ‘sample’ refers to the cells that were 
removed from the VSG switch assay on the final day, fixed, stained and analysed on 
the flow cytometer. ‘Population’ refers to the cells contained within the culture flask 
on the final day of the switch assay. The number of beads and the number of intact 
single cells acquired for each sample were entered in columns 2 and 3 of the table, 
respectively. The number of counting beads that were added to the FACS sample 















This is shown in column 5 of Table 3.1. The dilution factor refers to the 
proportion of the final VSG switch assay culture that was removed and fixed for 
FACS analysis. For example, if half of the final culture was removed and fixed for 
FACS analysis, then the equation on the left was multiplied by 2. The number of 
cells gated into the VSG AnTat1.1 negative population (Figure 3.8b, circled) was 





considered since it was only an indicator of switch mechanism, not frequency. The 
absolute number of VSG AnTat1.1 negative cells in the population was then 
calculated in the same way as was done for the absolute number of cells in the 
population, replacing ‘total cells acquired’ for ‘total switchers acquired’. This was 
plotted in column 7. By dividing the absolute number of VSG AnTat1.1 negative 
cells in the population by the absolute number of cells in the population, the 
proportion of VSG AnTat1.1 negative cells in the population was calculated (column 
8). To convert this to VSG switches/cell/generation (column 10), the proportion 
generated in column 8 was divided by the total number of population doublings that 
were counted during the VSG switch assay (column 9). As acknowledged in Section 
1.2.7, this calculation did not account for the phenotypic or genetic diversity of the 
‘switched’ population, nor potential differences in growth rate between different 
variants, it simply presented the proportion of the population at the time of sampling 
that did not express the initiating VSG (Hovel-Miner et al., 2012). This is 
problematic when calculating absolute switch frequency. For the nature of these 
experiments however, i.e. a comparison of two populations prior to and after 
induction of RNAi, a comparison of the relative VSG switching frequencies suffices. 
It was assumed that an increase in VSG switch frequency would result in a higher 
proportion of VSG negative cells within the population, and vice versa. 
To determine the percentage of VSG switches that were generated by DNA 
recombination, the number of VSG AnTat1.1 negative cells in the sample that gated 
as GFP positive (Figure 3.8c, right gate) was divided by the total number of VSG 












































3.7 Validating the flow cytometry approach as a suitable 
method to measure VSG switch rate 
Before investigating whether the induction of monomorphism caused a 
reduction in VSG switch frequency, I first sought to validate (a) the ability of the 
VSG switch assay to detect change in VSG switch frequency, (b) the ability of the 
switch assay to correctly determine VSG switch rate, and (c) the ability of the switch 
assay to discriminate between in situ and DNA recombination-based switches. 
3.7.1 The FACS-based VSG switch assay detected induced VSG 
switches and could determine the mechanism of VSG 
switching 
To test first, the ability of the assay to detect a change in VSG switch rate, 
and secondly, how accurately it could predict the type of VSG switch mechanism, 
the VSGup strain was acquired from the Horn Lab (Dundee, UK). The VSGup strain 
contains an I-SceI restriction site and the puromycin N-acetyltransferase (PAC) gene 
adjacent to the 70 bp repeats upstream of VSG 221 (Figure 3.9a, top) (Glover et al., 
2013a; Glover et al., 2013b). A tetracycline inducible I-SceI meganuclease ORF is 
furthermore integrated into a silent RRNA spacer locus (Glover et al., 2007). Upon 
the induction of I-SceI expression by the addition of doxycycline, the meganuclease 
recognizes its 18bp cleavage site in the ES and generates a double-stranded break 
(DSB). This break is repaired through 70 bp repeat recombination, thus translocating 
a new, antigenically distinct VSG into the ES. Transcription is not altered. The 
VSGup strain was therefore useful as it tested whether the VSG switch assay detected 
the increase in VSG switching upon induction and, when GFP was transfected into 
the VSG 221 ES, it tested whether the assay correctly identified the recombination-
mediated VSG switches as VSG 221 negative and GFP positive (Figure 3.9a). The 
pLF12 eGFP_BLA construct contained an I-SceI cleavage site upstream of the eGFP 
start codon (Figure 3.9b). Induction of DSBs in the ES promoter proximal region 
have been shown not to induce VSG switches (Glover et al., 2013a). To avoid 
cleavage at two sites upon induction, site directed mutagenesis was performed to 





plasmid (Figure 3.9c, top). A diagnostic digest with recombinant I-SceI and BamHI 
confirmed that the meganuclease no longer cut at the site (Figure 3.9c, bottom). 
 
 
Figure 3.9 Transfection of the GFP reporter construct into the active VSG221 ES of the 
VSGup cell line (a) Top: The VSG 221 ES of the VSGup strain contained an I-SceI 
recognition sequence (RS) and the PAC gene adjacent to the 70 bp repeats. Tetracycline-
inducible I-SceI was encoded from a RRNA spacer locus. Bottom: Transfection of the 
VSGup strain with the pLF12 eGFP-BLA construct allowed us to determine if the assay 
correctly identified DNA recombination. (b) pLF12 eGFP_BLA encoded an I-SceI cleavage 
site upstream of the eGFP start codon. (c) Top: The 5’ 18bp sequence recognised by the I-
SceI meganuclease before, and after, site directed mutagenesis. The red line denotes where 
the cut is made. The two mutated bases are shown in red. Bottom: Plasmid DNA from the 






































(-I-SceI) was digested with recombinant I-SceI and BamHI. When the I-SceI cleavage site 
was present, the digest produced three products, as opposed to two when the site was absent. 
Following mutagenesis, the digest of the plasmid produced two bands, indicating that the 
meganuclease no longer recognised the digest site. The expected band sizes for the pLF12 
eGFP_PUR plasmid are 5983bp + 738bp + 863bp. The expected band sizes for the mutated 
pLF12 eGFP_BLA plasmid are 6271bp +663bp. 
 
The VSGup strain was transfected with the mutated pLF12 -I-SceI 
eGFP_BLA plasmid and three VSG 221/GFP positive clones generated following 
selection with 10µg/ml blasticidin. To test whether an enrichment for VSG 221 
negative/GFP positive cells was detected by the FACS assay, the three clones were 
induced for three days with 1µg/ml doxycycline (Figure 3.10a). Since it had been 
demonstrated that only ~5% of VSGup cells survive upon induction of I-SceI 
expression (Glover et al., 2013a), cultures were initiated at 104cells/ml to produce 
enough material for analysis. The populations of uninduced and induced cells were 
taken from the same starting logarithmic culture of uninduced cells. On day 3 of the 
assay, ~1.5x106 cells from the uninduced and induced cultures were washed and 
fixed for FACS analysis. Cells were stained with an a-VSG 221 antibody (courtesy 
of Monica Mugnier, Baltimore, USA) and analysed for VSG and GFP positivity as 
described in Figure 3.8. 10,000 events were acquired by the flow cytometer. 
Following three days of uninduced growth without meganuclease production, 
the populations of Clones 1, 2 and 3 were largely VSG 221 and GFP positive (77.4 ± 
8.5%, 90.6 ± 3.1% and 88.4 ± 6%, respectively) (Figure 3.10b and c). Since the 
starting cultures were not homogenous for GFP and VSG 221 expression it could not 
be determined how many of the VSG 221 negative cells arose from independent 
switch events, as opposed to the propagation of a pre-existing VSG 221 negative cell. 
Upon induction, there was a clear shift away from VSG 221 expression, such that the 
populations of Clones 1, 2 and 3 were significantly enriched (p<0.05, student’s t-test) 
for VSG 221 negative cells with mean fold changes of 3.1, 7.7 and 5.7, respectively 
(Figure 3.10c). Upon the induction of I-SceI expression in the parental VSGup line, 
Glover et al. (2013) reported that the VSG switches/cell increased 5000-fold 





for laboratory-adapted monomorphs, however they never tested the switch rate of the 
uninduced cell line itself.  
Expression of the I-SceI meganuclease, and formation of a DSB adjacent to 
the 70 bp repeats induces a change in VSG expression via recombination through the 
70bp repeats. Therefore, in the induced populations, cells should stain as VSG 221 
negative but remain GFP positive. In the three induced clones, the populations of 
VSG 221 negative cells were 72.2 ± 1.7%, 71.5 ± 2.3% and 69.2 ± 5.6% positive for 
GFP expression, such that the majority of induced switches had been generated by 
DNA recombination (Figures 3.10b and d). Whilst significantly more VSG221 
negative cells were detected in the induced populations overall, the proportion of 
VSG 221 negative cells which remained GFP positive was not significantly different 
(p>0.05, student’s t-test) between the uninduced and induced populations for clones 
1 and 2 (Figure 3.10d). This suggests that the VSG switches detected in the 
uninduced populations could have been the result of leaky I-SceI expression. As can 
be seen in Figure 3.10b, the number of VSG 221 negative cells that were also GFP 
negative increased upon induction too, however the fold-changes (2, 3.9 and 2.6, 
respectively) were of a lesser magnitude than that seen for the VSG 221 negative 
GFP positive cells. 
The rapid formation of DSBs at the I-SceI restriction site was confirmed by 
Southern blot detection of the 9kb XhoI fragment (Figure 3.9a) using a probe 
specific to PAC (Figure 3.10e) (Glover et al., 2013a). In uninduced cell populations 
the fragment was present, but upon induction of I-SceI expression, and the 
subsequent digestion of the VSG 221 ES, the fragment was lost. All three clones 
demonstrated inducible I-SceI expression and efficient DSB formation within 
24hours of doxycycline addition. Levels of detection of the 9kb fragment were 







Figure 3.10 DNA recombination-mediated VSG switches were detected upon induction 
of I-SceI expression in three VSGup pLF12 -I-SceI eGFP_BLA clones (a) Cumulative in 





















































































































































































































vitro growth of three uninduced (bold line) and induced (dotted line) VSGup pLF12 -I-SceI 
eGFP_BLA clones. Three replicates were performed for each condition and clone. 
Doxycycline was added on day 0 and replaced following addition of fresh HMI-9. Data 
represents the mean ± S.D., n=3 (where error bars were smaller than the symbols they were 
not drawn). (b) VSG 221 and GFP expression of cells isolated on day 3. A total of 10,000 
events were captured. The plots show the data for all three triplicates superimposed onto 
each other. The mean proportions of cells in the quadrants are shown (n=3). VSG 221 
expression was determined by a-VSG 221 staining. No antibody was required to detect GFP 
fluorescence. The VSG 221 positivity gate was determined using a VSG 221 positive control 
(the logarithmic population from which the assays were started), a VSG AnTat1.1 expressing 
negative control and a VSG 221 expressing secondary only control. The GFP positivity gate 
was determined using a GFP positive control (the logarithmic population from which the 
assays were started) and a cell line which had not been transfected with GFP for a negative 
control. (c) The percentage of cells which were classified as VSG 221 negative on day 3. 
Upon induction of I-SceI expression, populations were significantly enriched for VSG 221 
negative cells. Data represents the mean ± S.D. (n=3). ** = p<0.01, **** = p<0.0001, t-test. 
(d) The percentage of VSG 221 negative cells which were GFP positive on day 3. Data 
represents the mean ± S.D. (n=3). * = p<0.05. (e) Southern blot detection of the 9kb XhoI 
DNA fragment with a PAC specific probe. Rapid loss of the 9kb fragment was observed 
following the induction of I-SceI expression. Presence of the 9kb fragment was compared to 
the uninduced VSGup parental stock (no GFP expression). The XhoI digested DNA is shown 
below as a loading control. 
 
The FACS-based VSG switch assay was therefore able to both detect induced 
VSG switches and infer whether an ES switch or DNA recombination-based VSG 
switch had occurred. This allowed us to estimate the relative switch rate of a 
population and thus, by monitoring the proportion of the population consisting of 
VSG switched cells, we could deduce whether a given treatment influenced VSG 
switching. I next decided to test if absolute VSG switch frequency could be 
accurately calculated by the assay. Upon induction of DSBs upstream of the 
expressed VSG gene, Glover et al. (2013) estimated that the VSG switch rate 
increased 5000-fold to 5x10-2 switches/induced cell. Critically, however, this increase 





monomorphs, and not an untreated control. Therefore, the antigen switch rate of the 
uninduced VSGup line was assumed to be ~1x10-5 switches/cell/generation, though 
this may not have been the case. The induced assays were each ran for one day 
longer than the respective uninduced clone’s assay (Figure 3.11a). However, for each 
of the three clones, there was no statistically significant difference (p >0.05, student’s 
t-test) in the mean number of generations that the uninduced and induced assays were 
run for (26.45 ± 0.92 vs 26.38 ± 0.68, 27.97 ± 0.44 vs 27.63 ± 1.63 and 26.72 ± 0.44 
vs 26.11 ± 0.13 generations, respectively). Each of the three uninduced clones were 
estimated to switch their expressed VSG at a greater rate than the published estimates 
for monomorphic trypanosomes. Clone 1 was estimated to switch its expressed VSG 
at a rate of 9.56x10-3 ± 0.004 switches/cell/generation, Clone 2 at 2.03x10-3 ± 0.001 
switches/cell/generation and Clone 3 at 5.24x10-3 ± 0.002 switches/cell/generation 
(Figure 3.11b). Upon induction, it appeared from the data presented in Figure 3.11b 
that the number of VSG switches/cell/generation increased. When the number of 
VSG switches/cell before normalization to the number of generations was 
considered, however, this equated to 1 (0.999 ± 0.0006, 0.998 ± 0.003 and 1 ± 
0.00006 switches/cell, respectively) for each of the three clones, therefore indicating 
that all cells were VSG 221 negative. The most likely explanation for the entire 
population of cells staining as VSG 221 negative by the end of the VSG switch 
assay, was that an I-SceI induced VSG switch preceded the first parasite division and 
therefore the negative cells were not real ‘switchers’ but the progeny of a cell which 
had already undergone a gene conversion (GC) VSG switch. Glover et al. (2013) 
demonstrated that, in two strains with I-SceI restriction sites in other portions of their 
VSG 221 expression sites, DSBs had begun to be processed by 6 hours post 
induction (data prior to 24 hours induction with the VSGup strain was not presented). 
Since the three VSGup pLF12 -I-SceI eGFP_BLA clones divided ~ every 6-8 hours, a 
GC switch occurring prior to division was feasible. In the event a parasite division 
occurred before a DSB was processed, it is still unsurprising that the whole 
population would be VSG221 negative since Glover et al. (2013) reported that 100% 
of their induced cells underwent DSB-mediated VSG switching. In the current 
experimental format where populations are established from a single cell, these 







Figure 3.11 The FACS-based VSG switch assay could not be used to determine the 
VSG switch rate of induced VSGup pLF12 -I-SceI eGFP_BLA clones (a) VSG switch 
assay growth of VSGup pLF12 -I-SceI eGFP_BLA clones 1 (left), 2 (middle) and 3 (right). 
Uninduced populations are shaded in teal and induced in plum. Cells were induced on day 0. 
Assays were performed once in triplicate (n=3), except for the induced clone 2 and 3 
replicates where n=2. (b) Calculated VSG switches/cell/generation for the uninduced 
(circular symbols) and induced (square symbols) populations of Clone 1 (plum), Clone 2 
(blue) and Clone 3 (teal). Data represents the mean ± S.E.M (n=3, except for the induced 
clone 2 and 3 replicates where n=2). 
 
Although the VSG switch rate of the uninduced VSGup cells was never 
presented in the Glover et al. (2013) paper, the calculated VSG 
switches/cell/generation for the uninduced cells in Figure 3.11b still seemed very 
high in comparison to most other published VSG estimates for monomorphic Lister 
427 lines (~1x10-7-1x10-5 switches/cell/generation). It was therefore hypothesized 
that leaky expression of the I-SceI enzyme could be the cause for the higher than 












































































































































expected VSG switch rates. Although the Southern blot in Figure 3.10e confirmed 
that induction was inducible compared to the parental VSGup stock, this was not 
proof that the parental stock itself was not inherently leaky. Therefore, the cell line 
depicted in Figure 3.12a was generated. A T. brucei Lister 427 cell line was 
transfected with the same I-SceI restriction site, PAC gene and 5’ and 3’ UTRs 
targeting the VSG221 ES as were present in the original VSGup strain, however it did 
not contain an inducible copy of the I-SceI ORF and therefore no DSBs could be 
formed. Diagnostic PCRs confirmed that for two clones (1 and 3) the entire construct 
was present (primer set iv) and that it had integrated in the right orientation in the 
VSG 221 ES (primer sets i, ii and iii) (Figure 3.12b). 
 
Figure 3.12 Generation of the VSGup -I-SceI cell line (a) An I-SceI restriction site (*) and 
PAC gene were targeted to the VSG 221 ES, adjacent to the 70bp repeats. The cell line did 
not express an inducible I-SceI meganuclease and therefore could not be ‘leaky’. Diagnostic 
primer pairs and the desired product size are shown below. Primer set (i) tested for correct 
5’end integration. Primer set (ii) tested for correct 3’ end integration. Primer set (iii) tested 
that the construct had integrated in the VSG 221 ES. Primer set (iv) confirmed the whole 
construct was present. INT= Integration region. (b) Results of the diagnostic PCRs. Clones 1 
*















































































and 3 were positive in all 4 PCRs. Wild-type Lister 427 DNA and -DNA samples served as 
controls. 
 
The expression of the 9kb XhoI fragment in day 1 uninduced and induced 
VSGup pLF12 -I-SceI eGFP_BLA clones was compared to the expression levels in 
the VSGup -I-SceI Clone 3 cell line by Southern blot (Figure 3.13). The expression 
level of the 9kb XhoI fragment was equivalent between the cell line which contained 
no I-SceI ORF and the three uninduced VSGup pLF12 -I-SceI eGFP_BLA clones, 
thus suggesting that expression of I-SceI was well controlled and therefore that leaky 
expression of I-SceI, and consequently the generation of DSBs in the VSG 221 ES, 
was not responsible for the high VSG switch rates measured in Figure 3.11b.  
 
 
Figure 3.13 Leaky expression of the I-SceI enzyme does not explain the high VSG 
switch rates calculated for the uninduced VSGup pLF12 cells Southern blot detection of 
the 9kb XhoI DNA fragment with a PAC specific probe. Similar levels of PAC expression 
were obtained for the -I-SceI control (far left) and the uninduced VSGup pLF12 clones 1-3, 
therefore displaying that the enzyme’s expression is inducible. The XhoI digested DNA is 





























Using a monomorphic cell line with an inducible DSB site adjacent to the 
70bp repeats in the active ES, we demonstrated that our FACS-based VSG switch 
assay was able to detect induced VSG switches and correctly identify whether a VSG 
switch was generated by a transcriptional switch or DNA rearrangement (Figure 
3.10). The assay was therefore a useful tool to interrogate whether a given treatment 
(such as the induction of monomorphism) changed VSG switch rate. With regard to 
calculating the absolute (rather than relative) VSG switch frequency, our assay, 
admittedly, did have limitations. As discussed in Section 1.2.7, by calculating the 
proportion of a population which consisted of switched cells, one did not take into 
account the phenotypic or genetic diversity within this negatively staining population 
(Hovel-Miner et al., 2012) and nor was the potential difference in growth rates 
between variants accounted for. The VSG switch assay estimated that the uninduced 
(and monomorphic) VSGup strain switched its expressed VSG at a rate of 5.24x10-3 – 
9.56x10-3 switches/cell/generation, at least 100-fold greater than published estimated 
for laboratory-adapted trypanosomes (Figure 3.11). Generation of DSBs through 
leaky expression of the I-SceI enzyme did not account for this high switch frequency. 
However, since the VSG switch rate of the uninduced parental line was not 
published, the ability of the VSG switch assay to accurately determine absolute VSG 
switch frequency cannot yet be determined definitively. 
 
3.8 Inducibly monomorphic populations did not reduce 
their VSG switch rate upon induction 
To investigate if induction of monomorphism was associated with a reduction 
in VSG switch rate, the GFPESproAnTat1.1ES HYP2, NEK and DYRK RNAi lines were 
tested twice, in triplicate, by the in vitro VSG switch assay described in Section 3.6 
(Figure 3.14a). Overall, the induced GFPESproAnTat1.1ES HYP2 RNAi switch assays 
ran for significantly longer than the uninduced assays (11 days vs 10.3±0.5 days, 
p=0.0250, Welch’s t-test), suggesting that induction of RNAi may have caused a 
very slight growth defect. However, the mean number of generations completed 





respectively) were not significantly different (p>0.05, student’s t-test). In the 
GFPESproAnTat1.1ES NEK and DYRK RNAi switch assays, there was no significant 
difference between the uninduced and induced conditions for either the mean number 
of days (9.5±0.5 vs 9 and 9.5±1.6 vs 8.4 ± 0.5, respectively) or the mean number of 
generations (26.9±0.6 vs 26.4±0.3 and 27.1±0.7 vs 27.3±1.2, respectively) that the 
assays were run for (p>0.05, student’s t-test).  
Pleomorphic trypanosomes are estimated to switch their expressed VSG at a 
rate of 10-4 to 10-2 switches/cell/generation (Turner and Barry, 1989; Turner, 1997) 
and Figure 3.9b shows that the calculated VSG switch rates for the uninduced, 
differentiation competent GFPESproAnTat1.1ES HYP2, NEK and DYRK RNAi lines 
were in agreement with these estimations (6.97x10-4 ± 0.0004, 6.3x10-4 ± 0.0002 and 
2.07x10-3 ±0.002 switches/cell/generation, respectively). However, upon the 
induction of RNAi, and therefore the loss of differentiation competence, each of the 
three inducibly monomorphic trypanosome lines did not reduce their respective VSG 
switch rates to become equivalent to the estimated 10-7 to 10-5 VSG 
switches/cell/generation of laboratory adapted trypanosomes. In fact, there was a 
significant increase in switch frequency upon induction of RNAi against HYP2 (to 
2.51x10-3 ± 0.0009 switches/cell/generation p=0.0008, student’s t-test). NEK 
knockdown caused a slight increase in VSG switching (to 7.34x10-4 ± 0.0002 
switches/cell/generation) and DYRK knockdown decreased the VSG switch rate to 
1.2x10-3 ± 0.0007 switches/cell/generation, however neither of these changes were 
significant (p>0.05, student’s t-test). 
The VSG switched cells were analysed for GFP positivity (which would 
indicate that they had switched their VSG by DNA recombination as opposed to a 
transcriptional switch) (Figure 3.9c). Differentiation-competent pleomorphic cells 
preferentially use DNA recombinatorial mechanisms to switch expressed VSGs 
(Robinson et al., 1999), whilst laboratory-adapted monomorphs have been shown to 
predominantly switch transcription between ESs instead (Liu et al., 1985; McCulloch 
et al., 1997). The VSG AnTat1.1 negative cells in the uninduced GFPESproAnTat1.1ES 
DYRK RNAi populations appeared to be mostly GFP positive, whilst the VSG 





populations were roughly evenly split between the GFP positive and negative gates, 
however these results showed considerable variability (Figure 3.9c).  Compared to 
the uninduced populations, there was a small decrease in the presence of GFP 
positive AnTat1.1 negative cells in the induced GFPESproAnTat1.1ES NEK (52.7 ± 
24.5% vs 49.75 ± 20.4%) and DYRK (84.63 ± 11.2% vs 70.56 ± 21.5%) RNAi 
populations following the induction of monomorphism, however these changes were 
not significant (p>0.05, student’s t-test). The proportion of GFP positive VSG 
AnTat1.1 negative cells in the induced GFPESproAnTat1.1ES HYP2 RNAi populations 
increased from 44.67 ± 25% to 71.68 ± 22.6%, however such was the variability in 







Figure 3.14 The induction of monomorphism did not significantly reduce VSG switch 
rate nor change the predominant mechanism of VSG switching (a) VSG switch assay 
growth of the GFPESproAnTat1.1ES HYP2 (left), NEK (middle) and DYRK (right) RNAi lines. 
Uninduced populations are shaded in teal and induced in plum. Assays were performed twice 
in triplicate (n=6), except for the induced DYRK RNAi experiment where one assay was 
performed in triplicate and one in duplicate (n=5). (b) The calculated VSG 
switches/cell/generation for the uninduced and induced GFPESproAnTat1.1ES HYP2 (blue), 
NEK (plum) and DYRK (teal) RNAi lines. Upon the induction of RNAi against NEK and 
















































































































































































pleomorphs (p>0.05, student’s t-test). VSG switching increased significantly upon the 
induction of RNAi against HYP2 (p=0.0008, student’s t-test). ***= p<0.001. (c) The 
percentage of switched GFPESproAnTat1.1ES HYP2 (blue), NEK (plum) and DYRK (teal) 
RNAi cells which had switched their expressed VSG by DNA recombination (i.e. VSG 
AnTat1.1 negative/ GFP positive). There was no significant difference in the percentage of 
VSG switches elicited by DNA recombination upon the induction of RNAi against HYP2, 
NEK or DYRK (p>0.05, student’s t-test). 
 
The data collected from the in vitro FACS-based VSG switch assays showed 
that, upon the inducible knockdown of a component of the stumpy formation 
pathway (and therefore the loss of stumpy differentiation capacity) in three different 
RNAi lines, there was no significant reduction in VSG switch frequency, nor a 
significant change in the proportion of switches elicited by either DNA 
recombination or in situ switches of transcription (Figure 3.14). The results, 
therefore, strongly suggest that stumpy differentiation capacity and VSG switch 
frequency can be uncoupled. It is interesting to note that the GFPESproAnTat1.1ES 
HYP2 and NEK RNAi lines, which displayed the lowest switch frequencies, also 
switched least by DNA recombination when compared to the faster switching 
GFPESproAnTat1.1ES DYRK RNAi line. This is reminiscent of the differences in 
switch frequency and mechanism between pleomorphic (frequent VSG switching and 
preferentially by DNA recombination) and laboratory-adapted monomorphic 
(infrequent VSG switching and preferentially by switches of transcription) 
population. That the GFPESproAnTat1.1ES  HYP2 and NEK RNAi lines have a reduced 
VSG switch rate and frequency of DNA recombination-based VSG switching 
compared to the GFPESproAnTat1.1ES DYRK RNAi cell line, yet still retain 
pleomorphism, supports the hypothesis that reduced VSG switch frequency and 
monomorphism can be independently selected for during laboratory passage, but at 
different rates. Without knowing the VSG switch rate of the HYP2 or NEK RNAi 
lines at different periods of their laboratory passage prior to this study, however, this 






3.9 A monomorphic GFPESpro 221ES Lister 427 cell line 
switches expression of VSGs as frequently as 
pleomorphic AnTat1.1 90:13 cells 
As part of the VSG switch assay validation experiments in Section 3.7, a 
monomorphic GFPESpro 221ES Lister 427 cell line from our lab was tested in the 
FACS-based VSG switch assay format using a VSG221 antibody (Figure 3.15). We 
found that our monomorphic cell line switched its expressed VSG at a mean rate of 
5.99x104 ± 0.0004 switches/cell/generation (Figure 3.15b, left) which is comparable 
to the rates of antigenic variation seen in the pleomorphic GFPESpro AnTat1.1ES HYP2 
and NEK RNAi cell lines and less than two-fold slower than the fast switching DYRK 
RNAi cell line (Figure 3.14). In agreement with the literature, however, this 
monomorphic cell line did preferentially switch by in situ switches of transcription 







Figure 3.15 A GFPESpro 221ES Lister 427 cell line preferentially switched VSG 
expression by in situ switches of transcription at a high rate (a) VSG switch assay growth 
of the GFPESpro221ES Lister 427 replicates. Replicates 1-3 were performed as one assay and 
replicates 4-7 as another. The assays lasted for an average of 6.5 ± 0.5 days and the 
populations were fixed following a mean of 27.4 ± 0.9 generations. (b) Left: The calculated 
VSG switches/cell/generation for the 7 GFPESpro221ES Lister 427 replicates. The 
monomorphic populations switched expression of their VSG at a similar rate to pleomorphic 
cells. Data represents the mean ± S.E.M (n=7) Right: The percentage of switched 
GFPESpro221ES Lister 427 cells which had switched their expressed VSG by DNA 
recombination (i.e. VSG 221 negative/ GFP positive). The monomorphs preferentially used 
ES switching to switch VSG expression. Data represents the mean ± S.D (n=7). 
 
The published VSG switch rates of the T. brucei Lister 427 cell line typically 
span 10-7 to 10-5 switches/cell/generation, and therefore our rates represent a ~10-
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proximal to the ES promoter to induce VSG switches, since it has only been reported 
that disruption of the region directly upstream of the expressed VSG gene, the co-
transposed region, causes an increase in VSG switching (Davies et al., 1997). To the 
best of our knowledge, since being in our hands, this clone has not been tested in any 
other VSG switch assay format. 
 
3.10 Discussion 
The cyclical passage of T. brucei through laboratory rodents selects against 
tsetse transmission potential and generates highly virulent populations of laboratory-
adapted monomorphic trypanosomes. It has long been reported that these 
monomorphic lines of T. brucei switch their expressed VSG at a rate significantly 
lower rate than biologically relevant pleomorphic populations (Turner and Barry, 
1989). Using the same cell line and method of measuring VSG switch frequency, 
Turner (1997) demonstrated that cells that had been subject to cyclical syringe 
passage switched expression of their VSG at a lower rate than cells that had recently 
been transmitted through a tsetse fly (albeit not consistently so). It has never been 
addressed, however, whether the loss of stumpy differentiation capacity that occurs 
upon laboratory-adaptation is directly associated with a concomitant reduction in 
VSG switch frequency, or whether the two processes, though both selected by 
multiple passage, are in fact independent.  
In this Chapter, I have studied pleomorphic T. brucei cells lines which, upon 
the induction of RNAi against a particular gene in the stumpy formation pathway 
(either HYP2, NEK or DYRK), turned-off the capacity of the cell line to differentiate 
to transmission competent stumpy forms (Figure 3.5). This ‘inducible 
monomorphism’ model allowed us to probe VSG switching in the same cell lines 
where pleomorphism could either be switched ‘on’ or ‘off’, without long term 
passage. In our VSG switch assay, we have shown that the induction of 
monomorphism did not provoke a corresponding drop in VSG switch rate for any of 
the three RNAi cell lines (Figure 3.14). A GFP reporter integrated at a promoter-





populations were switching VSG by DNA recombination or in situ switches of 
transcription. It has been suggested that monomorphic strains preferentially use in 
situ switches of transcription (Liu et al., 1985; McCulloch et al., 1997); however, 
upon the induction of monomorphism we did not see a reduction in the mean 
percentage of switches that were mediated by DNA recombination. Our results 
therefore present evidence that T. brucei antigen switch frequency and stumpy 
differentiation capacity can be uncoupled. 
In the VSG switch assays included in Figure 3.14, it was observed that the 
induction of RNAi against HYP2 caused a significant 3.5-fold increase in VSG 
switch rate, from 6.97x10-4 ±0.0004 to 2.5x10-3 ± 0.0009 switches/cell/generation. 
Therefore, HYP2 could be involved in both the regulation of antigen switching and 
differentiation to stumpy forms. It must however be noted that we have been unable 
to repeat this VSG switching phenotype upon the induction of RNAi in further 
experiments and that VSG switch rate stays relatively static upon the knockdown of 
HYP2. We do not yet know the source for this experimental variability. If we were 
able to replicate the increase in VSG switch rate upon the induction of 
monomorphism, it would be interesting to perform single-cell RNAseq on induced 
cells to ask if the knock-down of HYP2 was causing an increase in VSG switch rate 
or causing a deregulation of antigen expression. For example, the loss of monoallelic 
control could result in cells expressing two, or more, VSG surface coats, which 
would then be gated as a bona fide switcher in our FACS analysis. 
Our FACS-based VSG switch assay was validated through the use of the 
VSGup pLF12 -I-SceI eGFP cell line. Upon the induction of I-SceI expression in three 
VSGup pLF12 -I-SceI eGFP clones, our analysis indicated that the induced 
populations were significantly more enriched for VSG 221 negative cells compared 
to uninduced populations (p<0.05, student’s t-test) and that 71 + 3.4% of the induced 
switched populations were gated as GFP +ve (n=9), thus demonstrating that the 
FACS-assay could both detect VSG switches and DNA recombination. Within this 
assay format, however, our use of a promoter-proximal eGFP ORF as a marker for 
ES transcriptional activity does have limitations. Principally, whilst promoter-





within 24 hours of ES shut down (Zimmermann et al., 2017), GFP protein has been 
shown to have a half-life of ~80 hours in L. infantum promastigotes (Kamau et al., 
2001) and ~26 hours in mammalian cells (Corish and Tyler-Smith, 1999). Aresta-
Branco et al. (2016) demonstrated by FACS that the fluorescence emitted by 
trypanosomes expressing a promoter proximal GFP ORF matched that of the 
negative control 120 hours after transcriptional shut down of the active VSG ES 
(though earlier timepoints were not tested). This suggests that switched cells may 
still express residual GFP, albeit at decreasing levels, for up to 5 days after a 
transcriptional switch. Nevertheless, this is not the first study to use GFP 
fluorescence encoded from a promoter-proximal GFP ORF as a marker of T. brucei 
BES activity. Both Aitcheson et al. (2005) and Devlin et al. (2016) used GFP 
negativity, as determined by IFA analysis, for classifying cells which had switched 
transcription of ESs. Since flow cytometry can detect changes in fluorescence to a far 
better degree than the human eye, our method of quantitating GFP fluorescence is 
more accurate than the use of microscopy alone. We have tried to circumvent the 
underestimation of ES switching by positioning the gate defining GFP negativity as 
close to the positive control peak as possible without introducing false negatives (as 
discussed in Section 3.6.2). Nonetheless, an improvement to our method could 
involve the incorporation of a reporter protein which is more rapidly turned-over 
following transcriptional shut-down. Fusion of the C-terminus PEST sequence of 
mouse ornithine decarboxylase (MODC) to eGFP has been shown to reduce the half-
life of the protein to 2 hours in mammalian cells (Li et al., 1998). Of course, if using 
such a method it would have to be established that the protein was stable enough to 
retain fluorescence following fixation for FACS so that false negatives would not be 
introduced into the analysis. 
We must acknowledge, that in these in vitro VSG switch assay experiments, 
we did not validate the knockdown of the HYP2, NEK or DYRK transcripts at the end 
of the switch assays (in order to preserve material for FACS analysis), nor 
demonstrate the loss of differentiation capacity in the induced population compared 
to the uninduced. Regarding the transcript knockdown, growth assays (which were 
used for VSG diversity studies) demonstrated efficient knockdown of HYP2, NEK 





this Chapter (see Chapter 4, Section 4.2.2). Furthermore, consistent growth 
phenotypes upon the induction of RNAi were observed, furthermore suggesting that 
the induction conditions were working. Upon induction of HYP2 RNAi, the cells 
consistently proliferated at a lower rate, with the induced assays lasting significantly 
longer than the uninduced VSG switch assays (Figure 3.14a). In contrast, the induced 
DYRK RNAi cells were consistently observed to proliferate marginally quicker than 
the uninduced cells with the induced assays lasting a mean of 8.4 ± 0.5days 
compared to 9.5 ± 1.6 days for the uninduced cells (this difference was not 
significant however). Regardless, future VSG switch assays should make sure to 
extract RNA from the final population to confirm the respective transcript 
knockdown via qRT-PCR. In this assay’s format, it is not possible to directly 
compare the differentiation capacity of the uninduced and induced populations via, 
for e.g., attempting to stimulate in vitro differentiation of the populations to the 
insect procyclic form by cold shock and treatment with cis-aconitate. This is because 
the uninduced population is maintained at densities which would not provoke a 
density-dependent differentiation response to stumpy forms and therefore would not 
permit further development through the life-cycle. Uninduced populations are 
maintained at these densities since differentiation to the stumpy form would 
essentially decrease the VSG switch rate of the population as the stumpy cells are 
committed to cell cycle arrest and cannot generate new variants. 
In our assay’s current format, VSG AnTat1.1 negative/GFP negative cells are 
presumed to have changed their expressed VSG via an in situ switch of transcription. 
It must be acknowledged however, that if a gene conversion event were to occur 
anywhere in the 463bp between the ES promoter and the eGFP ORF, the same FACS 
profile would be produced. Duplication of an entire BES is rarer than ES switching, 
but it does happen- in a T. brucei Lister 427 strain, Hertz-Fowler et al. (2008) found 
that 3/28 switched clones had replaced their entire BES via duplicative transposition 
of the new BES (Hertz-Fowler et al., 2008). To the best of our knowledge, no VSG 
switch assay using traditional PCR, FACS or IFA methods has found a way to 
distinguish in situ switches (with deletion of the old ES) from duplications of an 
entire BES. In the pleomorphic GFPESproAnTat1.1ES DYRK RNAi populations, we 





3.14). An analysis of the first two relapse peaks of a single T. brucei EATRO 797 
rabbit infection isolated 88 switched clones which expressed 11 different VATs in 
total Robinson et al. (1999). In this pleomorphic cell line 11/13 VSGs (84.6%) were 
activated by duplicative gene conversion. With these results in mind, it seems 
unlikely that we are significantly underestimating the proportion of switches that 
occur by DNA recombination. Although the uninduced GFPESproAnTat1.1ES HYP2 
and NEK RNAi lines were demonstrated to switch less by DNA recombination, this 
may have biological significance (as discussed in Section 3.8). 
In our VSG switch assay, we found that a monomorphic GFPESpro 221ES Lister 
427 cell line switched expression of VSGs at a rate comparable to the pleomorphic 
RNAi lines tested in Section 3.8. Although most published estimates of VSG switch 
frequency in monomorphic T. brucei Lister 427 strains are in the range of 10-7-10-5 
switches/cell/generation, there is evidence of monomorphic trypanosomes switching 
their expressed VSG more frequently. Aitcheson et al. (2005) measured the VSG 
switch rate of an induced T. brucei Lister 427 90:13 cell line expressing an RNAi 
construct targeting VSG221 and a promoter proximal eGFP ORF as approximately 
1x10-4 switches/cell/generation in their in vitro switch assays. Fluctuation analysis 
confirmed that the observed VSG switches were occurring spontaneously and not as 
a result of the induction of VSG 221 RNAi (Luria and Delbruck, 1943). Aitcheson et 
al. (2005) reasoned that the experimental procedure, in particular the method of 
negative selection against VSG 221 expressing parasites, could be the reason that 
more switched cells are detected. They hypothesised that negative selection using 
VSG 221 RNAi perhaps allowed the recovery of cells which had recently switched 
VSG expression (and therefore contained the transcripts of the old and new VSGs). 
This contrasts with another in vitro negative selection method using TK and 
Ganciclovir (that generated switch frequencies in the range of 1-3x10-5 
switches/cell/generation (Cross et al., 1998) that only recovered early switchers 
where the expressed TK transcripts had dropped to very low levels (Aitcheson et al., 
2005). Using a similar method of analysis as it utilised for our VSG switch assays, 
Briggs et al. (2018) also detected rates of VSG switching in wild type T. brucei 
Lister 427 cells that were higher than would normally be expected. At four 





for VSG expression by IFA using a-VSG 221 antiserum. Without any negative 
selection against VSG 221, ~1-2 out of every 1000 wild type cells were detected that 
had switched expression away from VSG 221 (Briggs et al., 2018).  
Why then might we, and others, measure relatively high VSG switch rates for 
monomorphic cell lines? We must firstly consider that in these studies, and indeed 
most other VSG switch studies, although the genetic background being used is the 
same (i.e. T. brucei Lister 427), the cells will have been handled differently between 
laboratories. For example, some clones may have been subject to years of high 
density passage whilst others have been kept at a (relatively) low passage number. 
As a result of these disparities, ‘laboratory specific’ adaptations may occur in given 
cell lines and influence the biology of the parasite. As it is not uncommon to see 
different growth rates between different clones of the same line, perhaps we could 
also expect to see differences in VSG switch rates. Although we know that long-term 
passage in the absence of tsetse transmission causes monomorphism, we do not know 
the specific mechanism behind this loss in response to SIF. For instance, if 
monomorphism has arisen multiple times but by different means in each laboratory 
then the ‘umbrella term’ monomorph could actually comprise many different 
phenotypes, including high or low VSG switch frequency. 
Although phenotypic differences between cell lines may account for why we 
measured a switch rate of 5.99x10-4 ± 0.0004 switches/cell/generation in our 
monomorphic GFPESpro 221ES Lister 427 cell line, it does not explain our finding in 
Figure 3.11 where we measured the mean VSG switch rate of three uninduced VSGup 
pLF12 -I-SceI eGFP clones as 5.61x10-3±0.004 switches/cell/generation. The 
parental uninduced VSGup line was published to switch VSG expression at a rate of 
~1x10-5 switches/cell (however, this was just an estimation of VSG switch frequency 
compared to published values for wild type monomorphic cells (Glover et al., 
2013a)). As discussed in Section 1.2.7, there is a wide range of in vivo and in vitro 
techniques that are used to measure VSG switch rate. An explanation for why we 
(and others) have estimated monomorphic T. brucei Lister 427 cell lines to switch at 
relatively high frequency could lie in the chosen methods of analysis. As previously 





selection could remove cells which have only very recently switched expression from 
one VSG to another. If this is true, then it is less surprising that in studies such as our 
own and Briggs et al. (2018), where no negative selection against the initiating VSG 
was performed, the highest VSG switch rates are generated. With in vivo 
experiments, or with in vitro experiments utilising VSG-specific antiserum, cross 
reacting antibodies may clear newly generated variants whose epitopes are 
sufficiently similar to that of the VSG under negative selection. Since the number of 
surviving clones is incorporated into the calculation of VSG switch rate, as shown in 
Section 1.2.7, this would result in an underestimation of the VSG 
switches/cell/generation. As mentioned above, HSV-TK/Ganciclovir negative 
selection could result in an underestimation of switch frequency when newly 
switched variants still have enough TK to render them sensitive to Ganciclovir 
treatment. Similarly, MACS depletion of the initiating VSG could also underestimate 
the VSG switch frequency if a newly switched variant still retained enough of the 
initial VSG on its surface to bind the magnetic column. A negative selection step 
against the initiating VSG, whether by immunological or biochemical means, could 
therefore lead to an underestimation of VSG switch rate. However, that is not to say 
that the approach used in our study, as well as those adopted by Aitcheson et al. 
(2005) and Briggs et al. (2018), have not overestimated VSG switch rate of the 
monomorphic T. brucei Lister 427 line. Suboptimal fixation and a-VSG 221 staining 
conditions could influence the FACS or IFA interpretations (though such is the 
consistency of our observations that this seems unlikely), whilst Aitcheson et al. 
(2005) suggested that undetectable levels of RNAi ‘leakiness’ could also explain the 
relative increase in VSG switch rate. 
As discussed in Section 3.6.2, the gate defining VSG AnTat1.1 or VSG 221 
positivity was positioned directly to the left of the positive control to account for the 
time taken for cells to fully replace their VSG surface coat (Figure 3.8b). It was 
argued that placing the gate to the right of the secondary antibody only and negative 
controls would wrongly exclude cells from the analysis which had undergone a VSG 
switch, but had yet to completely replace their surface coats with the new VSG. 





negatives into the analysis. For instance, if there was suboptimal antibody staining 
then some cells may wrongly appear VSG negative or if cells which had recently 
divided and did not yet possess a full VSG AnTat1.1 or VSG 221 complement on 
their surface were present these too could be wrongly classified as VSG 
AnTat1.1/221 negative. If the gating strategy was introducing too many false VSG 
221 negative cells this could account for the unusually high VSG switch rates 
measured in the monomorphic T. brucei Lister 427 lines. To ask if the FACS gating 
strategy was responsible for the high rates of VSG switching observed in the T. 
brucei Lister 427 lines, the data presented in Figure 3.15 was reanalysed by placing 
the gate defining VSG221 positivity directly to the right of the negative control 
(Figure 3.16). When the VSG 221 gate was moved, the mean VSG 
switches/cell/generation dropped only very marginally from 5.99x10-4 + 0.0004 
switches/cell/generation to 4.31x10-4 + 0.0003 switches/cell/generation (p>0.05, 
Welches t-test). At 4.31x10-4 + 0.0003 switches/cell/generation, this change in gating 
strategy still did not reduce to calculated VSG switch rate of the monomorphic 
population to the published VSG switch rates of between 1x10-7 and 1x10-5 
switches/cell/generation. Therefore, whilst it must be acknowledged that the gating 
strategy adopted in this study could incorporate false negatives, the gating strategy is 
not the sole reason for the higher than expected VSG switch rates calculated for the 







Figure 3.16 The FACS VSG gating strategy is not responsible for the calculation of 
high rates of VSG switching in the monomorphic T. brucei GFPESproVSG221ES Lister 
427 strain The calculated VSG switches/cell/generation for the 7 GFPESpro221ES Lister 427 
replicates when the original gating strategy was used (left) and when the gate determining 
VSG positivity was moved to the right of the negative control (right). When using the trial 
VSG gating strategy, the VSG switch rate dropped approximately 1.4-fold, however the 
change was not significant (p>0.05, Welches t-test) The data represents the mean ± S.E.M 
(n=7) 
 
Together then, the use of laboratory specific stocks of Lister 427 cells and the 
application of different experimental techniques could explain why some studies, 
including ours, calculate the VSG switch rate of monomorphic T. brucei Lister 427 
cells as ~10-3 to 10-4 switches/cell/generation rather than the more commonly quoted 
10-7-10-5 switches/cell/generation. If different cell stocks and switch assays can 
produce VSG switch rates differing by 1,000-10,000-fold, then this has huge 
implications when calculating absolute VSG switch frequency for any trypanosome 
cell line. In the absence of a gold standard of VSG switch assay, how do we decide 
what the ‘real’ VSG switch rate of our cell lines are? In the context of studies such as 


















































































frequency?’, but rather ‘How does the relative VSG switch rate change within my 
experimental design?’.  
In summary, we have used an ‘inducible monomorphism’ model to investigate if 
VSG switch frequency and slender to stumpy differentiation capacity are directly 
linked. Using our in vitro FACS-based VSG switch assay, we have demonstrated that 
the induction of monomorphism did not reduce the VSG switch rate nor change the 
preferred mechanism of VSG switching. In doing so, we have presented the first 
evidence that slender to stumpy differentiation capacity and antigen switch frequency 
can be uncoupled. We have also shown that the experimental design and use of 
laboratory-specific cell stocks can change the estimated VSG switch rate for a given 
genetic background by up to 1,000-fold. Therefore, in studies such as ours 
investigating the effect of a given treatment on VSG switch rate, a comparison of the 
relative VSG switch rate within a given experimental set-up is more informative than 







4 : DETERMINING THE EXPRESSED 
VSG DIVERSITY OF PLEOMORPHIC 
AND INDUCIBLY MONOMORPHIC 









The inducible knockdown of a gene involved in the stumpy formation pathway, and 
the subsequent loss of slender to stumpy differentiation capacity, did not elicit a 
reduction in VSG switch frequency compared to the parental pleomorphs (Figure 
3.9). This suggests that antigen switch frequency and life cycle competency can be 
uncoupled, contrary to the common conception that monomorphic populations 
switch their expressed VSG at rates ~100-1000-fold less than pleomorphic 
populations. In Chapter 3, the VSG switch rates of the pleomorphic and inducibly 
monomorphic populations were calculated through in vitro FACS-based VSG switch 
assays, which are conceptually similar to other published methods. Following a short 
period of in vitro growth, VSG switched cells were quantified (either following an 
enrichment step or not, as is the case with the assays presented in Chapter 3) and the 
ratio of these compared to the total population analysed used to estimate VSG 
switches/cell (Boothroyd et al., 2009; Devlin et al., 2016; Hertz-Fowler et al., 2008; 
Horn and Cross, 1997; Hovel-Miner et al., 2016; Hovel-Miner et al., 2012; Kim and 
Cross, 2010; Schulz et al., 2016).  
 
Recent advances in technology now allow us to assess VSG switching at a much 
deeper level by analysing the expressed VSG diversity within populations using 
Illumina deep sequencing (McCulloch and Field, 2015; Mugnier et al., 2015). In 
particular, VSGseq is a targeted RNAseq approach developed and validated by 
Mugnier et al. (2015). Exploiting the conserved 5’ spliced leader and 3’ 14mer 
sequences at the end of all mature VSG mRNAs, VSG cDNA is specifically 
amplified from total RNA. The VSG cDNA is sequenced and then VSG sequences 
assembled de novo (Mugnier et al., 2015). In this Chapter, this approach was used to 
quantitively examine the expressed VSG diversity in populations of pleomorphic and 
inducibly monomorphic cells to corroborate the VSG switch assay results from 






4.2 A workflow to determine the expressed VSG diversity 
incorporating MACS and VSGseq 
For VSGseq analysis, the same GFPESproAnTat1.1ES HYP2, NEK and DYRK 
RNAi cell lines used in Chapter 3 would be studied when uninduced, and therefore 
differentiation competent, or induced, and so incapable of differentiation to stumpy 
forms. For consistency, the growth assays prior to RNA extraction were again be 
performed in vitro, scaling up culture volumes rather than diluting them, to prevent 
bottlenecking (see Section 4.2.1). Through discussions with Monica Mugnier (a 
collaborator in the study) the concern was raised that rare or minor VSG switch 
variants may not be detected due to the high prevalence of VSG AnTat1.1 expressors 
in the populations. Therefore, to increase the depth of analysis it was decided to 
deplete the populations of VSG AnTat1.1 expressors by MACS prior to the isolation 
of parasite RNA from the remaining switched cells (Boothroyd et al., 2009; Schulz et 
al., 2016). We were worried, however, that a MACS-enrichment step could introduce 
bias into the analysis of expressed VSG diversity or that MACS enrichment may not 
be equivalent between samples. Therefore, it was decided to collect a sample of total 
population RNA prior to MACS enrichment (this will be referred to as the “pre-
MACS” sample), as well as isolating RNA from the VSG switch-enriched population 
after MACS selection (this will be referred to as the “post-MACS” sample). Analysis 
of the pre-MACS dataset would allow us to take an unbiased approach to quantitate 
overall VSG expression diversity, whilst the post-MACS datasets would instead 
allow us to examine in depth which VSGs were being activated and whether some 
VSG genes (or cohorts of genes) were preferentially activated by pleomorphs or 
inducible monomorphs.  
The above considerations were consolidated into the workflow presented in 
Figure 4.1. At each step of the workflow prior to VSGseq, FACS and/or IFA samples 
were taken to either validate VSG expression or to confirm that both the uninduced 
and induced populations were proliferative. Triplicate pre- and post-MACS RNA 
samples for each uninduced and induced GFPESproAnTat1.1ES HYP2, NEK and DYRK 






Figure 4.1 Workflow to determine expressed VSG diversity in vitro Following a period 
of in vitro growth in non-induced or induced conditions (Step 1), a fraction of the total 
parasite population was used to extract total RNA. This is referred to as the “pre-MACS” 
RNA sample and provided an unbiased analysis of overall VSG expression diversity within 
the population. At this stage a small number of parasites were further isolated and fixed for 
FACS analysis of VSG expression (to confirm the population originated from a VSG 
AnTat1.1 expressing cell) and for IFA analysis of cell cycle and PAD1 expression (to 
confirm the population was PAD1 negative and so slender and replicative). The remainder of 
the population was enriched for VSG AnTat1.1 negative cells by MACS. Cells were 
incubated with magnetic beads coupled to the a-VSG AnTat1.1 antibody before being 
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passed through a magnetic column (see Section 4.2.1) (Step 2). Following the MACS step, a 
small number of parasites were removed from the ‘VSG AnTat1.1 negative’ population for 
IFA analysis of VSG AnTat1.1 expression in order to validate that the enrichment step had 
worked. The remainder of the enriched population was used to extract RNA. This is the 
“post-MACS” RNA sample, used to determine if specific VSG genes or gene cohorts were 
preferentially expressed by the pleomorphic or inducibly monomorphic cells. This process 
was repeated in triplicate for all the induced and uninduced GFPESproAnTat1.1ES HYP2, NEK 
and DYRK RNAi populations, generating 36 RNA samples. The expressed VSG diversity in 
these 36 samples is assessed by VSGseq (Step 3) where VSG cDNA is specifically amplified 
from the SL and 14mer sequences, sequenced and assembled de novo. 
 
4.2.1 MACS was effective for depleting a population of VSG 
AnTat1.1 expressing cells 
Minor VSG switch variants (i.e. those which form < 1% of the total 
population as defined by Mugnier et al. (2015)) could be lost to the background 
sequencing noise when the population is dominated by a single VSG (which in the 
case of the in vitro GFPESproAnTat1.1ES RNAi populations is VSG AnTat1.1). 
Mugnier et al. (2015) demonstrated that VSGseq could reliably detect VSG variants 
comprising 0.01% of the population, and accurately quantify a variant’s presence 
within the population when the variant formed > 0.1% of the population (Mugnier et 
al., 2015). To ensure the detection of switched variants, populations of cells were 
depleted of VSG AnTat1.1 expressing cells by MACS (Step 2, Figure 4.1) after the 
in vitro growth phase and the isolation of total population RNA (Step 1, Figure 4.1). 
Briefly, the population was incubated with a rabbit a-VSG AnTat1.1 antibody 
followed by a-rabbit magnetic beads such that, when passed through a magnetic 
column, the VSG AnTat1.1 expressing cells bind, whilst switched, antigenically 
distinct cells are collected in the flow-through (Boothroyd et al., 2009; Schulz et al., 
2016). To prevent internalisation of the a-VSG AnTat1.1 antibody (the cells are not 
fixed prior to the procedure) all incubation, centrifugation and column steps were 





To generate switch events, populations of cell lines where RNAi targeted 
genes involved in stumpy formation (±induction) were expanded in non-selective 
medium from a single VSG AnTat1.1 and GFP positive cell as was performed in 
Chapter 3. The populations were maintained at < 1x106 cells/ml by the addition of 
HMI-9 medium to dilute the cultures, rather than remove cells. This strategy reduced 
bottle-necking during the workflow (Figure 4.2a). From the final population, RNA, 
FACS and IFA samples were required, in addition to sufficient cells for MACS. This 
required an additional scale-up step, bringing the final culture volume to 125ml and 
the total assay duration to 12 days (Figure 4.2a), thereby generating 1.25x108 cells 
assuming the culture density was 1x106 cells/ml. Extending the growth phase of the 
assay further, whilst maintaining cells in logarithmic growth, was not feasible due to 
the culture volumes required. 
The capacity of the MACS columns used for the depletion of VSG AnTat1.1 
expressing trypanosomes (LD Columns, Miltenyi Biotec) was 1x108 magnetically 
labelled cells from a total population of 5x108 cells. The FACS-based VSG switch 
assays presented in Chapter 3 demonstrated that, following 8-11 days growth in non-
selective medium, ~0.01% of the population were VSG AnTat1.1 negative. 
Therefore, since the majority of the population would still be expressing VSG 
AnTat1.1 by day 12, it was decided that no more than 1x108 cells should be loaded 
onto a MACS column. From the remaining ~2.5x107 cells in the flask, two aliquots 
of 1x106 cells were each fixed for the IFA and FACS analysis and RNA extracted 
from the remaining ~2.3x107 cells (pre-MACS RNA). Thereafter, the Schulz et al. 
(2016) MACS protocol for the depletion of specific VSG expressors from an in vitro 
population was performed, as described in Section 2.17.2, using an a-VSG AnTat1.1 
primary antibody. From the final column flow-through, 1ml was washed and fixed 
for IFA analysis of VSG expression and the remainder used for the post-MACS RNA 
extraction. 
Using the above in vitro growth and VSG AnTat1.1 depletion conditions, 3 
trial VSGseq workflows were performed using uninduced pLF12GFPESproAnTat1.1ES 
NEK RNAi cells to validate the protocol. Two trials followed the full protocol 





the effectiveness of the MACS depletion of VSG AnTat1.1 expressors from the 
population. To preserve as much material as possible for the post-MACS RNA 
extractions, FACS samples for assessing MACS efficiency were not removed from 
the column flow-through in the first two trials or the final sequencing experiments. 
The FACS profiles generated from the population before and after VSG AnTat1.1 
depletion during the third trial workflow are shown in Figure 4.2b. Following 12 
days in vitro growth, 87.7% of the unsorted pLF12 GFPESproAnTat1.1ES population 
remained VSG AnTat1.1 positive (Figure 4.2b, left panel). Following MACS VSG 
AnTat1.1 depletion, the flow-through population was 43.8% VSG AnTat1.1 negative 
(Figure 4.2b, middle panel) demonstrating that the MACS step was effective at 
enriching for VSG AnTat1.1 negative cells, however that some positive cells were 
still present in the column flow-through. Although, for this single trial, 91.7% of 
cells gated as VSG AnTat1.1 negative in the unsorted population were GFP negative, 
77.6% of the VSG AnTat1.1 negative cells in the column flow through were gated as 
GFP positive. As explained in Section 3.6.2, the gate defining VSG AnTat1.1 
positivity was placed directly to the left of the VSG AnTat1.1 positive control peak. 
If the multiple steps of the MACS protocol were causing VSG to be shed from VSG 
AnTat1.1 positive and GFP negative cells, this could explain why a higher 
proportion of GFP positive cells were quantitated in the column flow-through. This 
hypothesis is supported by the observation that 8.84% of the column-bound 
population gated as VSG AnTat1.1 negative. Thus, VSG protein may have been shed 
during the multiple centrifugation steps or forceful plunging of bound cells from the 
column, or a-VSG AnTat1.1 antibody/magnetic beads used for the MACS step may 
have blocked binding of the a-VSG AnTat1.1 antibody used for the FACS analysis. 
Regardless of the reason(s) for this discrepancy, the MACS step of the VSGseq 
workflow was demonstrated to be efficient at depletion of VSG AnTat1.1 positive 
cells from the population, with the flow-through population being 43.8% VSG 







Figure 4.2 Validation of the proposed VSGseq workflow (a) In vitro growth phase to 
generate VSG AnTat1.1 negative cells. 10ml of a logarithmic uninduced population of 
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in 100µl volumes in a 96-well plate. Doxycycline was added to the +DOX populations 
following dilution and prior to distribution in the 96 well plate. After 7 days of incubation at 
37oC, the cell density of the arising clones was counted using a haemocytometer. Three 
clones which had similar cell densities, and appeared healthy when visualised with a 
microscope, were selected for progression through the assay. Over the course of a further 5 
days, cell counts were taken daily and the cultures are progressively scaled up by the 
addition of HMI-9 to prevent the populations from overgrowing. Where fresh HMI-9 was 
added to the induced cultures, doxycycline was ‘topped up’ also. On day 12, there were at 
least 1.25x108 cells (b) MACS depletion of VSG AnTat1.1 positive cells. Cells were stained 
with an a-VSG AnTat1.1 antibody at 1:20,000. 10,000 events were captured for the unsorted 
(left panel) and the column-bound (far right panel) populations. Approximately 400 intact 
cells were detected in the MACS-sorted population (middle panel). Prior to MACS 
separation the population was 87.7% positive for VSG AnTat1.1. Following the depletion of 
VSG AnTat1.1 expressing parasites, the flow through population was 43.8% VSG AnTat1.1 
negative (c) Amplification of VSG-specific cDNA from a post-MACS RNA sample. 10ng 
RNA was converted to single stranded cDNA using a primer specific to the 14mer and 
varying concentration of SS cDNA used for the amplification of DS VSG cDNA. 1µl of a 
1:10 dilution of the SS cDNA product was sufficient to amplify a product corresponding to 
the size of a VSG. 
 
Both haemocytometer counts and FACS analysis of the MACS column flow-
through populations from workflow trials 1 and 2 suggested that only ~400-2000 
VSG AnTat1.1 negative cells were present after depletion of the VSG AnTat 1.1 
expressors. Following removal of a 1ml sample for IFA analysis, RNA was extracted 
and Turboä DNase (Invitrogen) treated using the protocols in Section 2.10. To aid in 
recovery of the low concentrations of nucleic acids present, the RNA was co-
precipitated with the nucleic acid carrier glycogen (Thermo Scientific) (Section 
2.17.3). In the presence of ethanol and salt, glycogen forms a precipitate which helps 
to ‘trap’ the target RNA. Upon centrifugation, the glycogen forms a visible pellet in 
which the RNA is contained, thus aiding the handling of the low concentration RNA. 
Unlike other nucleic acid carriers such as yeast tRNA, glycogen has been 
demonstrated not to interfere with downstream enzymatic or sequencing processes at 





precipitation of the two post-MACS RNA samples, the lowest concentration sample 
(10ng RNA/µl) was used to test whether the RNA extracted was of sufficient yield 
and quality to amplify VSG cDNA. Hence, single stranded VSG cDNA was 
generated from 1µl of the 10ng/µl RNA stock using a primer specific to the 14mer 
(Table 2.2), and RT-PCR using the SL and 14mer primers attempted with 1µl of a 
1:10 dilution of the cDNA stock, 1µl of cDNA stock or 3µl of cDNA stock (Figure 
4.2c) (Section 2.11). A minus reverse transcriptase (-RT) control confirmed that the 
DNase treatment was effective. In all three conditions, a single tight band was 
visualised between 1500 and 2000bp indicating that the amplification of double-
stranded VSG cDNA had been successful despite the low quantities of RNA present 
in the initial step.  
The trial VSGseq workflows therefore demonstrated that the proposed in 
vitro growth protocol generated a sufficient number of VSG switched cells from 
which post-MACS RNA could be extracted and double-stranded VSG cDNA 
successfully amplified. Further, FACS analysis of cell populations pre- and post-
MACS separation found that the MACS-sorted populations were 43.8% negative for 
VSG AnTat1.1, an enrichment which would aid in the detection of rare VSG variants 
within the population. 
4.2.2 Generation and validation of pre- and post-MACS samples for 
VSGseq 
To quantitate the expressed VSG diversity in populations of pleomorphic and 
inducibly monomorphic trypanosomes, the GFPESproAnTat1.1ES HYP2, NEK and 
DYRK RNAi cell lines were tested in triplicate using the validated VSGseq 
workflow. For each RNAi line, the differentiation competent and differentiation 
defective populations were grown in triplicate at the same time, but for reasons of 
practicality the MACS VSG AnTat1.1 depletion step was performed separately as 
two groups of three on the same day. 
Each growth phase lasted exactly 12 days, with the cultures being scaled-up 
by the addition of drug-free HMI-9 on days 7, 9 and 11 (Figure 4.3a). The mean 





significantly less (p=0.0004, student’s t-test) than that of the induced HYP2 RNAi 
cells’ (26.7 ± 0.2 vs 28.9 ± 0.3 generations). No significant difference (p>0.05, 
student’s t-test) was found in the number of population doublings between the 
uninduced and induced NEK RNAi (25.8 ± 2.1 vs 29.2 ± 0.4 generations) or DYRK 
RNAi (28.9 ± 0.05 vs 28.7 ± 0.02 generations) populations, respectively. The 
number of population doublings is an estimate since the exact time when each cell 
count was performed was not noted; the assumption was made that 24 hours passed 
between each timepoint. 
The knock-down of each stumpy formation quorum-sensing component was 
verified by qRT-PCR using Turboä DNase treated pre-MACS RNA (Figure 4.3b). 
Single-stranded cDNA was generated from 300ng total RNA using an oligo(dT)20 
primer. A gene-specific stretch of ~100bp was then amplified from 2.5µl of a 1:20 
dilution of the SS cDNA using gene-specific primers (Table 2.2). Upon the induction 
of RNAi, the HYP2 transcripts dropped to 0.24 ± 0.005, 0.12 ± 0.002 and 0.23 ± 
0.006 relative to the uninduced levels, respectively, and the NEK transcripts to 0.27 ± 
0.001, 0.34 ± 0.006 and 0.12 ± 0.01 relative to the uninduced levels, respectively 
(Figure 4.3b, left and middle panels). The transcript knock-down was not as 
pronounced in the induced DYRK RNAi line, with the transcript levels dropping to 
0.66 ± 0.02, 0.33 ± 0.02 and 0.66 ± 0.05 relative to the pleomorphic uninduced 








Figure 4.3 Validation of HYP2, NEK and DYRK knockdown in the induced 
GFPESproANTat1.1ES populations (a) In vitro growth curves of the GFPESproAnTat1.1ES 
HYP2 (left), NEK (middle) and DYRK (right) RNAi lines (± induction) prior to pre-MACS 
RNA extraction, MACS depletion of VSG AnTat1.1 positive cells and extraction of post-
MACS RNA. Uninduced populations are shaded in teal and induced in plum. Assays were 
performed once in triplicate (n=3). (b) Validation of HYP2 (left panel), NEK (middle panel) 
and DYRK (left panel) transcript knock down upon induction. Uninduced replicates are 
shaded in teal, induced in plum. cDNA was generated from 300ng pre-MACS RNA. Data 
represents the mean ± S.D (n=3). *** = p<0.001 **** = p<0.0001. 
 
Prior to labelling the populations with magnetic beads coupled to the a-VSG 
AnTat1.1 antibody, 1x106 cells were removed, washed and fixed for FACS analysis 
















































































(Figure 4.4a) and a further 1x106 fixed for cell cycle and PAD expression analysis by 
IFA (Figure 4.4b). The FACS profiles in Figure 4.4a show that the majority of the 
triplicate uninduced and induced populations for all three GFPESproAnTat1.1ES RNAi 
cell lines were both VSG AnTat1.1 and GFP positive, strongly suggesting that the 
single cell from which the populations were expanded from was also doubly positive. 
To perform a valid comparison of the expressed VSG diversity between 
differentiation competent and incompetent populations, it was important that both 
populations remained proliferative. This was because a high proportion of stumpy 
cells within the populations, which are irreversibly arrested in their cell cycle, would 
affect the comparison since they could not form new VSG switch variants (Amiguet-
Vercher et al., 2004). Proliferative cells with a 2K1N or 2K2N configuration 
represented ~20-25% of the populations (Figure 4.4b), and for each of the uninduced 
and induced RNAi lines there was no significant difference (p>0.05, student’s t-test) 
in the proportion that were replicative. PAD1 protein expression was determined 
from the same IFA samples which were used to determine cell cycle status. In each 
of the GFPESproAnTat1.1ES HYP2, NEK and DYRK RNAi lines, the percentage of the 
population which expressed PAD1 was always higher in the uninduced population 
compared to the induced population (6.9% ± 0.8 vs 0.5% ± 0.5, 2% ± 1.8 vs 0.7% ± 
1.2 and 8% ± 3.6 vs 2.7% ± 1.7, respectively), though this was only significant in the 
case of HYP2 (p=0.0003, student’s t-test). This was still only a very small proportion 
of the respective populations however, and since cell cycle analysis showed no 
accumulation in G1, the populations were considered proliferative. 
Following the MACS depletion step, the number of parasites in a 10µl 
sample from the column flow-through was counted on a haemocytometer. No more 
than 4 parasites were ever visualised in a given sample, and in 8 of the 18 flow-
through samples no parasites were counted at all. A 1ml sample from the column 
flow through was fixed for IFA analysis of VSG expression. The number of cells in 
each IFA sample was variable but consistently low (no more than 17 cells were 
counted for a single sample) (Figure 4.4c). Prior FACS analysis had suggested that 
the MACS column flow-through was >40% negative for VSG AnTat1.1 (Figure 
4.2b). This level of VSG AnTat1.1 depletion was attained for all of the 





GFPESproAnTat1.1ES NEK RNAi flow-through population (33.5% ± 19.1 VSG 
AnTat1.1 negative parasites) and the induced GFPESproAnTat1.1ES NEK RNAi flow-
through population (14.3% VSG AnTat1.1 negative parasites) where very high levels 
of contamination with VSG AnTat1.1 expressing variants were observed. Since 
VSGseq is capable of reliably detecting variants which are expressed by 0.01% of 
the population however, these levels of VSG AnTat1.1 depletion were considered 




Figure 4.4 The GFPESproAnTat1.1ES populations originated from a VSG AnTat1.1/GFP 
positive cell and were proliferative (a) FACS analysis of VSG and GFP expression in cells 
fixed on day 12 prior to MACS depletion. For each replicate (R) 10,000 events were 
captured. VSG AnTat1.1 positivity was measured by a-VSG AnTat1.1 antibody binding and 
GFP positivity by fluorescence emission in the FITC channel alone. The majority of the 
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populations were grown from was also GFP and VSG AnTat1.1 positive. Variants which had 
arisen from in situ switches (GFP/VSG AnTat1.1 -ve) or DNA recombination (GFP 
+ve/VSG AnTat1.1 -ve) accumulated during the growth phase (b) Cell cycle and PAD1 
expression analysis of paraformaldehyde fixed cells. Cells were stained with DAPI and an a-
PAD1 antibody. The uninduced, differentiation competent cells did not accumulate as cell 
cycle arrested, PAD1 expressing stumpy forms. Data represents the mean±S.D (n=3), 250 
cells were counted for each replicate. *** = p < 0.001 (c) IFA analysis of VSG expression in 
cells collected from the MACS column flow through. 1ml of sample was removed from the 
column flow through immediately post-MACS, washed in PBS and fixed in 
paraformaldehyde. Cells were stained with an a-VSG AnTat1.1 antibody and the entire 
sample loaded to a single well. Flow through populations were enriched for non-VSG 
AnTat1.1 expressors. Data represents the mean±S.D (n=3, except for the HYP2 -DOX and 
DYRK +DOX samples where n=1 and the NEK -DOX sample where n=2). 
 
4.2.3 RNA extraction and library preparation for Illumina 
sequencing 
Pre- and post-MACS RNA was extracted, DNase treated and glycogen co-
precipitated (post-MACS only) as previously described (Section 2.17.3). The RNA 
concentrations of the 36 samples were estimated using a NanoDrop 
spectrophotometer (Thermo Fisher Scientific) and ranged from 188.5-459.8ng/µl for 
the pre-MACS samples and 8-98.5ng/µl for the post-MACS samples (the post-
MACS samples with the highest RNA concentrations corresponded to the replicates 
in which numerous contaminating VSG AnTat1.1 expressors were observed). The 
VSGseq protocol was performed in collaboration with Monica Mugnier at the Johns 
Hopkins Bloomberg School of Public Health (Baltimore, USA). RNA samples were 
shipped on dry ice and stored at -80oC until their time of use.  
First strand cDNA synthesis and the subsequent PCR amplification of VSGs 
was performed as described in Section 2.17.4. Following the latter, 5µl of the PCR 
product from 6 samples was run on an agarose gel to confirm the steps had 
successfully generated double-stranded VSG cDNA (Figure 4.5). A single band 
corresponding to the size of a VSG amplicon was visualised in all of the samples, 








Figure 4.5 VSG Specific RT-PCR products VSG-specific RT-PCR produced a ~1600bp 
double stranded cDNA product, corresponding to the size of a VSG. ‘Pre’ refers to pre-
MACS RNA, -/+ refers to the absence or presence of doxycycline. 
 
VSG amplicons were simultaneously fragmented and tagged with universal 
overhangs (tagmentation) using the NextEra XT DNA Library Prep Kit (Illumina) 
(see Section 2.17.4). It is to these universal overhangs that specific pairs of index 
sequences were annealed during a further PCR amplification. As a final quality 
control step, small aliquots from 11 different library preparations (selected to give a 
broad representation of the sample set) were ran on a bioanalyzer in order to test the 
effectiveness of the fragmentation step (Appendix B). Typical libraries consist of a 
range of fragments between 250-1000bp. Each of the library preparations in 
Appendix B did consist of a broad range of fragments between ~200 and 1000bp, 
however a sharp peak at ~1000bp followed by a second large peak at ~1500bp was 
observed in samples 8, 9 and 10 (DYRK pre-MACS -DOX2/3 and DYRK pre-MACS 
+DOX1, respectively). Since the mean fragment size in these library preparations 
was still within the expected range however (738bp, 937bp and 697bp, respectively), 
the libraries were considered satisfactory. The peaks at 35 and 10380bp represent 
low and high molecular weight markers.  
The 36 libraries were pooled such that 0.02pmol of each sample was present in 




































flow cell and 100bp single-end sequencing was performed in-house on an Illumina 
HiSeq 2500. The VSGseq data was analysed using the pipeline available on 
https://github.com/mugnierlab/VSGSeqPipeline, with the identified ORFs being 
compared by BLAST to the EATRO1125_vsgs reference database in order to 
identify VSG sequences (for more information see Section 2.17.5). The output 
MULTo analysed csv. file shows the expression of each VSG in each sample, both in 
terms of RPKM (reads per kilobase of transcript, per million mapped reads) and 
percentage of the population (RPKM for that VSG/total RPKM), and the BLAST 
similarity results for each given VSG compared to the EATRO 1125 reference 
database.  
 
4.3 Overall VSG expression diversity is similar between 
pleomorphic and inducibly monomorphic populations 
FACS analysis demonstrated that the majority of the parasites contained in the 
pre-MACS samples had not switched expression from VSG AnTat1.1 (Figure 4.4a) 
and this was reciprocated in the VSGseq analysis. When the uninduced and induced 
triplicates were combined, the mean percentage of the pre-MACS populations 
expressing VSG AnTat1.1 was >99.6% for each of the three GFPESproAnTat1.1ES 
RNAi lines (Figure 4.6, top). IFA results, whilst limited in their usefulness due to < 
20 cells being analysed per replicate, had confirmed enrichment for VSG AnTat1.1 
negative parasites following the MACS depletion step but also suggested that VSG 
AnTat1.1 expressing contaminants were present in the flow through (Figure 4.4c). 
The post-MACS VSGseq datasets corroborated this observation. The mean 
percentage of the 6 replicate post-MACS populations expressing VSG AnTat1.1 
dropped to 89.8% ± 7.8, 74.4% ± 19.8 and 91.4% ± 8.8 for the GFPESproAnTat1.1ES 
HYP2, NEK and DYRK RNAi lines, respectively, representing a 34-, 85.3- and 21.5-






Figure 4.6 Post-MACS samples are enriched for non-VSG AnTat1.1 sequences Pie 
charts represent the mean percentage of reads within the combined uninduced and induced 
populations which mapped to VSG AnTat1.1 (blue) or any other VSG (plum), as determined 
by VSGseq analysis. Post-MACS HYP2, NEK and DYRK populations were enriched 34-, 
85.3- and 21.5-fold for non-VSG AnTat1.1 expressors. 
 
The pre-MACS samples allowed us to take an unbiased approach to examine 
overall VSG expression diversity in pleomorphic and inducibly monomorphic 
populations. As a first measure of VSG expression diversity, the numbers of different 
VSGs detected within the respective uninduced and induced populations were plotted 
alongside the percentage of the population which was made up of non-VSG 
AnTat1.1 expressing cells (VSG switch variants) (Figure 4.7). By accounting for 
both the number of VSGs and the proportion of the population which consisted of 
VSG switched cells, we would be able to discriminate whether induction of 
monomorphism had an effect on expressed VSG diversity, and therefore antigen 
switching. Since VSGseq does not reliably detect variants which are expressed by 
less than 0.01% of the population, any VSG whose expression fell below this 
threshold was excluded from the analysis. 
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The number of VSGs accounting for >0.01% of the population ranged from 3 
(HYP2 RNAi +DOX 2) up to 14 (DYRK RNAi +DOX 2). Upon induction of RNAi 
against HYP2, the mean number of expressed VSGs detected within the triplicate 
populations dropped from 7.67 ± 1.5 to 4.67 ± 1.5, whilst induction of RNAi against 
NEK or DYRK contrarily increased the number of detectable VSGs within the 
populations (7 ± 2 vs 6.7 ± 1.5 and 8.3 ± 5.1 vs 6.3 ± 1.5). None of these changes, 
however, were statistically significant (p>0.05, student’s t-test). A similar number of 
detectable VSGs, but differences in the proportion of the total population made up of 
VSG switched cells, could indicate differences in either the kinetics of VSG 
switching, the stability of the newly activated antigen variant(s) or the growth rates 
of switched clones. As previously demonstrated in Figure 4.6, where the values for 
the uninduced and induced populations were combined, the percentage of the 
populations expressing VSGs other than VSG AnTat1.1 was consistently low. When 
considered separately, there was no statistically significant (p>0.05, student’s t-test) 
difference between the percentage of VSG switched cells in differentiation 
competent and differentiation defective populations for any of the 
GFPESproAnTat1.1ES RNAi lines (Figure 4.7). Together, these results suggest that the 
induction of monomorphism does not reduce expressed VSG diversity compared to 
the parental pleomorphic population. Since the number of expressed VSGs, and the 
proportion of the population consisting of switched cells, remains consistent between 
the two groups, this suggests that the pleomorphs and inducible monomorphs are 







Figure 4.7 Induction of monomorphism does not reduce VSG expression diversity The 
number of VSGs (dot symbols) expressed by over 0.01% of the total population (reliability 
threshold) was counted for the uninduced (-DOX, teal) and induced (+DOX, plum) 
GFPESproAnTat1.1ES HYP2 (left), NEK (middle) and DYRK (right) RNAi lines. The 
percentage of cells in these populations that consisted of non-VSG AnTat1.1 expressors is 
represented by the coloured bars. Induction of monomorphism did not significantly reduce 
the number of detectable VSGs, nor the prevalence of VSG switched cells within the 
population, suggesting that the uninduced and induced populations are switching their 
expressed VSGs at a similar rate. Data represents the mean±S.D. (n=3). 
 
Although the overall numbers of expressed VSGs within the pleomorphic and 
inducibly monomorphic populations were similar, this did not rule out the possibility 
that induction of monomorphism was influencing which VSGs were being selected 
for expression. Monomorphic laboratory-adapted cells are suggested to preferentially 
change expressed VSGs via in situ switches whilst pleomorphic populations more 
often employ DNA recombination (Liu et al., 1985; McCulloch et al., 1997; 
Robinson et al., 1999). The repertoires of expressed VSGs within the pre-MACS 
datasets were explored for VSGs unique to either uninduced or induced conditions to 
investigate if induction of monomorphism changed VSG expression bias (Figure 
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populations, half of which were present in at least one replicate of both the 
uninduced and induced populations (Figure 4.8, ‘combined’). No single VSG 
transcript appeared in all three replicates of all three GFPESproAnTat1.1ES RNAi lines. 
Three VSGs were unique to at least one of the uninduced, pleomorphic replicates, 
whilst more than twice this were unique to at least one of the inducibly monomorphic 
replicates. Although this could seem to suggest that the induction of monomorphism 
can drive the monomorphic populations to select distinct VSGs to those in the 
pleomorphic populations, these results are biased by the +DOX2 DYRK RNAi 
replicate in which 2-3x more VSG types were identified than in any other replicate 
(Figures 4.7 and 4.8, DYRK RNAi). Coincidently this replicate was the only DYRK 
RNAi replicate which saw levels of transcript knock down over 50% (Figure 4.3b). 
On balance, it is likely that the numbers of unique VSGs in the inducibly 
monomorphic and pleomorphic populations were more similar overall, as seen in the 
HYP2 and NEK RNAi lines (Figure 4.8, HYP2 and NEK RNAi). Of the VSGs 
‘unique’ to either the uninduced or induced conditions, only two 
(DN171_c0_g1_i1_1_22_1453 and DN480_c0_g1_i3_1_45_1416) were expressed 
in more than one replicate (HYP2 -DOX 1/3 and HYP2 -DOX 1/2/3, respectively). 
Since both these VSGs were present in the pleomorphic and inducibly monomorphic 
NEK and DYRK RNAi populations, they do not seem to be preferentially activated 
by pleomorphic populations. 
The induction of monomorphism was not associated with the selection of 
VSGs distinct from the those activated in the pleomorphic populations. Therefore, I 
next asked if the proportions of certain VSGs were always higher in one population 
compared to another. For this, I studied those VSGs which were consistently 
expressed in every triplicate within a given condition, rather than those which 
appeared transiently in a single replicate. Figure 4.8b shows that no one VSG 
predominated in every triplicate demonstrating, even in these pre-enrichment sample 
sets, that a diverse range of VSGs are being expressed by both the different 
populations, and within the triplicates themselves. Indeed, no consistent pattern of 
expression was observed within any of the uninduced or induced populations of the 
three GFPESproAnTat1.1ES RNAi lines. Apparently, therefore, any differences in VSG 





their inherent diversity, and not caused by the induction of RNAi against a gene 
involved in stumpy formation. 
 
Figure 4.8 The majority of the VSGs identified in the pre-MACS datasets were 
expressed by both the pleomorphs and inducible monomorphs (a) Venn diagrams 
showing intersections of expressed VSGs in the pre-MACS datasets. The ‘combined’ dataset 
incorporates the data from the HYP2, NEK and DYRK GFPESproAnTat1.1ES lines. -/+ refers to 
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the addition of doxycycline (b) Pie charts showing the proportion of reads which map to 
VSGs occurring in every triplicate for a given condition (- or + DOX) in the pre-MACS 
datasets. VSG AnTat1.1 was excluded from the analysis. Each VSG is represented by a 
different colour, the colours are consistent between each condition. The number of VSGs is 
denoted by ‘n’. 
 
4.4 Post-MACS analysis shows that the induction of 
monomorphism is not associated with the selection of 
specific VSG genes 
VSGseq analysis of the pre-MACS samples demonstrated that the induction of 
monomorphism does not reduce the diversity of VSGs expressed within the 
population (measured by the number of VSGs identified within the populations), 
change the identity of the VSGs selected for expression or influence the extent to 
which certain VSGs are represented within the population compared to the 
pleomorphic populations. However, no VSG other than VSG AnTat1.1 was reported 
to be expressed in >0.26% of any of the populations and, therefore, many variants 
expressed at very low levels within the population could have fallen below the pre-
MACS sequencing threshold. Therefore, MACS depletion of VSG AnTat1.1 
expressing parasites was carried out facilitating the identification of rare variants 
within the populations. As highlighted earlier, MACS depletion enriched for 
AnTat1.1 expressors in the GFPESpro AnTat1.1ES HYP2, NEK and DYRK RNAi 
populations (uninduced and induced combined) 34-, 85.3- and 21.5-fold, respectively 
(Figure 4.6).  
The application of MACS to enrich for VSG switched parasites complicates 
the use of VSG counts as a method of comparison between inducibly monomorphic 
and pleomorphic populations, as was performed in Section 4.3. For example, a 
higher number of VSGs identified within the populations could indicate either a 
higher level of expressed VSG diversity, or simply that the MACS depletion step had 
been more efficient for a given replicate. However, since there was no significant 





VSG switched cells between uninduced and induced HYP2, NEK and DYRK RNAi 
lines (6.97% ± 5.1 vs 13.5% ± 9.7, 24.04% ± 15.6 vs 27.1% ± 26.9 and 6.04% ± 5.3 
vs 11.2% ± 12.1 VSG AnTat1.1 negative reads >0.01% population), it was assumed 
that the MACS depletion step had worked similarly as well between the uninduced 
and induced populations of each RNAi line. 
Overall, 106 individual VSGs were identified in the post-MACS datasets, 
representing a 5.3-fold increase on the number identified by the pre-MACS analysis. 
The percentage of each replicate population (VSG RPKM/total population RPKM) 
expressing a given VSG was log10 transformed and the results expressed in the 
heatmaps in Figure 4.9a. VSG AnTat1.1 appears as a dark red band at the top of all 
the heat plots, indicating that it is still the most prevalent VSG sequenced in the 
populations despite the MACS depletion step. Before considering the differences in 
VSG gene expression between the uninduced and induced populations, it was 
observed that even within the uninduced or induced triplicates themselves there were 
high levels of VSG expression diversity. For each condition, the percentage of VSGs 
which appeared in all three triplicates is shown in the horizontal bar chart below the 
heatmaps, and ranges from only 13% (DYRK RNAi inducible monomorphs) to 39% 
(NEK RNAi pleomorphs). 
The identity of these consistently expressed VSGs, and the proportion to which 
they appeared in their respective populations, was investigated in order to determine 
a) whether any were more common to pleomorphic or inducibly monomorphic 
populations, or b) whether they were expressed to a greater extent in one population 
compared to another (Figure 4.9b). VSG AnTat1.1 reads were again excluded from 
the analysis to increase resolution. As was observed in the pre-MACS analysis, there 
was no consistent pattern of VSG expression either within the triplicates, or within 
the pleomorphic and inducibly monomorphic populations themselves. Only 2 
assembled VSGs were present in every uninduced and induced population in all three 
of the GFPESproAnTat1.1ES RNAi lines. The first of these, 
DN921_c0_g1_i1_1_1_1543, never surpassed expression by >0.22% of any of the 
populations however the second, DN30_c0_g1_i2_1_2_1484, was expressed by a 





that these were calculated when VSG AnTat1.1 was included in the analysis; the 
relative proportions are exaggerated in the pie charts in Figure 4.9b since VSG 
AnTat1.1 was removed for these). DN103_c0_g1_i1_1_16_1477 was the only 
example in the post-MACS datasets of a VSG which was the most highly expressed 
VSG after VSG AnTat1.1 in every replicate within a condition (DYRK RNAi 
+DOX1/2/3) (Figure 4.9a, purple box and Figure 4.9b). 
DN103_c0_g1_i1_1_16_1477 was also the most highly expressed VSG after VSG 
AnTat1.1 in one other inducibly monomorphic replicate (HYP2 RNAi +DOX3), 
however it otherwise appeared at various percentages within both pleomorphic and 
inducibly monomorphic populations, suggesting that it is not preferentially activated 
following the induction of monomorphism. There was only one instance where a 
VSG was consistently expressed in all three uninduced replicate populations at levels 
10-fold greater than all three induced replicates (mean 1.42% ± 0.47 in the uninduced 
populations and 0.07% ± 0.05 in the induced populations) (Figure 4.9a, black box 
and Figure 4.9b). DN104_c0_g1_i2_1_0_1523 was not a direct match to any of the 
VSGs contained on the EATRO 1125 database, but showed 84% identity over 86% 
of its length to Tb1125VSG-276. No VSGs were consistently expressed at levels 
>10-fold greater in the inducibly monomorphic populations compared to the 
pleomorphic populations for any of the three RNAi cell lines and furthermore, no 
VSG was ever found in all three replicates of either the uninduced or induced 
population and not at all in the corresponding uninduced or induced populations. 
These observations therefore corroborate the pre-MACS analysis in Section 4.3, and 
demonstrate that the induction of monomorphism is not associated with a change in 







Figure 4.9 VSG expression in the post-MACS samples is highly diverse (a) VSG 
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uninduced and induced HYP2, NEK and DYRK RNAi populations expressing a given VSG. 
The percentage of the population expressing a given VSG was calculated by the VSG 
specific RPKM divided by the total population RPKM. Where a VSG was not expressed in a 
given replicate (i.e. expression = 0), 0.001 was added in order to allow for the log10 
transformation. Each row represents a different VSG. The black box around three NEK 
RNAi -DOX replicates indicates the only instance where VSG expression was 10-fold 
greater in all three population replicates for one condition (for e.g. -DOX) than the other (for 
e.g. +DOX). The purple box around three DYRK RNAi +DOX replicates indicates the only 
instance where a VSG was consistently the highest expressed VSG (excluding VSG 
AnTat1.1) in all triplicates for a given condition (-DOX or +DOX). The colour intensity 
scale on the right ranges from dark red (100% of the population) to dark blue (0.001% of the 
population). The order of the listed VSGs is consistent between the uninduced and induced 
samples, but not between the three GFPESproAnTat1.1 lines. For each GFPESproAnTat1.1ES 
RNAi line, the number of VSGs which were identified in all the uninduced (black) or 
induced (grey) triplicates is shown as a percentage of the total VSG population in the bar 
charts below each heat plot. “–” and “+” represents the absence or presence of doxycycline. 
(b) Pie charts showing the number of reads which map to VSGs occurring in every triplicate 
for a given condition in the post-MACS datasets. VSG AnTat1.1 was excluded from the 
analysis. Each VSG is represented by a different colour (the colours are consistent between 
each condition and the pie-charts in Figure 4.8). The number of VSGs is denoted by ‘n’. The 
VSGs mentioned in the text are shown in the key at the bottom. 
 
Mugnier et al. (2015) used VSGseq analysis to quantitively analyse VSG 
expression during in vivo infections of mice, and demonstrated that high levels of 
VSG expression diversity were present throughout the populations, even within the 
parasitaemic valleys. Of the 192 variants that were identified during their study, the 
majority of these (86%) appeared in more than one infection and almost half (46%) 
appeared in all. Of the VSGs identified in the post-MACS datasets, 60 (56.6%) 
appeared in at least one of both the uninduced and induced GFPESproAnTat1.1ES 
RNAi populations (Figure 4.10, combined) and only 2 (1.9%) were assembled in 
every replicate of every condition in each of the GFPESproAnTat1.1ES RNAi 
populations. Higher levels of VSG expression diversity in an in vitro setting is likely 
explained by a lack of immune selection against variants. Alternatively, the greater 





deploy MACS to rid their populations of the initiating VSGs, or because of the 
inherent VSG instability of the AnTat1.1 90:13 cell lines used (Chapter 3 has already 
demonstrated that the cell lines switch their expressed VSG at rates of ~2x103-5x104 
switches/cell/generation). When studying the intersections of expressed VSGs in 
pleomorphs and inducible monomorphs for each of the three GFPESproAnTat1.1ES 
RNAi lines individually, the majority of the VSG genes expressed by the HYP2 and 
NEK RNAi lines were found in both populations (59% and 58%, respectively) 
(Figure 4.10, HYP2, NEK). However, as was observed for the pre-MACS datasets, 
less than half of the VSG genes (38%) expressed by the DYRK RNAi line were 
common to both the pleomorphic and inducibly monomorphic populations (Figure 
4.10, DYRK). Unlike our observation in Figures 4.7 and 4.8a, in this case the low 
percentage of shared VSGs between the pleomorphs and inducible monomorphs 
could not be explained by a single replicate in one condition expressing 2-3X more 
VSGs than any other replicate. None of the VSGs unique to either the DYRK RNAi 
pleomorphs or inducible monomorphs were present in triplicate, and only one VSG 
was present at >1% in the population (DN112_c0_g1_i3_1_4_1501 was expressed 
by 2.7% of a pleomorphic DYRK RNAi population). Since these VSGs are expressed 
at such low levels within the populations, and 87.5% are expressed in only one 
replicate, the differences in VSG expression observed in Figure 4.10 between the 
DYRK RNAi pleomorphs and inducible monomorphs were likely the result of the 
inherent antigen instability of this line of trypanosomes and the semi-random nature 
of VSG switching, not the loss of differentiation capacity. The VSGs unique to either 
the inducibly monomorphic or pleomorphic populations for each of the 
GFPESproAnTat1.1ES HYP2, NEK or DYRK RNAi lines were distributed 
approximately evenly between the two populations. This suggests, that while there 
may have been some differences in which VSGs were selected for expression, the 
new variants were being generated at the same rate in the pleomorphic and inducibly 






Figure 4.10 In vitro populations of DYRK RNAi pleomorphs and inducible 
monomorphs are highly diverse in their VSG expression but appear to generate new 
variants at roughly the same rate Venn diagrams showing intersections of expressed VSGs 
in the post-MACS dataset. The ‘combined’ dataset incorporates the data from the HYP2, 
NEK and DYRK GFPESproAnTat1.1ES lines. -/+ refers to the addition of doxycycline. 
 
Overall, pre- and post-MACS VSGseq analysis of the triplicate pleomorphic 
and inducibly monomorphic GFPESproAnTat1.1ES HYP2, NEK and DYRK RNAi 
populations identified 107 different VSGs (Figure 4.11a). Just under 60% of the 
VSGs were shared between at least one replicate in a pleomorphic and inducibly 
monomorphic population. The remainder of the VSGs were evenly distributed 
between the two groups- 18% were only assembled in a pleomorphic population and 
the remaining 23% were only assembled in an inducibly monomorphic population. 
Diverse VSG expression was witnessed at all stages of the analysis, both within the 
triplicates of a given uninduced or induced RNAi population, and between the 
inducibly monomorphic and pleomorphic populations themselves. In addition to this, 
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and perhaps somewhat surprisingly, VSG expression was not particularly consistent 
between the three GFPESproAnTat1.1ES RNAi lines either, despite these having the 
same AnTat1.1 90:13 genetic background. Of the 107 assembled VSG genes, less 
than half (40.1%) were expressed by all three of the GFPESproAnTat1.1ES RNAi lines. 
The GFPESproAnTat1.1ES HYP2 RNAi cell line appeared to exhibit the most diverse 
VSG gene expression; 12% of the VSGs expressed within its populations were never 
expressed in a NEK or HYP2 RNAi line for the duration of the experiment (Figure 
4.11b). This could signify that the HYP2 RNAi line has started to become divergent 
in its VSG expression compared to the NEK and DYRK RNAi lines during their 
different laboratory passage, or that during the growth phase of the experiment some 
populations underwent an extra VSG switch. The pleomorphic and inducibly 
monomorphic HYP2 RNAi populations did not undergo a greater number of 
population doublings compared to the NEK or DYRK RNAi populations, though 
FACS-based VSG switch assays did demonstrate that switching occurred more 
frequently in this line compared to the NEK RNAi line (~2x10-3 vs ~5x10-4 
switches/cell/generation) (Chapter 3). No VSGs unique to either the NEK or DYRK 
RNAi lines were assembled.  
 
FIGURE 4.11 The GFPESproAnTat1.1ES HYP2 RNAi line expresses VSGs not assembled 
in the NEK and DYRK RNAi lines Venn diagrams showing intersections of expressed 
VSGs (a) in the inducibly monomorphic and pleomorphic populations (pre-and post-MACS 
data for each of the three RNAi lines is combined) and (b) in the GFPESproAnTat1.1ES HYP2, 
NEK and DYRK RNAi lines (pre- and post-MACS data for each of the pleomorphic and 















4.5 In vitro populations of trypanosomes do not readily 
express mosaic VSGs 
Mosaic VSGs, formed by segmental gene conversion, are critical to the 
expansion of a parasite’s VSG repertoire and therefore facilitate the maintenance of 
long-term infection (Mugnier et al., 2015). Although it was not anticipated that in an 
in vitro setting, and after only 12 days passage, mosaic sequences would be identified 
at a detectable level, the datasets were nevertheless searched for the presence of 
potential mosaic VSGs. Within their datasets, Mugnier et al. (2015) defined mosaic 
VSG candidates as having <80% of their length aligning to any sequence within two 
independently assembled EATRO 1125 genomes and as being present in only one 
infection at >0.1% of the population (for the purpose of this in vitro study, this was 
interpreted as one culture replicate). Three mosaics were validated by PCR as being 
present within the gDNA of the parasites collected from the infection, but absent in 
the gDNA of the parental strain (Mugnier et al., 2015). As expected, however, no 
assembled VSGs from the inducibly monomorphic or pleomorphic populations fitted 
these criteria.  
 
4.6 Discussion 
It has long been reported that laboratory-adapted, monomorphic strains of T. 
brucei switch their expressed VSG at a significantly lower rate than differentiation 
competent pleomorphic trypanosomes (Turner, 1997). Despite the wide-spread 
nature of this claim, it has never been demonstrated whether the reduction of antigen 
switch frequency and loss of differentiation capacity are directly linked, or whether 
the two processes are simply co-selected during long-term passage. Our results in 
Chapter 3 showed that the induction of monomorphism, mediated by the inducible 
knock-down of a gene involved in the stumpy formation pathway, did not 
significantly reduce the frequency of antigenic variation nor significantly change the 





pleomorphic populations. This suggested that pleomorphism and antigen switch 
frequency can be uncoupled. In this Chapter we have explored a second method for 
establishing whether the induction of monomorphism directly influences the rate of 
antigenic variation- VSGseq. Developed by Mugnier et al. (2015), VSGseq is a 
targeted RNA sequencing approach whereby primers specific to the conserved 5’ and 
3’ ends of all mature VSG mRNAs are used to amplify VSG cDNA. Illumina 
sequencing and de novo sequence assembly follows, providing a comprehensive 
view of which VSGs were being expressed, and at which frequency, within the 
population at the time of sampling. 
Triplicate populations of pleomorphs and inducible monomorphs were grown 
from a single VSG AnTat1.1/GFP positive cell in vitro for each of the 
GFPESproAnTat1.1ES HYP2, NEK and DYRK RNAi lines. For each of the final 
populations, both total population RNA (pre-MACS) and RNA enriched for non-
VSG AnTat1.1 sequences following MACS depletion of VSG AnTat1.1 expressing 
parasites (post-MACS) was extracted and sequenced. VSGseq analysis of pre-MACS 
RNA samples allowed for an unbiased quantification of VSG expression diversity 
within the pleomorphic and inducibly monomorphic populations. For each of the 
RNAi lines, induction of monomorphism was shown to not reduce the number of 
VSGs identified, nor the extent to which these VSGs were represented within the 
population, compared to the pleomorphic population. To discriminate if the induction 
of monomorphism had influenced the selection of VSGs for expression, the post-
MACS GFPESproAnTat1.1ES HYP2, NEK and DYRK RNAi datasets, which are 
enriched 34-, 85.3- and 21.5-fold for reads which do not map to VSG AnTat1.1, were 
analysed. The analysis found that there were no VSGs which were preferentially 
activated in pleomorphic or inducibly monomorphic populations. Consequently, any 
differences observed in VSG expression diversity were due to the inherent instability 
of VSG expression in these trypanosome lines and the semi-random nature of VSG 
switching, not the induction of monomorphism. Overall, these results provide further 






On the most basic level of comparison, the conclusions drawn from the 
VSGseq analysis support the evidence presented in the FACS-based VSG switch 
assay experiments namely that antigen switch frequency and differentiation capacity 
can be uncoupled. The induction of monomorphism did not significantly reduce the 
number of VSGs identified in the pre-MACS datasets, nor the extent to which non-
VSG AnTat1.1 VSGs were represented in the population, in the same way that 
FACS-based VSG switch assays did not detect a significant drop in the proportion of 
the populations staining negatively for VSG AnTat1.1. The FACS-based VSG switch 
assays furthermore found that there was no significant change in the preferred 
method of VSG switching (i.e. transcriptional switches or DNA rearrangements) 
following the induction of monomorphism. In support of this, the VSGseq analysis 
did not detect a shift in VSG expression towards a ‘monomorph-specific’ VSG 
expression profile. 
In Chapter 3, it was demonstrated that the VSG switch rate increased 
approximately 3.5-fold following the knock-down of HYP2. The evidence presented 
in Figure 4.7 did not corroborate this observation and, in fact, the induced 
GFPESproAnTat1.1ES HYP2 RNAi populations were found to contain the lowest mean 
number of detectable VSGs (4.67 ± 1.5 VSGs) of all the conditions and reporter cells 
tested. It was discussed in Section 3.10 that HYP2 could contribute to the 
maintenance of monoallelic expression, such that when the RNAi was induced, cells 
began to express more than one VSG on their surface, diluting the presence of VSG 
AnTat1.1 on the surface of the cells and therefore leading to them being gated as 
negative in the VSG switch assays. If HYP2 RNAi did indeed lead to a loss of 
monoallelic control, the transcript levels from dysregulated BESs would be so low 
that it would be very unlikely that they would be identified at the population level. 
This would explain why we did not measure a higher number of VSGs being 
expressed in the induced GFPESproAnTat1.1ES HYP2 RNAi populations. Since a 
repertoire of antibodies targeting T. brucei AnTat1.1 90:13 ES VSGs was not 
available to us, we could not test this hypothesis by IFA. As previously suggested, 






As discussed in Sections 1.2.7 and 3.10, a limitation of the FACS-based VSG 
switch assay is that within the VSG AnTat1.1 negative staining population it is 
impossible to know the phenotype or genotype of the cells. Are each of the VSG 
AnTat1.1 negative cells the product of multiple switch events? Or alternatively are 
they the progeny of an early switch event to another stably expressed VSG? 
Furthermore, are these the result of primary or secondary VSG switches? And is the 
same VSG being activated by different methods? Whilst the VSGseq analysis does 
not answer the latter two questions (for this the VSG switched cells would have to be 
cloned and analysed by PCR and Southern Blot (Hovel-Miner et al., 2012)), it does 
address whether the VSG AnTat1.1 negative staining cells within the pleomorphic 
and inducibly monomorphic populations are similar with regard to their VSG 
expression. Since this was indeed the case, the VSGseq analysis thereby adds weight 
to the conclusions formed in Chapter 3. 
Both the uninduced and induced GFPESproAnTat1.1ES NEK RNAi 
populations, and the uninduced GFPESproAnTat1.1ES HYP2 RNAi population, were 
consistently shown to switch expression of their VSGs at rates ~4-fold less than the 
GFPESproAnTat1.1ES DYRK RNAi populations via FACS-based switch assays (Figure 
3.14). The results in Figure 4.7 do not obviously present evidence for these lines 
switching their expressed VSGs less frequently than the others. In fact, compared to 
the induced HYP2 RNAi cells, which were reported to have a significantly greater 
VSG switch rate, they consist of a greater proportion of VSG AnTat1.1 negative cells 
and express a greater number of VSGs. In theory, if a population switches VSG 
expression at a high rate, the number of different VSGs assembled will be greater 
than that of a population switching VSG expression at a low rate. Hovel-Miner et al. 
(2012) determined the expressed VSG diversity in populations of TERT-/- mutants for 
which they had already calculated the observed switching frequency (OSF) and 
found that whilst a small trend towards increased depth of VSG expression with 
increased OSF, there was not a linear relationship. This was demonstrated when 
sequencing identified only one expressed VSG within the population of cells with the 
highest OSF (Hovel-Miner et al., 2012). The VSG expression diversity in this case, 
however, was determined following the subcloning of VSG RT-PCR products into 





sequences. Subcloning of RT-PCR products, as opposed to VSGseq, could introduce 
bias for a highly expressed variant and therefore prevent the identification of rarer 
VSG switch variants within the population. That only 4 VSGs were identified in a 
TERT-/- population which switched VSG expression with an OSF of 2.1x10-4, despite 
enrichment for switched cells via MACS, could be a testament of the reduced depth 
of this method. For example, in the uninduced GFPESproAnTat1.1ES NEK RNAi cell 
line which switched at a rate of 6.3x10-4 switches/cell/generation, between 35 and 37 
VSGs were identified by VSGseq. Within their population of frequently switching 
TERT-/- mutants however, Hovel-Miner et al. (2012) discovered that the low 
diversity of VSG expression was the result of multiple independent VSG switch 
events generating the expression of the same VSG. Figure 4.9b, in which the identity 
of the consistently expressed VSGs within the populations were analysed, does show 
that a higher number of these common VSGs were expressed within the uninduced 
and induced NEK RNAi populations compared to the HYP2 and DYRK RNAi 
populations. However, this result is likely due to the increased detection of rare 
variants within the NEK RNAi populations due to the more efficient MACS 
depletion of VSG AnTat1.1 expressing cells (Figure 4.6). Thus, overall both the NEK 
RNAi populations and the uninduced HYP2 RNAi population expressed as many 
different VSGs (and to a similar extent within the population) as the DYRK RNAi 
line, which had a ~4-fold greater VSG switch rate. Further, post-MACS VSGseq 
analysis of the VSGs activated within the population did not provide strong evidence 
to support the hypothesis that the more frequently switching DYRK RNAi line was 
reactivating a given VSG more often than the slower switching NEK or HYP2 RNAi 
lines. Therefore, there may be limitations to using expressed VSG diversity as a 
proxy for VSG switch rate. However, within the context of this study, the important 
comparison was whether the induction of monomorphism either reduced the numbers 
of VSGs identified, decreased the extent to which switched VSGs were represented 
within the population or changed the VSG expression hierarchy compared to the 
corresponding uninduced pleomorphic population. For each of these questions, the 
answer remains no. 
In Chapter 3, GFP expression was used as a marker of the transcriptional 





preferentially switch expressed VSG using DNA rearrangements while monomorphs 
more often switch their transcribed ES (Liu et al., 1985; McCulloch et al., 1997; 
Robinson et al., 1999). In this Chapter I found that, after the in vitro growth phase, 
the majority of the uninduced and induced populations for all three 
GFPESproAnTat1.1ES RNAi lines remained GFP positive. This implies that the lines 
were mainly switching expressed VSG by DNA recombination rather than by using 
an in situ switch. In each of the post-MACS datasets, no fewer than 24 individual 
VSGs were found to be expressed within a single GFPESproAnTat1.1ES HYP2 or NEK 
RNAi replicate. Since this is greater than the estimated number of sub-telomeric 
BESs (~15-20), the VSGseq analysis further implies that the inducible monomorphs 
and pleomorphs do switch their expressed VSG by DNA rearrangements. However, 
without knowing the identity of the ES resident VSG genes in the EATRO 1125 cell 
line, the extent to which DNA recombination or ES switches are happening cannot 
be established by this analysis alone. In three DYRK RNAi replicates (one uninduced 
and two induced), the number of VSGs assembled within the populations dropped to 
those which could be consistent with expression solely from ESs (19, 13 and 20). 
However, the lower numbers of VSGs identified within these DYRK RNAi 
populations are unlikely to signify preference for in situ switches of transcription 
since it was within these exact replicates that VSG AnTat1.1 contamination of the 
MACS flow-through was highest (97.4%, 98.7% and 92.4% of reads mapping to 
VSG AnTat1.1, respectively). Therefore, it is likely that many of the rarer variants 
within the populations were not detected. In the remaining two uninduced DYRK 
RNAi replicates 23 and 35 VSGs were detected, respectively, and 33 in the 
remaining induced population, thus confirming the presence of switches mediated by 
DNA recombination. Full annotation of the EATRO 1125 VSGnome and 
subtelomeric ESs, as is available for the Lister 427 strain (Cross et al., 2014; Hertz-
Fowler et al., 2008; Muller et al., 2018), would allow us to more confidently 
determine whether VSG switches were mediated by in situ switches of transcription 
or DNA rearrangements. At present however, this information is not available. 
Sequence-based quantifications of VSG expression during chronic infections of 
rodents have demonstrated that VSG expression is highly diverse, even within the 





VSGs which were expressed in our 18 pre-enrichment cultures, Hall et al. (2013) (via 
VSG subcloning and sequencing) sequenced ~800 VSGs from 11 infections over a 
period of ~30 days, whilst Mugnier et al. (2015) (via VSGseq) assembled 192 VSG 
sequences from 4 infections over a period of 30 days (Hall et al., 2013; McCulloch 
and Field, 2015; Mugnier et al., 2015). On average, Hall et al. (2013) and Mugnier et 
al. (2015) (neither of whom enriched their populations for VSG switched parasites 
prior to the isolation of RNA) measured 20 and 28 variants per peak of parasitaemia, 
respectively. Whilst this is far greater than the average number of variants detected 
by RNAseq in our pre-MACS samples (~7), Mugnier et al. (2015) observed that the 
same VSGs occurred frequently within the different infections. 86% of the 
assembled VSGs appeared in more than one infection whilst almost half appeared in 
every infection. In contrast, only 1.9% of the VSGs assembled in this study (pre- and 
post-MACS combined) were present in every sequenced replicate. That such VSG 
expression diversity occurs between the different in vitro populations could be due to 
the absence of immune selection. In chronic infections, pre-existing cross-reacting 
antibodies can limit the effective VSG repertoire by clearing newly generated 
variants before they have a chance to establish within the population. In vitro, 
however, this immune selection is absent and the parasites are free to exploit their 
full VSG archive. This ‘freedom of expression’ and the inherent semi-random nature 
of VSG switching, could explain why different replicates of the same cell line exhibit 
such diversity in their VSG expression.  
Hall et al. (2013) and Mugnier et al. (2015) both studied expressed VSG 
diversity over periods of approximately 30 days in chronic mouse models. In 
contrast, our study has investigated VSG expression diversity in in vitro populations 
of cells over only 11-12 days. Furthermore, in our post-MACS samples we are 
realistically only measuring VSG expression in hundreds to thousands of parasites, 
many of which were shown by IFA to still be expressing VSG AnTat1.1 (Figure 4.4). 
Are we generating, and analysing, enough VSG switched cells in order to make 
conclusions about diversity? We chose to analyse VSG diversity in in vitro 
populations of cells over approximately 12 days for three primary reasons. Firstly, by 
repeating the growth phase of the VSG switch assays, our VSGseq results would 





AnTat1.1 negative population’ consisted of (as previously discussed). Secondly, it 
has recently been suggested that VSG hierarchy is decided by the metabolic costs of 
expressing a given VSG, i.e. parasites will preferentially activate a shorter VSG 
which is not so energetically unfavourable (Liu et al., 2018). If we were to culture 
the cells for long periods of time, it could be that cells expressing shorter VSGs 
outgrow the rest of the population and the variants present earlier in the growth phase 
are lost from the analysis. Finally, as discussed in Chapter 3, to avoid the loss of rare 
variants through bottle-necking and the density-dependent differentiation of 
uninduced pleomorphic populations, the cell culture volume must be ‘scaled-up’ 
rather than diluted. To continue in our assays format for longer periods of time would 
require unrealistically large volumes of HMI-9. Could we then use a chronic mouse 
model instead? In our experimental set-up, and to answer our questions, no. A 
chronic infection mouse model would require the trypanosomes to differentiate to 
stumpy forms, however our inducible monomorphs were observed in Figure 3.5 to 
replicate to extremely high densities with little to no sign of growth arrest. Therefore, 
it would be highly unlikely these cells could be grown for long periods of time in any 
mouse model without risk of significant pathology or host death. Our uninduced 
differentiation competent reporter cell lines could of course be kept in a chronic 
mouse model however, the production of stumpy forms would limit the expressed 
VSG repertoire since they cannot form new variants. This would therefore not allow 
for a fair comparison between the uninduced and induced conditions. Thus, whilst 
measuring VSG expression diversity in small populations of cells after 11-12 days 
does reduce accuracy and not shed light on parasite-host interactions, in the context 
of our study and asking whether antigen switch rate and slender to stumpy 
differentiation capacity are mechanistically tethered, we believe our approach is 
informative. 
Only ~5% of the annotated archival VSG genes are functional (Marcello and 
Barry, 2007). Mosaic VSG gene formation, catalysed by segmental gene conversion, 
is therefore central to the expansion of the pre-existing VSG repertoire in the later 
stages of infection (Hall et al., 2013; Marcello and Barry, 2007; Mugnier et al., 
2015). Marcello and Barry (2007), who sequenced subcloned VSGs in a manner 





onwards, Hall et al. (2013) from day 16 of infection, and Mugnier et al. (2015) from 
day 21 of infection. Using the criteria set out by Mugnier et al. (2015) (see Section 
4.5) no candidate mosaic VSGs were identified in our datasets. The parasites from 
which the RNA was isolated had only been cultured in the absence of selection for 
12 days and therefore it was highly unlikely that a mosaic VSG would be found, 
though to the best of our knowledge, no other in vitro study has identified the 
presence of mosaic VSGs. It would be interesting to observe if, following longer 
periods of unselected growth, mosaic VSGs would occur in an in vitro culture or 
whether, in the absence of immune selection, parasites would preferentially revert 
back to the expression of previously expressed VSGs once the repertoire of intact 
VSG genes (estimated to be ~400 for the Lister 427 strain (Cross et al., 2014)) was 
exhausted. 
In summary, VSGseq analysis of pleomorphic and inducibly monomorphic 
populations of T. brucei has revealed vast levels of VSG expression diversity, but the 
induction of monomorphism was not associated with a reduction in VSG expression 
diversity compared to the pleomorphic population, or the selection of VSGs distinct 
from those activated by the pleomorphic population. The conclusions reached from 
this work corroborate the findings in Chapter 3, where it was first found, through 
FACS-based VSG switch assays, that VSG switch frequency and stumpy 











5 : MEASURING THE VSG SWITCH 









The literature states that monomorphic trypanosomes switch their expressed 
VSG surface coat at a significantly lower frequency than pleomorphic trypanosomes, 
suggesting that antigen switch frequency and stumpy differentiation capacity may be 
linked. Through in vitro FACS-based VSG switch assays (Chapter 3) and targeted 
VSGseq analysis (Chapter 4) however, I have shown that VSG switch frequency and 
slender to stumpy differentiation capacity can be uncoupled. By adopting an 
inducible monomorphism model (whereby induction of RNAi in pleomorphic cells 
against a component of the stumpy formation pathway rendered the population 
insensitive to SIF), the VSG switch frequency and VSG expression diversity of the 
same cell lines, in which differentiation capacity was either switched ‘on’ or ‘off’, 
was addressed. VSG switch assays demonstrated that upon the induction of 
monomorphism in three separate GFPESproAnTat1.1ES RNAi lines, each of the cell 
lines lost their differentiation capacity but continued to switch VSG expression at 
rates between 6x10-4 and 2x10-3 switches/cell/generation. Furthermore, induction of 
monomorphism similarly did not elicit a change in the proportion of cells switching 
their expressed VSG by DNA recombination. VSGseq analysis revealed high levels 
of VSG expression diversity, however the induction of monomorphism was not 
associated with a reduction in VSG expression diversity, nor the selection of distinct 
VSG genes. 
These results contradicted what has been reported in the literature based on 
monomorphs generated by serial passage. As such, a second strategy was adopted to 
verify the conclusions from Chapters 3 and 4. The approach entailed generating 
populations of selected monomorphs de novo through repeated in vitro passage of the 
pleomorphic reporter cell lines used in Chapters 3 and 4 and comparing their VSG 
switch rates to the respective parental populations using the FACS-based VSG 
switch assay. Since the same cell line is followed throughout the process of selection, 
and the switch rates both before and after selection are measured, the results can thus 
make it very clear whether VSG switch frequency and slender to stumpy 
differentiation capacity are coupled, or can be selected for independently of one 





5.2 Long term culture of trypanosome populations causes 
increased resistance to 8-pCPTcAMP in vitro 
Historically, virulent monomorphic trypanosome lines have been generated by 
the repeated syringe-passage of parasites through rodents. Turner (1990) estimated 
that to lose pleomorphism by this method, cells would need to be passaged between 
mice every 2-3 days between 30 and 50 times. Therefore, to replicate the methods 
used in these studies for each of our three reporter cell lines, would require between 
90 and 150 mice. Virulent cells incapable of differentiation to cell cycle arrested 
stumpy forms are selected for in the absence of tsetse fly transmission, a condition 
which is obviously easily attainable in a culture model. Therefore, to reduce the 
number of rodents used, we chose to generate our selected monomorphs in vitro. 
To generate monomorphic populations of the GFPESproAnTat1.1ES HYP2, NEK 
and DYRK RNAi cell lines used in Chapters 3 and 4, the populations were subjected 
to repeated in vitro passage in culture flasks for a period of 58-73 days (Figure 5.1). 
To avoid the accumulation of SIF, and therefore cell cycle arrest, pleomorphic 
bloodstream form (BSF) parasites should be maintained at densities below 106 
cell/ml (Hirumi and Hirumi, 1989; Vassella et al., 1997a). To select for cells 
insensitive to a density dependent differentiation signal, the culture densities were 
gradually increased until the populations could be maintained between densities of 1-
3x106 parasites/ml. Cells were kept in selective drug medium to prevent loss of 
expression of both the GFP and RNAi machinery, but RNAi was not induced. To aid 
in tracing the dynamics of selection, an aliquot of each population was frozen at -







Figure 5.1 In vitro selection for monomorphism by repeated passage at high parasite 
density. Growth profiles for the uninduced GFPESproAnTat1.1ES HYP2 (purple), NEK (blue) 
and DYRK (teal) RNAi cell lines. Days when an aliquot of the respective population was 
frozen are shown by the dotted lines. 
 
After the selection period, all three of the populations displayed noticeably 
reduced population doubling times and were able to maintain proliferation at 
markedly higher cell densities compared to the respective ‘Start’ populations. Rapid 
proliferation and growth at high densities are typical characteristics of monomorphic 
cell populations and therefore the final selected populations were tested in vitro for 















































































































As expected, the uninduced pleomorphic ‘Start’ populations for all three cell 
lines rapidly underwent cell cycle arrest upon incubation with 100µM 8-pCPTcAMP. 
The final selected populations, however, differed in their responses- both to their 
respective pleomorphic ‘Start’ populations and to each other. The selected 
GFPESproAnTat1.1ES DYRK RNAi population showed increased resistance to 8-
pCPTcAMP compared to the ‘Start’ population, however its growth had begun to 
slow by day 4. In contrast, both the selected GFPESproAnTat1.1ES HYP2 and NEK 
RNAi lines sustained their growth in the presence of 8-pCPTcAMP, growing only 
marginally slower than selected populations in the absence of 8-pCPTcAMP and 
equally as well as their respective ‘Start’ populations in the absence of 8-
pCPTcAMP. To confirm that this decrease in sensitivity to 8-pCPTcAMP was not 
the result of the loss of regulation of the RNAi machinery during the selection 
process, the selected populations were induced with doxycycline for three days and 
the respective levels of HYP2, NEK or DYRK transcripts probed by Northern Blot 
and compared to an uninduced and wild type (WT) control (Figure 5.2 insets). In all 
three selected populations, RNAi of the quorum-sensing components remained 
inducible and therefore the increased resistance to 8-pCPTcAMP could not be 
explained by leaky expression of T7 RNA polymerase but instead was more likely 







Figure 5.2 8-pCPTcAMP response cumulative growth profiles of the pleomorphic 
‘Start’ and selected GFPESproAnTat1.1ES populations. Treatment with 8-pCPTcAMP 
caused the pleomorphic parental ‘Start’ populations to arrest. Passaged populations showed 
varying degrees of resistance to the compound. The 8-pCPTcAMP was added on day 1. The 
gene targeted by the RNAi machinery is denoted above the respective graph. Data represents 
the mean+S.D (n=3). Inset Northern blot detection of HYP2, NEK and DYRK transcripts in 
the selected populations. A pleomorphic T. brucei AnTat1.1 90:13 line was used as the WT 
control. The RNAi machinery remained inducible and therefore knock down of a stumpy 
formation gene could not explain the acquired 8-pCPTcAMP resistance. rRNA was used as a 
loading control. 
 
To explore if the acquisition of 8-pCPTcAMP resistance proceeded as a 
gradual process over the period of in vitro selection or whether the phenotype 
occurred suddenly, each of the frozen ‘Intermediate’ aliquots were thawed and tested 
for their 8-pCPTcAMP resistance (Figure 5.3). Remarkably, each of the three 
GFPESproAnTat1.1ES RNAi lines had already increased in resistance to 8-pCPTcAMP 
as early as 7 days into the selection period, when the cultures were still being 
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maintained at densities below 106 cells/ml. This modest rise in resistance gradually 
increased with continued passage, although an obvious jump in resistance 
approximately midway through the selection process was observed in each of the 
lines (Figure 5.3 (a), (b) and (c), top right panels). This did not occur simultaneously 
between the three populations and nor did it always immediately follow a large 
population bottleneck event. In the presence of 8-pCPTcAMP, the 
GFPESproAnTat1.1ES HYP2 and DYRK RNAi selected populations grew at 10-15% of 
the rate of the untreated selected population. The GFPESproAnTat1.1ES NEK RNAi 
selected monomorphs, however, exhibited much greater resistance, growing to 60% 
of that of the untreated cells. 
Since a decrease in generation time was also observed in the selected 
populations, the cumulative growth of the final and each of ‘Intermediate’ 
populations in -8-pCPTcAMP conditions was quantified and compared with the 
respective starting population (Figure 5.3 (a), (b) and (c), bottom right panels). The 
large shift in 8-pCPTcAMP resistance always preceded the drop in generation time 
(visualised as an increase in cumulative growth). However, the increases in 8-
pCPTcAMP resistance and decreases in generation time did not precisely track each 
other, and nor was high 8-pCPTcAMP resistance always an indicator of lower 
generation time (and vice versa). All three cell lines showed a gradual increase in 
growth rate during the in vitro passage selection. Interestingly, although the 
GFPESproAnTat1.1ES HYP2 and DYRK RNAi lines showed similar levels of resistance 
to 8-pCPTcAMP, the kinetics of their changes in relative growth compared to the 
‘Start’ populations were very different. Whilst the GFPESproAnTat1.1ES HYP2 RNAi 
population showed a slow and moderate rise to ~2-fold greater cumulative growth, 
the GFPESproAnTat1.1ES DYRK RNAi population instead remained relatively stable 
until a large shift to ~3-fold greater cumulative growth in the latter stages of 
selection. If this drop in generation time was coupled to a plateau in 8-pCPTcAMP 
resistance, this could explain why the population appears to lose 8-pCPTcAMP 
resistance in the final weeks of selection. The inconsistency between the dynamics of 
8-pCPTcAMP and growth rate selection between the three lines indicates that 8-
pCPTcAMP resistance and rapid generation time were likely selected for 


































































































































































































































































































































































































Figure 5.3 Changes in 8-pCPTcAMP resistance and growth rates over a 10-week in 
vitro period of passage. Central figures. The three large central graphs plot the in vitro 
cumulative growth profiles of the (a) HYP2 (b) NEK and (c) DYRK RNAi 
GFPESproAnTat1.1ES populations in response to 8-pCPTcAMP exposure with increasing 
passage time. The cumulative growth of the final selected populations in the absence of 8-
pCPTcAMP are shown for reference. Top right figures Relative cumulative growth of the 
‘Start’, ‘End’ and ‘Intermediate’ populations in the presence of 8-pCPTcAMP compared to 
the cumulative growth of the respective populations in the absence of the compound. With 
increasing passage, resistance to 8-pCPTcAMP increased. The HYP2 dataset is missing the 
pleomorphic ‘Start’ population and therefore values were normalised to the + 1 week 
population. The NEK dataset is missing the + 1 week population. The data represents the 
mean + S.D. (n=3). Bottom right figures Relative cumulative growth of the ‘Intermediate’ 
and final populations in the absence of 8-pCPTcAMP compared to the parental population. 
With increasing passage number, the generation time decreased. The data represents the 
mean + S.D. (n=3). The NEK dataset is missing the ‘Start’ and + 1 week population data and 
therefore the values were normalised to the +2 week values. 
 
5.3 A selected monomorphic GFPESproAnTat1.1ES NEK 
RNAi population does not respond to SIF in vivo 
To investigate if the increase in 8-pCPTcAMP resistance corresponded to in 
vivo resistance to SIF, duplicate mouse infections with the ‘Start’ and selected 
populations for each of the three GFPESproAnTat1.1ES RNAi cell lines were initiated. 
Parasitaemia, morphology and cell-cycle status were monitored over the course of 
infection and PAD1 expression was assessed from trypanosomes purified from the 
blood on the final day of infection. Since monomorphic trypanosomes would be 
predicted to replicate without restraint in the mouse model, the infections with the 
selected trypanosome infections were initiated with less cells to allow time for the 
pleomorphic ‘Start’ populations to arrest and differentiate in response to the 
accumulation of SIF. The selected GFPESproAnTat1.1ES NEK RNAi population 
displayed the highest resistance to 8-pCPTcAMP in vitro. In vivo, the selected 
GFPESproAnTat1.1ES NEK RNAi cells continued to proliferate over 5 days, whilst the 





The parental pleomorphic cells in the blood on day 5 of infection had transformed 
morphologically to stumpy forms with pronounced undulating membranes, however 
the selected populations, despite being at a far greater parasitaemia, retained the 
typical slender morphology associated with proliferative bloodstream forms (Figure 
5.4 b). Consistent with these observations, the proportion of non-selected 
pleomorphic cells with a 1K1N configuration increased as the cells differentiated and 
the parasitaemia plateaued. In contrast, the proportion of selected cells in 1K1N 
remained constant throughout the infection, indicating an absence of G1/G0 arrest 
(Figure 5.4 c). Western blot analysis furthermore revealed PAD1 expression to be 
greatly diminished in the selected populations on day 5 of infection compared to the 
pleomorphic ‘Start’ populations (Figure 5.4 d). Taken together, this data suggests 
that the sustained in vitro passage of the GFPESproAnTat1.1ES NEK RNAi cell line had 
selected for a population of cells that had lost their differentiation capacity. As such, 
these cells will now be referred to as ‘selected monomorphs’. 
 
Figure 5.4 GFPESproAnTat1.1ES NEK RNAi selected monomorphs do not respond to SIF 
in vivo. (a) In vivo growth of NEK RNAi GFPESproAnTat1.1ES selected monomorphs 
compared to the pleomorphic parental population. Selected monomorphs remained 
proliferative, whilst the parental cells arrested in response to SIF. (b) Morphological analysis 
of methanol-fixed cells isolated on the final day of infection. Parental cells (right) displayed 
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the typical morphological characteristics of stumpy cells, such as a shortened free-flagellum, 
pronounced undulating membrane and an expanded flagellar pocket, whilst selected 
monomorphs (left) remained largely long and slender. Nuclear and kinetoplast DNA was 
visualised by DAPI staining. Bar=10µm. (c) Cell-cycle analysis of cells in the blood on days 
3, 4 and 5 of infection. Pleomorphic cells (purple) arrested in G1/G0 as they differentiated, 
seen as an accumulation of 1K1N cells between days 4 and 5. The proportion of cells in 
1K1N within the selected monomorph population (teal) remained constant. 250 cells were 
counted for each individual infection. (d) Western blot detection of PAD1. At high 
parasitaemia, selected monomorphs did not express PAD1 on their surface. Slender and 
stumpy T. brucei AnTat1.1 90:13 WT cells served as controls. Detection of EF1a was 
performed as a loading control. 
 
The GFPESproAnTat1.1ES HYP2 RNAi selected population displayed moderate 
levels of 8-pCPTcAMP resistance in vitro (Figure 5.2). In the mouse model, the 
selected population’s parasitaemia gradually ascended without indication of plateau 
(Figure 5.5 a), consistent with the in vitro growth rate observations in Figure 5.3. 
Selected cells isolated on day 6 were morphologically slender and did not express the 
stumpy specific protein PAD1 (Figure 5.5 b, d). Fluorescence microscopy showed 
that, at every timepoint, a smaller proportion of the selected population was in G1/G0 
compared with the parental population. However, as the passaged populations’ 
parasitaemias increased, there was nevertheless a gradual accumulation of cells in 
1K1N (Figure 5.5 c). Therefore, it appears that the GFPESproAnTat1.1ES HYP2 RNAi 
passaged population is not entirely monomorphic and instead has a diminished 







Figure 5.5 The selected GFPESproAnTat1.1ES HYP2 RNAi population has a diminished 
response to SIF in vivo. (a) In vivo growth of the GFPESproAnTat1.1ES HYP2 RNAi selected 
population compared to the pleomorphic parental cells. The selected population’s 
parasitaemia continued to ascend over the infection time course. The pleomorphic parental 
cells arrested in response to SIF. (b) Morphological analysis of cells isolated on the final day 
of infection. The pleomorphic parental cells became morphologically stumpy (right), whilst 
the selected cells (left) remained largely long and slender. Nuclear and kinetoplast DNA was 
visualised by DAPI staining. Bar=10µm. (c) Cell-cycle analysis of cells in the blood on days 
3-6 (parental population) and days 4-6 (passaged population) of infection. Pleomorphic cells 
(purple) arrested in G1/G0 as they differentiated, seen as an accumulation of 1K1N cells. 
The proportion of replicative cells was always greater in the selected population throughout 
the infection time course, however an accumulation of 1K1N cells as the parasitaemia 
increased was nevertheless observed. 250 cells were counted for each individual infection. 
(d) Western blot detection of PAD1. The passaged population did not express PAD1 on its 
surface on the final day of infection. Slender and stumpy T. brucei AnTat1.1 90:13 WT cells 
served as controls. Detection of EF1a was performed as a loading control. 
 
After extensive in vitro passage, the GFPESproAnTat1.1ES DYRK RNAi 
selected population displayed levels of 8-pCPTcAMP resistance similar to that of the 
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GFPESproAnTat1.1ES HYP2 RNAi selected population. Despite rapid in vitro 
proliferation, the GFPESproAnTat1.1ES DYRK RNAi selected cells grew relatively 
slowly over the first few days of infection, before the parasitaemia finally ascended 
rapidly from day 5 onwards (Figure 5.6 a). Akin to the response of the 
GFPESproAnTat1.1ES HYP2 RNAi passaged population, the selected 
GFPESproAnTat1.1ES DYRK RNAi cells maintained their slender morphology, even at 
high parasitaemia (Figure 5.6 b) and a greater proportion of the population remained 
proliferative (Figure 5.6c). However, again, an accumulation of cells in 1K1N over 
the infection time course was observed. Since at no point did the parasitaemia of the 
selected population surpass that of the parental line, it cannot be ruled out that the 
GFPESproAnTat1.1ES DYRK RNAi passaged population may have been observed to 
morphologically transform and express PAD1 if a later timepoint had been taken. 
 
 
Figure 5.6 The selected GFPESproAnTat1.1ES DYRK RNAi population has a low level of 
resistance to SIF in vivo. (a) In vivo growth of the GFPESproAnTat1.1ES DYRK RNAi 
selected population compared to the pleomorphic parental cells. The selected population’s 
early growth was delayed, however later continued to ascend as the parental cells 

































































differentiated to stumpy forms. (b) Morphological analysis of cells isolated on the final day 
of infection. Parental cells became morphologically stumpy (right), whilst selected cells 
(left) remained largely long and slender. Nuclear and kinetoplast DNA was visualised by 
DAPI staining. Bar=10µm. (c) Cell-cycle analysis of cells in the blood on days 3-7 (parental 
population) and days 4-7 (passaged population) of infection. Pleomorphic cells (purple) 
arrested in G1/G0 as they differentiated, seen as an accumulation of 1K1N cells (solid line). 
The proportion of replicative cells was greater in the selected population throughout the 
infection time course, however a large accumulation of 1K1N cells as the parasitaemia 
increased was nevertheless observed and by day 7 almost 90% of the selected population had 
accumulated in 1K1N. 250 cells were counted for each individual infection.  
 
5.4 Selected monomorphs do not exhibit a lower VSG 
switch rate compared to the parental pleomorphic 
population 
Induction of monomorphism in the GFPESproAnTat1.1ES HYP2, NEK and DYRK 
RNAi lines did not significantly reduce the VSG switch rate, change the mechanism 
of VSG switching, nor decrease the diversity of expressed VSGs as demonstrated by 
in vitro FACS-based VSG switch assays and VSGseq analysis (Chapters 3 and 4). 
This therefore provides strong evidence that stumpy differentiation capacity and 
VSG switch frequency can be uncoupled. Over the 10 week period of in vitro 
passage, varying degrees of monomorphism were selected for in the 3 populations- 
the GFPESproAnTat1.1ES NEK RNAi selected monomorphs demonstrated complete 
resistance to the accumulation of SIF in vivo (Figure 5.4) but whilst the 
GFPESproAnTat1.1ES HYP2 and DYRK RNAi lines did not transform morphologically 
to stumpy forms or express PAD1 on their surface, they did accumulate in G1/G0 
over an infection time course (Figures 5.5 and 5.6). To investigate if a reduced VSG 
switch frequency was simultaneously selected alongside the loss of stumpy 
differentiation capacity, the VSG switch rates of the passaged GFPESproAnTat1.1ES 
HYP2, NEK and DYRK RNAi populations were tested using the in vitro FACS-based 
VSG switch assays (as described in Section 3.6) and compared to the respective 





with increased rates of proliferation, the switch assays measuring the 
GFPESproAnTat1.1ES HYP2 and NEK RNAi passaged cells’ switch rates lasted 
significantly shorter than those for the parental pleomorphs (9 days vs 10.3 + 0.5 
days, p=0.0015 Welch’s t-test and 7 days vs 9 + 1.1 days, p=0.0066 Welch’s t-test, 
respectively). However, the mean number of generations undergone in the 
pleomorph and selected monomorph GFPESproAnTat1.1ES HYP2 and NEK RNAi 
switch assays (26.8 + 0.6 vs 26.8 + 0.7 and 26.4 + 0.7 vs 26.9 + 0.4, respectively) 
were not statistically different (p>0.05). In the GFPESproAnTat1.1ES DYRK RNAi 
pleomorph and selected monomorph switch assays, there was no significant 
difference in either the mean number of days (9 + 1.1 vs 9) or the mean number of 
generations (27 + 0.9 vs 27.5 + 0.8) that the assays were run for (p>0.05). Statistical 
analysis found no significant difference in the mean number of VSG 
switches/cell/generation calculated for the pleomorphic parental GFPESproAnTat1.1ES 
HYP2 and DYRK RNAi populations compared to the values calculated for the 
uninduced lines in Figure 3.9 of Chapter 3 (6.67x10-4 + 0.0005 vs 6.97x10-3 + 0.0004  
and 1.43x10-3 + 0.0014 vs 2.01x10-3 + 0.002 switches/cell/generation, respectively). 
In this set of experiments, the VSG switch rate of the GFPESproAnTat1.1ES NEK 
RNAi parental pleomorphs was measured as significantly lower than the VSG switch 
rate calculated for the uninduced pleomorphs in Chapter 3 (3.1x10-4 + 0.00009 vs 
6.31x10-4 + 0.0002 switches/cell/generation. 
The results of the selected monomorph VSG switch assays clearly show that in 
all three lines the VSG switch rate had not dropped to the published estimates for 
monomorphic cells lines, despite the loss of pleomorphism (Figure 5.7b). The 
GFPESproAnTat1.1ES HYP2 RNAi selected monomorphs and GFPESproAnTat1.1ES 
DYRK RNAi passaged population each marginally increased their mean switch rates 
to 1.39x10-3 + 0.0006 and 2x10-3 + 0.0009 switches/cell/generation, respectively, 
whilst the switch rate of the NEK RNAi passaged population decreased to 2.88x10-4 
+ 0.0001 switches/cell/generation. None of these changes, however, were significant 
(p>0.05). 
Monomorphic cells are reported to preferentially switch their expressed VSG 





Robinson et al., 1999). To investigate if selection for monomorphism and in situ 
switching occurred concurrently, the VSG AnTat1.1 negative cells were observed for 
their GFP positivity (Figure 5.7c). In these assays, the pleomorphic 
GFPESproAnTat1.1ES HYP2 and DYRK RNAi lines switched VSG expression by DNA 
recombination at a similar extent to what was seen previously in the uninduced 
assays performed in Figure 3.9 (49.93 + 25.01% vs 44.67 + 31.43% and 75.62 + 
20.3% vs 84.63 + 11.16%, respectively). The pleomorphic GFPESproAnTat1.1ES NEK 
RNAi line under these experimental conditions however, switched significantly less 
by DNA recombination (25.02 + 16.46% vs 52.7 + 24.53%, p=0.045 t-test). These 
results were all underpinned by high variability, however. Figure 5.7c shows that, 
during the 10 week period of passage, the selection of monomorphism was not 
directly accompanied by a selection for increased in situ VSG switches. Conversely, 
switching by DNA recombination appeared to increase in the monomorphic 
GFPESproAnTat1.1ES HYP2 and DYRK RNAi lines compared to the pleomorphic 
‘Start’ populations (54.63 + 37.9% vs 49.93 + 31.4% and 91.78 + 1.8% vs 75.62 + 
20.3%, respectively). None of the observed changes were statistically significant, 
however it must be noted that the results for the GFPESproAnTat1.1ES HYP2 RNAi 
selected monomorphs, in particular, were characterised by high rates of variability. 
The literature states that pleomorphic cells switch their expressed surface VSG 
at a rate of ~10-4 to 10-2 switches/cell/generation and monomorphic cells at ~10-7 to 
10-5 switches/cell/generation (Turner, 1997). In this set of experiments, the VSG 
switch rate of three cell lines before and after a ten-week period of in vitro selection 
were measured. Whilst the ability of the cells to effectively differentiate to 
transmission-competent stumpy forms was lost during the period of selection, the 
VSG switch rate remained consistently high, thus demonstrating that VSG switch 







Figure 5.7 Monomorphism can be selected for independently of VSG switch rate (a) 
VSG switch assay growth of the GFPESproAnTat1.1ES HYP2 (left), NEK (middle) and DYRK 
(right) RNAi pleomorphs and selected monomorphs. The parental pleomorphic populations 
are shaded in plum and the passaged populations in teal. The assays were performed twice in 
triplicate (n=6), except for the pleomorphic DYRK RNAi experiment where one assay was 

































































































































































































parental and selected GFPESproAnTat1.1ES HYP2 (blue), NEK (plum) and DYRK (teal) RNAi 
lines. There was no significant difference in VSG switches/cell/generation after selection for 
monomorphism, p>0.05, t test. (c) The percentage of switched GFPESproAnTat1.1ES HYP2 
(blue), NEK (plum) and DYRK (teal) RNAi cells that had switched their expressed VSG by 
DNA recombination (i.e. VSG AnTat1.1 negative/ GFP positive). Selection for 
monomorphism was not associated with a significant reduction in DNA recombination based 
switching (p>0.05, t-test). n=6 except for: passaged GFPESproAnTat1.1ES HYP2 RNAi 
population (n=5); pleomorphic GFPESproAnTat1.1ES NEK population (n=5); passaged 
GFPESproAnTat1.1ES NEK RNAi population (n=4); and pleomorphic GFPESproAnTat1.1ES 
DYRK RNAi population (n=5). 
 
5.5 gDNA and RNA sequencing of pleomorphic and 
monomorphic NEK RNAi GFPESproAnTat1.1ES 
populations 
Evolve and resequence (E & R) experiments combine experimental evolution 
and next generation sequencing to follow molecular evolution at a genome-wide 
scale in real time. By sequencing populations exposed to controlled selective 
conditions, researchers can explore the molecular components of adaptation through 
the identification of single nucleotide polymorphisms (SNPs) and causative genes 
(Long et al., 2015). Sustained in vitro passage at high parasite density caused varying 
degrees of monomorphism in the three selected populations. This was most apparent 
in the GFPESproAnTat1.1ES NEK RNAi line, where a population of selected 
monomorphs that remained highly proliferative, morphologically slender and did not 
express the stumpy marker PAD1on their surface in the presence of SIF were 
selected (Figure 5.4). Application of the E & R approach to understand the loss of 
pleomorphism upon laboratory adaptation of trypanosome populations could provide 
us with important insights into the process and dynamics of laboratory adaptation 
and moreover, identify novel molecular components regulating the hierarchical 
quorum-sensing differentiation pathway. Therefore, the pleomorphic 
GFPESproAnTat1.1ES NEK RNAi parental population, monomorphic 





were chosen for genomic DNA and total RNA deep sequencing with the aim of 
identifying novel regulators of slender to stumpy differentiation (Figure 5.8a). 
 
 
Figure 5.8 Preparation of material for whole genome and transcriptome sequencing of 
the GFPESproAnTat1.1ES NEK RNAi selected monomorphs. (a) Total population DNA and 
RNA from the highlighted time points were sent for sequencing. For genome sequencing, 
only the ‘Start’ (pleomorphic) and ‘End’ (selected monomorph) samples were processed. All 
four samples had their transcriptomes sequenced. ‘Intermediate’ sample 1 and ‘Intermediate’ 
sample 2 were selected for sequencing since they flanked the marked increase in 8-
pCPTcAMP resistance and it was hoped that the changes directly influencing resistance 
might be obvious in their analysis. (b) For each timepoint, triplicate RNA preparations were 
sequenced and a single gDNA sample. For the triplicate RNA growth curves, the data 
represents the mean + S.D. (n=3). Parasites were carefully maintained in vitro in logarithmic 
phase and at densities <106 cells/ml before DNA and RNA was isolated. (c) The RNA 
samples were visualised as three tight bands on an ethidium bromide stained formaldehyde 
gel. 200ng of RNA were loaded per sample. (d) The extracted DNA had a high molecular 




















































































































































Genetic material was prepared from populations of cells that had been 
expanded in vitro. Great care was taken to maintain the densities of the populations 
from which RNA was extracted under 106cells/ml so that any observed changes were 
not the result of a density dependent response of the pleomorphic population (Figure 
5.8b). RNA was extracted from triplicate populations for all four timepoints, whilst 
single gDNA samples were prepared from the starting pleomorphic and final selected 
populations. To verify the quality of the prepared material, 200ng of RNA (Figure 
5.8c) or 500ng gDNA (Figure 5.8d) were loaded on an agarose gel and visualised 
with ethidium bromide staining. The extracted RNA was visualised as three tight, 
and therefore nondegraded, bands and a single, tight, high molecular weight band 
furthermore signified that the prepared gDNA was also of high quality. Final quality 
control and the DNA/RNA sequencing services were provided by BGI Tech 
Solutions, Hong Kong. 
5.5.1 Transcriptome analysis of selected monomorphs 
Quality control of the raw transcriptome data, read alignments to the T. b. 
brucei TREU927 reference genome and groupwise comparisons of ‘reads per 
kilobase of transcript per million mapped reads’ (RPKM)-normalised datasets were 
kindly performed by Dr Alasdair Ivens (Edinburgh, UK) (see Section 2.18). The 
initial transcriptome analysis focused on the comparison of the selected monomorph 
(‘End’) population relative to the pleomorphic parental (‘Start’) population. When an 
adjusted p-value cut off of p<0.05 was applied to the dataset, 950 transcripts were 
found to be significantly less abundant in the selected monomorphs relative to the 
parental pleomorphs and 578 transcripts significantly more abundant (Figure 5.9, red 
dots). The vast majority of these changes in abundance, however, were subtle. A 
Log2FC value of +1 shows that a transcript has increased 2-fold in abundance 
relative to the comparator, whilst a Log2FC value of -1 indicates that the abundance 
of the transcript has halved. The highest Log2FC value generated in the ‘End’ dataset 
relative to the ‘Start’ dataset (once pseudogene, putative VSG and ‘unlikely 
hypothetical’ transcripts had been filtered from the analysis) was +0.73 (equivalent 





third less transcript). To remove the transcripts showing least changes in abundance, 
Log2FC boundaries were applied to the upregulated and downregulated gene lists, 
respectively, such that transcripts showing less up- or down-regulation than these 
values would not be considered for further analysis. The upregulated transcripts 
showed the least changes in abundance, and furthermore encoded no realistic 
regulators of slender to stumpy differentiation. Thus, a Log2FC cut off of +0.5 was 
applied to the dataset (Figure 5.9, top left). A Log2FC limit of -0.5 would have 
produced an unmanageably large downregulated dataset (Figure 5.9, bottom right), 
and therefore a cut off of -0.6 was applied to the downregulated dataset. Imposing 
this filtration criteria generated shortlists of 11 genes that were significantly 
upregulated in the selected monomorph population relative to the pleomorphic 
parental population, and 68 genes that were significantly downregulated. The genes 







Figure 5.9 GFPESproAnTat1.1ES NEK RNAi selected monomorph gene expression 
relative to the pleomorphic parental population. Main panel: Each transcript is denoted 
















































































































































horizontal line shows where gene expression was identical between the two populations and 
the two blue lines represent two-fold increases or decreases in expression. Before 
pseudogenes and VSG genes were removed from the analysis, 950 genes were recognised as 
being downregulated (16 over 2-fold) and 578 upregulated (1 over 2-fold). Top Left: 
Transcripts upregulated in the selected monomorphs compared to the parental pleomorphs 
(pseudogenes and VSG genes were removed from the list). The asterisk denotes the cut off 
for the upregulated genes shortlist Bottom Right: Transcripts downregulated in the selected 
monomorphs compared to the parental pleomorphs (pseudogenes and VSG gene were 
removed from the list). The asterisk denotes the cut-off for the downregulated genes 
shortlist. 
 
5.5.1.1 Selected monomorphs downregulate genes associated with 
the stumpy and insect forms of the parasite 
68 transcripts that were significantly less abundant in the GFPESproAnTat1.1ES 
NEK RNAi selected monomorph population compared to the parental pleomorph 
population were chosen for analysis. The Log2FC values for the top 9 most 
decreased transcripts ranged between -1.81 and -1, whilst the remainder extended 
from -0.97 to -0.61 (Appendix C). The majority of the genes identified (58%) 
encoded hypothetical proteins, whilst cell surface transporters and receptors were the 
next most downregulated group (Figure 5.10). Interestingly, 5.5% of the 68 
shortlisted transcripts encoded zinc finger proteins, over half of which belong to the 
novel RNA-binding CCCH (ZC3H) class. Such a finding may be of great 
significance since the ZC3H class of zinc finger proteins are implicated in the post 
transcriptional control of gene expression through the binding to, and stabilisation or 
destabilisation of, mRNA transcripts (Ling et al., 2011). One other downregulated 
RNA-binding protein, RBP32, was identified in the analysis. A number of protein 
kinases have been implicated in the regulation of slender to stumpy differentiation, 
for e.g. DYRK (Mony et al., 2014), MAPK5 (Domenicali Pfister et al., 2006), TOR4 
(Barquilla et al., 2012) and NEK17 (Jones et al., 2014). Consistent with this 
observation, a number of protein kinases and phosphatases were also associated with 









Figure 5.10 Downregulated genes in the selected monomorph population relative to the 
parental pleomorph population grouped by protein description. Total=68. 
 
The GFPESproAnTat1.1ES NEK RNAi selected monomorphs did not respond to 
SIF in vivo, and instead remained as rapidly proliferating slender forms. Consistent 
with this loss of life cycle competency, many of the 29 annotated downregulated 
genes had previously been demonstrated as being enriched in stumpy or insect form 



































The surface proteins PAD1 (Dean et al., 2009) and TbNT10 (Spoerri et al., 
2007) are both stumpy markers, although PAD1 is the only protein regularly used in 
the laboratory as a diagnostic measure for stumpy formation. TbNT10 is the main 
GENE 





Tb927.6.510 GPEET procyclin -1.63 0.0003
Major GPI-anchored 
surface coat protein in 
procyclic forms 
(Bütikofer et al., 1997).
Tb927.9.7470 TbNT10 -1.06 0.0003
Purine nucleoside 
transporter (Spoerri et 
al., 2007).
Tb927.7.5940 Protein Associated with Differentiation 2 (PAD2) -0.97 0.0003
Recieves CCA 
procyclic differentiation 
signal (Dean et al., 
2009).
Tb927.10.10260 EP1 procyclin -0.96 0.0056
Major GPI-anchored 
surface coat protein in 
procyclic forms 
(Bütikofer et al., 1997).
Tb927.9.11050 4E-interacting protein (4EIP) -0.78 0.0017
Contributes to 
tranlsation repression 
during differentiation to 
stumpy form (Terrao et 
al., 2018).
Tb927.7.5930 Protein Associated with Differentiation 1 (PAD1) -0.67 0.0014
Expressed on surface of 
stumpy forms (Dean et 
al., 2009).
Tb927.5.320 Receptor-type adenylate cyclase (GRESAG 4) -0.64 0.0024
Midgut specific adenyl 
cyclase. Marker for late 
procyclic stage (Imhof 
et al., 2014). 
Tb927.11.2690 Succinyl-CoA:3-ketoacid coenzyme A transferase -0.64 0.0229
Mitochondrial enzyme 
(Vertommen et al., 
2008).
Tb927.7.6830 Trans-sialidase (putative) -0.64 0.0006
Membrane-bound and 
expressed on surface. 
Enable procylic cells to 
utilise host sialic acid 
(Engstler et al., 2003).





P1-type purine transporter of adenosine, guanosine and inosine in procyclic 
trypanosomes (Al-Salabi et al., 2007). The expression of the gene is developmentally 
regulated, with the highest expression being found in the stumpy form, followed by 
procyclic cells and finally, at barely detectable levels in the proliferative slender form 
(Sanchez et al., 2004). Expression levels seem to be strain specific, however. For 
instance, in the T. brucei AnTat1.1 line, TbNT10 was reported to be expressed at the 
highest level in the procyclic form of the parasite, although expression was still 
greatly upregulated in the stumpy form compared to the slender (Spoerri et al., 
2007). Being a surface transporter upregulated in the form of the parasite pre-adapted 
for transmission, TbNT10 has been tested for a role in SIF uptake. A TbNT10 null 
mutant in the pleomorphic T. brucei AnTat1.1 line was viable, and furthermore able 
to complete a full life cycle in vivo however, thus demonstrating that TbNT10 was 
neither essential nor the receptor of SIF (Spoerri et al., 2007). PAD2 is fundamental 
to the process of stumpy to procyclic form differentiation within the tsetse midgut. 
PAD2, a surface-carboxylate transporter, is upregulated and localised to the surface 
upon cold-shock, sensitising the cell for the perception of the CAA procyclic 
differentiation signal in the tsetse midgut (Czichos et al., 1986; Dean et al., 2009; 
Engstler and Boshart, 2004).  
4E-interacting protein (4EIP) interacts with the T. brucei cap-binding protein 
EIF4E1 (Terrao et al., 2018). Both proteins have been demonstrated as strong 
repressors of gene expression when tethered to a reporter mRNA, with 4EIP 
specifically inhibiting the initiation of translation and promoting mRNA decay 
(Terrao et al., 2018). BSF and PCF cells deficient in 4EIP display little to no growth 
phenotype, however upon differentiation to stumpy forms, pleomorphic D4EIP BSF 
trypanosomes consistently display elevated protein synthesis compared to arrested 
WT stumpy cells, as determined by [35S] methionine incorporation into proteins. 
Furthermore, when these D4EIP stumpy cells were stimulated to differentiate to 
procyclic forms by treatment with CCA and incubation in procyclic medium at 27oC, 
the cells did not accumulate EP procyclin on their surface nor generate a stable 
proliferative culture (Terrao et al., 2018). Therefore, 4EIP appears to be required for 





initiation during stumpy form differentiation. 4EIP-bound mRNAs have 
comparatively short median half-lives, and are therefore unstable. The bound 
mRNAs, however, are not enriched for PCF specific transcripts, and nor is any 
protein motif or family found to be significantly enriched (Terrao et al., 2018). 
The remaining transcripts in Table 5.1 are enriched in the procyclic form. 
GPEET and EP procyclin are the major surface glycoproteins present on the surface 
of procyclic form cells, whilst succinyl-CoA:3-ketoacid coenzyme A transferase and 
glutamate dehydrogenase are enzymes involved in mitochondrial metabolism. The 
receptor-type adenylate cyclase Tb927.5.320 was shown by SILAC to be upregulated 
~6.25-fold in late compared to early procyclic forms (Imhof et al., 2014). Most 
receptor-type adenylate cyclases (ACs) belong to the large polymorphic Genes 
Related to ESAG4 (GRESAG4) family. GRESAGs are distinct from the BSF 
specific, ES-resident ESAG4 in that the ~65 copies are spread throughout the 
genome and (most) are expressed throughout the parasite’s lifecycle (Alexandre et 
al., 1996; Berriman et al., 2005; Salmon et al., 2012). The universal signalling 
molecule cAMP is produced from ATP by ACs. In the BSF parasite, ACs inhibit the 
host’s early innate immune response by producing ~250-fold greater levels of cAMP 
upon phagocytosis into an acidic environment or TNF-mediated lysis (Salmon et al., 
2012). The trypanosome-produced cAMP ‘hijacks’ the host’s cAMP signalling 
pathways and blocks the synthesis of TNFa by inflammatory cells or macrophage 
through activation of host protein kinase A (Salmon et al., 2012). In the insect form 
of the parasite, procyclic-specific AC dimers localise to defined subdomains on the 
flagellum (Saada et al., 2014). Although the function of many of these is not known, 
it has been shown that ACP1, ACP4 and ACP4 specifically localise to the tip of the 
flagellum and that the activity of ACP6 is responsible for the regulation of social 
motility (Lopez et al., 2015; Saada et al., 2014). 
RBP10 is a cytosolic, developmentally regulated RNA-binding protein with 
one RNA recognition motif (RRM) near its N-terminus (Wurst et al., 2012). Made 
solely in the slender bloodstream form, the protein promotes the retention of 
bloodstream form characteristics. Ectopic overexpression of RBP10 in PCF induces 





for survival (De Pablos et al., 2017; Mugo and Clayton, 2017). Conversely, depletion 
of RBP10 by RNAi in BSF causes a rapid inhibition of growth that is reversed once 
cells are placed in PCF growth conditions (De Pablos et al., 2017; Mugo and 
Clayton, 2017). RBP10 binds to PCF-specific mRNAs with a UA(U)6 motif in their 
3’ UTR, preventing their translation and furthermore, targeting them for destruction 
(Mugo and Clayton, 2017). Tandem affinity purification of RBP10 bound mRNAs, 
and subsequent RNAseq analysis of the bound and unbound fractions, identified 260 
mRNAs that were at least 3X more abundant in the bound fraction relative to the 
unbound. Over 40% of the proteins encoded by these mRNAs had already been 
quantitated during differentiation, with exactly 50% being more enriched in PCF 
than BSF. Proteins that showed an enrichment 2-12hrs post stumpy differentiation 
initiation were clearly enriched in the bound fraction (Mugo and Clayton, 2017). 
Table 5.1 presents evidence that the selected monomorph population was 
characterised by a global decrease in stumpy and insect specific transcripts. This 
evidence is further corroborated when considering the proportion of the significantly 
downregulated transcripts that were bound by the slender retainer, RBP10. Of the 68 
downregulated transcripts in this screen, 31 (45.6%) were identified in the bound 
fraction as part of the Mugo & Clayton study (2017) (Table 5.2). RBP10 binds PCF 
transcripts and targets them for destruction. Accordingly, many of the transcripts in 
Table 5.2, such as GPEET procyclin, ZC3H20 and glutamate dehydrogenase, are 
already known to be expressed highly in the stumpy and/or procyclic forms. The 
selected monomorph population has therefore significantly downregulated a large 










Table 5.2 Downregulated transcripts that are bound by RBP10. RBP10 targets procyclic 




GENE CODE ANNOTATION LOG2 FC ADJUSTED P VALUE
Tb927.6.510 GPEET procyclin -1.63 0.0003
Tb927.7.2660 ZC3H20 (zinc finger protein) -1.41 0.0004
Tb927.11.15010 NEK21 (serine/threonine-protein kinase) -1.00 0.0029
Tb927.5.2260 Hypothetical protein, conserved -0.93 0.0015
Tb927.9.4560 RBP32 -0.92 0.0004
Tb927.7.6330 Hypothetical protein -0.90 0.0020
Tb927.11.6890 DNA repair and recombination helicase protein, TbPIF1 -0.90 0.0136
Tb927.6.860 Hypothetical protein -0.81 0.0033
Tb927.3.1650 Hypothetical protein -0.81 0.0422
Tb927.11.2410 Hypothetical protein, conserved -0.80 0.0045
Tb927.4.1000 Hypothetical protein, conserved -0.79 0.0017
Tb927.10.3360 Hypothetical protein, conserved -0.77 0.0011
Tb927.10.8050 TFIIF-stimulated CTD (C terminal domain) phosphatase, putative -0.75 0.0064
Tb927.10.10770 Generative cell specific 1 protein, putative -0.75 0.0009
Tb927.7.6300 Hypothetical protein, conserved -0.72 0.0126
Tb927.9.2320 Hypothetical protein, conserved -0.71 0.0016
Tb927.8.4300 Hypothetical protein -0.70 0.0306
Tb927.10.12060 Hypothetical protein, conserved -0.70 0.0069
Tb927.8.5350 Hypothetical protein, conserved -0.69 0.0069
Tb927.3.2920 Hypothetical protein, conserved -0.66 0.0126
Tb927.7.520 Hypothetical protein, conserved -0.65 0.0075
Tb927.11.14070 Protein kinase, putative -0.65 0.0023
Tb927.6.3880 Hypothetical protein, conserved -0.64 0.0274
Tb927.4.2410 Hypothetical protein, conserved -0.64 0.0017
Tb927.5.320 Adenylyl cyclase, putative -0.64 0.0024
Tb927.9.5900 Glutamate dehydrogenase -0.63 0.0029
Tb927.11.2450 Hypothetical protein -0.62 0.0092
Tb927.9.7540 Cysteine peptidase, Clan CA, family C2 -0.62 0.0024
Tb927.10.15610 Zinc finger protein, putative -0.62 0.0299





The observation that the GFPESproAnTat1.1ES NEK RNAi selected 
monomorph population downregulated a number of stumpy and insect stage enriched 
transcripts compared to the parental pleomorphic population was an encouraging 
validation of the RNAseq data. Where this data’s real value lies however, is in the 
identification the factors that regulate the changes in gene expression, and therefore 
loss of life cycle competency, in response to long term passage. 
The trypanosome genome is organised into multiple long polycistronic 
transcription units (Berriman et al., 2005). Genes are co-transcribed and coupled 
5’trans-splicing and 3’poly-adenylation produces the individual mRNAs (Matthews 
et al., 1994; Ullu et al., 1993). In most eukaryotes, regulation at the level of 
transcription governs individual mRNA levels. The trypanosome transcriptional 
machinery however, lacks the capability to regulate the individual control of 
transcription initiation and as such the parasites rely unusually heavily on post-
transcriptional means of gene expression control, such as mRNA processing through 
stabilisation or degradation and translational efficiency. RNA-binding proteins 
typically control differential expression of genes by binding to regulatory AU-rich 
elements (AREs) in the 3’UTRs of their targets (Mayho et al., 2006). The T. brucei 
genome encodes 49 potential CCCH zinc finger proteins (ZC3Hs) that may be able 
to bind RNA (Benz et al., 2011; Ouna et al., 2012). ZC3Hs are a novel class of zinc 
finger protein that bind and either stabilise or destabilise RNA (most other zinc 
finger family members bind DNA or are involved in protein-protein interactions) 
(Singh et al., 2014). Three ZC3Hs have already been implicated in the regulation of 
trypanosome differentiation. TbZFP1 is procyclic specific and has is involved in 
kinetoplast repositioning (Hendriks and Matthews, 2005), whilst both TbZFP2 and 
TbZFP3 regulate surface procyclin acquisition and cellular remodelling during BSF 
to PCF transformation (Hendriks et al., 2001; Paterou et al., 2006). TbZFP3 may also 
play a wider role in the developmental events associated with BSF to PCF 
transformation, demonstrated by a significant enrichment for stumpy specific 
markers in lists of ZFP3 regulated transcripts (Walrad et al., 2012). 
Three ZC3Hs and two putative zinc finger proteins were identified as being 





pleomorphic parental population (Table 5.3). Indeed, one of the ZC3Hs, ZC3H20, 
was the fourth most downregulated transcript behind GPEET procyclin and two 
hypothetical proteins. ZC3H20 is stage-specifically enriched in PCF trypanosomes 
relative to BSF, and is required for their normal growth (Ling et al., 2011). ZC3H20 
was the first ZC3H to be described as stabilising, rather than destabilising, its target 
mRNAs and was furthermore shown to bind two developmentally-regulated PCF-
enriched transcripts, mitochondrial carrier protein 12 (MCP12) and trans-sialidase 
(TS-like E), via regulatory elements in their 3’ UTRs (Ling et al., 2011). In addition 
to MCP12 and TS-like E, another 10 transcripts were found to decrease >2-fold in 
abundance upon inducible knock down of ZC3H20. Three of these (Table 5.4) are 
also downregulated in the selected monomorph population. Perhaps the most 
intriguing of these is Tb927.5.4020, which encodes a hypothetical protein and is the 
third most downregulated transcript. Tb927.5.4020 is enriched in the PCF form of the 
parasite, relative to the BSF, with expression peaking at around 12hrs after the 
initiation of stumpy to PCF differentiation in vitro (Jensen et al., 2009; Queiroz et al., 
2009). The protein is included in the T. brucei cell surface phylome as a member of 
Fam50 Clade III (Jackson et al., 2013). Fam50 includes major surface glycoproteins 
related to the invertebrate to vertebrate transition such as BARP and GARP, two 
GPI-anchored epimastigote specific surface coat proteins (Jackson et al., 2013). 
Clade III however, contains surface proteins whose expression is specifically 
increased in PCF. Despite inclusion in this group, no GPI-anchor is predicted for the 
protein. A BLASTP search reveals that the predicted protein encoded by 
Tb927.5.4020 has some similarities to the bacterial surface transporter TolA, 
although at only 52% identity and 14% query cover, the E-value is poor. The TolA 
protein is involved in the translocation of colicins, antibiotics produced by 
Escherichia coli to reduce competition from closely related species (Penfold et al., 





Tb927.5.4020 encodes a surface transporter, and may instead be an integral 
membrane protein. 
 
Table 5.3 Zinc finger proteins identified in the downregulated dataset. 
 
 
Table 5.4 mRNAs bound, and stabilised, by ZC3H20 in the downregulated dataset. 
 
 
Both ZC3H37 and ZC3H11 have been demonstrated to bind trypanosome 
MKT1 (Singh et al., 2014), a cytosolic protein that is associated with polysomes. 
MKT1 plays a role in stress resistance, but also interacts with a number of other 
RNA-binding proteins and regulators thus suggesting it could be at the core of a 
large post-transcriptional regulatory network (Singh et al., 2014). ZC3H11 interacts 
with MKT1 through its C-terminus, whilst its N-terminus binds, and stabilizes, RNA. 
It is interesting that ZC3H11 is downregulated in the selected monomorphs 
compared to the parental pleomorphs, since it is essential for the survival of BSF 
cells (Droll et al., 2013). ZC3H11 however, was demonstrated to bind chaperones 
required for the heat shock response during differentiation to the procyclic form and 
RNAi depletion of the protein resulted in the ~2-fold decrease in abundance of many 
heat shock protein transcripts, amongst others (Droll et al., 2013; Singh et al., 2014). 
GENE CODE ANNOTATION LOG2 FC
ADJUSTED P 
VALUE
Tb927.7.2660 ZC3H20 -1.41 0.0004
Tb927.10.12780 ZC3H37 -0.91 0.0056
Tb927.5.810 ZC3H11 -0.82 0.0154
Tb927.1.2200 Zinc finger protein, putative -0.62 0.0302
Tb927.10.15610 Zinc finger protein, putative -0.62 0.0299
GENE CODE ANNOTATION LOG2 FC
ADJUSTED P 
VALUE
Tb927.5.4020 Hypothetical protein -1.50 0.0005
Tb927.5.2160 Hypothetical protein, conserved -0.74 0.0057





Of the 22 transcripts showing a 2-fold decrease in abundance after ZC3H11 RNAi in 
BSF cells, only one was found to be downregulated in this dataset, GPEET2. 
ZC3H37 is likewise associated with increasing translation and/or mRNA stability 
and this was demonstrated by tethering fragments of the protein to a blasticidin 
resistance protein marker (Erben et al., 2014). Blasticidin resistance in BSF was 
increased by an average of 64.7-fold when fragments of ZC3H37 were tethered to 
the resistance marker. 
39 of the 68 significantly downregulated transcripts encoded hypothetical 
proteins. These 39 hypothetical proteins were analyzed for conserved protein 
domains or features using the InterPro Protein Sequence Analysis and Classification 
Tool (Version 71.0, EMBL-EBI) (Table 5.5). Tb927.1.5260 was the transcript 
showing the most downregulation between the selected monomorphs and parental 
pleomorphs and encoded a hypothetical protein. The protein, however, was predicted 
to have a GPI-anchor, transmembrane domain, cleavage site and was most highly 
expressed in proliferative BSF cells, thus making it likely that Tb927.1.5260 encodes 
a VSG or ISG. No one protein domain, or family, was enriched in the downregulated 
group of hypothetical proteins, however the META domain did occur twice. The 
META domain (PFAM family, PF03724) is present in a number of small bacterial 
proteins of unknown function and has been linked to motility, protein secretion and 
the heat shock response (Ramos et al., 2011). In Leishmania, META1 and META2 
were shown to be specifically upregulated in the metacyclic promastigote form of the 
parasite (Ramos et al., 2004; Ramos et al., 2011; Uliana et al., 1999). Whilst 
overexpression of META1 was associated with increased virulence, META2 was 
shown to be important in protection against heat shock and stress (Ramos et al., 
2011; Uliana et al., 1999). The WD40 domain of Tb927.7.6300 has interestingly 
been associated with the regulation of a variety of cellular pathways, including 
signaling pathways, the cell cycle and translation (Choudhury et al., 2011; Xu and 
Min, 2011). The WD40 domain features abundantly throughout eukaryotic genomes 
and is furthermore one of the top interacting domains (Xu and Min, 2011). Within 
the WD40-repeat protein family are the highly conserved RACK1 proteins. In 
Saccharomyces pombe cells deficient in the RACK1 homologue, cpc2, are delayed in 





stimuli that would normally provoke G1 arrest (McLeod et al., 2000). In mammalian 
cells, RACK1 physically associates with numerous signal transducers, such as 
protein kinase C (PKC) (McLeod et al., 2000; Mochly-Rosen et al., 1991). The T. 
brucei homologue of RACK1, TRACK, is expressed throughout the lifecycle and 
able to functionally complement cpc2 null mutants of S. pombe (Rothberg et al., 
2006). RNAi of TRACK demonstrated that TRACK was a required for the initiation 
of, and progression through, the final stages of mitosis, cytokinesis (in BSF cells) 
and cell cleavage (in PCF cells) (Rothberg et al., 2006).  
 
Table 5.5 Signal peptides, transmembrane domains and InterPro protein 
family/domains predicted for the Hypothetical proteins regulated in the selected 
monomorphs, according to Tritryp. 
 






Tb927.1.5260 No -1.81 No 2 GPI-anchor
Tb927.5.4020 No -1.50 Yes No -
Tb927.5.2260 Yes -0.93 No - META domain
Tb927.7.6330 No -0.90 No 4 -
Tb927.10.8730 Yes -0.90 No - ABC1 family
Tb927.10.8740 No -0.88 Yes 1 -
Tb11.v5.0513 Yes -0.83 No - NLI interacting factor-like phosphatase domain
Tb927.10.15620 No -0.82 Yes 3 -
Tb927.3.1650 No -0.81 No 2 -
Tb927.11.16820 Yes -0.80 Yes - -
Tb927.11.2410 Yes -0.80 No - BAR/IMD domain-like
Tb927.11.8340 No -0.79 Yes 3 -
Tb927.11.810 Yes -0.79 No - TPR-like domain
Tb11.1390 Yes -0.74 Yes 6 -
Tb927.5.2160 Yes -0.74 No - META domain
Tb927.7.6300 Yes -0.72 No - WD40 domain, G-beta repeat
Tb927.3.1640 No -0.71 No 3 -
Tb927.11.240 Yes -0.71 Yes - -
Tb927.10.5100 No -0.71 No 3 -
Tb927.9.2320 Yes -0.71 No - Methyltransferase domain 
Tb927.8.4300 No -0.70 Yes 3 -
Tb927.10.12060 Yes -0.70 No - F-box domain
Tb927.3.5760 Yes -0.69 Yes - -
Tb927.11.6040 Yes -0.67 No - MFS general substrate transporter family
Tb927.7.520 Yes -0.65 No - Cytochrome b5-like Heme/Steroid binding domain
Tb927.4.2410 Yes -0.64 No - Glycosyl hydrolase family 65 central catalytic domain
Tb11.v5.0209 Yes -0.64 Yes - Adenylate and Guanylate cyclase catalytic domain 
Tb927.11.2480 No -0.62 No 2 -





5.5.1.2 Selected monomorphs upregulate genes associated with the 
proliferative slender bloodstream form 
Far fewer transcripts were upregulated in the selected monomorph population 
relative to the parental pleomorphic population and moreover these changes were to 
a much lesser extent than the downregulated genes (Appendix D). Only 11 
transcripts that showed a significant increase in abundance after the 10-week passage 
were selected for further analysis. The highest Log2FC recorded was +0.7315 (a 
fold-change of roughly 1.66) for Tb927.7.3250 (ESAG 6), whilst the 10 remaining 
genes scored Log2FC values between +0.6997 and +0.5018. Over 60% of the 
transcripts identified as being upregulated encoded either glycosomal or surface 
proteins, whilst one transcript each encoded the remaining proteins shown in Figure 
5.11. 
 
Figure 5.11 Upregulated genes in the selected monomorph population relative to the 
parental pleomorph population grouped by protein description. Total=11. 
 
Many of the proteins encoded by the transcripts downregulated in the selected 
monomorphs relative to the parental pleomorphs, such as GPEET and PAD2 are 
required for correct progression from the proliferative long slender BSF to the 
transmission-competent stumpy form and onwards to the insect procyclic form. This 
shift of the transcriptome away from pleomorphism is further corroborated by the 
upregulation of numerous transcripts encoding proteins primarily associated with the 
proliferative slender form of the parasite (Table 5.6). 
The top two hits in the upregulated dataset are ESAG 6 and ESAG 7, that 











essential for the growth of BSF parasites and must be acquired entirely form the 
mammalian host. The trypanosome’s heterodimeric transferrin receptor (TbTfR) 
bares no structural resemblance to the human receptor and is instead postulated to 
have evolved from VSG N-terminal domains (Pays et al., 2001; Salmon et al., 1997).  
 
Table 5.6 Annotated upregulated genes that are associated with the proliferative long 
slender bloodstream form. 
 
 
BSF parasites produce ATP by glycolysis, a process that occurs within the 
membrane-enclosed glycosome (Opperdoes and Borst, 1977). A handful of 
transcripts encoding glycosomal structural or enzymatic components were identified 
as being significantly upregulated by the selected monomorphs. Gim5a dimerises 
together with gim5b to form the constitutively expressed glycosomal membrane 
protein GIM5, the most abundant protein found within the glycosomal membrane 
and essential for survival of BSF parasites (Maier et al., 2001), and the glycolytic 
enzymes identified, triosephosphate isomerase and glyceraldehyde 3-phosphate 
dehydrogenase, catalyse the interconversion of DHAP and G3P and G3P to BPGA 
within the glycosome, respectively (Figure 5.12). The Tb927.6.4300 GAPDH 
GENE 
CODE ANNOTATION LOG2 FC
ADJUSTED P 
VALUE GENE FUNCTION
Tb927.7.3250 ESAG 6 0.73 0.0277 Transferrin receptor (Steverding et al., 1994).
Tb927.7.3260 ESAG 7 0.70 0.0219 Transferrin receptor (Steverding et al., 1994).
Tb927.9.11580 gim5A 0.59 0.0061
One monomer of the 
glycosomal membrane 
protein dimer, GIM5 
(Maier et al., 2001).
Tb927.11.5520 Triosephosphate isomerase (TPI or TIM) 0.51 0.0066
Glycosomal enzyme 















transcript is slightly longer than that of Tb927.6.4280, otherwise the two transcripts 
are identical. 
 
Figure 5.12 Glycolytic enzyme activities of Tb927.11.5520 and Tb927.6.4280/4300. 
Aerobic glycolysis within BSF T. brucei. Tb927.11.5520, triosephosphate isomerase, 
catalyses step 7 and Tb927.6.4280/4300, GAPDH, catalyses step 8. Adapted from (Achcar et 
al., 2012).  
 
A 44kDa calflagin (Tb44) was identified in the significantly upregulated 
dataset. Calflagins are a family of calcium-binding proteins containing an EF-hand 
calcium-binding loop that localise to the flagellar membrane, where they associate 
with lipid raft microdomains and presumably act as calcium signalling proteins 
(Emmer et al., 2010; Wu et al., 1992). The expression of Tb44, as well two other 
calflagins, Tb17 and Tb24, is regulated during the life cycle, with approximately 10-
fold greater expression in BSF parasites than PCF (Emmer et al., 2010). The 
remaining upregulated transcripts encoded an amino acid transporter (Tb927.4.4860), 






5.5.1.3 Changes in transcript abundance occur early in selection 
In addition to investigating the identity of the genes that showed changes in 
transcript abundance following prolonged laboratory passage, the RNAseq analysis 
was furthermore used as a tool to observe how the expression of these genes changed 
occurred over time. Did the changes in gene expression occur gradually, akin to the 
acquisition of in vitro 8-pCPTcAMP resistance, or were they restricted to a certain 
period of the passage? The ‘Intermediate’ samples 1 and 2 (Figure 5.8a) flanked the 
sudden increase in 8-pCPTcAMP resistance and it was hypothesised that sequencing 
RNA from these timepoints could reveal the underlying cause for such a rise in 8-
pCPTcAMP resistance. 
Of the 68 genes that were significantly downregulated in the final selected 
population relative to the ‘Start’ population, 55 were also significantly 
downregulated in the ‘Intermediate’ 1 population relative to the ‘Start’ population 
(Figure 5.13a). Neither the ‘Intermediate 2 relative to Intermediate 1’ nor the ‘End 
relative to Intermediate 2’ comparisons identified significant changes in transcript 
abundance (p< 0.05). Of the 13 genes that did not also appear in the ‘Intermediate 1 
relative to Start’ comparison, and therefore only significantly decreased in abundance 
in the latter stages of selection, 12 encoded hypothetical proteins. The exception to 
this was Tb927.1.2200, which codes for a putative zinc finger protein. The fold 
change heatmap in Figure 5.13a demonstrates that the vast majority of the changes in 
transcript abundance occurred in the early stages of selection. Despite most 
transcriptome changes occurring in the first few weeks of passage, 33 of the 55 genes 
that appeared in both the ‘End relative to Start’ and ‘Intermediate 1 relative to Start’ 
comparisons showed a slight progression in downregulation after the initial 
significant drop in transcript abundance. The remaining 22 genes showed stable 
expression, or slightly decreased expression compared to the ‘End’ selected 
population at the ‘Intermediate’ 1 time point, however in these cases the differences 







Figure 5.13 Gene expression over three selection timepoints. Fold change of transcript 
abundance in the ‘Intermediate 1’ and ‘End’ populations relative to the starting pleomorphic 
population, respectively. (a) Downregulated genes. The 55 genes that were significantly 
downregulated in both the ‘End relative to Start’ and ‘Intermediate 1 relative to Start’ 
comparisons are plotted in blue. (b) Upregulated genes. The 10 genes that were significantly 
upregulated in both the ‘End relative to Start’ and ‘Intermediate 1 relative to Start’ 
comparisons are plotted in red. Each row represents a different transcript, denoted by the 
gene codes on the left. The transcripts are ordered from the highest fold change to the lowest. 
No significant changes were observed in the ‘Intermediate 2 relative to Intermediate 1’ and 
‘End relative to Intermediate 2’ comparisons. 
 
The changes in expression of the 11 upregulated transcripts followed a similar 
pattern (Figure 5.13b). Again, no significant changes in transcript abundance were 
observed in the ‘Intermediate 2 relative to Intermediate 1’ or ‘End relative to 
Intermediate 2’ comparisons. Ten genes were significantly downregulated in the 
‘Intermediate 1 to Start’ comparison. The transcript encoding triosephosphate 
isomerase, Tb927.11.5520, was the only transcript not identified in the ‘Intermediate 
(a) (b)





1 relative to Start’ comparison. Although most of the largest changes to transcript 
abundance again materialised early during selection, all ten of the transcripts showed 
a progression in their upregulation throughout the in vitro selection that was more 
profound that that observed for the downregulated genes. This can be most easily 
visualised for transcripts Tb927.9.11580 (gim5a), Tb927.4.4860 (amino acid 
transporter 8) and Tb927.11.7700 (hypothetical protein) (Figure 5.13b). 
5.5.1.4 The RNAseq data is validated by qRTPCR 
Validation of the RNAseq data was performed by qRTPCR of three 
downregulated genes, Tb927.11.15010 (NEK21), Tb927.5.4020 (Hypothetical 
protein) and Tb927.7.2660 (ZC3H20). The transcript levels in one replicate of the 
RNA acquired from the parental pleomorphs (‘Start’) were compared to transcript 
levels in the triplicate selected monomorph RNA samples (‘End 1-3’) for each of the 
three genes (Figure 5.14). The validation was performed on the same material that 
had been sent for RNA sequencing. The mean fold change of transcript abundance 
when calculated by qRTPCR closely matched that generated from the RNAseq data 
analysis (ZC3H20- 0.317 vs 0.355, Tb927.5.4020- 0.27 vs 0.376, NEK21- 0.442 vs 








Figure 5.14 Validation of the RNAseq data by qRTPCR. Expression levels of NEK21, 
Tb927.5.4020 and ZC3H20 were determined in three RNA replicates from the selected 
monomorphs (‘End 1-3’) relative to one of the pleomorphic parental population RNA 
samples (‘Start’). The respective transcripts measured for abundance are inset into each plot. 
Data represents the mean + S.D (n=3). 
 
5.5.1.5 Two independent monomorphic T. brucei lines differ in gene 
expression 
The monomorphic T. brucei Lister 427 line is routinely used in laboratory 
studies. The life history of these parasites is complicated, but it has been proposed 
that all current T. brucei Lister 427 lines likely originate from the Shinyanga III 
strain that was isolated from cattle in Tanganyika (present day Tanzania) in 1956 
(Cross, 2018). Over 6 decades, the parasite has been extensively passaged under 
different conditions in different laboratories around the world. As such, it is highly 
likely that T. brucei Lister 427 lines from different laboratories are not 
phenotypically nor genotypically identical. Since 1956, the parasite has become 
laboratory adapted and consequently lost its capacity for slender to stumpy to 
differentiation (Cross, 2018) . In total, the GFPESproAnTat1.1ES NEK RNAi selected 






monomorphs significantly downregulated 950 genes relative to the pleomorphic 
parental population. To study if any of the genes for which expression was selected 
against in these selected monomorphs had also been selected against in our 
laboratory’s T. brucei Lister 427 strain, the primers used in Section 5.4.1.4 were used 
to quantify NEK21, ZC3H20 and Tb927.5.4020 gene expression in a logarithmic in 
vitro population of T. brucei Lister 427 cells.  
Interestingly, the results in Figure 5.15 show that bloodstream form T. brucei 
Lister 427 cells consistently express greater levels of NEK21, ZC3H20 and 
Tb927.5.4020 than the GFPESproAnTat1.1ES NEK RNAi selected monomorphs. Whilst 
NEK21 transcript abundance is only ~1.5-fold greater in the selected monomorph 
population relative to the T. brucei Lister 427 population, both ZC3H20 and 
Tb927.5.4020 are expressed to a much greater extent (~3- and 4.5-fold, respectively). 
Although the T. brucei Lister 427 cell line did express NEK21 and ZC3H20 at a 
significantly lower level than the GFPESproAnTat1.1ES NEK RNAi pleomorphs, the T. 
brucei Lister 427 cells in fact expressed significantly more Tb927.5.4020 than the 
pleomorphic GFPESproAnTat1.1ES NEK RNAi population (up 125%). Whilst only a 
very small fraction of the downregulated genes was tested, these results appear to 
suggest that the genes identified in this screen as being downregulated upon 
laboratory adaptation have not also been selected for in another line of monomorphic 
BSF cells and that in fact other monomorphic lines may express these to a greater 







Figure 5.15 NEK RNAi GFPESproAnTat1.1ES selected monomorphs and T. brucei Lister 
427 monomorphs do not express similar levels of NEK21, ZC3H20 or Tb927.5.4020. 
Expression was determined by qRTPCR. The respective transcripts measured for abundance 
are inset into each plot. Data represents the mean + S.D (n=3). 
 
5.5.2 Genome analysis of selected monomorphs 
To try and understand why the observed changes in gene expression may 
have occurred upon the loss of differentiation competency, DNA from the parental 
pleomorph ‘Start’ population and the selected monomorph ‘End’ population was sent 
for whole genome sequencing (WGS) and analysed for single nucleotide 
polymorphisms (SNPs) or insertions/deletions (indels). The processing of raw 
























































reference T. b. brucei TREU927 genome were kindly performed by Dr Alasdair 
Ivens (see Section 2.19).  
When a PHRED-scaled QUAL score threshold of 200 was applied to the 
Variant Call Format (VCF) data, a total of 33,609 SNPs and 935 indels were found in 
the selected monomorph’s assembled genome compared to the parental pleomorph’s. 
The 301bp regions containing these SNPs or indels were mapped to the T. b. brucei 
TREU927 reference genome and those which did not fall into the coding sequence 
(CDS) of a differentially expressed gene identified by the transcriptome analysis 
filtered from the dataset. Overall, 82 SNPs and 1 indel were identified in the selected 
monomorph’s genome compared to the parental pleomorph’s, although the single 
indel was excluded from further analysis since it occurred in a highly repetitive 
region and was likely to have been the result of sequencing error. The 82 SNPs 
occurred over 25 of the genes identified as being significantly downregulated in the 
selected monomorphs, and 3 of the genes identified as being significantly 
upregulated in the selected monomorphs compared to the parental pleomorphs 
(Appendix E). With the exception of the GT to T deletion in ZC3H37, for which the 
selected monomorphs were homozygous for, the selected monomorphs were 
heterozygous at each SNP site, with one allele encoding the original nucleotide 
present in the pleomorphic genome and one allele encoding an alternative base 
(Appendix E).  
During the SNP identification process, the reads generated from the WGS of 
the ‘End’ selected monomorph population were aligned against what was essentially 
a haploid ‘Start’ reference genome which assumed homozygosity at every site. In 
reality however, trypanosomes are diploid organisms. Therefore, it was important to 
assess whether there was already underlying genetic variation in the ‘Start’ 
population at each of the proposed SNP sites. To achieve this, the reads generated 
from the WGS of the ‘Start’ selected monomorph population were aligned against 
the ‘Start’ reference genome and the SNPs identified compared to those shown in 
Appendix E. At each of the previously identified heterozygous SNP sites from the 
‘End’ vs ‘Start’ analysis, the ‘Start’ parental pleomorphs were also identified as 





expressed genes identified in the transcriptome analysis did not appear to be 
responsible for the changes in gene expression between the parental pleomorphs and 
the selected monomorphs. 
The T. brucei genome is organised into large polycistronic transcription units 
(PTUs) (Berriman et al., 2005; Johnson et al., 1987) which are transcribed by 
RNApol II, with mature mRNA transcripts being processed by coupled trans-
splicing and polyadenylation (Matthews et al., 1994). The lack of transcriptional 
control within these PTUs requires that T. brucei gene expression is controlled 
largely at the post-transcriptional level, either through mRNA stability or 
translational efficiency. Most post-transcriptional control of gene expression is 
governed through regulatory elements in the 3’UTRs of genes (Berberof et al., 1995; 
Hotz et al., 1995; Hug et al., 1993), although upstream open reading frames (uORFs) 
in the 5’ UTRs can also influence gene expression (Jensen et al., 2014; Siegel et al., 
2005; Vasquez et al., 2014). Therefore, a SNP within either the 5’ or 3’ UTRs of a 
gene could significantly impact its expression. To explore whether differential gene 
expression between the selected monomorphs and parental pleomorphs was the result 
of a SNP (or SNPs) disrupting a regulatory motif, splice acceptor site or 
polyadenylation site, the list of SNPs identified in the ‘End’ vs ‘Start’ comparison 
was searched for those which fell within the 5’ or 3’ UTR of one of the differentially 
expressed genes. To account for the diploid genome, the SNPs identified in the ‘End’ 
vs ‘Start’ alignment were again compared to those from the ‘Start’ vs ‘Start’ 
alignment, and only those for which there was a difference in genotype between the 
selected monomorphs and parental pleomorphs analysed further. With these filters in 
place, only one SNP was identified- a T to A substitution on one allele within the 
3’UTR of Tb927.8.8320, a hypothetical protein. The genotype of the starting 
pleomorphic population at this site (TT) however, was called with low confidence. 
As part of the Variant Call Format output, for each SNP site a ‘normalised’ PHRED 
score of the likelihood of each possible genotype is generated. The score of the most 
likely genotype is 0 and this score increases up to 255 with decreasing likelihood. 
For this site in the ‘Start’ genome, a score of 0 was given to the genotype TT, a score 
of 3 given to the genotype TA and a score of 162 for the genotype AA. Therefore, 





programme could not confidently predict whether this site was TT or TA. This is 
reflected in the number of reads for either T or A at this site- out of 34 reads, 19 were 
for T and 12 were for A. In contrast, the genotype at this site in the selected 
monomorphs’ genome was predicted with high confidence (244 for TT, 0 for TA and 
209 for AA). Since the reads were split almost equally between T and A at this site, 
and the genotype confidence score was poor, this SNP was not chosen for further 
analysis. 
Since focusing on the genes differentially expressed between the parental 
pleomorphs and selected monomorphs had not identified any SNPs which could 
explain the differences in gene expression, we next turned our attention to the SNP 
sites which occurred in the CDS of any gene and at which there was a difference in 
genotype between the pleomorphs and selected monomorphs. If a SNP had occurred 
in a ‘master regulator’ gene which did not affect its transcription but had impacted its 
efficiency, this could explain why the gene was not identified in the transcriptome 
analysis but gene expression changes were measurable. For this analysis, the 
PHRED-scaled QUAL score threshold was raised to 999. The Variant Call Format 
identified 15 SNP sites at which there was a difference in genotype between the 
parental pleomorphs and the selected monomorphs (Table 5.7). Most of the SNPs 
occurred within unannotated regions of the genome or pseudogenes. Three SNPs, 
however, fell within the CDS of a gene and one of these caused a non-synonymous 
mutation, therefore changing the amino acid sequence of the protein encoded. The 
H157L mutation in Tb927.11.2600, a hypothetical protein which localises to the 
nucleus (Dean et al., 2017), furthermore changed the properties of the amino acid 
encoded- from a polar histidine to a non-polar leucine. A search for functional 
domains and sites using the InterPro Protein Sequence Analysis and Classification 
Tool (Version 71.0, EMBL-EBI) found that no part of the protein resembled any 
annotated functional domains, however it did contain 5 predicted regions of disorder 
across its length (although the SNP did not occur in any of these regions). Expression 
of Tb927.11.2600 did not significantly change between the pleomorphs and selected 
monomorphs, as determined by the transcriptome analysis. However, as was the case 
for the SNP site within the UTR of Tb927.8.8320, the genotype at the site of the SNP 





pleomorphs or selected monomorphs. The ‘normalised’ PHRED scores for the 
likelihood of each genotype in the parental pleomorphs were 0 for AA (the given 
genotype), 7 for TA and 255 for TT and for the selected monomorphs the scores 
were 0 for TA (the given genotype), 13 for AA and 255 for TT. Therefore, whilst it 
is clear that the genotype at this site is not TT, it is unclear for both populations 
whether the genotype is AA or TA. 
 
Table 5.7 SNP sites at which there was a difference in genotype between the selected 









709, Pos 693 CC TC Non-coding region - -
1515, Pos 2908 CA CC
Region with SNP has BLAST 
similarity to pseudogenic VSG 
transcript
- -
1721, Pos 2041 AG GG Non-coding region - -
2041, Pos 2526 GG AG Non-coding region - -





2103, Pos 3529 CA CC
Region with SNP has low 
BLAST similarity to 
pseudogenic VSG transcript
- -
2333, Pos 1081 TC TT Tb927.1.2880 Pteridine transporter, putative Synonymous
3664, Pos 2748 GG AG
Region with SNP has low 
BLAST similarity to 
pseudogenic VSG transcript
- -
3978, Pos 409 AC CC Tb927.2.1330
Retrotransposon hot spot 
protein 6 (RHS6), 
degenerate
-
4118, Pos 454 GA AA Non-coding region - -
4143, Pos 1414 GG AG
Region with SNP has BLAST 
similarity to pseudogenic VSG 
transcript
- -
4808, Pos 2305 AA TA Tb927.11.2600 Conserved hypothetical protein, nuclear
Non-synonymous. 
H157L
4977, Pos 730 CA AA Tb927.9.1240 VSG pseudogene -
5978, Pos 526 CC TC Region with SNP has BLAST similarity to Tb10.v4.0188
Hypothetical protein, 
predicted to be 
glycosyltransferase
Synonymous
10940, Pos 856 CT CC
Region with SNP has low 








Throughout the literature, it is widely reported that laboratory-adapted 
monomorphic strains of T. brucei switch their expressed VSG at a rate significantly 
lower than that of differentiation-competent pleomorphic strains. However, it has not 
been demonstrated whether the loss of pleomorphism and reduction in VSG switch 
rate associated with laboratory-adaptation occurs concomitantly and therefore are 
directly linked, or whether the two processes can be selected for independently and 
thus uncoupled. By using an ‘inducible-monomorphism’ model, we have 
demonstrated by in vitro FACS-based VSG switch assays and VSGseq that VSG 
switch frequency and differentiation capacity can be uncoupled. Inducible 
knockdown of a gene involved in the slender to stumpy quorum sensing pathway 
(Mony et al., 2014) did not cause a reduction of VSG switch rate in three 
independent RNAi lines or change the expressed VSG diversity. 
In this Chapter, I adopted a second approach to ask whether VSG switch 
frequency and differentiation capacity can be uncoupled. Populations of selected 
monomorphs were generated by repeated in vitro passage of the pleomorphic 
reporter cell lines used in Chapters 3 and 4. In vivo, the populations of selected 
monomorphs demonstrated reduced responsiveness to SIF as exemplified by the 
retention of slender morphology, diminished expression of the stumpy marker 
protein PAD1 and decreased accumulation in the G0/G1 stage of the cell cycle. 
When the VSG switch rate of the selected monomorphs was compared to that of the 
parental pleomorphs using the FACS-based switch assay format it was observed that, 
although the cells had lost the capacity to differentiate to stumpy forms and therefore 
become monomorphic, the VSG switch rate had not changed. Therefore, VSG switch 
rate and slender to stumpy differentiation capacity had been uncoupled. These results 
corroborate our findings using the inducible monomorphism model. To investigate 
the changes that had occurred to confer monomorphism during the in vitro passage, 
an ‘evolve and re-sequence’ approach and RNAseq analysis was adopted. 
Transcriptome analysis found that the selected monomorphs were depleted of a 
number of transcripts which were required for the stumpy and procyclic forms of the 





Conversely, a number of transcripts required by the slender bloodstream form stage 
of the parasite were upregulated, such as the two subunits of the transferrin receptor, 
ESAGs 6 and 7 and the glycosomal enzymes triosephosphate isomerase and 
glyceraldehyde 3-phosphate dehydrogenase. In addition, a number of CCCH zinc 
finger proteins were significantly downregulated in the selected monomorphs 
compared to the parental pleomorphs. The zinc finger protein ZC3H20 binds to and 
stabilises its target mRNAs and is already known to bind two developmentally-
regulated, PCF-enriched transcripts. ZC3H20 could represent a novel regulator of 
slender to stumpy differentiation. Whole genome sequencing and SNP/INDEL 
analysis could not identify any mutations within the differentially expressed genes 
which would explain the changes in transcription between the parental pleomorphs 
and selected monomorphs. In Chapter 3, it was observed that the knock down of 
HYP2 caused a significant increase in VSG switch rate, from 6.97x10-4 ±0.0004 to 
2.5x10-3 ± 0.0009 switches/cell/generation, suggesting that HYP2 could be involved 
in the regulation of both antigen switching and differentiation from slender to stumpy 
forms. These switch assay results were not reproducible, however, and furthermore, 
VSGseq analysis in Chapter 4 did not present evidence for a greater number of VSGs 
being expressed in the induced GFPESproAnTat1.1ES HYP2 RNAi population 
compared to the uninduced population. HYP2 could therefore be involved in the 
regulation of monoallelic control (which would only be observed at a single-cell 
level using the VSGseq approach), as discussed in Section 3.10. Future work should 
look at the single cell level to establish the role of HYP2 in antigen switching. The 
evidence presented in this Chapter, however, clearly demonstrated that despite the 
loss of efficient differentiation capacity, VSG switch rate in the selected 
GFPESproAnTat1.1ES HYP2 RNAi population did not significantly change. This result 
therefore corroborates our results with the GFPESproAnTat1.1ES NEK and DYRK 
RNAi cell lines to show that antigen switch rate and slender to stumpy differentiation 
capacity are not mechanistically tethered. 
In both this Chapter and in Chapter 3, it was observed that the pleomorphic 
GFPESproAnTat1.1ES HYP2 and NEK RNAi lines consistently switched expression of 
VSGs at a rate approximately 4 times lower, and more so by in situ switches of 





trypanosomes are frequently characterised by low VSG switch rates and infrequent 
DNA recombination-based VSG switches (Liu et al., 1985; McCulloch et al., 1997; 
Turner, 1997). It is interesting then, that the GFPESproAnTat1.1ES NEK RNAi cell line 
was the first cell line out of the three passaged reporter cell lines to lose the capacity 
to differentiate to stumpy forms in response to the accumulation of SIF, but without a 
reduction in VSG switch rate. What this evidence suggests is that, in the 
GFPESproAnTat1.1ES NEK RNAi cell line, loss of slender to stumpy differentiation 
capacity and reduced VSG switch rate have been selected for, however at different 
rates and independently of one another. The data, alongside the in vitro 8-
pCPTcAMP growth curves in Figure 5.3 where a steady progression in resistance 
was observed over time, also demonstrates that both reduced VSG switch rate and 
loss of differentiation capacity are not abrupt ‘on-off’ events, but rather progress 
along a spectrum over time (this relies on the assumption that all three reporter RNAi 
cell lines were generated from the same T. brucei AnTat1.1 genetic background and 
therefore that the VSG switch rate and differentiation capacity at an earlier timepoint 
were identical). The pleomorphic GFPESproAnTat1.1ES NEK RNAi cell line could 
have demonstrated reduced VSG switch rate compared to, and lost its differentiation 
capacity sooner than, the GFPESproAnTat1.1ES HYP2 and DYRK RNAi cell lines 
because it had been passaged in vitro for a longer period of time prior to its use in 
this study. However, without knowing the culture history of the cell line this is 
difficult to prove. It would be interesting to continue passage of the selected 
GFPESproAnTat1.1ES NEK RNAi population to observe how long it would take before 
a significant shift in VSG switch frequency was observed. 
The selected monomorphs were depleted of a number of transcripts which were 
associated with the stumpy and insect stages of the parasite’s lifecycle. Rather than 
an accumulation of mutations in each of these genes being the reason for the loss of 
pleomorphism, it was more likely that these changes were the result of changes to an 
upstream regulator (or regulators). Three CCCH zinc finger proteins (ZC3Hs) were 
identified as being significantly downregulated in the selected monomorphs 
compared to the parental pleomorphs- ZC3H11, ZC3H20 and ZC3H37 (Table 5.3). 
Of these, ZC3H20, the fourth most downregulated transcript behind GPEET 





in the regulation of slender to stumpy differentiation. In addition to its role of 
stabilising the mRNA of two developmentally-regulated, PCF-enriched transcripts 
(MCP12 and TS-like E (Ling et al., 2011)), the zinc-finger protein has furthermore 
been identified in two other unpublished differentiation screens performed in the 
Matthews Lab at the University of Edinburgh. The first of these screens, performed 
by Dr Lindsay McDonald, used a genome-wide RNAi library screen to identify 
downstream effectors of the differentiation-inducing compound GlaxoSmithKline 
Kinase Inhibitor (GKI) 7 (Diaz et al., 2014). Treatment with 1.44µM GKI7 for 24 
hours causes G1 arrest and upregulation of PAD1 protein expression in T. brucei 
AnTat1.1 90:13 cells (Lindsay McDonald Thesis, 2016). In a method similar to the 
RNAi library screen which identified components of the T. brucei quorum sensing 
pathway (Mony et al., 2014), triplicate induced populations of a monomorphic RNAi 
library were treated with GKI7 and the RNAi inserts of the GKI7 resistant cells 
subsequently subjected to Ion Torrent Sequencing. ZC3H20 was identified in one of 
the three replicates, suggesting that it could be a factor involved in slender to stumpy 
differentiation. The second screen was performed by Dr Mathieu Cayla and made use 
of mass-spectrometry to identify differentially phosphorylated proteins in a T. brucei 
AnTat1.1 90:13 ΔDYRK cell line. When DYRK, a known component of the quorum 
sensing signalling pathway, was deleted, ZC3H20 was significantly less 
phosphorylated. Dr Cayla was also able to demonstrate that the protein was 
phosphorylated when purified T. brucei lysate was used as a substrate of a purified 
active kinase. 
The role of ZC3H20 as a regulator of slender to stumpy differentiation was 
validated in vivo by Dr Mathieu Cayla (data unpublished, Figure 5.16). In vivo, the 
parasitaemia of T. brucei AnTat1.1 J1339 ΔZC3H20 cells ascended rapidly, with one 
mouse required to be humanely culled on day 5 of the experiment (Figure 5.16a). 
Despite the high density of parasites in the blood, the ZC3H20 knock out cells did 
not show any evidence of accumulation in G0/G1 (Figure 5.16b) or increased 
expression of PAD1 (Figure 5.16c). This data demonstrates that ZC3H20 plays a role 
in the regulation of slender to stumpy differentiation and furthermore, validates the 





finger proteins identified, ZC3H11 and ZC3H37, also contribute to slender to stumpy 
form differentiation remains to be confirmed in vivo. 
 
 
Figure 5.16 ZC3H20 knock out in a pleomorphic cell line confers increased resistance 
to SIF Generation of the ZC3H20 knock out cell line and collection of all of the above data 
was performed by Dr Mathieu Cayla (University of Edinburgh). (a) In vivo growth of T. 
brucei AnTat1.1 J1339 ΔZC3H20 cells compared parental cell line. The ΔZC3H20 cells 
remained proliferative, whilst the parental cells arrested in response to SIF. The ΔZC3H20 
replicate 3 was culled on day 5 of the experiment on humane grounds. (b) Cell-cycle 
analysis of cells in the blood on days 4, 5 and 6 of infection. Pleomorphic cells (purple) 
arrested in G1/G0 as they differentiated, seen as an accumulation of 1K1N cells between 
days 4 and 5. The proportion of cells in 1K1N within the ΔZC3H20 population (teal) 
remained relatively constant over the infection time course. At least 80 cells were counted 
for each individual infection. (c) IFA analysis of PAD1 expression. Despite the high 
parasitaemia at later infection timepoints, no ΔZC3H20 cells were found to express the 



























The Log2FC value of ZC3H20 in the selected monomorphs compared to the 
parental pleomorphs was -1.41. Whole genome sequencing and SNP/INDEL analysis 
however, did not identify any mutations within the genomic sequence of the selected 
monomorphs’ ZC3H20 which could explain the changes in expression. Therefore, it 
is possible that there may be a further regulator whose expression impacts that of 
ZC3H20. Analysis of the CDS and UTR sequences of all the differentially expressed 
genes identified in the transcriptome analysis found only one site, within the 3’ UTR 
of the hypothetical protein, Tb927.6.810, where the genotype differed between the 
parental GFPESproAnTat1.1ES NEK RNAi pleomorphs and the GFPESproAnTat1.1ES 
NEK RNAi selected monomorphs. The confidence with which the genotype could be 
predicted at this site, however, was very poor and therefore there is a strong 
possibility that the genotype may actually be the same. There was only SNP within 
the length of the entire selected monomorphs’ genome which was predicted to cause 
a non-synonymous mutation in the CDS of a gene (another hypothetical protein, 
Tb927.11.2600), however in this instance the confidence scores for the genotype 
predictions in both the parental pleomorph and selected monomorphs populations 
were poor. 
For both the RNAseq and WGS, genomic material prepared from the whole 
population was sent for sequencing. Although the period of in vitro passage began 
with a clonal pleomorphic GFPESproAnTat1.1ES NEK RNAi population, we do not 
know if, during the ten-week selection period, the population has remained relatively 
homogenous or whether the selected monomorphs are composed of multiple 
different genotypes which all confer the same phenotypic traits. That only 15 SNPs 
which caused a change in genotype at that site were identified across the entire 
length of the selected monomorphs’ genome, suggests that the population could still 
be homogenous. However, without sequencing the genomes of multiple clones from 
both populations, this is hard to prove. By performing WGS on clones derived from 
the selected monomorphs population, we could firstly deduce whether the population 
is clonal and secondly clarify whether the SNPs in the CDS of Tb927.11.2600 and 






The SNP/INDEL analysis only focused on those areas of the T. brucei TREU 
927 genome which are annotated as CDSs or UTRs. Table 5.7 shows that 4 of the 15 
SNPs in the selected monomorphs’ genome occurred in unannotated regions. It may 
be, despite their lack of annotation, that one of more of these regions are important in 
the regulation of slender to stumpy differentiation and their identity remains to be 
discovered. Alternatively, the differential gene expression between the selected 
monomorphs and parental pleomorphs could be the result of changes to epigenetic 
control mechanisms, such as chromatin structure or histone post-translational 
modifications (methylation, ubiquitylation, phosphorylation and SUMOylation). It is 
already known that a variety of epigenetic mechanisms are critical to the 
maintenance of monoallelic VSG expression (see Section 1.2.5) and furthermore, 
that a histone methyltransferase, DOT1B, is essential for differentiation to the 
procyclic form of the parasite (Janzen et al., 2006). In addition to the whole genome 
sequencing of clones derived from the selected monomorph population, future work 
could ask if the epigenome of the selected monomorphs has been altered relative to 
the parental pleomorphs. 
In addition to the ‘End’ versus ‘Start’ comparison, two ‘Intermediate’ RNA 
samples, 1 and 2, were sent for sequencing with the aim of observing how any 
changes in gene expression were occurring over time. The two ‘Intermediate’ 
samples were selected for RNAseq analysis since they flanked the timepoint where a 
sudden jump in the resistance to 8-pCPTcAMP treatment was observed in the 
passaged GFPESproAnTat1.1ES NEK RNAi population (Figure 5.8a). The results of the 
transcriptome analysis found that the majority of the differentially expressed genes 
identified in the ‘End’ versus ‘Start’ comparison were also significantly up- or down-
regulated in the ‘Intermediate 1’ relative to ‘Start’ comparison. No genes 
significantly changed in expression in the ‘Intermediate 2’ relative to ‘Intermediate 
1’ comparison nor the ‘End’ relative to ‘Intermediate 2’ comparisons. From these 
results, it could be concluded that the changes in gene expression which confer 
monomorphism happened early in the period of selection. Since only the final 
population was tested for SIF resistance and we do not know what ‘level’ of 8-
pCPTcAMP resistance corresponds to resistance to SIF, it is not known whether the 





the ‘End’ selected monomorph population, is also resistant to SIF. Since the 
transcriptome profiles of the ‘Intermediate 1’ and ‘End’ selected populations are so 
similar, it seems likely that these cells may have already lost differentiation capacity 
(providing the genes that we have identified are indeed the ones driving the loss of 
differentiation capacity). The differentiation capacity of the ‘Intermediate 1’ 
population should be tested in vivo, and if life cycle competency has been lost, the 
aliquots frozen in the earlier during the passage should also be tested in order to 
establish exactly where differentiation capacity was lost. What is important to 
consider, however, is that before RNA could be isolated from the ‘Intermediate 1’ 
population, the cells had to be thawed and grown to a sufficient density. This 
freeze/thaw cycle represents a significant bottleneck and also requires approximately 
a week of in vitro culture. In this time frame, the ‘Intermediate 1’ population’s 
transcriptome could have changed to closer resemble that of the ‘Intermediate 2’ 
population, thus confusing the analysis. An improvement to any future study 
performing this kind of in vitro selection would involve isolating genomic material at 
the same time as cell stabilates as frozen. 
To ask whether the changes in gene expression which were observed in our 
selected monomorph line were consistent between different populations of 
monomorphic trypanosomes, the expression of three genes significantly 
downregulated in the selected monomorphs (ZC3H20, NEK21 and Tb927.5.4020, a 
binding partner of ZC3H20) was tested by qRTPCR in the well-studied 
monomorphic T. brucei Lister 427 strain. Interestingly, the T. brucei Lister 427 cell 
line expressed each of the three genes to a significantly greater extent than the 
GFPESproAnTat1.1ES NEK RNAi selected monomorphs and furthermore expressed 
Tb927.5.4020, a hypothetical protein, at a significantly higher level than the parental 
GFPESproAnTat1.1ES NEK RNAi pleomorphs (Figure 5.15). In a study by Nilsson et 
al. (2010), RNAseq was used to analyse transcript abundance in a slender 
pleomorphic T. brucei AnTat1.1 strain and a monomorphic T. brucei Lister 427 
strain. Just as there were inconsistencies in gene expression between the 
GFPESproAnTat1.1ES NEK RNAi selected monomorphs and the T. brucei Lister 427 
monomorphs for each of the three tested genes, there were also inconsistencies in 





strain used in this study and the one used by Nilsson et al. (2010). Though Nilsson et 
al. (2010) also described ZC3H20 expression to be significantly lower in the T. 
brucei Lister 427 monomorphs compared to the T. brucei AnTat1.1 pleomorphs, the 
results for the remaining two genes are the opposite of what was reported in this 
study. They found that NEK21 expression was higher in the T. brucei Lister 427 cells 
compared to T. brucei AnTat1.1 cells and furthermore that the T. brucei Lister 427 
cells expressed less Tb927.5.4020 than pleomorphic T. brucei AnTat1.1 cells 
(Nilsson et al., 2010). These data sets add weight to the conclusions reached in 
Chapter 3, where it was argued that differences in trypanosome culture techniques 
between laboratories could induce ‘laboratory specific’ adaptations and therefore 
complicate comparisons between different populations of the same genetic 
background (Section 3.10). Since each of the three monomorphic cell lines expressed 
the three genes to different extent, this could suggest, as was discussed in Section 
3.10, that monomorphism has arisen multiple times by different means, and that 
‘monomorphism’ may actually comprise several genotypes and phenotypes. To test 
this hypothesis, the whole transcriptomes and genomes of multiple monomorphic T. 
brucei strains would have to be compared. It must also be noted, however, that both 
the slender T. brucei AnTat1.1 and T. brucei Lister 427 cells used in the Nilsson et 
al. (2010) study were derived from mouse blood, not in vitro culture, and therefore 
that this may have impacted gene expression levels. Mulindwa et al. (2018) recently 
suggested that the largest contributing factor to inconsistencies between measured 
gene expression were due to differences in RNA preparation (Mulindwa et al., 2018). 
However, since RNA was prepared in the same way for our GFPESproAnTat1.1ES 
NEK RNAi selected monomorphs and T. brucei Lister 427 cells, this argues against 
this hypothesis. Our transcriptome datasets were subject to filtration and the 
application of defined Log2FC threshold cut-offs prior to analysis (as described in 
Section 5.5.1). By only considering the transcripts with the highest fold changes and 
resemblance to already known regulators of differentiation, we have potentially 
excluded novel regulators of differentiation from our dataset. Future work will 
consider the entire list of differentially regulated transcripts and compare the genes 
identified in our analysis to those identified in a genome-wide RIT-seq screen as 





growth) (Alsford et al., 2011). Although this approach is limited by the use of a 
monomorphic RNAi library in the RIT-seq screen (differentiation is measured as 
slender to PCF form and not slender to stumpy) this approach may still aid in 
identifying novel regulators which were not considered as part of this analysis. Genes 
identified in both datasets will be validated as a novel regulator of differentiation by 
CRISPR-Cas9 knock out in pleomorphic cell lines (Beneke et al., 2017). 
Historically, lines of selected monomorphs were generated through rapid 
syringe passage between rodents every 2-3 days (Turner, 1990) and it was in these 
lines of trypanosomes that homogenous VSG expression and low switch rates were 
reported. How might our results have looked like if our selected monomorphs were 
generated in vivo rather than in vitro? In vitro, it is considerably easier to control the 
driving selection force-in this case, culture at high density to select for cells that are 
unresponsive to the density-dependent differentiation signal. In the mouse model, 
however, the selection pressures would differ in that the density of the parasites in 
the blood would not be so easy to control nor to push to as high levels without killing 
the animal. Furthermore, additional selection pressures and bottlenecks, such as the 
host immune response, migration to the adipose tissue and the efficiency of injection 
could all influence the outcome of the period of passage. As has been seen in the 
literature, in vivo passage of our reporter cell lines could have generated 
homogenous, antigenically stable populations which had furthermore lost 
pleomorphism. In this scenario, however, such would be the additional selection 
pressures exerting their force on antigen expression that it would be hard to tease 
apart co-selection of VSG switch rate and slender to stumpy differentiation capacity. 
Our in vitro high density passage strategy is therefore advantageous since it directly 
tests for mechanistic tethering between VSG switch rate and slender to stumpy 
differentiation capacity by only exerting selection pressure against pleomorphism. 
Regarding what the transcriptome of our selected monomorphs might have looked 
like if they were generated in vivo rather than in vitro, I do not believe we would 
have observed identical temporal selection dynamics, nor the exact same lists of 
significantly up and down-regulated genes being generated. This is because, as 





and monomorphism seems to have been generated by varying means in different 
trypanosome isolates (Figure 5.15).   
In summary, we have generated a population of selected monomorphs 
through the continuous in vitro passage of a pleomorphic T. brucei 
GFPESproAnTat1.1ES NEK RNAi cell line and demonstrated that a reduction in VSG 
switch rate did not accompany the loss of pleomorphism. Therefore, the results 
corroborate our observations in Chapters 3 and 4 that slender to stumpy 
differentiation capacity and VSG switch frequency can be uncoupled. RNAseq 
analysis identified that the selected monomorphs were depleted of a number of 
CCCH zinc finger proteins, one of which, ZC3H20, has now been validated in vivo 
as a novel regulator of slender to stumpy differentiation. Further whole genome 
sequencing of clones derived from the selected monomorph population may shed 































The cyclical waves of parasitaemia associated with a bloodstream T. brucei 
infection are characterised by antigenic variation (a process by which the parasite 
switches its expressed VSG surface coat to evade host antibody-mediated clearance) 
and the density-dependent differentiation of proliferative slender forms to 
transmission competent, cell-cycle arrested stumpy forms. Laboratory-adapted lines 
of T. brucei have been reported to switch their expressed VSG surface coats at a 
significantly lower rate than pleomorphic populations of trypanosomes which have 
recently been transmitted through a tsetse fly (Turner, 1997). Upon laboratory-
adaptation, these populations also lose the capacity to differentiate into transmission 
competent stumpy forms and thus become monomorphic. Until now, it has not been 
established if the reduction in VSG switch frequency is directly coupled to the loss of 
slender to stumpy differentiation capacity, or whether the two processes, though co-
selected by multiple passage, are in fact independent. 
The aim of this thesis was to establish if there is a direct relationship between 
T. brucei stumpy formation capacity and VSG antigen switch frequency. To address 
this, I exploited pleomorphic T. brucei RNAi cell lines that could each inducibly 
silence a gene involved in stumpy formation in an approach that we termed 
‘inducible monomorphism’. Using this model, I sought to compare the VSG switch 
rate and expressed VSG diversity between uninduced pleomorphic populations and 
induced monomorphic populations. 
A quantifiable in vitro flow cytometry-based VSG switch assay found that 
VSG switch rate did not significantly decrease following the induction of 
monomorphism and nor was the preferred mechanism of VSG switching altered 
(Figure 3.14). Sequencing of the expressed VSGs in populations of pleomorphic and 
induced monomorphic cells demonstrated that the induction of monomorphism did 
not cause a reduction in expressed VSG diversity (Figure 4.7), nor change the 
expressed VSG subset (Figure 4.9). To corroborate these results, populations of 
selected monomorphs were generated by the prolonged in vitro passage of the 
pleomorphic T. brucei RNAi cell lines (Figure 5.1). These cells, which had varying 
degrees of reduced responsiveness to SIF in vivo (Figures 5.4-5.6), were tested in the 





pleomorphic populations. Despite having lost the capacity to effectively respond to 
SIF, the selected monomorphs were found to switch VSG expression at the same rate 
as the parental pleomorphic populations (Figure 5.7). 
Overall, the results presented within this thesis clearly demonstrate that VSG 
switch frequency and slender to stumpy differentiation capacity are not coupled, and 
instead are co-selected for during long term passage. So how then do our results 
relate to previously published studies that state laboratory-adapted monomorphs 
switch VSG expression at lower rates than pleomorphic populations? Past 
trypanosome studies have frequently compared parasite lines derived from 
independent selections or for which the passage history (which can span decades) is 
unknown. In contrast however, this study has made use of isogenic populations 
which allows a direct comparison to be made and rules out the potential for 
differences in laboratory specific adaptations influence, and complicate, VSG switch 
study outcomes. 
 Turner (1997) stated that “the rates of antigenic variation are several orders 
of magnitude lower in syringe-passaged lines, such as those routinely used in the 
majority of laboratory studies, compared with most recently fly-transmitted lines”. 
Critically, whilst the populations of trypanosomes compared by Turner (1997) were 
laboratory-adapted and isogenic, the cell lines must have retained pleomorphism in 
order to maintain tsetse infectivity and transmissibility. Similarly, the T. brucei 
AnTat1.1 90:13 cell line which was used throughout this study is both pleomorphic 
and adapted for laboratory culture. Our results showed that progression of these 
pleomorphic populations to monomorphism did not impact the VSG switch rate 
(Figure 5.7). Taking into account the conclusions from the 1997 Turner study, 
perhaps laboratory adaptation (without the loss of pleomorphism) has caused a 
significant drop in VSG switch rate in our cell line, but we could not observe this 
since the drop had preceded the beginning of this study. Without having been able to 
track VSG switch rate during the entirety of the cell line’s ‘life history’, it is 
impossible to tell. If this explanation did hold true, however, this would provide yet 
more evidence that monomorphism and VSG switch rate are co-selected 





To make definitive conclusions about the ability to uncouple VSG switch rate 
and slender to stumpy differentiation capacity, it could be argued that our selected 
monomorphs should be transmitted through a tsetse fly and the VSG switch rate 
measured after transmission, in a repeat of the Turner study (1997). There are, 
however, considerable setbacks with this approach. Firstly, the transcriptome 
analysis in Section 5.5.1 demonstrated that the selected monomorphs have 
downregulated a number of transcripts essential for survival and life cycle 
progression in the tsetse fly. The commonly used T. brucei Lister 427 strain which 
has also lost slender to stumpy differentiation capacity has been demonstrated to 
differentiate to procyclic in the midgut of the tsetse fly, however progress no further 
than this (Peacock et al., 2008; Szoor et al., 2006). It therefore seems realistically 
very unlikely that the selected populations would survive transmission. Secondly, for 
the interpretation of our VSG switch assay it is essential that the starting clone 
expresses VSG AnTat1.1 (to which we have an antibody against). If the selected 
monomorphs were successfully transmitted by the tsetse fly, the subsequent 
bloodstream forms may first be expressing a metacyclic VSG and would therefore 
require passage until the population switched to expression of VSG AnTat1.1. 
During this period of passage, a change in VSG switch rate could already be selected 
for and thus complicate he interpretation of results. Finally, if it was hypothesised 
that slender to stumpy differentiation capacity and antigen switch frequency were 
indeed linked and that the antigen switch frequency would increase upon 
transmission through the tsetse fly, this hypothesis would suggest that the cell line 
switched at extremely high rate when first isolated from tsetse flies since we 
calculated VSG switch rates between 2.88x10-4 and 2x10-3 switches/cell/generation 
for our selected monomorphs. 
It is possible that Turner (1997) may also have observed a lower switch 
frequency in serially passaged cells due to the indirect nature of the assays used in 
their study. As discussed in Section 1.2.7, VSG switching experiments that rely on in 
vivo infections and the clearance of ‘non-VSG switched’ cells by immune methods 
(such as complement-mediated lysis, as used by Turner(1997)) can underestimate the 
VSG switch rate as a result of the clearance of new VSG variants by off-target 





VSG switch rate between different cell lines. In contrast, our assay directly measured 
VSG switching through the use of a VSG specific antibody and at a higher 
resolution- flow cytometry is considerably more sensitive than microscope 
immunofluorescence analysis and permits the analysis of millions of cells in contrast 
to hundreds). The VSG switch rate of the populations following tsetse fly 
transmission increased significantly (perhaps due to the upregulation of different 
VSG genes in the VSG repertoire as has been observed for members of the cir 
multigene family in P. c. chabaudi (Spence et al., 2013)). It would have been 
interesting to have seen the VSG switch rate of the trypanosome populations 
measured prior to the serial passage and then compared to the VSG switch rates of 
the passaged and tsetse transmitted populations in order to see the VSG switch 
frequency decrease with increasing passage, however this was not performed. 
As a continuation of this study, it would be interesting to maintain the in vitro 
passage of the GFPESproAnTat1.1ES NEK RNAi selected monomorphs and to monitor 
if there was a significant decrease in their VSG switch frequency. The approach used 
to determine the factors accounting for the loss of pleomorphism in the selected 
monomorph population could then be adopted to investigate the observed drop in 
VSG switch frequency (e.g. genomic, transcriptomic analysis). As discussed in 
Section 1.2.5, a compendium of epigenetic control mechanisms regulates VSG 
switching. Therefore, it is also possible that a change in VSG switch frequency 
would be brought about by a change in one or more of these epigenetic factors and 
thus, in addition to WGS and RNAseq, the epigenomes of the pleomorphic and 
selected monomorphic cells should be compared. It has been demonstrated that there 
is an inverse relationship between telomere length and VSG switch frequency, 
whereby trypanosomes with short telomeres switch more frequently than those with 
longer telomeres and furthermore, that cells with short telomeres also switch more 
frequently by gene conversion than those with longer telomeres (Hovel-Miner et al., 
2012). The pleomorphic GFPESproAnTat1.1ES NEK RNAi population was observed to 
consistently switch expression of its VSGs at a rate approximately 4 times lower, and 
preferentially by in situ switches of transcription, than the GFPESproAnTat1.1ES HYP2 
and DYRK RNAi lines (albeit not significantly so) (Figure 3.14). It would be 





RNAi lines, or if alternative epigenetic factors accounted for the differences in VSG 
switch rate and mechanism. Monomorphic lines of trypanosomes have lost their 
capacity to complete the full lifecycle and therefore elements of their biology could 
be considered ‘biologically irrelevant’ when compared to pleomorphic trypanosomes 
which are more akin to field isolates (with regard to differentiation capacity). This 
study, however, has shown that populations of inducible monomorphs, generated 
through the knockdown of a quorum-sensing signalling gene, and selected 
monomorphs, generated by continuous high density in vitro passage of the 
pleomorphic reporter cell lines, do not switch VSG expression at a rate lower than 
pleomorphs nor significantly change the proportion of VSG switches elicited by 
DNA recombination. These results therefore suggest that monomorphic lines of 
trypanosomes that have recently lost pleomorphism are valid models for studying 
VSG switch rate and mechanism. Most monomorphic cell lines in the literature, 
however, have been demonstrated to show increased antigen stability and a 
preference for in situ switches of transcription compared to the pleomorphic reporter 
cell lines used in this study. It therefore must still be acknowledged that additional 
selection pressures during their continued passage have altered VSG switching in 
ways that differ them from pleomorphic cell lines. Of course, the pleomorphic cell 
lines used in this study, despite retaining transmission competence, have been subject 
to considerable in vitro and in vivo passage during their passage which may have 
altered their VSG switching dynamics compared to field strains. A useful study for 
the trypanosome field would involve studying VSG expression dynamics in the 
native bovine host. 
In addition to demonstrating that VSG switch frequency and pleomorphism 
can be uncoupled, the work presented here has identified a number of potential novel 
regulators of slender to stumpy differentiation. An evolve and resequence approach 
coupled with RNA sequencing was applied to understand the loss of pleomorphism 
in the GFPESproAnTat1.1ES NEK RNAi selected monomorph population. 
Transcriptome analysis found that the selected monomorphs were depleted in a 
number of transcripts associated with the stumpy and insect life stages of the 
parasites (Table 5.1) and, most interestingly, that a number of CCCH zinc finger 





(Table 5.3). One of these, ZC3H20, has subsequently been confirmed in vivo as a 
novel regulator of slender to stumpy differentiation (Figure 5.16) and thus validates 
the transcriptome data collected. Our RNAseq dataset is replete with potential 
regulators of slender to stumpy differentiation, such as: two additional CCCH zinc 
finger proteins, ZC3H11 and ZC3H37; a serine/threonine protein kinase, NEK21; an 
RNA binding protein, RBP32; and many more hypothetical proteins that we do not 
yet know the function of. Future analysis will implement the recently described 
CRISPR Cas9 approach (Beneke et al., 2017) to create independent knockout lines 
for the differentially expressed genes of interest and test these for their in vitro and in 
vivo responses to 8-pCPTcAMP and SIF, respectively. 
Although a change in the encoded amino acid sequence of a differentiation 
regulator could underlie the observed changes in gene expression between the 
selected monomorphs and parental pleomorphs, no SNP anywhere within the 
selected monomorph genome could be predicted with high confidence (Table 5.7). 
Experimental evolution under controlled conditions, followed by next-generation re-
sequencing of the whole genome, has been instrumental in determining the mutations 
responsible for a plethora of phenotypes in viral, yeast, bacterial and Drosophila 
melanogaster experimental systems (Long et al., 2015). Though there are less 
examples in the field of parasitology, E&R approaches have been used to 
demonstrate that mdr1 duplication is a contributor to artemisinin combination 
therapy resistance in Plasmodium chabaudi (Rodrigues et al., 2010) and that PBAP2-
G is essential for commitment to gametocytogenesis in Plasmodium berghei (Sinha 
et al., 2014). These E&R studies both share one feature in common- the final selected 
populations were cloned by limiting dilution prior to WGS. In contrast, in this study, 
total population DNA and RNA was isolated from the GFPESproAnTat1.1ES NEK 
RNAi pleomorph and selected monomorph populations (as discussed in Section 5.6). 
We do not know if the final selected monomorph population was clonal or consisted 
of multiple genotypes conferring the same phenotype and therefore this confounds 
our analysis. Whilst the RNAseq data has since been validated in vivo (Figure 5.16), 
the SNP analysis was not able to confidently predict any changes in genome 
sequence. This could simply be because there were none, and the differential gene 





mechanism, or perhaps because the selected monomorph population consisted of 
multiple genotypes. Therefore, before any firm conclusions can be drawn from the 
WGS analysis, I believe that the selected monomorph population should be cloned 
by limiting dilution and multiple clones sent for resequencing of the genome. By 
sequencing clones we can, importantly, ease the analysis of the SNP data, and also 
establish whether monomorphism arose due one or multiple independent mutations 
within the population. It would be interesting to continue the high density in vitro 
passage of the GFPESproAnTat1.1ES HYP2 and DYRK RNAi selected monomorphs 
until their in vivo differentiation phenotype closely matched that of the 
GFPESproAnTat1.1ES NEK RNAi selected monomorphs and then ask by WGS and 
RNAseq if monomorphism had occurred in the same way in all three independent 
lines, or if there were differences between the populations. 
It has long been reported that monomorphic lines of T. brucei switch their 
expressed VSG at a rate significantly lower than that of recently isolated 
pleomorphic trypanosomes. However, in this thesis I have demonstrated by multiple 
approaches that VSG switch frequency and slender to stumpy differentiation capacity 
can be uncoupled, thus showing that monomorphic trypanosomes are capable of 
switching VSG expression at rates comparable to pleomorphic populations. The 
interplay between antigen switching and slender to stumpy differentiation is the 
major parasite intrinsic determinant of bloodstream infection dynamic, chronicity 
and transmissibility (Gjini et al., 2010; MacGregor et al., 2011). Mathematical 
modelling has demonstrated that the production of stumpy forms limits the expressed 
antigen repertoire within the population since stumpy cells are irreversibly 
committed to G0/G1 cell cycle arrest and cannot produce new variants (MacGregor 
et al., 2011). When considering only proliferative slender cells, however, our study 
has demonstrated that there is no direct mechanistic linkage between VSG switch 
frequency and differentiation competence. By being able to individually select for 
each trait, this creates the potential for a multivariate normal distribution of VSG 
switch rate and relative pleomorphism between different trypanosome isolates. This 
could be advantageous for the parasite in different host settings where higher or 
lower antigen switch frequencies could be required to maintain infection chronicity, 





congolense) where the ability to proliferate to higher densities without arresting 
could confer a growth advantage. The ability to uncouple antigen switch rate and 
slender to stumpy differentiation capacity may also have facilitated the emergence of 
trypanosomes such as T. evansi, a monomorphic parasite which is mechanistically 
transmitted by biting and sucking insects, but where the potential for chronic 
infection is maintained through effective antigenic variation. 
Finally, this study has also highlighted the considerable impact of 
experimental design and laboratory-specific cell stocks on calculated VSG switch 
frequency and recommends that a comparison of the of the relative VSG switch rate 
within a given experimental set-up is more informative than a comparison to the 
published absolute VSG switch rates in other studies. This has important 
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Appendix A: Antibody concentrations 













conjugated ⍺-VSG 221 
(Monica Mugnier, USA)
FACS 1:5000
 ⍺-rabbit Cy5 (Jackson 
ImmunoResearch) FACS 1:1000
IFA (PAD1) 1:500
IFA (VSG AnTat1.1) 1:1000
 ⍺-rabbit IRDye® 800CW 
(LI-COR) Western 1:7000
 ⍺-mouse IRDye® 560CW 
(LI-COR) Western 1:5000
Rabbit ⍺-VSG AnTat1.1 
(Jay Bangs, USA)
Mouse ⍺-EF1⍺ (Millipore)








Appendix B: Bioanalyzer profiles of 11 VSGseq 
library preparations 
Libraries were analysed for efficient fragmentation during the tagmentation 
step by in-house providers on an Agilent 2100 Bioanalyzer at Johns Hopkins 
Bloomberg School of Public Health (USA). Typical libraries will consist of a range 
of fragments between 250-1000bp. Sample identities are provided above each profile 






















































LANE 1: HYP2 +DOX3 PRE-MACS LANE 2: HYP2 –DOX1 POST-MACS
LANE 3: HYP2 –DOX2 POST-MACS LANE 4: NEK -DOX1 PRE-MACS







Figure B: The VSGseq library preparations were efficiently fragmented (1) ‘Gel-like’ 
image generated by the bioanalyzer after the electrophoretic separation of the DNA 
LANE 7: DYRK –DOX1 PRE-MACS LANE 8: DYRK –DOX2 PRE-MACS
LANE 9: DYRK –DOX3 PRE-MACS LANE 10: DYRK +DOX1 PRE-MACS





fragments. The purple band represents the high molecular weight marker and the green band 
the low molecular weight marker (2) Fragment sizes plotted for each of the individual library 










Appendix C: Selected monomorphs downregulated 
transcripts 
Table C: The shortlist of 68 transcripts which were significantly downregulated in 
the GFPESproAnTat1.1ES NEK RNAi selected monomorphs compared to the parental 
pleomorphs, in order of most to least downregulated. 
 
GENE 
CODE ANNOTATION LOG2 FC
ADJUSTED P 
VALUE NOTES
LOG2FC IF INCLUDED 
IN INT1 RELATIVE TO 
START DATASET
Tb927.1.5260 Hypothetical protein -1.81 0.0040 GPI-anchor and 2 TM domains predicted. -
Tb927.6.510 GPEET procyclin -1.63 0.0003 Major GPI-anchored surface coat protein in procyclic forms (Bütikofer et al., 1997). -1.39
Tb927.5.4020 Hypothetical protein -1.50 0.0005
Member of cell surface phylome Fam50, clade III (Jackson et al., 2013). 
No transmembrane domain/GPI anchor predicted but has a signal 
peptide. Stabilised by ZC3H20 (Ling et al., 2011). Protein has BLASTP 
similarity to TolA, a bacterial surface transporter.
-1.33
Tb927.7.2660 ZC3H20 -1.41 0.0004
Zinc finger protein. Required for growth of procyclic forms. Binds and 
stabilises at least two developmentally regulated procyclic specific 
RNAs (Ling et al., 2011).
-1.59
Tb927.8.8320 Hypothetical protein, conserved -1.26 0.0012 - -1.15
Tb927.7.5770 PK53 -1.20 0.0079 Nuclear Dbf2 related kinase. Knockdown leads to defect in cytokenesis and kinetoplast duplication/segregation (Jones et al., 2014). -0.92
Tb927.6.810 Hypothetical protein -1.18 0.0229 - -
Tb927.9.7470 TbNT10 -1.06 0.0003 Purine nucleoside transporter (Spoerri et al., 2007). -1.18
Tb927.11.15010 NEK21 -1.00 0.0029 Serine/threonine-protein kinase. Bound by RBP10 (Mugo and Clayton, 2017). -1.16
Tb927.7.5940 Protein Associated with Differentiation 2 (PAD2) -0.97 0.0003 Recieves CCA procyclic differentiation signal (Dean et al., 2009). -0.93
Tb927.10.10260 EP1 procyclin -0.96 0.0056 Major GPI-anchored surface coat protein in procyclic forms (Bütikofer et al., 1997). -0.61
Tb927.5.2260 Hypothetical protein, conserved -0.93 0.0015 Bound by RBP10 (Mugo and Clayton, 2017). META domain. -
Tb927.9.4560 RBP32 -0.92 0.0004 Bound by RBP10 (Mugo and Clayton, 2017). -0.91
Tb927.10.12780 ZC3H37 -0.91 0.0056 Zinc finger protein. Increased blasticidin resistance when tethered to a drug resistance marker (Erben et al., 2014). -1.15
Tb927.7.6330 Hypothetical protein -0.90 0.0020 Bound by RBP10 (Mugo and Clayton, 2017). 4 TM domains predicted. -0.79
Tb927.11.6890 TbPIF1 -0.90 0.0136
DNA repair and recombination helicase protein. Essential for kinetoplast 
minicircle replication (Liu et al., 2010). Bound by RBP10 (Mugo and 
Clayton, 2017).
-1.00
Tb927.10.8730 hypothetical protein, conserved -0.90 0.0036 ABC1 family. -0.94
Tb927.7.6010 Hypothetical protein -0.89 0.0492 - -
Tb927.10.8740 Hypothetical protein -0.88 0.0449 1 TM domain and signal peptide predicted. -
Tb11.v5.0513 Hypothetical protein, conserved -0.83 0.0354 NLI interacting factor-like phosphatase domain -0.86
Tb927.10.15620 Hypothetical protein -0.82 0.0091 3 TM domains and signal peptide predcited. -0.73
Tb927.5.810 ZC3H11 -0.82 0.0154 Zinc finger protein. Binds chaperones required for heat shock response during procyclic differentiation (Droll et al., 2013) -0.90
Tb927.6.860 Hypothetical protein -0.81 0.0033 Bound by RBP10 (Mugo and Clayton, 2017). -0.91
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Tb927.11.16820 Hypothetical protein, conserved -0.80 0.0395 Signal peptide predicted. -
Tb927.11.2410 Hypothetical protein, conserved -0.80 0.0045 Bound by RBP10 (Mugo and Clayton, 2017). BAR/IMD domain-like. -0.79
Tb927.11.8340 Hypothetical protein -0.79 0.0227 3 TMs and signal peptide predicted. -
Tb927.11.810 Hypothetical protein, conserved -0.79 0.0431 TPR-like domain. -
Tb927.4.1000 Hypothetical protein, conserved -0.79 0.0017 Bound by RBP10 (Mugo and Clayton, 2017). -1.05
Tb927.9.11050 4E-interacting protein (4EIP) -0.78 0.0017
Contributes to tranlsation repression during differentiation to stumpy 
form (Terrao et al., 2018). -0.59
Tb927.10.3360 Hypothetical protein, conserved -0.77 0.0011
Active form triggers differentiation to procyclic forms. Glycosomal 
enzyme (Szoor et al., 2010) -0.81
Tb927.10.8050




In yeast and mammals, TFIIF-stimulated CTD phosphatase (FCP1) 
catalyses the dephosphorylation of the CTD of RNApolII (Kobor et al., 
1999). Bound by RBP10 (Mugo and Clayton, 2017).
-0.91
Tb927.10.10770 Generative cell specific 1 (GCS1) protein -0.75 0.0009
In plants, GCS1 localises to PM of generative cells. Essential fertilisation 
factor in angiosperms, required for guidance of sperm cells to ovules 
(Mori et al., 2006; von Besser et al., 2006). Bound by RBP10 (Mugo and 
Clayton, 2017).
-0.66
Tb11.1390 Hypothetical protein, conserved -0.74 0.0227 6 TM domains and signal peptide predicted. -0.60
Tb927.5.2160 Hypothetical protein, conserved -0.74 0.0057 Stabilised by ZC3H20 (Ling et al., 2011). META domain. -0.59
Tb927.7.6300 Hypothetical protein, conserved -0.72 0.0126 Bound by RBP10 (Mugo and Clayton, 2017). WD40 domain. -0.62
Tb927.3.1640 Hypothetical protein -0.71 0.0056 3 TM domains predicted. -0.67
Tb927.11.240 Hypothetical protein, conserved -0.71 0.0012 Signal peptide predicted. -0.49
Tb927.10.5100 Hypothetical protein -0.71 0.0133 3 TM domains predicted. -0.50
Tb927.9.2320 Hypothetical protein, conserved -0.71 0.0016 Bound by RBP10 (Mugo and Clayton, 2017). Methyltransferase domain. -0.60
Tb927.8.4300 Hypothetical protein -0.70 0.0306 Bound by RBP10 (Mugo and Clayton, 2017). 3 TM domains predicted. -
Tb927.10.12060 Hypothetical protein, conserved -0.70 0.0069 Bound by RBP10 (Mugo and Clayton, 2017). F-box domain. -0.61
Tb927.8.5350 Hypothetical protein, conserved -0.69 0.0069 Bound by RBP10 (Mugo and Clayton, 2017). -0.59
Tb927.3.5760 Hypothetical protein, conserved -0.69 0.0009 Signal peptide predicted. -0.81
Tb927.11.6040 Hypothetical protein, conserved -0.67 0.0029 MFS general substrate transporter family -0.76
Tb927.7.5930 Protein Associated with Differentiation 1 (PAD1) -0.67 0.0014 Expressed on surface of stumpy forms (Dean et al., 2009). -0.59
Tb927.11.11560 DNA topoisomerase II, putative -0.66 0.0003 Nuclear. Role in trypanosomes unclear (Kulikowicz and Shapiro, 2006). -0.75
Tb927.3.2920 Hypothetical protein, conserved -0.66 0.0126 Bound by RBP10 (Mugo and Clayton, 2017). -0.59
Tb927.8.5870 Hypothetical protein, conserved -0.65 0.0026 - -0.54
Tb927.7.520 Hypothetical protein, conserved -0.65 0.0075
Bound by RBP10 (Mugo and Clayton, 2017). Cytochrome b5-like 
Heme/Steroid binding domain. -0.59
Tb927.11.14070 Repressor of differentiation kinase 1 (RDK1) -0.65 0.0023
Negative regulator of procyclic differentiation (Jones et al., 2014). 
Bound by RBP10 (Mugo and Clayton, 2017). -0.74
Tb927.6.3880 Hypothetical protein, conserved -0.64 0.0274 Bound by RBP10 (Mugo and Clayton, 2017). -0.72
Tb927.10.3700
Gamma regulatory subunit 
of AMP-activated protein 
kinase (AMPK)
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Tb927.4.2410 Hypothetical protein, conserved -0.64 0.0017
Bound by RBP10 (Mugo and Clayton, 2017). Glycosyl hydrolase family 
65 central catalytic domain. -0.73
Tb927.5.320 Receptor-type adenylate cyclase (GRESAG 4) -0.64 0.0024
Midgut specific adenyl cyclase, marker for late procyclic stage (Imhof et 
al., 2014). Bound by RBP10 (Mugo and Clayton, 2017). -0.57
Tb11.v5.0209 Hypothetical protein, conserved -0.64 0.0043
Adenylate and Guanylate cyclase catalytic domain. Signal peptide 
predicted. -0.56
Tb927.11.2690 Succinyl-CoA:3-ketoacid coenzyme A transferase -0.64 0.0229 Mitochondrial enzyme (Vertommen et al., 2008). -0.80
Tb927.7.6830 Trans-sialidase (putative) -0.64 0.0006 Adenylate and Guanylate cyclase catalytic domain. Signal peptide predicted. -0.50
Tb927.9.5900 Glutamate dehydrogenase -0.63 0.0029 Mitochondrial enzyme (Mantilla et al., 2017). -0.67
Tb927.11.2450 Hypothetical protein -0.62 0.0092 Bound by RBP10 (Mugo and Clayton, 2017). -
Tb927.11.2480 Hypothetical protein -0.62 0.0328 2 TMs predicted. -
Tb927.5.285b ESAG4 -0.62 0.0031 Modulation of the host innate immune response (Salmon et al., 2012). -0.55
Tb11.v5.0217 Receptor-type adenylate cyclase (GRESAG 4) -0.62 0.0037
Midgut specific adenyl cyclase, marker for late procyclic stage (Imhof et 
al., 2014). Stabilised by ZC3H20 (Ling et al., 2011). -0.57
Tb927.1.2200 Zinc finger protein family member, putative -0.62 0.0302 - -
Tb927.9.7540 Calpain-like cysteine peptidase -0.62 0.0024
Calcium-dependant activity. Bound by RBP10 (Mugo and Clayton, 
2017). -0.62
Tb927.10.15610 Zinc finger protein, putative -0.62 0.0299 Bound by RBP10 (Mugo and Clayton, 2017). -0.73
Tb927.11.1830 Hypothetical protein, conserved -0.61 0.0004 6 TMs predicted. Bound by RBP10 (Mugo and Clayton, 2017). -0.51
Tb927.11.13940 Ubiquitin-conjugating enzyme E2, putative -0.61 0.0041
E2 one of three enzymes (E1-3) which bring about polyubiquitination 





Appendix D: Selected monomorphs upregulated 
transcripts 
Table D: The shortlist of 11 transcripts which were significantly upregulated in the 
GFPESproAnTat1.1ES NEK RNAi selected monomorphs compared to the parental 
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Tb927.7.3250 ESAG 6 0.73 0.02766 Transferrin receptor (Steverding et al., 1994). 0.64
Tb927.7.3260 ESAG 7 0.70 0.02192 Transferrin receptor (Steverding et al., 1994). 0.61
Tb927.9.11580 Gim5a 0.59 0.00615
One monomer of the glycosomal 
membrane protein dimer, GIM5 
(Maier et al., 2001).
0.38
Tb927.4.4860 AAT8, putative 0.58 0.00003
Amino acid transporter. 
Downregulated in Repressor of 
Differentiation Kinase 1 (RDK1) 
RNAi screen (Jones et al., 2014).
0.41
Tb927.9.1960 Nitrilase (NIT1), putative 0.57 0.00001
Metabolic repair enzyme. 
Catalyses the hydrolysis of 
deaminated glutathione (Peracchi 
et al., 2017).
0.47
Tb927.11.7700 Hypothetical protein 0.57 0.00020
Potential ortholog of p27 
(mitochondrial membrane protein 
in Leishmania).
0.37
Tb927.8.5460 44 kDa calcimedin, Tb44 0.52 0.00002
Calcium-binding protein which 
localises to the FP. In vivo 
knockdown associated with 
prologation of infection and 
increased survival of mice (Emmer 
et al., 2010).
0.37
Tb927.4.2310 Asparaginyl-tRNA synthetase, putative 0.51 0.00000
Charge tRNAs with asparagine. 
Asparagine plays key role in 
biosynthesis of glycoproteins.
0.21
Tb927.11.5520 Triosephosphate isomerase (TPI or TIM) 0.51 0.00661
















Appendix E: SNPs identified in the selected 
monomorphs’ genome 
Table E: The 82 SNPs which occurred in the assembled selected monomorph 
genome compared to the parental pleomorph genome. The SNPs have been filtered 
to only include those that fall within the coding sequence of a gene which was 
identified as being significantly upregulated or downregulated in the selected 
monomorphs population compared to the parental pleomorph. 
 
 



























Tb11.v5.0513 Hypothetical protein -0.83 G_A
Tb927.5.810 ZC3H11 -0.82 A_G
Tb927.6.860 Hypothetical protein -0.81 T_G
Tb927.11.16820 Hypothetical protein -0.8 A_G







































Tb927.11.6040 Hypothetical protein -0.67 G_A
































































Tb927.4.2310 Asparaginyl-tRNA synthetase 0.51 T_G
AAT8Tb927.4.4860
NIT1Tb927.9.1960
Putatative Zinc finger proteinTb927.10.15610
0.58
0.57
-0.62
